The Scotts Miracle-Gro Company 10-K
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 10-K
|
|
|
(Mark One)
|
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended September 30, 2007
|
OR
|
|
|
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
For the transition period from
to
|
|
|
|
|
|
Commission file number 1-13292
|
The Scotts
Miracle-Gro Company
(Exact name of registrant as
specified in its charter)
|
|
|
Ohio
|
|
31-1414921
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
14111 Scottslawn Road, Marysville, Ohio
|
|
43041
|
|
|
|
(Address of principal executive
offices)
|
|
(Zip Code)
|
Registrants telephone number, including area
code: 937-644-0011
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of Each Class
|
|
Name of Each Exchange On Which Registered
|
|
Common Shares, without par value
|
|
New York Stock Exchange
|
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes þ No o
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(§ 229.405 of this chapter) is not contained herein,
and will not be contained, to the best of registrants
knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer. See definition of accelerated filer and large
accelerated filer in
Rule 12b-2
of the Exchange Act. (Check one):
Large accelerated
filer þ Accelerated
filer o Non-accelerated
filer o
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). Yes o No þ
The aggregate market value of Common Shares (the only common
equity of the registrant) held by non-affiliates of the
registrant computed by reference to the price at which Common
Shares were last sold as of the last business day of the
registrants most recently completed second fiscal quarter
(March 30, 2007) was approximately $1,755,904,160.
Indicate the number of shares outstanding of each of the
registrants classes of common stock, as of the latest
practicable date: The number of Common Shares of the registrant
outstanding as of November 23, 2007 was 64,238,715.
DOCUMENT
INCORPORATED BY REFERENCE:
Portions of the definitive Proxy Statement for
Registrants 2008 Annual Meeting of Shareholders to be held
January 31, 2008, are incorporated by reference into
Part III hereof.
PART I
Company
Description
The Scotts Miracle-Gro Company, an Ohio corporation
(Scotts Miracle-Gro and, together with its
subsidiaries, the Company), traces its roots to two
businesses launched by entrepreneurs. In 1868, Civil War veteran
O.M. Scott launched a seed business in Marysville, Ohio, based
on the conviction that farmers shall have clean, weed-free
fields. Beginning in 1907, the Company expanded its reach
by selling grass seed to consumers and eventually exited the
agricultural market. By 1988 both through innovation
and acquisition the Company had become a leading
marketer of lawn fertilizer, grass seed and growing media
products within the United States.
Separately, Horace Hagedorn and his partner Otto Stern launched
Sterns Miracle-Gro Products, Inc. in 1951 in New York.
Their easy-to-use plant food quickly revolutionized the
gardening category. Through aggressive and innovative marketing,
Miracle-Gro®
eventually became the leading plant food product in the
gardening industry. In 1995, The Scotts Company and Sterns
Miracle-Gro Products, Inc. merged, marking the start of a
significant evolution for the Company.
In the late 1990s, the Company launched a geographic and
category expansion. It acquired companies with industry-leading
brands in France, Germany and the United Kingdom. In fiscal
1999, the Company acquired the
Ortho®
brand in the United States and exclusive rights for the
marketing and distribution of consumer
Roundup®*
brand products within the United States and other specified
countries, thereby adding industry-leading controls to its
portfolio. The Company has rapidly expanded into the lawn care
service industry with the launch of Scotts
LawnService®
in 1998. Since fiscal 2001, the Company has invested nearly
$125 million in the acquisitions of local and regional lawn
care businesses to provide a platform for our rapid expansion
throughout the U.S. In October 2004, the Company entered
the fast growing outdoor living category with the acquisition of
Smith & Hawken, Ltd. The Company entered the North
America wild bird food category in fiscal 2006 with the
acquisition of Gutwein & Co., Inc. and its Morning
Song®
brand of wild bird food.
As the Company celebrates more than 100 years of selling
products to consumers, we own the leading brands in nearly every
category of the lawn and garden industry. A list of some of our
North America leading consumer brands is as follows:
|
|
|
Category
|
|
Brands
|
|
|
Lawns
|
|
Scotts®;
Turf
Builder®
|
Gardens
|
|
Miracle-Gro®;
Osmocote®;
LiquaFeed®
|
Growing Media
|
|
Miracle-Gro®;
Scotts®;
Hyponex®;
Earthgro®;
SuperSoil®
|
Grass Seed
|
|
Scotts®;
Turf
Builder®
|
Controls
|
|
Ortho®;
Bug-B-Gon®;
Weed-B-Gon®;
Roundup®
|
Outdoor Living
|
|
Smith &
Hawken®
|
Wild Bird Food
|
|
Morning
Song®;
Scotts®
|
In addition, we have the following significant brands in Europe:
Miracle-Gro®
plant fertilizers,
Weedol®
and
Pathclear®
herbicides,
EverGreen®
lawn fertilizers and
Levington®
growing media in the United Kingdom;
KB®
and
Fertiligène®
in France;
Celaflor®,
Nexa-Lotte®
and
Substral®
in Germany and Austria; and
ASEF®,
KB®
and
Substral®
in Belgium, the Netherlands and Luxembourg (the Benelux
countries).
Roundup®
is also a significant brand in the United Kingdom, France,
Germany and other European markets.
Business
Segments
For fiscal 2007, we continued to report our business in the
following segments:
* Roundup®
is a registered trademark of Monsanto Technology LLC, a company
affiliated with Monsanto Company.
2
|
|
|
|
|
Scotts
LawnService®;
|
|
|
|
International; and
|
|
|
|
Corporate & Other.
|
These reportable segments are consistent with the Companys
structure and the management of these units. Financial
information about these segments for the three years ended
September 30, 2007 is presented in Note 20 to the
Consolidated Financial Statements included in this Annual Report
on
Form 10-K.
North
America
In our North America segment, the Company manufactures and
markets products that provide easy, reliable and effective
assistance to homeowners who seek to nurture beautiful, weed-
and pest-free lawns, gardens and indoor plants. These products
incorporate many of the best technologies available. In
addition, we manufacture and market a broad line of professional
products designed to meet the specific needs of commercial
nurseries, greenhouses and specialty crop growers in North
America. The North America segment sells products in the
following categories:
Lawns: A
complete line of granular lawn fertilizer and combination
products, including fertilizer and crabgrass control, weed
control or pest control, is sold under the
Scotts®
Turf
Builder®
brand name. The Turf
Builder®
line of products is designed to make it easy for do-it-yourself
consumers to select and properly apply the right product in the
right quantity for their lawns.
Gardens: A
complete line of plant foods is marketed under the
Miracle-Gro®
brand name. In fiscal 2006, we introduced
Miracle-Gro®
LiquaFeed®,
an innovative product that allows consumers to easily feed and
water their outdoor plants simultaneously. In addition to our
high-quality water-soluble plant foods, we have liquid plant
foods, and a continuous-release line of plant foods,
Osmocote®,
for extended feeding and convenience.
Growing
Media: A
complete line of growing media products for indoor and outdoor
uses is marketed under the
Miracle-Gro®,
Scotts®,
Hyponex®,
Earthgro®,
Nature
Scapes®,
and
SuperSoil®
brand names, as well as other labels. These products include
potting mix, garden soils, topsoil, manures, sphagnum peat and
decorative barks and mulches. The addition of the
Miracle-Gro®
brand name and fertilizer to higher quality potting mix and
garden soils has turned previously low-margin commodity products
into value-added category leaders.
Grass
Seed: We
offer a broad line of grass seed products for both the consumer
and the professional user. The fiscal 2006 acquisitions of
certain brands and assets from Turf-Seed, Inc. and Landmark Seed
Company allowed for the integration of these companies
extensive professional grass seed sales and distribution
networks with the Companys existing professional presence
and industry-leading brands in the consumer grass seed market.
Our leading grass seed products are sold under the
Scotts®
Pure
Premium®,
Classic®,
Turf
Builder®
and
PatchMaster®
brand names in the consumer market and the
Scotts®
Turf-Seedtm
and the
Scotts®
Landmarktm
brand names in the
professional market.
Controls: A
broad line of weed control, indoor and outdoor pest control and
plant disease control products is marketed under the
Ortho®
brand name.
Ortho®
products are available in aerosol, ready-to-use liquids,
concentrated, granular and dust forms.
Ortho®
control products include Weed-B-Gon
MAX®,
Bug-B-Gon
MAX®,
Home Defense
MAX®,
Ortho
MAX®,
Brush-B-Gon®,
RosePride®,
Ortho-Klor®
and
Orthene®
Fire Ant Killer.
In fiscal 1999, the Company entered into a long-term marketing
agreement with Monsanto Company (Monsanto) and
became Monsantos exclusive agent for the marketing and
distribution of consumer
Roundup®
non-selective herbicide products in the consumer lawn and garden
market within the United States and other specified countries,
including Australia, Austria, Belgium, Canada, France, Germany,
Holland and the United Kingdom. (See the
Roundup®
Marketing Agreement discussion later in this Item 1
for a more detailed explanation of the Companys agreement
with Monsanto.)
Wild Bird
Food: In
November 2005, the Company acquired Gutwein & Co.,
Inc. (Gutwein). Through its Morning
Song®
brand, Gutwein is a leader in the growing North America wild
bird food category, generating approximately $80.0 million
in annual revenues. Morning
Song®
products are sold at leading mass retailers, grocery, pet and
general merchandise stores. The Company launched a
Scotts®
branded line of wild bird food in fiscal 2007, with higher
quality content and innovative packaging.
3
Other Consumer
Products: The
Company also manufactures and markets several lines of
high-quality lawn spreaders under the
Scotts®
brand name - Deluxe
EdgeGuard®
spreaders,
SpeedyGreen®
rotary spreaders,
AccuGreen®
drop spreaders and Handy
Green®II
handheld spreaders. We sell a line of hose-end applicators for
water-soluble plant foods such as
Miracle-Gro®
products, and lines of applicators under the
Ortho®,
Dial N
Spray®,
and Pull N
Spray®
trademarks for the diluted application of control products sold
in the concentrated form.
The North America segment also includes our North American
Professional, Canadian consumer and Australia consumer and
professional business operations. The North American
Professional business sells professional products to commercial
nurseries, greenhouses and specialty crop growers in North
America, the Caribbean and throughout Latin America, the Far
East, New Zealand and Japan. Our professional products include a
broad line of sophisticated controlled-release fertilizers,
water-soluble fertilizers, pesticide products and wetting agents
that are sold under brand names that include
Banrot®,
Miracle-Gro®,
Osmocote®,
Peters®,
Poly-S®,
Rout®,
ScottKote®,
Sierrablen®,
Shamrock®
and
Sierra®.
In Canada, we believe we are the leading marketer of branded
consumer lawn and garden products. We sell a full range of lawn
and garden fertilizer, control products, grass seed, spreaders,
and value-added growing media products under the
Scotts®,
Turf
Builder®,
Miracle-Gro®,
Killex®,
and
Roundup®
brands.
Scotts
LawnService®
The Scotts
LawnService®
segment provides residential lawn care, lawn aeration, tree and
shrub care and external pest control services in the United
States. These services consist primarily of fertilizer, weed
control, pest control and disease control applications. As of
September 30, 2007, Scotts
LawnService®
had 80 company-operated locations serving 46 metropolitan
markets and 78 independent franchises primarily operating in
secondary markets.
International
The International segment sells consumer lawn and garden
products in more than 25 countries outside of North America. We
also sell a broad line of professional products throughout
Europe to commercial nurseries, greenhouses and specialty
retailers.
International products and brand names vary from country to
country depending upon the brand name strength and the nature of
our strategic relationships in a given country. For example, in
the United Kingdom, we sell
Miracle-Gro®
plant fertilizers and growing media,
Weedol®
and
Pathclear®
herbicides,
EverGreen®
lawn fertilizers and
Levington®
growing media. Our other International brands include
KB®
and
Fertiligène®
in France;
Celaflor®,
Nexa-Lotte®
and
Substral®
in Germany and Austria; and
ASEF®,
KB®
and
Substral®
in the Benelux countries. As noted earlier,
Roundup®
is also a significant brand in Europe.
For information concerning risks attendant to our foreign
operations, please see ITEM 1A. RISK
FACTORS Cautionary Statement on Forward-Looking
Statements Foreign Operations and Currency
Exposures.
Corporate and
Other
The Corporate and Other segment includes Smith &
Hawken®,
a leading brand in the fast growing outdoor living and gardening
lifestyle category. Smith &
Hawken®
products, which include high-end outdoor furniture, pottery,
garden tools, gardening containers and live goods, are sold in
the United States through its 61 retail stores, catalog and
Internet sales, and other trade and wholesale relationships.
Competitive
Marketplace
Our major customers include home improvement centers, mass
merchandisers, warehouse clubs, large hardware chains,
independent hardware stores, nurseries, garden centers, food and
drug stores, commercial nurseries and greenhouses, and specialty
crop growers. Each of our segments participates in markets that
are highly competitive and many of our competitors sell their
products at prices lower than ours. The Company attributes its
market leadership and continued success in the lawn and garden
category to our industry-leading brands, innovative products,
award-winning advertising, supply chain excellence, highly
effective field sales and merchandising organization, and the
strength of our relationships with major retailers in our
product categories.
4
In the North American consumer do-it-yourself lawn and garden
markets and pest control markets, we compete primarily against
control label products as well as branded products.
Control label products are those sold under a
retailer-owned label or a supplier-owned label, which are sold
exclusively at a specific retail chain. The control label
products that we compete with include
Vigoro®
products sold at Home Depot, and
Sta-Green®
products sold at Lowes. Our competitors in branded lawn
and garden products and the consumer pest control markets
include Spectrum Brands, Bayer AG, Central Garden &
Pet Company, Garden Tech, Enforcer Products, Inc., Green Light
Company and Lebanon Chemical Corp.
With respect to growing media products, in addition to
nationally distributed, branded competitive products, we face
competition from regional competitors who compete primarily on
the basis of price for commodity growing media business.
In the North American professional horticulture markets, we face
a broad range of competition from numerous companies such as
Agrium, Haifa Chemicals Ltd., Chisso Asahi Fertilizer Co. Ltd.,
Syngenta, and Bayer AG. Some of these competitors have
significant financial resources and research departments.
We have the second largest market share position in the
U.S. do-it-for-me lawn care service market. We compete
against
TruGreen-ChemLawn®,
a division of ServiceMaster, which has the leading market share
in the U.S. lawn care service market and has a
substantially larger share of this market than Scotts
LawnService®,
as well as numerous regional and local lawn care services
operations.
Internationally, we face strong competition in the consumer
do-it-yourself lawn and garden market, particularly in Europe.
Our competitors in the European Union include Bayer AG,
Kali & Salz (which owns the Compo, Algoflash brands),
Westland and a variety of local companies.
The International professional horticulture markets in which we
compete are also very competitive, particularly the markets for
controlled-release and water-soluble fertilizer products. We
have numerous U.S. and European competitors in these
international markets, including Pursell Industries, Inc., Compo
GmbH, a subsidiary of Kali & Salz, Norsk Hydro ASA,
Haifa Chemicals Ltd. and Kemira Oyj.
Significant
Customers
Approximately 70% of our worldwide net sales in fiscal 2007 were
made by our North America segment. Within the North America
segment, approximately 29% of our net sales in fiscal 2007 were
made to Home Depot, 16% to Lowes and 15% to Wal*Mart. We
face strong competition for the business of these significant
customers. The loss of any of these customers or a substantial
decrease in the volume or profitability of our business with any
of these customers could have a material adverse effect on our
earnings and profits.
Competitive
Strengths
Strong
Brands
By far, the Company considers its industry-leading brands to be
its single largest competitive advantage, though hardly its only
advantage. The Company believes it has the leading market share
in every major U.S. category in which its North American
business competes. The Company also owns many of the leading
brands in the European marketplace.
The Company has helped to build the awareness of its brands
through a continuous increase in its investment in advertising.
As a result, consumer awareness of the Companys key
brands especially in the United States - rivals that
of nearly any other consumer products company. The strength of
the
Scotts®
brand, in particular, has been a critical aspect of the success
of Scotts
LawnService®.
The Company believes it has successfully grown its service
business because of the high level of consumer confidence
associated with the
Scotts®
brand.
Trademarks,
Patents and Licenses
The Company considers its brands, patents and licenses all to be
key competitive advantages. We pursue a vigorous brand
protection strategy consisting of registration and maintenance
of key trademarks and proactive monitoring and enforcement
activities to protect against infringement. The
Scotts®,
Miracle-Gro®,
Ortho®,
Smith &
Hawken®,
Osmocote®,
Hyponex®
and
Earthgro®
brand names and logos, as well as a number of product
trademarks, including Turf
Builder®,
Organic
Choice®,
Home Defense
5
and
Weed-B-Gon®,
are federally
and/or
internationally registered and are considered material to our
business.
As of September 30, 2007, we held 93 issued patents in the
United States covering fertilizer, chemical and growing media
compositions and processes; grass varieties; and mechanical
dispensing devices such as applicators, spreaders and sprayers.
Many of these have similar patents which have also been issued
or are pending internationally, bringing our total worldwide
patent portfolio to 461 United States and International patents
and applications. The issued patents provide protection
generally extending to 20 years from the date of filing,
subject to the payment of applicable governmental maintenance
and annuity fees. Accordingly, many of our patents will extend
well into the next decade.
In addition, we continue to file new patent applications each
year covering new, commercially significant developments
conceived by our R&D associates. Currently, we have 89
pending patent applications worldwide, including 14 pending U.S.
applications, some of which have been allowed for issuance of
patents. We also hold exclusive and non-exclusive patent
licenses and supply arrangements with various active ingredient
and raw material suppliers, permitting the use and sale of
additional patented fertilizers, pesticides and mechanical
devices.
During fiscal 2007, we were granted 2 U.S. and 22 foreign
national patents. Representative of the patent coverage provided
by these new patents are coated fertilizers including granular
water soluble fertilizers and fertilizers that are specifically
formulated to provide delayed-release or triggered-start action
when applied to turf; improved spraying devices and the design
of such spraying devices; new broadcast spreader devices and
coconut coir pith containing growth media products and
processes. We continue to extend patent coverage of our core
technologies to provide protection of our developments
nationally and in additional countries within our Canadian,
European, Asia/Pacific and South American markets.
Four U.S. patents expired in fiscal 2007. These expired
patents covered fertilizer gel compositions; Kentucky Bluegrass
plant varieties; and spreader devices. The loss of these patents
is not expected to materially affect our business.
Supply Chain and
Sales Force
Because the Company sells a substantial majority of its products
to a small number of retail accounts, it is critical to maintain
strong relationships with these partners. We believe our supply
chain and sales force have become major competitive advantages
that have allowed us to build relationships with our key retail
partners that are unrivaled in the industry.
Major investments in technology have allowed the Companys
supply chain to be a more efficient supplier to its key retail
accounts. The Company considers its order fill rate
which measures the accuracy of shipments to be an
important measure of customer service. In fiscal 2007, the
Company achieved a customer service rate of 98.9 percent in
its core North American business, its highest ever.
Additionally, the supply chain has helped the Company to improve
its inventory turns over the past several years, as well as
those of its retail partners.
The Companys nationwide sales force is another major
competitive advantage. By increasing the size of the sales force
over several years, the Company has taken a more proactive role
in helping our retail partners merchandise the lawn and garden
department and maximize the productivity of this space. In
addition to working closely with our retail partners, our sales
force works directly with consumers. By serving as
in-store counselors on weekends, our associates help
consumers answer their lawn and garden questions, which, we
believe, drives higher sales of our products.
Innovation
The Company views its commitment to innovation as a competitive
advantage. Consequently, we continually invest in research and
development and consumer research to improve existing products
and develop new products, manufacturing processes, and packaging
and delivery systems. Spending on research and development was
$38.8 million, $35.1 million and $38.0 million in
fiscal 2007, fiscal 2006, and fiscal 2005, including
registrations of $9.3 million, $8.2 million and
$7.5 million, respectively. The Companys
long-standing commitment to innovation is evidenced by a
portfolio of patents worldwide that supports many of our
fertilizers, grass seeds and application devices. In addition to
the benefits of
6
our own research and development, we benefit from the research
and development activities of our suppliers.
Our research and development worldwide headquarters is located
at the Dwight G. Scott Research Center in Marysville, Ohio. We
also have research and development facilities in the United
Kingdom, France, the Netherlands and Sydney, Australia, as well
as several research field stations located throughout the United
States.
The Companys biotechnology program is evidence of its
commitment to responsible research in search of more effective
and easier-to-use products that are preferred by consumers and
are better for the environment. By employing technology already
proven in agriculture, the Company is working to develop turf
varieties that could one day require less maintenance, less
water and fewer chemical inputs to resist insects, weeds and
disease.
Before a product enhanced with biotechnology may be sold in the
United States, it must be deregulated by appropriate
governmental agencies. Deregulation involves compliance with the
rules and regulations of, and cooperation with, the United
States Department of Agriculture (the USDA), Animal
and Plant Health Inspection Service, the United States
Environmental Protection Agency (the U.S. EPA)
and/or the
Food and Drug Administration (the FDA). As part of
the deregulation process for any product enhanced with
biotechnology, we are required to present evidence to the USDA
in the form of scientifically rigorous studies showing that the
product poses no additional toxicological or ecological risk
than products of the same species that have not been enhanced
with biotechnology. We are also required to satisfy other
agencies, such as the U.S. EPA and the FDA, as to their
appropriate areas of regulatory authority. This process
typically takes years to complete and also includes at least two
opportunities for public comment. Therefore, any enhanced
product for which we seek commercialization through submission
of a petition for deregulation will be subjected to rigorous and
thorough governmental regulatory review.
We submitted a petition for deregulation of a non-residential
turfgrass product enhanced with biotechnology to the USDA on
April 14, 2003. This turfgrass has been shown, through our
research trials, to provide simple, more flexible and better
weed control for golf courses in a manner we believe is more
environmentally friendly. The USDA has a variety of options in
adjudicating a petition to deregulate a
biotechnology-derived plant product. The USDA has decided to
employ the formal Environmental Impact Statement
(EIS) process to judge the acceptability of our
petition for deregulation. We welcome this process as the most
thorough evaluative step available to the USDA. However, there
can be no assurance our petition for deregulation of this
product will be approved, or if approved and commercially
introduced, this product will generate any revenues or
contribute to our earnings.
Roundup®
Marketing Agreement
The Company is Monsantos exclusive agent for the marketing
and distribution of consumer
Roundup®
products (with additional rights to new products containing
glyphosate or other similar non-selective herbicides) in the
consumer lawn and garden market within the United States and
other specified countries, including Australia, Austria,
Belgium, Canada, France, Germany, Holland and the United
Kingdom. Under the Marketing Agreement, we and Monsanto are
jointly responsible for developing global consumer and trade
marketing programs for consumer
Roundup®.
We have assumed responsibility for sales support, merchandising,
distribution and logistics for consumer
Roundup®.
Monsanto continues to own the consumer
Roundup®
business and provides significant oversight of its brand. In
addition, Monsanto continues to own and operate the agricultural
Roundup®
business.
We are compensated under the Marketing Agreement based on the
success of the consumer
Roundup®
business in the markets covered by the agreement. We receive a
graduated commission to the extent that the earnings before
interest and taxes of the consumer
Roundup®
business in the included markets exceed specified thresholds.
Regardless of these earnings, we are required to make an annual
contribution payment against the overall expenses of the
consumer
Roundup®
business. The minimum annual contribution payment is
$20 million until 2018 or the earlier termination of the
agreement.
The gross commission earned under the Marketing Agreement, the
contribution payments to Monsanto and the amortization of the
initial marketing fee paid to Monsanto are included in net sales
in the Companys Consolidated Statements of Operations. For
fiscal 2007 and fiscal 2006, the net amount earned under the
Marketing Agreement was income of $41.9 million and
$39.9 million, respectively. For
7
fiscal 2005, an expense of $5.3 million (including a
$45.7 million charge for contribution payments previously
deferred) was recognized. For further details, see Note 4
to the Consolidated Financial Statements included in this Annual
Report on
Form 10-K.
The Marketing Agreement has no definite term, except as it
relates to the European Union countries where the term extends
through September 30, 2008. The parties may agree to renew
the agreement with respect to the European Union countries for
two successive terms ending on September 30, 2015 and 2018,
with a separate determination being made by the parties at least
six months prior to the expiration of each such term as to
whether to commence a subsequent renewal term. However, if
Monsanto does not agree to either of the remaining renewal terms
with respect to the European Union countries, the commission
structure will be renegotiated within the terms of the Marketing
Agreement.
Monsanto has the right to terminate the Marketing Agreement upon
certain specified events of default by us, including an uncured
material breach, material fraud, material misconduct or
egregious injury to the
Roundup®
brand. Monsanto also has the right to terminate the Marketing
Agreement upon a change of control of Monsanto or the sale of
the consumer
Roundup®
business. In addition, Monsanto may terminate the Marketing
Agreement within specified regions, including North America, for
specified declines in the consumer
Roundup®
business.
The Company has rights similar to Monsantos to terminate
the Marketing Agreement upon an uncured material breach,
material fraud or material willful misconduct by Monsanto. In
addition, we may terminate the Marketing Agreement upon
Monsantos sale of the consumer
Roundup®
business or in certain other circumstances, in which case we
would not be able to collect the termination fee described below.
If Monsanto terminates the Marketing Agreement upon a change of
control of Monsanto or the sale of the consumer
Roundup®
business prior to September 30, 2008, we will be entitled
to a termination fee in excess of $100 million. If we
terminate the Marketing Agreement upon an uncured material
breach, material fraud or material willful misconduct by
Monsanto, we will be entitled to receive a termination fee in
excess of $100 million if the termination occurs prior to
September 30, 2008. The termination fee declines over time
from in excess of $100 million to a minimum of
$16 million for terminations between September 30,
2008 and September 30, 2018.
Monsanto has agreed to provide us with notice of any proposed
sale of the consumer
Roundup®
business, allow us to participate in the sale process and
negotiate in good faith with us with respect to a sale. In the
event we acquire the consumer
Roundup®
business in such a sale, we would receive credit against the
purchase price in the amount of the termination fee that would
otherwise have been paid to us upon termination by Monsanto of
the Marketing Agreement upon the sale. If Monsanto decides to
sell the consumer
Roundup®
business to another party, we must let Monsanto know whether we
intend to terminate the Marketing Agreement and forfeit any
right to a termination fee or whether we will agree to continue
to perform under the Marketing Agreement on behalf of the
purchaser, unless and until the purchaser terminates our
services and pays any applicable termination fee.
Strategic
Initiatives
The Company has developed a strategic plan that focuses its
efforts and capitalizes on its strengths to further own the
relationship with its consumers and distance itself from the
competition. The execution of this strategy will sustain future
growth and further secure the Companys franchise. The
critical elements of this strategy are as follows.
Leveraging our
core strengths and competitive advantages in the United
States
As stated previously, the Company has succeeded, in large
degree, due to our ability to leverage our competitive
advantages, including our world-class supply chain,
industry-leading brands and our commitment to innovation. The
opportunity to further build upon these strengths is a major
focus of the Company and will be key to driving continued growth
and financial improvement.
Specifically, the Company is investing behind a key initiative
to further improve upon its technologies and processes with the
goals of enabling increased supply chain synergies and creating
global shared services that result in lower selling, general,
and administrative costs. In addition to this effort, the
Company is currently exploring other supply chain initiatives
designed to lower our cost structure without compromising our
commitment to quality. For example, the Company will launch a
pilot
8
program in fiscal 2008 to explore the economic viability of
regional manufacturing and distribution of lawn fertilizer.
In addition, the Company intends to increase its investment in
its sales force, an area that is also considered to be a key
competitive advantage. The Companys interaction with its
major retail partners is a key reason for its success. In fact,
several of the Companys largest retail partners have
awarded us with vendor of the year or similar honors
over the past several years. In addition to working closely with
retailers, the sales force also provides the Company an
opportunity to interact with consumers on a 1-to-1 basis in
stores. Our in-store counseling program, which is utilized
during the peak of the lawn and garden season, provides the
Company with a critical advantage by helping consumers. Of
course, the Company also uses other means to build upon its
relationships with consumers. To that end, in fiscal 2008, the
Company intends to launch a state-of-the-art website that will
improve our ability to communicate with consumers while also
creating an online experience that allows them to speak with
each other in public chat rooms, message boards and blogs. In
addition to the website, the Company plans to increase its
investment in promotions, cross-branding and other key marketing
initiatives in fiscal 2008.
Research and development initiatives also will be increasingly
focused on helping to create a more positive experience for
consumers who use our products. Over the years, we have a proven
track record of growing our business by providing consumers with
value-added products that make success in the lawn or garden
easier to attain. Looking ahead, we are focused on developing
even more products that are easier to buy, easier to use and
easier to store. Our commitment to environmental stewardship
also will become increasingly evident in products currently
under development or being considered.
Strengthening our
International Business
We continue to believe in the long-term growth potential of our
International business. In order to maximize shareholder value
in this business, we have sharpened our focus by:
(i) reducing costs in the business to improve profitability
and to allow for marketing investments; (ii) aligning the
organization by category rather than by geography to better
leverage our knowledge of the marketplace and the consumer; and
(iii) better leveraging the Companys innovation
competencies. We plan to achieve these goals through a variety
of initiatives, including reducing the complexity of the
business and the product portfolio, improving supply chain
efficiency and effectiveness, and aggressively pursuing new
business opportunities. As part of a broader corporate
initiative, we will invest to improve our technology platform in
the International business, which we believe will continue to
reduce costs while allowing us to continue improving our
customer service levels.
Expanding Scotts
LawnService®
The number of lawn owners who want to maintain their lawns and
gardens but do not want to do it themselves represents a
significant portion of the total market. We recognize that our
portfolio of well-known brands provides us with a unique ability
to extend our business into lawn and garden services and the
strength of our brands provides us with a competitive advantage
in acquiring new customers. We have spent the past several years
developing our Scotts
LawnService®
business model. The business has grown significantly from
revenues of $41.2 million in fiscal 2001 to revenues of
$230.5 million in fiscal 2007. This growth has come from
geographic expansion, acquisitions and organic growth fueled by
our direct marketing programs. We invested $22.5 million in
lawn service acquisitions in fiscal 2007. We anticipate
continuing to make selective acquisitions in fiscal 2008 and
beyond. Ongoing investments will continue to be made in the
Scotts
LawnService®
business infrastructure in order to continually improve our
customer service throughout the organization and leverage scale
economies as we continue to grow.
Seasonality and
Backlog
Our business is highly seasonal with 70% to 75% of our annual
net sales occurring in our combined second and third fiscal
quarters.
Consistent with prior years, we anticipate significant orders
for the upcoming spring season will start to be received late in
the winter and continue through the spring season. Historically,
substantially all orders are received and shipped within the
same fiscal year with minimal carryover of open orders at the
end of the fiscal year.
9
Raw
Materials
We purchase raw materials for our products from various sources
that we presently consider to be adequate, and no one source is
considered essential to any of our segments or to our business
as a whole. We are subject to market risk from fluctuating
market prices of certain raw materials including urea, resins,
grass seed, and wild bird food components. Our objectives
surrounding the procurement of these materials are to ensure
continuous supply and to minimize costs. We seek to achieve
these objectives through negotiation of contracts with favorable
terms directly with vendors. When appropriate, we will procure a
certain percentage of our needs in advance of the season to
secure pre-determined prices. Occasionally, we hedge certain
commodities to improve predictability and control costs.
Manufacturing and
Distribution
We manufacture products for our North American consumer business
at our facilities in Marysville, Ohio, Ft. Madison, Iowa
and Temecula, California, as well as at a number of third party
contract packers in the United States and Canada. In addition,
the Company manufactures growing media products in 27 regional
facilities located throughout North America. The primary
distribution centers for our North American consumer business
are managed by the Company and strategically placed across the
United States.
We also manufacture horticultural products for our North America
and International professional businesses at a leased fertilizer
manufacturing facility in Charleston, South Carolina and a
Company-owned site in Heerlen, the Netherlands. The remaining
products for our professional businesses are produced at other
Company-owned facilities and subcontractors in the United States
and Europe. The majority of shipments to customers are made via
common carriers or through distributors in the United States and
a network of public warehouses and distributors in Europe. We
are subject to market risk from fluctuating market prices of
diesel, which our common carriers pass on to the Company in the
form of fuel surcharges. When appropriate, the Company will
hedge a portion of these indirect fuel costs to improve
predictability and control costs.
We manufacture the non-growing media products for our
International business at our facilities in Howden, the United
Kingdom and Bourth, France. We also utilize a number of third
party contract packers. The primary distribution centers for our
International businesses are located in the United Kingdom,
France and Germany and are managed by a logistics provider.
The growing media products for our International segment are
produced at our facilities in Hatfield, the United Kingdom and
Hautmont, France and at a number of third party contract
packers. Growing media products are generally shipped direct
without passing through a distribution center.
Employees
As of September 30, 2007, we employed 5,081 full-time
employees in the United States and an additional
1,039 full-time employees located outside the United
States. During peak sales and production periods, we utilize
seasonal and temporary labor.
None of our U.S. employees are members of a union.
Approximately 45 of our full-time U.K. employees are members of
the Transport and General Workers Union and have full collective
bargaining rights. An undisclosed number of our full-time
employees at our office in Ecully, France are members of the
Confederation Francaise Democratique du Travail and
Confederation Generale du Travail, participation in which is
confidential under French law. In addition, a number of union
and non-union full-time employees are members of works councils
at three sites in Bourth, Hautmont and Ecully, France, and a
number of non-union employees are members of works councils in
Ingelheim, Germany. In the Waardenburg office and in the Heerlen
Plant in the Netherlands, approximately 120 employees are
members of a workers union, but we are not responsible for
collective bargaining negotiations with this union. In the
Netherlands, we are governed by the Works Councils Act with
respect to the union. Works councils represent employees on
labor and employment matters and manage social benefits.
We believe we have good relationships with our employees in the
United States, and both unionized and non-unionized
International employees.
10
Environmental and
Regulatory Considerations
Local, state, federal and foreign laws and regulations relating
to environmental matters affect us in several ways. In the
United States, all products containing pesticides must be
registered with the U.S. EPA (and similar state agencies)
before they can be sold. The inability to obtain or the
cancellation of any such registration could have an adverse
effect on our business, the severity of which would depend on
the products involved, whether another product could be
substituted and whether our competitors were similarly affected.
We attempt to anticipate regulatory developments and maintain
registrations of, and access to, substitute active ingredients,
but there can be no assurance that we will continue to be able
to avoid or minimize these risks. Fertilizer and growing media
products are also subject to state and foreign labeling
regulations. Our manufacturing operations are subject to waste,
water and air quality permitting and other regulatory
requirements of federal and state agencies.
The Food Quality Protection Act, enacted by the
U.S. Congress in August 1996, establishes a standard for
food-use pesticides, which standard is the reasonable certainty
that no harm will result from the cumulative effects of
pesticide exposures. Under this Act, the U.S. EPA is
evaluating the cumulative risks from dietary and non-dietary
exposures to pesticides. The pesticides in our products, certain
of which may be used on crops processed into various food
products, are typically manufactured by independent third
parties and continue to be evaluated by the U.S. EPA as
part of this exposure risk assessment. The U.S. EPA or the
third party registrant may decide that a pesticide we use in our
products will be limited or made unavailable to us. We cannot
predict the outcome or the severity of the effect of these
continuing evaluations.
In addition, the use of certain pesticide and fertilizer
products is regulated by various local, state, federal and
foreign environmental and public health agencies. These
regulations may include requirements that only certified or
professional users apply the product or that certain products be
used only on certain types of locations (such as not for
use on sod farms or golf courses), may require users to
post notices on properties to which products have been or will
be applied, may require notification to individuals in the
vicinity that products will be applied in the future or may ban
the use of certain ingredients. We believe we are operating in
substantial compliance with, or taking action aimed at ensuring
compliance with, these laws and regulations.
State and federal authorities generally require growing media
facilities to obtain permits (sometimes on an annual basis) in
order to harvest peat and to discharge storm water run-off or
water pumped from peat deposits. The state permits typically
specify the condition in which the property must be left after
the peat is fully harvested, with the residual use typically
being natural wetland habitats combined with open water areas.
We are generally required by these permits to limit our
harvesting and to restore the property consistent with the
intended residual use. In some locations, these facilities have
been required to create water retention ponds to control the
sediment content of discharged water.
Regulatory
Actions
In 1997, the Ohio Environmental Protection Agency (the
Ohio EPA) initiated an enforcement action against us
with respect to alleged surface water violations and inadequate
wastewater treatment capabilities at our Marysville, Ohio
facility and seeking corrective action under the federal
Resource Conservation and Recovery Act. The action related to
discharges from
on-site
waste water treatment and several discontinued
on-site
disposal areas, which date back to the early operations of the
Marysville facility that we had already been assessing and, in
some cases, remediating, on a voluntary basis. We are
remediating the Marysville site under the terms of a judicial
consent order under the oversight of the Ohio EPA.
We completed negotiations with the Philadelphia District of the
U.S. Army Corps of Engineers regarding the terms of site
remediation and the resolution of the Corps civil penalty
demand in connection with our prior peat harvesting operations
at our Lafayette, New Jersey facility. A final consent decree
was entered into on October 18, 2004 that required us to
perform five years of wetland monitoring, and the completion of
additional actions if after five years, the monitoring indicates
the wetlands have not developed satisfactorily.
At September 30, 2007, $4.6 million was accrued for
the environmental and regulatory matters described herein, the
majority of which is for site remediation. Most of the costs
accrued as of September 30, 2007 are expected to be paid in
fiscal 2008; however, payments could be made for a period
thereafter.
11
We believe the amounts accrued as of September 30, 2007 are
adequate to cover our known environmental exposures based on
current facts and estimates of likely outcome. However, the
adequacy of these accruals is based on several significant
assumptions, including the following:
|
|
|
|
|
that we have identified all of the significant sites that must
be remediated;
|
|
|
|
that there are no significant conditions of potential
contamination that are unknown to us; and
|
|
|
|
that with respect to the agreed judicial consent order in Ohio,
the potentially contaminated soil can be remediated in place
rather than having to be removed and only specific stream
segments will require remediation as opposed to the entire
stream.
|
If there is a significant change in the facts and circumstances
surrounding these assumptions, it could have a material impact
on the ultimate outcome of these matters and our results of
operations, financial position and cash flows.
During fiscal 2007, fiscal 2006 and fiscal 2005, we expensed
approximately $1.5 million, $2.4 million, and
$3.7 million for environmental matters. There were no
material capital expenditures during the last three fiscal years
related to environmental or regulatory matters.
General
Information
The Company maintains a website at http://investor.scotts.com
(this uniform resource locator, or URL, is an inactive textual
reference only and is not intended to incorporate our website
into this
Form 10-K).
We file reports with the Securities and Exchange Commission (the
SEC) and make available, free of charge, on or
through our website, our annual reports on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K,
and amendments to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as well as our proxy and information statements, as soon
as reasonably practicable after we electronically file such
material with, or furnish it to, the SEC.
On March 18, 2005, we consummated the restructuring of our
corporate structure into a holding company structure by merging
The Scotts Company (Scotts) which had been the
public company, into a newly-created, wholly-owned,
second-tier Ohio limited liability company, The Scotts
Company LLC (Scotts LLC), pursuant to the Agreement
and Plan of Merger, dated as of December 13, 2004 (the
Merger Agreement), among Scotts, Scotts LLC and
Scotts Miracle-Gro. As a result of this restructuring merger,
each of Scotts common shares issued and outstanding
immediately prior to the consummation of the restructuring
merger was automatically converted into one fully paid and
nonassessable common share of Scotts Miracle-Gro. Scotts
Miracle-Gro became the public company successor to Scotts and
Scotts LLC a direct, wholly-owned subsidiary of Scotts
Miracle-Gro. The restructuring merger did not affect the new
parent holding companys management, corporate governance
or capital stock structure. In addition, the consolidated assets
and liabilities of Scotts Miracle-Gro and its subsidiaries
(including Scotts LLC) immediately after the restructuring
merger were the same as the consolidated assets and liabilities
of Scotts and its subsidiaries immediately before the
restructuring merger.
Financial
Information About Geographic Areas
For certain information concerning our International revenues
and long-lived assets, see ITEM 7. MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS and Note 20 to the Consolidated Financial
Statements included in this Annual Report on
Form 10-K.
Cautionary
Statement on Forward-Looking Statements
We have made and will make forward-looking
statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934 in our 2007 Annual Report, in this Annual
Report on
Form 10-K
and in other contexts relating to future growth and
profitability targets and strategies designed to increase total
shareholder value. Forward-looking statements also include, but
are not limited to, information regarding our future economic
and financial condition, the plans and objectives of our
management and our assumptions regarding our performance and
these plans and objectives.
12
The Private Securities Litigation Reform Act of 1995 provides a
safe harbor for forward-looking statements to
encourage companies to provide prospective information, so long
as those statements are identified as forward-looking and are
accompanied by meaningful cautionary statements identifying
important factors that could cause actual results to differ
materially from those discussed in the forward-looking
statements. We desire to take advantage of the safe
harbor provisions of that Act.
Some forward-looking statements that we make in our 2007 Annual
Report, in this Annual Report on
Form 10-K
and in other contexts represent challenging goals for our
Company, and the achievement of these goals is subject to a
variety of risks and assumptions and numerous factors beyond our
control. Important factors that could cause actual results to
differ materially from the forward-looking statements we make
are described below. All forward-looking statements attributable
to us or persons working on our behalf are expressly qualified
in their entirety by the following cautionary statements.
Commodity Cost
Pressures
Our ability to manage our cost structure can be adversely
affected by movements in commodity and other raw material
prices, such as those experienced in fiscal 2007. Market
conditions may limit the Companys ability to raise selling
prices to offset increases in our input and distribution costs.
The uniqueness of our technologies can limit our ability to
locate or utilize alternative inputs for certain products. For
certain inputs, new sources of supply may have to be qualified
under regulatory standards, which can require additional
investment and delay bringing a product to market.
Competition
Each of our segments participates in markets that are highly
competitive. Many of our competitors sell their products at
prices lower than ours. The most price sensitive segment of our
category may be more likely to trade down to lower price point
products in a more challenging economic environment. We compete
primarily on the basis of product innovation, product quality,
product performance, value, brand strength, supply chain
competency, field sales support and advertising. Some of our
competitors have significant financial resources. The strong
competition that we face in all of our markets may prevent us
from achieving our revenue goals, which may have a material
adverse affect on our financial condition and results of
operations.
Environmental/Socio-Political
Local, state, federal and foreign laws and regulations relating
to environmental matters affect us in several ways. In the
United States, all products containing pesticides must be
registered with the U.S. EPA (and similar state agencies)
before they can be sold. The inability to obtain or the
cancellation of any such registration could have an adverse
effect on our business, the severity of which would depend on
the products involved, whether another product could be
substituted and whether our competitors were similarly affected.
We attempt to anticipate regulatory developments and maintain
registrations of, and access to, substitute active ingredients,
but there can be no assurance that we will continue to be able
to avoid or minimize these risks.
The Food Quality Protection Act, enacted by the
U.S. Congress in August 1996, establishes a standard for
food-use pesticides, which standard is the reasonable certainty
that no harm will result from the cumulative effects of
pesticide exposures. Under this Act, the U.S. EPA is
evaluating the cumulative risks from dietary and non-dietary
exposures to pesticides. The pesticides in our products, certain
of which may be used on crops processed into various food
products, are typically manufactured by independent third
parties and continue to be evaluated by the U.S. EPA as
part of this exposure risk assessment. The U.S. EPA or the
third party registrant may decide that a pesticide we use in our
products will be limited or made unavailable to us. For example,
in December 2000, the U.S. EPA reached agreement with
various parties, including manufacturers of the active
ingredient diazinon, regarding a phased withdrawal from
retailers by December 2004 of residential uses of products
containing diazinon, also used in our lawn and garden products.
We cannot predict the outcome or the severity of the effect of
their continuing evaluations.
In addition, the use of certain pesticide and fertilizer
products is regulated by various local, state, federal and
foreign environmental and public health agencies. These
regulations may include requirements that only certified or
professional users apply the product or that certain products be
used only on certain types of locations, may require users to
post notices on properties to which products have
13
been or will be applied, may require notification to individuals
in the vicinity that products will be applied in the future or
may ban the use of certain ingredients. Even if we are able to
comply with all such regulations and obtain all necessary
registrations, we cannot assure you that our products,
particularly pesticide products, will not cause injury to the
environment or to people under all circumstances. The costs of
compliance, remediation or products liability have adversely
affected operating results in the past and could materially
affect future quarterly or annual operating results.
Perceptions that the products we produce and market are not safe
could adversely affect us and contribute to the risk we will be
subjected to legal action. We manufacture and market a number of
complex chemical products, such as fertilizers, growing media,
herbicides and pesticides. On occasion, allegations are made
that some of our products have failed to perform up to
expectations or have caused damage or injury to individuals or
property. Based on reports of contamination at a third party
suppliers vermiculite mine, the public may perceive that
some of our products manufactured in the past using vermiculite
are or may be contaminated. Public perception that our products
are not safe, whether justified or not, could impair our
reputation, involve us in litigation, damage our brand names and
have a material adverse affect on our business.
The harvesting of peat for our growing media business has come
under increasing regulatory and environmental scrutiny. In the
United States, state regulations frequently require us to limit
our harvesting and to restore the property to an
agreed-upon
condition. In some locations, we have been required to create
water retention ponds to control the sediment content of
discharged water. In the United Kingdom, our peat extraction
efforts are also the subject of legislation.
In addition to the regulations already described, local, state,
federal and foreign agencies regulate the disposal, handling and
storage of waste, air and water discharges from our facilities.
The adequacy of our current environmental reserves and future
provisions is based on our operating in substantial compliance
with applicable environmental and public health laws and
regulations and several significant assumptions:
|
|
|
|
|
that we have identified all of the significant sites that must
be remediated;
|
|
|
|
that there are no significant conditions of potential
contamination that are unknown to us; and
|
|
|
|
that with respect to the agreed judicial consent order in Ohio
relating to the remediation of the Marysville site, the
potentially contaminated soil can be remediated in place rather
than having to be removed and only specific stream segments will
require remediation as opposed to the entire stream.
|
If there is a significant change in the facts and circumstances
surrounding these assumptions or if we are found not to be in
substantial compliance with applicable environmental and public
health laws and regulations, it could have a material impact on
future environmental capital expenditures and other
environmental expenses and our results of operations, financial
position and cash flows.
Manufacturing
We use a combination of internal and outsourced facilities to
manufacture our products. We are subject to the inherent risks
in such activities, including product quality, safety, licensing
requirements and other regulatory issues, environmental events,
loss or impairment of key manufacturing sites, disruptions in
logistics, labor disputes and industrial accidents. Furthermore,
we are subject to natural disasters and other factors over which
the Company has no control.
Customer
Concentration
In the North America segment, net sales represented
approximately 70% of our worldwide net sales in fiscal 2007. Our
top three North American retail customers together accounted for
60% of our North America segment fiscal 2007 net sales and
60% of our outstanding accounts receivable as of
September 30, 2007. Home Depot, Lowes and Wal*Mart
represented approximately 29%, 16% and 15%, respectively, of our
fiscal 2007 North America net sales. The loss of, or reduction
in orders from, Home Depot, Lowes, Wal*Mart or any other
significant customer could have a material adverse effect on our
business and our financial results, as could customer disputes
regarding shipments, fees, merchandise condition or related
matters. Our inability to collect accounts receivable from any
of these customers could also have a material adverse affect on
our financial condition and results of operations.
14
We do not have long-term sales agreements or other contractual
assurances as to future sales to any of our major retail
customers. In addition, continued consolidation in the retail
industry has resulted in an increasingly concentrated retail
base. To the extent such concentration continues to occur, our
net sales and income from operations may be increasingly
sensitive to deterioration in the financial condition of, or
other adverse developments involving our relationship with, one
or more customers.
Weather and
Seasonality
Weather conditions in North America and Europe can have a
significant impact on the timing of sales in the spring selling
season and overall annual sales. An abnormally wet
and/or cold
spring throughout North America or Europe could adversely affect
both fertilizer and pesticide sales and, therefore, our
financial results. Because our products are used primarily in
the spring and summer, our business is highly seasonal. For the
past three fiscal years, 70% to 75% of our annual net sales have
occurred in the second and third fiscal quarters combined. Our
working capital needs and borrowings typically peak during the
initial weeks of our third fiscal quarter because we are
incurring expenditures in preparation for the spring selling
season while the majority of our revenue collections occur later
in our third fiscal quarter. If cash on hand is insufficient to
pay our obligations as they come due, including interest
payments or operating expenses, at a time when we are unable to
draw on our credit facilities, this seasonality could have a
material adverse effect on our ability to conduct our business.
Adverse weather conditions could heighten this risk.
Debt
We have a significant amount of debt that could adversely affect
our financial health and prevent us from fulfilling our
obligations. Our substantial indebtedness could have important
consequences. For example, it could:
|
|
|
|
|
make it more difficult for us to satisfy our obligations under
outstanding indebtedness;
|
|
|
|
increase our vulnerability to general adverse economic and
industry conditions;
|
|
|
|
require us to dedicate a substantial portion of cash flows from
operating activities to payments on our indebtedness, which
would reduce the cash flows available to fund working capital,
capital expenditures, advertising, research and development
efforts and other general corporate requirements;
|
|
|
|
limit our flexibility in planning for, or reacting to, changes
in our business and the industry in which we operate;
|
|
|
|
place us at a competitive disadvantage compared to our
competitors that have less debt;
|
|
|
|
limit our ability to borrow additional funds; and
|
|
|
|
expose us to risks inherent in interest rate fluctuations
because some of our borrowings are at variable rates of
interest, which could result in higher interest expense in the
event of increases in interest rates.
|
Our ability to make payments and to refinance our indebtedness,
to fund planned capital expenditures and acquisitions, and to
pay dividends will depend on our ability to generate cash in the
future. This, to some extent, is subject to general economic,
financial, competitive, legislative, regulatory and other
factors that are beyond our control.
We cannot provide assurance that our business will generate
sufficient cash flow from operating activities or that future
borrowings will be available to us under our credit facilities
in amounts sufficient to enable us to pay our indebtedness or to
fund our other liquidity needs. We may need to refinance all or
a portion of our indebtedness, on or before maturity. We cannot
assure you that we would be able to refinance any of our
indebtedness on commercially reasonable terms or at all.
Our credit facilities contain restrictive covenants and cross
default provisions that require us to maintain specified
financial ratios. Our ability to satisfy those financial ratios
can be affected by events beyond our control, and we cannot be
assured we will satisfy those ratios. A breach of any of these
financial ratio covenants or other covenants could result in a
default. Upon the occurrence of an event of default, the lenders
could elect to declare the applicable outstanding indebtedness
due immediately
15
and payable and terminate all commitments to extend further
credit. We cannot be sure that our lenders would waive a default
or that we could pay the indebtedness in full if it were
accelerated.
Foreign
Operations and Currency Exposures
We currently operate manufacturing, sales and service facilities
outside of the United States, particularly in Canada, France,
the United Kingdom, Germany and the Netherlands. In fiscal 2007,
International net sales, including Canada, accounted for
approximately 21% of our total net sales. Accordingly, we are
subject to risks associated with operations in foreign
countries, including:
|
|
|
|
|
fluctuations in currency exchange rates;
|
|
|
|
limitations on the remittance of dividends and other payments by
foreign subsidiaries;
|
|
|
|
additional costs of compliance with local regulations; and
|
|
|
|
historically, in certain countries, higher rates of inflation
than in the United States.
|
In addition, our operations outside the United States are
subject to the risk of new and different legal and regulatory
requirements in local jurisdictions, potential difficulties in
staffing and managing local operations and potentially adverse
tax consequences. The costs related to our International and
Canadian operations could adversely affect our operations and
financial results in the future.
Acquisitions
From time to time we make strategic acquisitions, including the
October 2004 acquisition of Smith &
Hawken®,
the October 2005 acquisition of Rod McLellan Company (RMC), the
November 2005 acquisition of Gutwein (Morning
Song®),
the May 2006 acquisition of certain assets of Turf-Seed, Inc.
and the June 2006 acquisition of certain assets of Landmark Seed
Company. Acquisitions have inherent risks, such as obtaining
necessary regulatory approvals, retaining key personnel,
integration of the acquired business, and achievement of planned
synergies and projections. We have approximately
$880 million of goodwill and intangible assets as of
September 30, 2007, primarily related to prior
acquisitions. Uncertainty regarding the future performance of
the acquired businesses also results in the risk of future
impairment charges related to the associated goodwill and
intangible assets, such as the impairment charge recorded in
fiscal 2007 relating to our investment in Smith &
Hawken®.
Significant
Agreement
If we were to commit a serious default under the Marketing
Agreement with Monsanto for consumer
Roundup®
products, Monsanto may have the right to terminate the Marketing
Agreement. If Monsanto were to terminate the Marketing Agreement
for cause, we would not be entitled to any termination fee, and
we would lose all, or a significant portion, of the significant
source of earnings and overhead expense absorption the Marketing
Agreement provides. Monsanto may also be able to terminate the
Marketing Agreement within a given region, including North
America, without paying us a termination fee if sales to
consumers in that region decline: (1) over a cumulative
three fiscal year period; or (2) by more than 5% for each
of two consecutive years.
Equity Ownership
Concentration
Hagedorn Partnership, L.P. beneficially owned approximately 32%
of our outstanding common shares as of November 23, 2007,
and has sufficient voting power to significantly influence the
election of directors and the approval of other actions
requiring the approval of our shareholders.
|
|
ITEM 1B.
|
UNRESOLVED
STAFF COMMENTS
|
None
We lease land from the Union County Community Improvement
Corporation in Marysville, Ohio for our headquarters and for our
research and development facilities. We own property in
Marysville, Ohio for our manufacturing and distribution
facilities. Combined, these facilities are situated on
approximately 750 acres of land.
16
The North America segment owns two additional research
facilities located in Apopka, Florida; and Gervais, Oregon. We
own a production facility, which encompasses 27 acres, in
Fort Madison, Iowa and lease a spreader and other durable
components manufacturing facility in Temecula, California. We
also lease a controlled-release fertilizer manufacturing
facility in Charleston, South Carolina. We operate
27 growing media facilities in North America 22
of which are owned by us and 5 of which are leased. Most of our
growing media facilities include production lines, warehouses,
offices and field processing areas. We lease sales offices in
Atlanta, Georgia; Mooresville, North Carolina; Rolling Meadows,
Illinois; and Bentonville, Arkansas. We also lease a facility in
Mississauga, Ontario that serves as the headquarters for our
Canadian subsidiary. We own 6 seed production facilities; one
for grass seed in Albany, Oregon and 5 for wild bird food in
Indiana, South Dakota, South Carolina and Texas.
Scotts
LawnService®
conducts its company-owned operations from 78 leased facilities,
primarily office/warehouse units in industrial/office parks,
across the United States serving 46 metropolitan markets.
Smith &
Hawken®
operates 61 retail stores, which are all leased facilities
primarily in shopping centers across the United States. It
leases its main headquarters in Novato, California.
The International segment leases its U.K. office, located in
Godalming (Surrey); its French headquarters and local operations
office, located in Ecully (Lyon); a German office, located in
Ingelheim; an Austrian office, located in Salzburg; an
Australian office, located in Baulkan Hills (New South Wales); a
Belgium sales office, located in Sint Niklaas; and a Netherlands
office for its professional business, located in Waardenburg. We
own manufacturing facilities in Howden, Hatfield (East
Yorkshire) and Sutton Bridge, in the United Kingdom. We also own
a blending and bagging facility for growing media in Hautmont,
France; and a plant in Bourth, France, that we use for
formulating, blending and packaging control products for the
consumer market. Our site in Heerlen, the Netherlands includes a
research facility, a distribution center and a manufacturing
site for coated fertilizers for the consumer and professional
markets. We own the land and the building for the manufacturing
facility, but lease the distribution center building. We lease a
research and development facility in Chazay, France. In the
United Kingdom, we own a research and development facility in
Levington and we lease a research and development facility in
Bramford.
We lease warehouse space throughout North America and
continental Europe as needed.
We believe that our facilities are adequate to serve their
intended purposes at this time and that our property leasing
arrangements are satisfactory.
|
|
ITEM 3.
|
LEGAL
PROCEEDINGS
|
As noted in the discussion in
ITEM 1. BUSINESS Environmental and
Regulatory Considerations and ITEM 1.
BUSINESS Regulatory Actions, we are involved
in several pending environmental matters. We believe that our
assessment of contingencies is reasonable and that related
reserves, in the aggregate, are adequate; however, there can be
no assurance that the final resolution of these matters will not
have a material adverse affect on our results of operations,
financial position and cash flows.
Pending significant legal proceedings are as follows:
U.S.
Horticultural Supply, Inc. (F/K/A E.C. Geiger, Inc.)
On November 5, 2004, U.S. Horticultural Supply, Inc.
(Geiger) filed suit against the Company in the
U.S. District Court for the Eastern District of
Pennsylvania. This complaint alleges that the Company conspired
with another distributor, Griffin Greenhouse Supplies, Inc., to
restrain trade in the horticultural products market, in
violation of Section 1 of the Sherman Antitrust Act. On
June 2, 2006, the Court denied the Companys motion to
dismiss the complaint. Fact discovery ended on March 8,
2007. The Company is currently engaged in expert discovery, the
deadline for completion of which is December 7, 2007.
Geigers damages expert quantifies Geigers alleged
damages at approximately $3.3 million, which could be
trebled under the antitrust laws. The deadline for dispositive
motions is January 17, 2008.
The Company continues to vigorously defend against Geigers
claims. The Company believes that Geigers claims are
without merit and that the likelihood of an unfavorable outcome
is remote. Therefore, no accrual has been established related to
this matter. However, the Company cannot predict the ultimate
outcome with certainty. If the above action is determined
adversely to the Company, the result could have a material
adverse effect on the Companys results of operations,
financial position and cash
17
flows. The Company had previously sued and obtained a judgment
against Geiger on April 25, 2005, based on Geigers
default on obligations to the Company, and the Company is
proceeding to collect that judgment.
The Scotts
Company LLC v. Liberty Mutual Insurance Company
On October 25, 2006, Scotts LLC (as sucessor to Scotts)
sued Liberty Mutual Insurance Company (Liberty
Mutual) in the U.S. District Court for the Southern
District of Ohio. In the suit, Scotts LLC seeks damages and the
rescission of a 2000 agreement between Scotts and Liberty Mutual
that purports to be a complete buyout by Scotts of any insurance
policies that Liberty Mutual might have issued to Scotts (the
2000 Agreement).
As alleged in Scotts LLCs complaint, in 1998, Scotts
tendered certain claims to Liberty Mutual, one of its
primary-layer insurers, in connection with costs incurred by
Scotts for environmental liabilities. Scotts believed that it
had coverage from Liberty Mutual for at least 10 years
beginning in 1958 but could only locate a single policy from
1967. Liberty Mutual responded to Scotts tender by stating
that, after conducting an internal search, Liberty Mutual did
not have sufficient evidence to establish that it had ever
insured Scotts before 1967. Based on Liberty Mutuals
representations and Scotts inability to locate any
additional Liberty Mutual policies in Scotts own files,
Scotts eventually entered into the 2000 Agreement. According to
Scotts LLCs complaint, in Fall 2006, Scotts LLC discovered
evidence confirming that, contrary to Scotts
representations during the negotiations leading to the 2000
Agreement, Liberty Mutual provided liability insurance to Scotts
beginning in at least 1958 and, in fact, paid claims to third
parties on Scotts behalf during that period.
The complaint seeks rescission of the 2000 Agreement and seeks
damages based on Liberty Mutuals breach of fiduciary duty,
fraud, breach of the implied covenant of good faith and fair
dealing, and bad faith denial of coverage. Scotts LLC intends to
prosecute these claims vigorously. Liberty Mutual has filed an
answer that denies the complaints allegations. Discovery
recently began in the case and the Court has not set a trial
date.
Other
The Company has been named a defendant in a number of cases
alleging injuries that the lawsuits claim resulted from exposure
to asbestos-containing products, apparently based on the
Companys historic use of vermiculite in certain of its
products. The complaints in these cases are not specific about
the plaintiffs contacts with the Company or its products.
The Company in each case is one of numerous defendants and none
of the claims seeks damages from the Company alone. The Company
believes that the claims against it are without merit and is
vigorously defending them. It is not currently possible to
reasonably estimate a probable loss, if any, associated with the
cases and, accordingly, no accrual or reserves have been
recorded in the Companys consolidated financial
statements. There can be no assurance that these cases, whether
as a result of adverse outcomes or as a result of significant
defense costs, will not have a material adverse effect on the
Companys financial condition, results of operations or
cash flows.
The Company is reviewing agreements and policies that may
provide insurance coverage or indemnity as to these claims and
is pursuing coverage under some of these agreements and
policies, although there can be no assurance of the results of
these efforts.
On April 27, 2007, the Company received a proposed Order On
Consent from the New York State Department of Environmental
Conservation (the Proposed Order) alleging that
during the calendar year 2003, the Company and James Hagedorn,
individually and as Chairman of the Board and the Chief
Executive Officer of the Company, unlawfully donated to a Port
Washington, New York youth sports organization forty bags of
Scotts®
LawnPro Annual Program Step 3 Insect Control Plus Fertilizer
which, while federally registered, was allegedly not registered
in the state of New York. The Proposed Order requests penalties
totaling $695,000. The Company has made its position clear to
the New York State Department of Environmental Conservation and
is awaiting a response.
On November 26, 2007, the United States Department of
Agriculture issued an administrative complaint alleging that
Scotts LLC had violated the Plant Protection Act and the
regulations promulgated thereunder, related to the testing of
genetically-modified Glyphosate-tolerant creeping bentgrass.
Without admitting or denying that it violated the law, on
November 26, 2007, Scotts LLC entered into a Consent
Decision and Order with the USDA resolving this matter. The
Company has agreed to pay a civil penalty of $500,000, which had
previously been accrued, and conduct three public workshops.
18
We are involved in other lawsuits and claims which arise in the
normal course of our business. In our opinion, these claims
individually and in the aggregate are not expected to result in
a material adverse effect on our results of operations,
financial position or cash flows.
|
|
ITEM 4.
|
SUBMISSION OF
MATTERS TO A VOTE OF SECURITY HOLDERS
|
There were no matters submitted to a vote of the security
holders of The Scotts Miracle-Gro Company during the fourth
quarter of fiscal 2007.
SUPPLEMENTAL
ITEM. EXECUTIVE OFFICERS OF THE REGISTRANT
The executive officers of The Scotts Miracle-Gro Company, their
positions and, as of November 23, 2007 their ages and years
with The Scotts Miracle-Gro Company (and its predecessors) are
set forth below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years with
|
Name
|
|
Age
|
|
Position(s) Held
|
|
Company
|
|
|
James Hagedorn
|
|
|
52
|
|
|
President, Chief Executive Officer and Chairman of the Board
|
|
|
20
|
|
David C. Evans
|
|
|
44
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
14
|
|
Denise S. Stump
|
|
|
53
|
|
|
Executive Vice President, Global Human Resources
|
|
|
7
|
|
Barry W. Sanders
|
|
|
43
|
|
|
Executive Vice President, North America
|
|
|
6
|
|
Claude Lopez
|
|
|
46
|
|
|
Executive Vice President, International and Chief Marketing
Officer
|
|
|
6
|
|
Executive officers serve at the discretion of the Board of
Directors and pursuant to employment agreements or other
arrangements.
The business experience of each of the individuals listed above
during at least the past five years is as follows:
Mr. Hagedorn has been serving as the Chairman of the Board
of the Company since January 2003; as Chief Executive Officer of
the Company since May 2001 and as President of the Company since
November 2006 and from May 2001 until December 2005. The Scotts
Miracle-Gro Company became the public company successor to The
Scotts Company which was merged into The Scotts Company LLC in
March 2005. He also serves as a director for Farms For City Kids
Foundation, Inc., Nurse Family Partnership, The CDC Foundation,
Embry Riddle/Aeronautical University, Northshore University
Hospital (New York), Scotts Miracle-Gro Foundation and the
Intrepid Sea-Air-Space Museum, all charitable organizations.
Mr. Hagedorn is the brother of Katherine Hagedorn
Littlefield, a director of The Scotts Miracle-Gro Company.
Mr. Evans was named Executive Vice President and Chief
Financial Officer of The Scotts Miracle-Gro Company on
September 14, 2006. From October 2005 to September 2006, he
served as Senior Vice President, Finance and Global Shared
Services of The Scotts Company LLC. From October 2003 to March
2005, he served as Senior Vice President, North America of The
Scotts Company and from March 2005 to September 2005, he served
in the same capacity for The Scotts Company LLC following the
merger of The Scotts Company into The Scotts Company LLC. From
June 2001 to September 2003, he served as Vice President,
Finance, North America Sales of The Scotts Company.
Ms. Stump was named Executive Vice President, Global Human
Resources of The Scotts Miracle-Gro Company in March 2005.
Ms. Stump was named Executive Vice President, Global Human
Resources of The Scotts Company in February 2003, which was
merged into The Scotts Company LLC in March 2005. She was named
Senior Vice President, Global Human Resources of The Scotts
Company in October 2002. From July 2001 until October 2002,
Ms. Stump served as Vice President, Human Resources North
America, of The Scotts Company. From September 2000 until July
2001, Ms. Stump served as Vice President, Human Resources
Technology and Operations, of The Scotts Company.
Mr. Sanders was named Executive Vice President, North
America of The Scotts Miracle-Gro Company in September 2007.
From January 25, 2005 until September 2007, he served as
Executive Vice President
19
of Global Technologies and Operations of the Scotts Miracle-Gro
Company, responsible for the Companys supply chain,
information systems as well as research and development efforts.
He previously led the North American and global supply chain
organizations as well as the North American sales force. In
2005, he ran the Smith &
Hawken®
business on an interim basis. Prior to joining the Company in
2001, he was a partner with CapGemini/Ernst & Young.
Mr. Lopez was named Executive Vice President, International
and Chief Marketing Officer of The Scotts Miracle-Gro Company in
October 2007. Mr. Lopez leads marketing for all global
consumer-facing business. He also has leadership responsibility
for the Companys Global Professional and Pro Seed
businesses. In September 2007, he was named Senior Vice
President, International and Chief Marketing Officer of The
Scotts Miracle-Gro Company. From December 2004 until September
2007, Mr. Lopez served as Senior Vice President,
International of The Scotts Miracle-Gro Company. From the time
Mr. Lopez joined the Company in 2001 until December 2004,
he served as general manager of the Companys French
business.
20
PART II
|
|
ITEM 5.
|
MARKET FOR
REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND
ISSUER PURCHASES OF EQUITY SECURITIES
|
The common shares of The Scotts
Miracle-Gro
Company (Scotts
Miracle-Gro)
trade on the New York Stock Exchange under the symbol
SMG. The quarterly high and low closing prices,
which have not been adjusted for the special one-time cash
dividend of $8.00 per share described below, for the fiscal
years ended September 30, 2007 and 2006 were as follows:
|
|
|
|
|
|
|
|
|
|
|
Sale Prices
|
|
|
|
High
|
|
|
Low
|
|
|
|
|
FISCAL 2007
|
|
|
|
|
|
|
|
|
First quarter
|
|
$
|
54.72
|
|
|
$
|
44.02
|
|
Second quarter
|
|
$
|
57.45
|
|
|
$
|
40.57
|
|
Third quarter
|
|
$
|
47.30
|
|
|
$
|
42.80
|
|
Fourth quarter
|
|
$
|
49.69
|
|
|
$
|
40.60
|
|
FISCAL 2006
|
|
|
|
|
|
|
|
|
First quarter
|
|
$
|
48.11
|
|
|
$
|
41.37
|
|
Second quarter
|
|
$
|
50.47
|
|
|
$
|
44.94
|
|
Third quarter
|
|
$
|
47.50
|
|
|
$
|
39.40
|
|
Fourth quarter
|
|
$
|
44.98
|
|
|
$
|
37.22
|
|
On June 22, 2005, Scotts Miracle-Gro announced that its
Board of Directors had approved the establishment of a quarterly
cash dividend. The $0.50 per share (adjusted for the
2-for-1
stock split distributed November 9, 2005) annual
dividend has been paid in quarterly increments since the fourth
quarter of fiscal 2005. In addition, the Company paid a special
one-time cash dividend of $8.00 per share on March 5, 2007.
The payment of future dividends, if any, on the common shares
will be determined by the Board of Directors of Scotts
Miracle-Gro in light of conditions then existing, including the
Companys earnings, financial condition and capital
requirements, restrictions in financing agreements, business
conditions and other factors. Future dividend payments are
currently restricted to $55 million annually under our
existing credit facilities. See discussion regarding the
recapitalization plan executed in the second quarter of fiscal
2007 in ITEM 7. MANAGEMENTS DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Note 10 to the Consolidated Financial Statements included
in this Annual Report on
10-K
provides further discussion regarding the restrictions on
dividend payments.
As of November 19, 2007, there were approximately
37,000 shareholders including holders of record and our
estimate of beneficial holders.
There were no purchases of common shares of Scotts Miracle-Gro
made by or on behalf of Scotts Miracle-Gro or any
affiliated purchaser of Scotts Miracle-Gro as
defined in
Rule 10b-18(a)(3)
under the Securities Exchange Act of 1934 for each of the three
months in the quarter ended September 30, 2007.
Scotts Miracle-Gro has recently determined that during a period
between October, 2006 and November 14, 2007, the trustee of
the Smith & Hawken 401(k) Plan purchased for the
Smith & Hawken 401(k) Plan 649 common shares of
Scotts Miracle-Gro which were not registered in accordance with
the Securities Act of 1933, as amended (the Securities
Act). Although all purchases made by the trustee of the
Smith & Hawken 401(k) Plan for the Smith &
Hawken 401(k) Plan were made in the open market and in a manner
consistent with the Smith & Hawken 401(k) Plan and the
investment elections of the Smith & Hawken 401(k) Plan
participants, because the common shares of Scotts Miracle-Gro
purchased by the Smith & Hawken 401(k) Plan trustee
for the Smith & Hawken 401(k) Plan were not
registered, the Smith & Hawken 401(k) Plan
participants may have a right to rescind their purchases made
through the Smith & Hawken 401(k) Plan. Scotts
Miracle-Gro believes that damages resulting from successful
claims against Scotts Miracle-Gro for its failure to register
the Scotts Miracle-Gro common shares that were purchased through
the Smith & Hawken 401(k) Plan would have a negligible
effect on Scotts Miracle-Gro. At this time, Scotts Miracle-Gro
does not intend to make a rescission offer to participants in
the Smith & Hawken 401(k) Plan.
21
|
|
ITEM 6.
|
SELECTED
FINANCIAL DATA
|
Five-Year
Summary(1)
For the fiscal year ended September 30,
(in millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006(2)
|
|
|
2005(2)
|
|
|
2004
|
|
|
2003
|
|
|
|
|
|
|
|
OPERATING RESULTS(3):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
2,871.8
|
|
|
$
|
2,697.1
|
|
|
$
|
2,369.3
|
|
|
$
|
2,106.5
|
|
|
$
|
1,941.6
|
|
|
|
|
|
Gross profit
|
|
|
1,004.5
|
|
|
|
955.9
|
|
|
|
860.4
|
|
|
|
792.4
|
|
|
|
701.7
|
|
|
|
|
|
Income from operations
|
|
|
277.1
|
|
|
|
252.5
|
|
|
|
200.9
|
|
|
|
252.8
|
|
|
|
231.6
|
|
|
|
|
|
Income from continuing operations (net of tax)
|
|
|
113.4
|
|
|
|
132.7
|
|
|
|
100.4
|
|
|
|
100.5
|
|
|
|
103.2
|
|
|
|
|
|
Net income
|
|
|
113.4
|
|
|
|
132.7
|
|
|
|
100.6
|
|
|
|
100.9
|
|
|
|
103.8
|
|
|
|
|
|
Depreciation and amortization
|
|
|
67.5
|
|
|
|
67.0
|
|
|
|
67.2
|
|
|
|
57.7
|
|
|
|
52.2
|
|
|
|
|
|
FINANCIAL POSITION:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital
|
|
|
412.7
|
|
|
|
445.8
|
|
|
|
301.6
|
|
|
|
396.7
|
|
|
|
364.4
|
|
|
|
|
|
Current ratio
|
|
|
1.7
|
|
|
|
1.9
|
|
|
|
1.6
|
|
|
|
1.9
|
|
|
|
1.8
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
365.9
|
|
|
|
367.6
|
|
|
|
337.0
|
|
|
|
328.0
|
|
|
|
338.2
|
|
|
|
|
|
Total assets
|
|
|
2,277.2
|
|
|
|
2,217.6
|
|
|
|
2,018.9
|
|
|
|
2,047.8
|
|
|
|
2,030.3
|
|
|
|
|
|
Total debt to total book capitalization(4)
|
|
|
70.0
|
%
|
|
|
30.8
|
%
|
|
|
27.7
|
%
|
|
|
41.9
|
%
|
|
|
51.0
|
%
|
|
|
|
|
Total debt
|
|
|
1,117.8
|
|
|
|
481.2
|
|
|
|
393.5
|
|
|
|
630.6
|
|
|
|
757.6
|
|
|
|
|
|
Total shareholders equity
|
|
|
479.3
|
|
|
|
1,081.7
|
|
|
|
1,026.2
|
|
|
|
874.6
|
|
|
|
728.2
|
|
|
|
|
|
CASH FLOWS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
246.6
|
|
|
|
182.4
|
|
|
|
226.7
|
|
|
|
214.2
|
|
|
|
216.1
|
|
|
|
|
|
Investments in property, plant and equipment
|
|
|
54.0
|
|
|
|
57.0
|
|
|
|
40.4
|
|
|
|
35.1
|
|
|
|
51.8
|
|
|
|
|
|
Investments in acquisitions, including seller note payments
|
|
|
21.4
|
|
|
|
122.9
|
|
|
|
84.6
|
|
|
|
20.5
|
|
|
|
57.1
|
|
|
|
|
|
PER SHARE DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share
|
|
$
|
1.74
|
|
|
$
|
1.97
|
|
|
$
|
1.51
|
|
|
$
|
1.56
|
|
|
$
|
1.68
|
|
|
|
|
|
Diluted earnings per common share
|
|
|
1.69
|
|
|
|
1.91
|
|
|
|
1.47
|
|
|
|
1.52
|
|
|
|
1.62
|
|
|
|
|
|
Total cash dividends paid
|
|
|
543.6
|
|
|
|
33.5
|
|
|
|
8.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Regular cash dividends per share(5)
|
|
$
|
0.50
|
|
|
$
|
0.50
|
|
|
$
|
0.125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special cash dividend per share(6)
|
|
|
8.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock price at year-end(6)
|
|
|
42.75
|
|
|
|
44.49
|
|
|
|
43.97
|
|
|
|
32.08
|
|
|
|
27.35
|
|
|
|
|
|
Stock price range High(6)
|
|
|
57.45
|
|
|
|
50.47
|
|
|
|
43.97
|
|
|
|
34.28
|
|
|
|
28.85
|
|
|
|
|
|
Stock price range Low(6)
|
|
|
40.57
|
|
|
|
37.22
|
|
|
|
30.95
|
|
|
|
27.63
|
|
|
|
21.77
|
|
|
|
|
|
OTHER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA(7)
|
|
|
382.6
|
|
|
|
385.9
|
|
|
|
291.5
|
|
|
|
310.5
|
|
|
|
283.8
|
|
|
|
|
|
Interest coverage (Adjusted EBITDA/interest expense)(7)
|
|
|
5.4
|
|
|
|
9.7
|
|
|
|
7.0
|
|
|
|
6.4
|
|
|
|
4.1
|
|
|
|
|
|
Weighted average common shares outstanding
|
|
|
65.2
|
|
|
|
67.5
|
|
|
|
66.8
|
|
|
|
64.7
|
|
|
|
61.8
|
|
|
|
|
|
Common shares and dilutive potential common shares used in
diluted EPS calculation
|
|
|
67.0
|
|
|
|
69.4
|
|
|
|
68.6
|
|
|
|
66.6
|
|
|
|
64.3
|
|
|
|
|
|
|
|
|
(1) |
|
All common share and per share information presented in the
above five-year summary have been adjusted to reflect the
2-for-1
stock split of the common shares which was distributed on
November 9, 2005 to shareholders of record on
November 2, 2005. |
|
(2) |
|
Fiscal 2006 includes Rod McLellan Company, Gutwein &
Co., Inc. and certain brands and assets acquired from Turf-Seed,
Inc. and Landmark Seed Company from the dates of acquisition.
Fiscal 2005 includes Smith &
Hawken®
from the October 2, 2004 date of acquisition. See further |
22
|
|
|
|
|
discussion of acquisitions in Note 7 to the Consolidated
Financial Statements included in this Annual Report on
Form 10-K. |
|
|
|
(3) |
|
Operating results includes the following items segregated by
accounts impacted on the Consolidated Statements of Operations
included with the Consolidated Financial Statements included in
this Annual Report on
Form 10-K. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Fiscal Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
|
|
Net sales includes the following relating to the
Roundup®
Marketing Agreement:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net commission income (expense)
|
|
$
|
41.9
|
|
|
$
|
39.9
|
|
|
$
|
(5.3
|
)
|
|
$
|
28.5
|
|
|
$
|
17.6
|
|
Reimbursements associated with the
Roundup®
Marketing Agreement
|
|
|
47.7
|
|
|
|
37.6
|
|
|
|
40.7
|
|
|
|
40.1
|
|
|
|
36.3
|
|
Deferred contribution charge (see Note 4 to the
Consolidated Financial Statements included in this Annual Report
on
Form 10-K)
|
|
|
|
|
|
|
|
|
|
|
(45.7
|
)
|
|
|
|
|
|
|
|
|
Cost of sales includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs associated with the
Roundup®
Marketing Agreement
|
|
|
47.7
|
|
|
|
37.6
|
|
|
|
40.7
|
|
|
|
40.1
|
|
|
|
36.3
|
|
Restructuring and other charges (income)
|
|
|
|
|
|
|
0.1
|
|
|
|
(0.3
|
)
|
|
|
0.6
|
|
|
|
9.1
|
|
Selling, general and administrative includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring and other charges
|
|
|
2.7
|
|
|
|
9.3
|
|
|
|
9.8
|
|
|
|
9.1
|
|
|
|
8.0
|
|
Impairment charges
|
|
|
35.3
|
|
|
|
66.4
|
|
|
|
23.4
|
|
|
|
|
|
|
|
|
|
Interest expense includes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs related to refinancings
|
|
|
18.3
|
|
|
|
|
|
|
|
1.3
|
|
|
|
45.5
|
|
|
|
|
|
|
|
|
(4) |
|
The total debt to total book capitalization percentage is
calculated by dividing total debt by total debt and
shareholders equity. |
|
(5) |
|
The Company began paying a quarterly dividend of 12.5 cents per
share in the fourth quarter of fiscal 2005. |
|
(6) |
|
The Company paid a special one-time cash dividend of $8.00 per
share on March 5, 2007. Stock prices have not been adjusted
for this special one-time cash dividend. |
|
(7) |
|
Given our significant borrowings, we view our credit facilities
as material to our ability to fund operations, particularly in
light of our seasonality. Reference should be made to
ITEM 1A. RISK FACTORS, in this Annual Report on
Form 10-K
for a more complete discussion of risks associated with the
Companys debt and our credit facilities and related
covenants. Our ability to generate cash flows sufficient to
cover our debt service costs is essential to our ability to
maintain our borrowing capacity. We believe that Adjusted EBITDA
provides additional information for determining our ability to
meet debt service requirements. The presentation of Adjusted
EBITDA herein is intended to be consistent with the calculation
of that measure as required by our borrowing arrangements, and
used to calculate a leverage ratio (maximum of 4.75 at
September 30, 2007) and an interest coverage ratio
(minimum of 2.75 for the year ended September 30, 2007).
The Companys leverage ratio was 3.56 at September 30,
2007 and our interest coverage ratio was 5.4 for the year ended
September 30, 2007. |
|
|
|
In accordance with the terms of our credit facilities, Adjusted
EBITDA is defined as net income before interest, taxes,
depreciation and amortization, as well as certain other items
such as the impact of discontinued operations, the cumulative
effect of changes in accounting, costs associated with debt
refinancings, and other non-recurring, non-cash items effecting
net income. Adjusted EBITDA does not represent and should not be
considered as an alternative to net income or cash flow from
operations as determined by accounting principles generally
accepted in the United States of America, and Adjusted EBITDA
does not necessarily indicate whether cash flow will be
sufficient to meet cash requirements. Interest coverage is
calculated as Adjusted EBITDA divided by interest expense
excluding costs related to refinancings. |
23
A numeric reconciliation of net income to Adjusted EBITDA is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
|
|
Net income
|
|
$
|
113.4
|
|
|
$
|
132.7
|
|
|
$
|
100.6
|
|
|
$
|
100.9
|
|
|
$
|
103.8
|
|
Interest
|
|
|
70.7
|
|
|
|
39.6
|
|
|
|
41.5
|
|
|
|
48.8
|
|
|
|
69.2
|
|
Income taxes
|
|
|
74.7
|
|
|
|
80.2
|
|
|
|
57.7
|
|
|
|
58.0
|
|
|
|
59.2
|
|
Deprecation and amortization
|
|
|
67.5
|
|
|
|
67.0
|
|
|
|
67.2
|
|
|
|
57.7
|
|
|
|
52.2
|
|
Impairment, restructuring and other charges
|
|
|
38.0
|
|
|
|
66.4
|
|
|
|
23.4
|
|
|
|
|
|
|
|
|
|
Discontinued operations
|
|
|
|
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
(0.4
|
)
|
|
|
(0.6
|
)
|
Costs related to refinancings
|
|
|
18.3
|
|
|
|
|
|
|
|
1.3
|
|
|
|
45.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
|
|
$
|
382.6
|
|
|
$
|
385.9
|
|
|
$
|
291.5
|
|
|
$
|
310.5
|
|
|
$
|
283.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ITEM 7.
|
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
The purpose of this discussion is to provide an understanding of
the financial results and condition of The Scotts Miracle-Gro
Company (Scotts Miracle-Gro) and its subsidiaries
(collectively, the Company) by focusing on
changes in certain key measures from year to year.
Managements Discussion and Analysis
(MD&A) is organized in the following sections:
|
|
|
|
|
Executive summary
|
|
|
|
Results of operations
|
|
|
|
Managements outlook
|
|
|
|
Liquidity and capital resources
|
|
|
|
Critical accounting policies and estimates
|
Executive
Summary
We are dedicated to delivering strong, consistent financial
results and outstanding shareholder returns by providing
consumers with products of superior quality and value to enhance
their outdoor living environments. We are a leading manufacturer
and marketer of consumer branded products for lawn and garden
care and professional horticulture in North America and Europe.
We are Monsantos exclusive agent for the marketing and
distribution of consumer
Roundup®
non-selective herbicide products within the United States and
other contractually specified countries. We entered the North
America wild bird food category with the acquisition of
Gutwein & Co., Inc. (Gutwein) in November
2005, and the outdoor living category with the acquisition of
Smith &
Hawken®
in October 2004. We have a presence in Australia, the Far East,
Latin America and South America. Also, in the United States, we
operate the second largest residential lawn service business,
Scotts
LawnService®.
In fiscal 2007, our operations continued to be divided into the
following reportable segments: North America, Scotts
LawnService®,
International, and Corporate & Other. The
Corporate & Other segment consists of the
Smith &
Hawken®
business and unallocated corporate general and administrative
expenses.
As a leading consumer branded lawn and garden company, we focus
our consumer marketing efforts, including advertising and
consumer research, on creating consumer demand to pull products
through the retail distribution channels. In the past three
years, we have spent approximately 5% of our net sales annually
on media advertising to support and promote our products and
brands. We have applied this consumer marketing focus for a
number of years, and believe that we receive a significant
return on these marketing expenditures. We expect continued
focus on consumer oriented marketing with additional targeted
investments in consumer marketing expenditures to continue
driving market share and sales growth.
Weather conditions can have an impact on our sales. For
instance, periods of wet weather can adversely impact sales of
certain products, while increasing demand for other products.
During fiscal 2007, our sales were adversely impacted by cold
weather during the critical April selling period in North
America and by an abnormally dry summer in the southeast United
States. We believe that our past acquisitions have somewhat
diversified both our product line risk and geographic risk to
weather conditions.
24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of Net Sales
|
|
|
|
by Quarter
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
First Quarter
|
|
|
9.5
|
%
|
|
|
9.3
|
%
|
|
|
10.4
|
%
|
Second Quarter
|
|
|
34.6
|
%
|
|
|
33.6
|
%
|
|
|
34.3
|
%
|
Third Quarter
|
|
|
38.2
|
%
|
|
|
38.9
|
%
|
|
|
38.0
|
%
|
Fourth Quarter
|
|
|
17.7
|
%
|
|
|
18.2
|
%
|
|
|
17.3
|
%
|
Due to the nature of our lawn and garden business, significant
portions of our shipments occur in the second and third fiscal
quarters. Retailers continue to place reliance on our ability to
deliver products in season when consumer demand is
the highest in order to help mitigate the need to carry large
seasonal inventories.
Management focuses on a variety of key indicators and operating
metrics to monitor the health and performance of our business.
These metrics include consumer purchases (point-of-sale data),
category growth, market share, net sales (including volume,
pricing and foreign exchange), gross profit margin rates, income
from operations, net income and earnings per share. To the
extent applicable, these measures are evaluated with and without
impairment, restructuring and other charges. We also focus on
measures to optimize cash flow and return on invested capital,
including the management of working capital and capital
expenditures.
Our consumer International business was a strength during fiscal
2007 with improved performance in every major market. Over the
past several years, we have reorganized and rationalized our
European supply chain and increased sales force productivity.
Current efforts are focused on improving our competitive
position, continuing to reduce supply chain and SG&A costs
within this segment, and realigning the organization to better
leverage our knowledge of the marketplace and the consumer. We
are working towards pan-European category management of our
consumer product portfolio. Now that we have shown we can
succeed in Europe, we intend to make necessary investments to
continue to win with consumers and our retail partners.
We view strategic acquisitions as a means to enhance our strong
core businesses, and were successful in completing several such
acquisitions during fiscal 2006. Rod McLellan Company
(RMC), a leading branded producer and marketer of
soil and landscape products in the western U.S., was acquired
and integrated into our existing Growing Media business.
Gutwein, a leader in the growing North America wild bird food
category, also was acquired. Gutweins Morning
Song®
products are sold at leading mass retailers, grocery, pet and
general merchandise stores. This acquisition marked our entry
into the wild bird food category that we believe has exciting
growth opportunities. Lastly, two additional acquisitions were
consummated that have strengthened the Companys overall
global position in the turfgrass seed category. First, we
acquired certain assets, including brands, turfgrass varieties
and intellectual property, from Oregon-based Turf-Seed, Inc.
(Turf-Seed), a leading producer of quality
commercial turfgrasses for the professional seed business. The
transaction included a 49% equity interest in Turf-Seed Europe,
which distributes Turf-Seeds grass varieties throughout
the European Union and other countries in the region. We also
acquired certain assets of Oregon-based Landmark Seed Company, a
leading producer and distributor of quality professional seed
and turfgrasses, including its brands, turfgrass varieties and
intellectual property.
Given Scotts Miracle-Gros strong performance and
consistent cash flows, our Board of Directors undertook several
actions over the past two years to return cash to our
shareholders. We began paying a quarterly cash dividend of 12.5
cents per share in the fourth quarter of fiscal 2005. In fiscal
2006, our Board launched a five-year $500 million share
repurchase program pursuant to which we repurchased
2.0 million common shares for $87.9 million during
fiscal 2006. Most recently, on December 12, 2006, we
launched a recapitalization plan to return $750 million to
the Companys shareholders. This plan expanded and
accelerated the previously announced five-year $500 million
share repurchase program (which was canceled). Pursuant to the
recapitalization plan, on February 14, 2007, we completed a
modified Dutch auction tender offer, resulting in
the repurchase of 4.5 million of our common shares for an
aggregate purchase price of $245.5 million ($54.50 per
share). On February 16, 2007, our Board of Directors
declared a special one-time cash dividend of $8.00 per share
($508 million in the aggregate) which was paid on
March 5, 2007, to shareholders of record on
February 26, 2007.
25
In order to fund the recapitalization, we entered into new
credit facilities effective February 2007, aggregating
$2.15 billion and terminated our prior credit facility. As
part of this debt restructuring, we also conducted a cash tender
offer for all of our outstanding
65/8% senior
subordinated notes in an aggregate principal amount of
$200 million. Reference should be made to Note 10 to
the Consolidated Financial Statements included in this Annual
Report on
Form 10-K
for further information as to the new credit facilities and the
repayment and termination of the prior credit facility and the
65/8% senior
subordinated notes.
The actions described above reflect managements confidence
in the continued growth of the Company. Strong and consistent
cash flows can support the higher levels of debt necessary to
finance these actions, as discussed in the Liquidity and Capital
Resources section of this MD&A. Even with an increase in
borrowings as a result of the fiscal 2007 recapitalization
transactions, we believe we will maintain the capacity to pursue
targeted, strategic acquisitions that leverage our core
competencies.
Results of
Operations
The following table sets forth the components of income and
expense as a percentage of net sales for the three years ended
September 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Net sales
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Cost of sales
|
|
|
65.0
|
|
|
|
64.6
|
|
|
|
63.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
35.0
|
|
|
|
35.4
|
|
|
|
36.3
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
24.4
|
|
|
|
23.6
|
|
|
|
26.7
|
|
Impairment, restructuring and other charges
|
|
|
1.4
|
|
|
|
2.8
|
|
|
|
1.4
|
|
Other income, net
|
|
|
(0.4
|
)
|
|
|
(0.4
|
)
|
|
|
(0.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
9.6
|
|
|
|
9.4
|
|
|
|
8.5
|
|
Costs related to refinancings
|
|
|
0.6
|
|
|
|
|
|
|
|
0.1
|
|
Interest expense
|
|
|
2.5
|
|
|
|
1.5
|
|
|
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
6.5
|
|
|
|
7.9
|
|
|
|
6.6
|
|
Income taxes
|
|
|
2.6
|
|
|
|
3.0
|
|
|
|
2.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
3.9
|
|
|
|
4.9
|
|
|
|
4.2
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
3.9
|
%
|
|
|
4.9
|
%
|
|
|
4.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Sales
Consolidated net sales for fiscal 2007 increased 6.3% to
$2.87 billion from $2.70 billion in fiscal 2006, while
for fiscal 2006, net sales increased 13.8% to
$2.70 billion from $2.37 billion in fiscal 2005.
Significantly impacting the rate of sales growth in both years
were the following items:
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
Net sales growth
|
|
|
6.3
|
%
|
|
|
13.8
|
%
|
Acquisitions
|
|
|
(1.3
|
)
|
|
|
(5.0
|
)
|
Impact of $45.7 million charge in fiscal 2005 associated
with deferred contribution liability under
Roundup®
Marketing Agreement
|
|
|
|
|
|
|
(1.9
|
)
|
Foreign exchange rates
|
|
|
(1.6
|
)
|
|
|
0.4
|
|
|
|
|
|
|
|
|
|
|
Adjusted net sales growth
|
|
|
3.4
|
%
|
|
|
7.3
|
%
|
|
|
|
|
|
|
|
|
|
The adjusted net sales increase of 3.4% is reflective of the
weather-related challenges we experienced this year in the
largest part of our business, the North America segment. Extreme
cold and wet weather in April discouraged consumer usage during
this key period, and these lost opportunities were not recovered
as the weather improved later in the spring. As we moved into
the summer, heat and
26
drought for large portions of the country created difficult lawn
care conditions discouraging many of our do-it-yourself
consumers from investing in their lawns. While we saw strong
growth in the gardening category, in our Scotts
LawnService®
business, and our International segment, the adverse impact of
weather on the important North American lawns business
overshadowed these successes.
The adjusted net sales growth of 7.3% in fiscal 2006 was driven
by strong growth in our North American consumer business and the
Scotts
LawnService®
business. In contrast, a difficult lawn and garden market in
Europe during fiscal 2006 contributed to a net sales decline
after adjusting for the effect of exchange rates.
Gross
Profit
As a percentage of net sales, gross profit was 35.0% of net
sales for fiscal 2007 compared to 35.4% for fiscal 2006. This
decline in gross profit percent was due to a 90 basis point
decline for the North America segment, due almost entirely to
unfavorable product mix. Strong net sales growth in the lower
margin wild bird food and growing media businesses, coupled with
a net sales decline in our higher margin lawns business, were
the drivers behind this decrease. Offsetting this decline in
North America were gross profit improvements from Scotts
LawnService®,
Smith &
Hawken®
and our International segment.
As a percentage of net sales, gross profit was 35.4% of net
sales for fiscal 2006 compared to 36.3% for fiscal 2005.
Adjusting for the effect of the $45.7 million
Roundup®
contribution charge recorded in fiscal 2005 (see Note 4 to
the Consolidated Financial Statements included in this Annual
Report on
Form 10-K),
the fiscal 2005 gross profit rate was 37.5%, 210 basis
points higher than fiscal 2006. Acquisitions accounted for
70 basis points of the decline, as the margins of these
businesses are below our historical average. Product mix
adversely affected margins by 80 basis points, due in part
to significant increases in sales of lower margin grass seed and
garden soils. Increased costs for fuel and commodities exceeded
price increases, resulting in 90 basis point decline in
gross margin as a percentage of net sales. The offsetting
30 basis point differential is comprised of miscellaneous
other items.
Selling, General
and Administrative Expenses (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Advertising
|
|
$
|
150.9
|
|
|
$
|
137.3
|
|
|
$
|
122.5
|
|
Advertising as a percentage of net sales
|
|
|
5.3
|
%
|
|
|
5.1
|
%
|
|
|
5.2
|
%
|
Selling, general and administrative (other SG&A)
|
|
$
|
519.2
|
|
|
$
|
468.7
|
|
|
$
|
486.6
|
|
Stock-based compensation
|
|
|
15.5
|
|
|
|
15.7
|
|
|
|
9.9
|
|
Amortization of intangibles
|
|
|
15.3
|
|
|
|
15.2
|
|
|
|
14.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
700.9
|
|
|
$
|
636.9
|
|
|
$
|
633.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advertising expenses in fiscal 2007 were $150.9 million, an
increase of $13.6 million or 9.9% from fiscal 2006. Fiscal
2006 advertising expenses were $137.3 million, an increase
of $14.8 million or 12.1% from fiscal 2005. On a percentage
of net sales basis, advertising expenses were 5.3% of net sales
in fiscal 2007, 5.1% in fiscal 2006, and 5.2% in fiscal 2005.
The fiscal 2007 increase as a percent of net sales was due to an
effort to drive consumer interest and reinvigorate the lawns
category following weak net sales performance in April. This
strategy continued on into the fourth quarter of fiscal 2007.
The percentage of net sales decline in fiscal 2006 versus fiscal
2005 was due to the shift of some planned increases in
traditional media advertising to consumer directed promotions
funded via programs with our retail partners, which are
accounted for as a reduction to net sales. The combination of
higher advertising spending and consumer promotions led to an
18% increase in spending for the North American consumer
business in fiscal 2006.
In fiscal 2007, other SG&A spending increased
$50.5 million or 10.8% from fiscal 2006. A sizable increase
in Scotts
LawnService®
infrastructure ($20.4 million), the adverse effect of
foreign exchange rates on spending outside the United States
($11.3 million), and a nonrecurring benefit in fiscal 2006
($10.1 million) for an insurance recovery relating to past
legal costs incurred in our defense of lawsuits regarding our
use of vermiculite were the primarily drivers behind the
increase. Spending on incentives
27
was at less than target in both fiscal 2007 and fiscal 2006,
with the benefit to fiscal 2007 approximating $10 million.
In fiscal 2006, other SG&A spending decreased
$17.9 million or 3.7% from fiscal 2005. This decrease
reflects savings from our fiscal 2005 Project Excellence
initiative coupled with the $10.1 million insurance
recovery benefit. Partially offsetting these decreases in other
SG&A spending were increased spending in support of our
rapidly expanding Scotts
LawnService®
business and $4.2 million attributable to our wild bird
food acquisition early in fiscal 2006.
We began expensing share-based awards commencing with grants
issued in fiscal 2003. The majority of our share-based awards
vest over three years, with the associated expense recognized
ratably over the vesting period. Prior to the fiscal 2006
adoption of Statement of Financial Accounting Standards
(SFAS) No. 123(R), Share-Based
Payment, forfeitures were recognized as incurred. Our
stock-based compensation expense now reflects an estimate of
forfeitures. The increase in stock-based compensation in fiscal
2006 as compared to fiscal 2005 was primarily attributable to an
increase in the number of fiscal 2006 awards to key employees
coupled with a higher unit grant value due to our relatively
higher stock price, and a forfeiture adjustment in fiscal 2005
that reduced expense in that year by approximately
$2.2 million.
Amortization expense of $15.3 million in fiscal 2007 is
comparable to $15.2 million in fiscal 2006 and
$14.8 million in fiscal 2005. Strengthening foreign
currencies relative to the dollar over the past two years has
served to increase amortization expense slightly along with the
addition of new amortizing intangibles from acquisitions.
Impairment,
Restructuring and Other Charges, net (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Goodwill and intangible asset impairment
|
|
$
|
35.3
|
|
|
$
|
66.4
|
|
|
$
|
23.4
|
|
Restructuring severance and related
|
|
|
|
|
|
|
9.3
|
|
|
|
26.3
|
|
Litigation related income
|
|
|
|
|
|
|
|
|
|
|
(16.8
|
)
|
Other
|
|
|
2.7
|
|
|
|
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
38.0
|
|
|
$
|
75.7
|
|
|
$
|
33.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Since its adoption of SFAS 142, Goodwill and Other
Intangible Assets, the Company has conducted its annual
impairment review of indefinite-lived tradenames and goodwill
during its first fiscal quarter. The impairment analysis for the
first quarter of fiscal 2007 indicated that no impairment
charges were required. During the third quarter of fiscal 2007,
the Company changed the timing of its annual goodwill impairment
testing from the last day of our fiscal first quarter to the
first day of our fiscal fourth quarter. Therefore, we performed
our annual impairment test again as of July 1, 2007. Moving
the timing of our annual goodwill impairment testing better
aligns with the seasonal nature of our business and the timing
of our annual strategic planning process. In addition, the
Company also changed the date of its annual indefinite life
intangible impairment testing to the first day of our fiscal
fourth quarter. Management engages an independent valuation firm
to assist in its impairment assessment reviews.
Our fourth quarter fiscal 2007 impairment review resulted in a
non-cash goodwill and intangible asset impairment charge of
$35.3 million. In part as a result of the disappointing
2007 lawn and garden season, management undertook a
comprehensive strategic update of its business initiatives in
the fourth quarter of fiscal 2007. One outcome of this update
was a decision to increase the focus of Company resources on our
core consumer lawn and garden do-it-yourself businesses. This
process also involved a re-evaluation of the strategy and cash
flow projections surrounding our Smith &
Hawken®
business, which has consistently performed below expectations
since it was acquired in early fiscal 2005. While management
remains committed to the outdoor living category and intends to
more vigorously leverage the Smith &
Hawken®
brand in other lawn and garden categories, we revised our Smith
&
Hawken®
strategy to reflect a scaled back retail expansion plan, with an
increased focus on aggressively expanding our wholesale aspect
of this business. This resulted in a decrease in our prior cash
flow projections for this business, resulting in a
$24.6 million goodwill impairment charge and a
$4.6 million impairment charge for an indefinite-lived
tradename. The goodwill impairment charge is an estimate, as
appraisals necessary to complete the required SFAS 142
evaluation of the Smith &
Hawken®
goodwill remain in process as of the date of this report. We
will finalize this evaluation in the first quarter of fiscal
2008 and, if necessary, update the impairment charge for
Smith &
Hawken®
goodwill in that reporting period.
28
Our fiscal 2007 fourth quarter strategic update also encompassed
other areas. We remain strongly committed to the development of
turfgrass varieties that could one day require less mowing, less
water and fewer treatments to resist insects, weeds and disease.
Our efforts to develop such turfgrass varieties include
conventional breeding programs, as well as research and
development involving biotechnology. Our efforts to develop
turfgrass varieties involving biotechnology have yielded
positive results; however, the required regulatory approval
process is taking longer than anticipated, impacting our ability
to commercialize our innovations. As result of our fiscal 2007
fourth quarter strategic update, we recorded a $2.2 million
goodwill impairment charge related to our turfgrass
biotechnology program. Similarly, a strategic update of certain
information technology initiatives in our Scotts
LawnService®
segment resulted in a $3.9 million impairment charge.
Our annual impairment review in the first quarter of fiscal 2006
resulted in an impairment charge of $1.0 million associated
with a tradename no longer in use in our U.K. consumer business.
Category declines in the European consumer markets during the
2006 season resulted in a decline in the profitability of the
consumer component of our International business segment in
fiscal 2006. As such, we undertook an interim impairment test
for this business in the fourth quarter of fiscal 2006. After an
evaluation, management reached the conclusion that the
projections supporting fiscal 2006 first quarter impairment
testing for the consumer component of our International business
segment were unlikely to be met. As a result of this evaluation,
we recorded a $65.4 million non-cash impairment charge,
$62.3 million of which was associated with indefinite-lived
tradenames that continue to be employed in the consumer portion
of our International segment. The balance of the fiscal 2006
fourth quarter impairment charge was in our North America
segment and consisted of $1.3 million for a Canadian
tradename being phased out and $1.8 million related to
goodwill of a pottery business we exited.
Other charges in fiscal 2007 relate to certain assets and
ongoing monitoring and remediation costs associated with our
turfgrass biotechnology program. Restructuring activities in
fiscal 2006 and fiscal 2005 related primarily to organizational
reductions associated with Project Excellence initiated in the
third quarter of fiscal 2005. As a result of this program,
approximately 110 associates accepted early retirement or were
severed during the last four months of fiscal 2005.
Approximately 110 additional associates exited in fiscal 2006.
Other Income,
net
Other income, net was $11.5 million for fiscal 2007,
$9.2 million for fiscal 2006, and $7.5 million for
fiscal 2005. Royalty income amounted to $9.9 million in
fiscal 2007 and $6.8 million in fiscal 2006. Other income
in fiscal 2005 included a $4.1 million gain from a legal
judgment.
Income from
Operations
Income from operations in fiscal 2007 was $277.1 million
compared to $252.5 million in fiscal 2006, an increase of
$24.6 million. Both years were negatively impacted by
impairment, restructuring and other charges that, if excluded,
results in a decline of $13.1 million of income from operations
in fiscal 2007 as compared to fiscal 2006. The adverse effects
of weather on net sales growth coupled with a 40 basis
point decline in gross profit and SG&A spending increases
were the drivers behind this decline.
Income from operations in fiscal 2006 increased
$51.6 million from fiscal 2005. Income from operations in
fiscal 2006 was negatively impacted by $66.4 million from
impairment charges and an additional $9.4 million of
restructuring charges. Income from operations in fiscal 2005 was
negatively impacted by the following charges:
(1) $45.7 million related to the
Roundup®
deferred contribution charge; (2) a $22.0 million
charge for impairment of U.K. intangibles; and
(3) $26.3 million in restructuring charges. These were
partially offset by $16.8 million of litigation related
income. If these unusual factors were excluded from the
year-over-year comparison, fiscal 2006 would show an 18%
improvement over fiscal 2005. Higher net sales and Project
Excellence savings, offset by a gross margin rate decline and
growth in advertising spending, were the major contributors to
the adjusted 18% growth in income from operations.
Interest Expense
and Refinancing Activities
Interest expense in fiscal 2007 was $70.7 million compared
to $39.6 in fiscal 2006. This increase in interest expense was
attributable to an increase in borrowings resulting from the
recapitalization transactions that were consummated during the
second quarter of fiscal 2007, coupled with an increase
29
in our weighted average interest rate resulting from our
increased leverage and higher LIBOR rates in general. Average
borrowings increased $422.5 million, and weighted average
interest rates increased by 70 basis points, in fiscal 2007
as compared to the prior fiscal year. We also recorded
$18.3 million in costs related to the refinancing
undertaken to facilitate the recapitalization transactions.
Income
Taxes
The effective tax rate for fiscal 2007 was 39.7% compared to
37.7% in fiscal 2006 and 36.5% in fiscal 2005. The increase in
the effective tax rate for fiscal 2007 was due to the goodwill
impairment charge which is not deductible for tax purposes. The
effective tax rate in fiscal 2006 was higher than fiscal 2005
due to favorable settlements in fiscal 2005 related to prior
year foreign tax audits. We anticipate the effective tax rate
will be in the range of 36% to 37% for fiscal 2008.
Net Income and
Earnings per Share
While income from operations increased $24.6 million over
fiscal 2006, net income decreased from $132.7 million or
$1.91 per diluted share in fiscal 2006 to $113.4 million or
$1.69 per diluted share in fiscal 2007. Adverse weather
conditions in North America negatively impacted net sales,
particularly during the important month of April. Costs related
to the refinancing, increased levels of debt, and a higher
weighted average interest rate resulting from the
recapitalization transactions coupled with a higher effective
tax rate caused the decline. Average diluted shares outstanding
decreased from 69.4 million in fiscal 2006 to
67.0 million in fiscal 2007, due to the modified
Dutch auction tender offer that resulted in the
repurchase of 4.5 million of our common shares, weighted
for the period outstanding, as part of the recapitalization
transactions consummated in the second quarter of fiscal 2007.
Net income increased from $100.6 million or $1.47 per
diluted share in fiscal 2005 to $132.7 million or $1.91 per
diluted share in fiscal 2006. As described in the Income
from Operations discussion, the benefit from net sales
growth and Project Excellence savings was offset by impairment
and restructuring charges in fiscal 2006, while similar factors
impacted fiscal 2005 along with the
Roundup®
deferred contribution charge. Average diluted shares outstanding
increased from 68.6 million in fiscal 2005 to
69.4 million in fiscal 2006, due to option exercises and
the impact on common share equivalents of a higher average share
price, partially offset by the repurchase of our common shares
under a share repurchase program approved by our Board of
Directors in November 2005.
Segment
Results
Our operations are divided into the following reportable
segments: North America, Scotts
LawnService®,
International, and Corporate & Other. The
Corporate & Other segment consists of
Smith &
Hawken®
and corporate general and administrative expenses. Segment
performance is evaluated based on several factors, including
income from operations before amortization, and impairment,
restructuring and other charges, which is a non-GAAP financial
measure. Management uses this measure of operating profit to
gauge segment performance because we believe this measure is the
most indicative of performance trends and the overall earnings
potential of each segment.
Net Sales by
Segment (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
North America
|
|
$
|
1,988.3
|
|
|
$
|
1,914.5
|
|
|
$
|
1,668.1
|
|
Scotts
LawnService®
|
|
|
230.5
|
|
|
|
205.7
|
|
|
|
159.8
|
|
International
|
|
|
469.8
|
|
|
|
408.5
|
|
|
|
430.3
|
|
Corporate & Other
|
|
|
184.0
|
|
|
|
169.2
|
|
|
|
159.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
2,872.6
|
|
|
|
2,697.9
|
|
|
|
2,417.8
|
|
Roundup®
deferred contribution charge
|
|
|
|
|
|
|
|
|
|
|
(45.7
|
)
|
Roundup®
amortization
|
|
|
(0.8
|
)
|
|
|
(0.8
|
)
|
|
|
(2.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,871.8
|
|
|
$
|
2,697.1
|
|
|
$
|
2,369.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30
Income from
Operations by Segment (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
North America
|
|
$
|
375.4
|
|
|
$
|
391.2
|
|
|
$
|
355.4
|
|
Scotts
LawnService®
|
|
|
11.3
|
|
|
|
15.6
|
|
|
|
13.1
|
|
International
|
|
|
35.0
|
|
|
|
28.5
|
|
|
|
34.3
|
|
Corporate & Other
|
|
|
(90.5
|
)
|
|
|
(91.0
|
)
|
|
|
(105.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
331.2
|
|
|
|
344.3
|
|
|
|
297.1
|
|
Roundup®
deferred contribution charge
|
|
|
|
|
|
|
|
|
|
|
(45.7
|
)
|
Roundup®
amortization
|
|
|
(0.8
|
)
|
|
|
(0.8
|
)
|
|
|
(2.8
|
)
|
Amortization
|
|
|
(15.3
|
)
|
|
|
(15.2
|
)
|
|
|
(14.8
|
)
|
Impairment of intangibles and goodwill
|
|
|
(35.3
|
)
|
|
|
(66.4
|
)
|
|
|
(23.4
|
)
|
Restructuring and other charges
|
|
|
(2.7
|
)
|
|
|
(9.4
|
)
|
|
|
(9.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
277.1
|
|
|
$
|
252.5
|
|
|
$
|
200.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North
America
Segment net sales were $1.99 billion in fiscal 2007, an
increase of 3.9% from fiscal 2006. Excluding the impact of
acquisitions, net sales improved 2.5%, approximately 1.9% of
which was a result of pricing. Adverse weather conditions for
much of the core selling season disproportionately impacted the
lawns business, which includes both fertilizers and grass seed,
resulting in a 5.6% decline in net sales. The other core
businesses were less impacted by the weather, with net sales in
the gardening category (growing media and plant food) up 7.4%
and
Ortho®
up 2.9%. Net sales in our wild bird food business improved 13.5%
as we began to see success from the launch of
Scotts®
branded bird food at Wal*Mart, combined with significant pricing
increases in the latter portion of fiscal 2007. The increase in
net sales did not generate the gross margin improvement needed
to offset the growth in advertising and other SG&A
spending, with the result being a decline in segment operating
income of $15.8 million or 4.0%.
For fiscal 2006, segment net sales were $1.91 billion, an
increase of 14.8% from fiscal 2005. Excluding the impact of
acquisitions, sales improved 7.9%, approximately 1.9% of which
was a result of pricing. Each of the core businesses performed
well, with lawns business up 10.5%, gardening up 16.0%
benefiting from the very successful launch of
Miracle-Gro®
LiquaFeed®,
and
Ortho®
net sales down 1.5% due to an unfavorable season for weed
control products. The overall net sales growth and Project
Excellence savings, offset by a gross margin rate decline and
growth in advertising spending, led to an increase in segment
operating income of $35.8 million or 10.1%.
Scotts
LawnService®
Segment net sales increased 12.1% to $230.5 million for
fiscal 2007. This revenue growth was primarily attributable to
an 11.9% increase in average customer count. Approximately 3.6%
of the revenue increase came from acquisitions completed in
fiscal 2006 and fiscal 2007. The increase in sales and customer
count in fiscal 2007 were lower than we expected. We believe the
extended cold weather from mid-February through mid-April had a
significant impact on the realized rate of growth. We further
believe that relative to our core business, our service segment
was more sensitive to the impact of broader economic factors on
consumer spending.
Operating income for this segment decreased to
$11.3 million from $15.6 million for fiscal 2006. The
decrease in operating income was primarily attributable to
higher planned SG&A spending to support higher volume and
continued service improvements. Improved labor productivity
helped to offset higher fertilizer and fuel costs, but revenue
growth was not adequate to cover the higher levels of SG&A
spending due to adverse weather conditions during the important
late winter / early spring period.
For fiscal 2006, segment net sales increased $45.9 million
or 28.7%. This growth in net sales came from increased customer
counts and revenue per customer, strong customer retention,
pricing to cover increased input costs, modest geographic
expansion and the full year impact of acquisitions. Operating
income for the segment increased $2.5 million or 19.1% in
fiscal 2006. This increase was the result of
31
revenue growth offset by investments in personnel and
infrastructure to support future growth and service levels.
We continue to expand our Scotts
LawnService®
business through internal growth and, to a lesser extent,
acquisitions. We invested $22.5 million of capital in lawn
care acquisitions in fiscal 2007, and $4.4 million in
fiscal 2006. Acquisitions had been a major factor in the growth
of the lawn care business prior to fiscal 2004. While we expect
to continue making selective acquisitions in future years, we
anticipate the majority of the future growth in our lawn care
business will be organic.
International
Net sales for the International segment in fiscal 2007 increased
by 15.0% or $61.3 million compared to fiscal 2006.
Excluding the effects of currency fluctuations, net sales
increased 5.5%. This segment saw improvement in every major
market, with our two largest markets, France and the United
Kingdom, up 11% and 2% for the fiscal year, respectively, as
measured in local currencies. Our international professional
business also delivered consistent growth with a 9% increase in
net sales from the prior year.
Net sales for the International segment in fiscal 2006 declined
by 5.1% or $21.8 million compared to fiscal 2005. Excluding
the effects of currency fluctuations, net sales declined 1.7%.
The retail environment in Europe was challenging with category
sales down in both the United Kingdom and France, our two
largest European markets. We believe listing improvements had
resulted in market share gains; however, these gains did not
result in top line growth due to the category declines.
In fiscal 2007, International operating income increased
$6.5 million or 22.8% as compared to fiscal 2006. A steady
gross margin on higher net sales and tight control over growth
in SG&A spending contributed to the increase. Operating
income decreased $5.8 million or 16.9% in fiscal 2006,
compared to fiscal 2005. Lower sales and gross margins were
partially offset by reduced SG&A spending, resulting in the
year-over-year decline.
Corporate &
Other
The loss from operations in Corporate & Other was
$90.5 million in fiscal 2007, $91.0 million in fiscal
2006, and $105.7 million in fiscal 2005. Spending at the
Corporate level declined more than the numbers indicate for
fiscal 2007, as fiscal 2006 benefited from the
$10.1 million insurance recovery. Significant reductions in
legal and Sarbanes-Oxley compliance costs in fiscal 2006 served
to reduce the loss as compared to fiscal 2005, although a loss
in our Smith &
Hawken®
business mitigated the impact of these cost reductions.
Managements
Outlook
We were satisfied with our financial performance in fiscal 2007
in light of the challenges caused by weather and macroeconomic
pressures that affected our major retail partners. Despite these
issues, we reported record net sales and improvement in consumer
purchases of our products as measured by point-of-sale data
provided by our major retail partners. In addition, net cash
provided by operating activities less capital investments
amounted to an impressive $192.6 million.
As we look to fiscal 2008, we expect that net income and
earnings per share are likely to be in line with the results we
reported in fiscal 2007. While we anticipate organic sales
growth in our core North America segment, a moderating retail
environment could result in lower growth rates in fiscal 2008
than we have reported in recent years. Additionally, the Company
expects to make certain incremental strategic investments as
well as report higher interest expense throughout fiscal 2008.
Some of the increased spending in fiscal 2008 will be
specifically focused on initiatives outlined in the
Strategic Initiatives section of ITEM 1.
BUSINESS, all of which are expected to increase operating
profits over the long-term.
From a financial perspective, the Company remains focused on
continuing to improve its Free Cash Flow and Return on Invested
Capital (ROIC), both of which the Company believes are important
drivers of shareholder value. Our regular quarterly dividend
will allow us to continue to return funds to shareholders while
maintaining our targeted capital structure and flexibility to
pursue strategic acquisition opportunities.
For certain information concerning our risk factors, see
ITEM 1A. RISK FACTORS.
32
Liquidity and
Capital Resources
Operating
Activities
Although net income plus noncash impairment charges, stock-based
compensation expense, depreciation and amortization declined by
$49.6 million from $281.8 in fiscal 2006 to
$232.2 million in fiscal 2007, net cash provided from
operating activities for fiscal 2007 increased by
$64.2 million over fiscal 2006. Factors that negatively
impacted operating cash flow in fiscal 2006 were the utilization
of $63.9 million in cash plus $34.3 million in
accounts payable to fund an increase of $98.2 million of
accounts receivable and inventories. We undertook an inventory
build in North America in the fourth quarter of fiscal 2006 to
take advantage of a historical trough in urea costs and to
increase the predictability of fiscal 2007 costs.
Smith &
Hawken®
inventories also increased in fiscal 2006 as a result of a
conscious early season effort to improve customer service;
however, sales subsequently did not meet expectations. By
comparison, there were only modest changes in outstanding
amounts of accounts receivable, inventories, and accounts
payable at the end of fiscal 2007 versus 2006. Fiscal 2006 also
used $43.0 million of operating cash flows to fund the
Roundup®
deferred contribution payment in October 2005. Lastly, fiscal
2007 operating cash flow includes the add back of
$18.3 million of financing costs related to the
recapitalization that are reflected as a financing cost.
The seasonal nature of our operations generally requires cash to
fund significant increases in working capital (primarily
inventory) during the first half of the year. Receivables and
payables also build substantially in the second quarter of the
year in line with the timing of sales to support our retailers
spring selling season. These balances liquidate during the June
through September period as the lawn and garden season unwinds.
Unlike our core retail business, Scotts
LawnService®
typically has its highest receivables balances in the fourth
quarter because of the seasonal timing of customer applications
and extra service revenues.
Investing
Activities
Cash used in investing activities was $72.2 million and
$174.1 million for fiscal 2007 and fiscal 2006,
respectively. Our acquisitions of Gutwein, RMC, and certain
brands and assets of Landmark Seed Company and Turf-Seed in
fiscal 2006 were the primary drivers behind the spending for
investing activities. No such acquisitions were undertaken in
fiscal 2007, with acquisition activity restricted to our Scotts
LawnService®
business. Capital spending was consistent at $54.0 million
in fiscal 2007 versus $57.0 million in fiscal 2006.
Financing
Activities
Financing activities used cash of $158.8 million and
$46.9 million in fiscal 2007 and fiscal 2006, respectively.
Our recapitalization plan that was consummated during the second
quarter of fiscal 2007 returned $750 million to
shareholders. In addition, we repurchased all of our
65/8% senior
subordinated notes in an aggregate principal amount of
$200 million. These actions were financed by replacing,
effective February 7, 2007, our prior revolving credit
facility with new senior secured $2.15 billion
multicurrency credit facilities that provide for revolving
credit and term loans through February 7, 2012.
As noted earlier, in fiscal 2006, we began a program to return
cash to our shareholders. We paid dividends of
$33.5 million and repurchased $87.9 million of our
common shares financed in part by a net increase in borrowings
under our prior revolving credit facility of $55.2 million.
Prior to fiscal 2006, our focus was on aggressively paying down
debt and managing our borrowings to maximize the benefit of our
improving capital structure and debt facilities. Proceeds from
the exercise of employee stock options were $29.2 million
in fiscal 2007 compared to $17.6 million in fiscal 2006.
Credit
Agreements
Our primary sources of liquidity are cash generated by
operations and borrowings under our credit agreements. In
connection with the recapitalization transactions discussed in
Note 2 to the Consolidated Financial Statements included in
this Annual Report on
Form 10-K,
Scotts Miracle-Gro and certain of its subsidiaries entered into
the following loan facilities totaling up to $2.15 billion
in the aggregate: (a) a senior secured five-year term loan
in the principal amount of $560 million and (b) a
senior secured five-year revolving loan facility in the
aggregate principal amount of up to $1.59 billion.
Borrowings may be made in various currencies including U.S.
dollars, Euros, British pounds sterling, Australian dollars and
Canadian dollars. The new $2.15 billion senior secured
credit facilities replaced the Companys former
33
$1.05 billion senior credit facility. In addition, we used
proceeds from the new senior secured credit facilities to
repurchase all of our then outstanding
65/8% senior
subordinated notes in an aggregate principal amount of
$200 million. Under our current structure, we may request
an additional $200 million in revolving credit
and/or term
credit commitments, subject to approval from our lenders. As of
September 30, 2007, there was $1,098.1 million of
availability under our new senior secured credit facilities.
Note 10 to the Consolidated Financial Statements included in
this Annual Report on
Form 10-K
provides additional information pertaining to our borrowing
arrangements. We were in compliance with all of our debt
covenants throughout fiscal 2007.
In April of fiscal 2007, we entered into a Master Accounts
Receivable Purchase Agreement (the MARP Agreement)
with a stated termination date of April 10, 2008, as
permitted under our senior secured credit facilities. The MARP
Agreement was entered into as it provides an interest rate
savings as compared to borrowing under our new senior secured
credit facilities. The MARP Agreement provides for the
discounted sale, on a revolving basis, of accounts receivable
generated by specified account debtors, with seasonally adjusted
monthly aggregate limits ranging from $55 million to
$300 million. The MARP Agreement also provides for
specified account debtor sublimit amounts, which provide limits
on the amount of receivables owed by individual account debtors
that can be sold. The Company accounts for the sale of
receivables under the MARP Agreement as short-term debt and
continues to carry the receivables on its Consolidated Balance
Sheet, in accordance with SFAS 140, Accounting for
Transfers and Servicing of Financial Assets and Extinguishments
of Liabilities. Sales under the MARP Agreement at
September 30, 2007 were $64.4 million.
At September 30, 2007, the Company had outstanding interest
rate swaps with major financial institutions that effectively
converted a portion of our variable-rate debt denominated in the
Euro, British pound and U.S. dollar to a fixed rate. The
swap agreements have a total U.S. dollar equivalent
notional amount of $720.0 million. The terms, expiration
dates and rates of these swaps are shown in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount in
|
|
|
|
|
|
Expiration
|
|
|
Fixed
|
|
Currency
|
|
USD
|
|
|
Term
|
|
|
Date
|
|
|
Rate
|
|
|
|
|
British pound
|
|
$
|
59.0
|
|
|
|
3 years
|
|
|
|
11/17/2008
|
|
|
|
4.76%
|
|
Euro
|
|
|
61.0
|
|
|
|
3 years
|
|
|
|
11/17/2008
|
|
|
|
2.98%
|
|
U.S. dollar
|
|
|
200.0
|
|
|
|
2 years
|
|
|
|
3/31/2009
|
|
|
|
4.90%
|
|
U.S. dollar
|
|
|
200.0
|
|
|
|
3 years
|
|
|
|
3/31/2010
|
|
|
|
4.87%
|
|
U.S. dollar
|
|
|
200.0
|
|
|
|
5 years
|
|
|
|
2/14/2012
|
|
|
|
5.20%
|
|
Our primary sources of liquidity are cash generated by
operations and borrowings under our credit facilities. We
believe our credit facilities will continue to provide the
Company with the capacity to pursue targeted, strategic
acquisitions that leverage our core competencies.
Judicial and
Administrative Proceedings
We are party to various pending judicial and administrative
proceedings arising in the ordinary course of business. These
include, among others, proceedings based on accidents or product
liability claims and alleged violations of environmental laws.
We have reviewed our pending environmental and legal
proceedings, including the probable outcomes, reasonably
anticipated costs and expenses, reviewed the availability and
limits of our insurance coverage and have established what we
believe to be appropriate reserves. We do not believe that any
liabilities that may result from these proceedings are
reasonably likely to have a material adverse effect on our
liquidity, financial condition or results of operations;
however, there can be no assurance that future quarterly or
annual operating results will not be materially affected by
final resolution of these matters.
34
Contractual
Obligations and off-Balance Sheet Arrangements
The following table summarizes our future cash outflows for
contractual obligations as of September 30, 2007 (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
More than
|
|
Contractual Cash Obligations
|
|
Total
|
|
|
Less than 1 year
|
|
|
1-3 years
|
|
|
4-5 years
|
|
|
5 years
|
|
|
|
|
Long-term debt obligations
|
|
$
|
1,117.8
|
|
|
$
|
86.4
|
|
|
$
|
244.4
|
|
|
$
|
783.0
|
|
|
$
|
4.0
|
|
Operating lease obligations
|
|
|
194.2
|
|
|
|
37.5
|
|
|
|
58.3
|
|
|
|
43.0
|
|
|
|
55.4
|
|
Purchase obligations
|
|
|
569.2
|
|
|
|
292.0
|
|
|
|
211.6
|
|
|
|
58.1
|
|
|
|
7.5
|
|
Other, primarily retirement plan obligations
|
|
|
50.7
|
|
|
|
16.8
|
|
|
|
7.5
|
|
|
|
7.8
|
|
|
|
18.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual cash obligations
|
|
$
|
1,931.9
|
|
|
$
|
432.7
|
|
|
$
|
521.8
|
|
|
$
|
891.9
|
|
|
$
|
85.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase obligations primarily represent outstanding purchase
orders for materials used in the Companys manufacturing
processes. Purchase obligations also include commitments for
warehouse services, seed, and out-sourced information services
which comprise the unconditional purchase obligations disclosed
in Note 16 to the Consolidated Financial Statements
included in this Annual Report on
Form 10-K.
Other includes actuarially determined retiree benefit payments
and pension funding to comply with local funding requirements.
Pension funding requirements beyond fiscal 2008 are not
currently determinable. The above table excludes interest
payments, and insurance accruals as the Company is unable to
estimate the timing of the payment for these items.
The Company has no off-balance sheet financing arrangements.
In our opinion, cash flows from operations and capital resources
will be sufficient to meet debt service and working capital
needs during fiscal 2008, and thereafter for the foreseeable
future. However, we cannot ensure that our business will
generate sufficient cash flow from operations or that future
borrowings will be available under our credit facilities in
amounts sufficient to pay indebtedness or fund other liquidity
needs. Actual results of operations will depend on numerous
factors, many of which are beyond our control.
Environmental
Matters
We are subject to local, state, federal and foreign
environmental protection laws and regulations with respect to
our business operations and believe we are operating in
substantial compliance with, or taking actions aimed at ensuring
compliance with, such laws and regulations. We are involved in
several legal actions with various governmental agencies related
to environmental matters. While it is difficult to quantify the
potential financial impact of actions involving environmental
matters, particularly remediation costs at waste disposal sites
and future capital expenditures for environmental control
equipment, in the opinion of management, the ultimate liability
arising from such environmental matters, taking into account
established reserves, should not have a material adverse effect
on our financial position, results of operations or cash flows.
However, there can be no assurance that the resolution of these
matters will not materially affect our future quarterly or
annual results of operations, financial condition or cash flows.
Additional information on environmental matters affecting us is
provided in ITEM 1. BUSINESS
Environmental and Regulatory Considerations,
ITEM 1. BUSINESS Regulatory Actions
and ITEM 3. LEGAL PROCEEDINGS of this Annual
Report on
Form 10-K.
Critical
Accounting Policies and Estimates
Our discussion and analysis of financial condition and results
of operations is based upon the Companys consolidated
financial statements, which have been prepared in accordance
with accounting principles generally accepted in the United
States of America (U.S. GAAP). Certain accounting policies
are particularly significant, including those related to revenue
recognition, goodwill and intangibles, certain employee
benefits, and income taxes. We believe these accounting
policies, and others set forth in Note 1 to the
Consolidated Financial Statements included in this Annual Report
on
Form 10-K,
should be reviewed as they are integral to understanding our
results of operations and financial position. Our critical
accounting policies are reviewed periodically with the Audit
Committee of our Board of Directors.
35
The preparation of financial statements requires management to
use judgment and make estimates that affect the reported amounts
of assets, liabilities, revenues and expenses, and related
disclosure of contingent assets and liabilities. On an on-going
basis, we evaluate our estimates, including those related to
customer programs and incentives, product returns, bad debts,
inventories, intangible assets, income taxes, restructuring,
environmental matters, contingencies and litigation. We base our
estimates on historical experience and on various other
assumptions that we believe to be reasonable under the
circumstances. Although actual results historically have not
deviated significantly from those determined using our
estimates, our results of operations or financial position could
differ, perhaps materially, from these estimates under different
assumptions or conditions.
Revenue
Recognition and Promotional Allowances
Most of our revenue is derived from the sale of inventory, and
we recognize revenue when title and risk of loss transfer,
generally when products are received by the customer. Provisions
for payment discounts, product returns and allowances are
recorded as a reduction of sales at the time revenue is
recognized based on historical trends and adjusted periodically
as circumstances warrant. Similarly, reserves for uncollectible
receivables due from customers are established based on
managements judgment as to the ultimate collectibility of
these balances. We offer sales incentives through various
programs, consisting principally of volume rebates, cooperative
advertising, consumer coupons and other trade programs. The cost
of these programs is recorded as a reduction of sales. The
recognition of revenues, receivables and trade programs requires
the use of estimates. While we believe these estimates to be
reasonable based on the then current facts and circumstances,
there can be no assurance that actual amounts realized will not
differ materially from estimated amounts recorded.
Long-lived
Assets, including Property, Plant and Equipment
Property, plant, and equipment are stated at cost. Depreciation
of property, plant, and equipment is provided on the
straight-line method and is based on the estimated useful
economic lives of the assets. Intangible assets with finite
lives, and therefore subject to amortization, include technology
(e.g. patents), customer relationships and certain tradenames.
These intangible assets are being amortized on the straight-line
method over periods typically ranging from 10 to 25 years.
The Company reviews long-lived assets whenever circumstances
change such that the indicated recorded value of an asset may
not be recoverable.
Goodwill and
Indefinite-lived Intangible Assets
We have significant investments in intangible assets and
goodwill. Whenever changing conditions warrant, we review the
assets that may be affected for realization. At least annually,
we review goodwill and indefinite-lived intangible assets for
impairment. As discussed in the Results of Operations
section of this MD&A, during the third quarter of fiscal
2007, the Company changed the timing of its annual goodwill
impairment testing from the last day of our fiscal first quarter
to the first day of our fiscal fourth quarter. The review for
impairment of intangibles and goodwill is primarily based on our
estimates of discounted future cash flows, which are based upon
budgets and longer-range strategic plans. These budgets and
plans are used for internal purposes and are also the basis for
communication with outside parties about future business trends.
While we believe the assumptions we use to estimate future cash
flows are reasonable, there can be no assurance that the
expected future cash flows will be realized. As a result,
impairment charges that possibly should have been recognized in
earlier periods may not be recognized until later periods if
actual results deviate unfavorably from earlier estimates. An
assets value is deemed impaired if the discounted cash
flows or earnings projections generated do not substantiate the
carrying value of the asset. The estimation of such amounts
requires management judgment with respect to revenue and expense
growth rates, changes in working capital and selection of an
appropriate discount rate, as applicable. The use of different
assumptions would increase or decrease discounted future
operating cash flows or earnings projections and could,
therefore, change impairment determinations.
Related to our annual impairment review of indefinite-lived
trade names and goodwill, fair values were determined using
discounted cash flow models involving several assumptions.
Changes in our assumptions could materially impact our fair
value estimates. Assumptions critical to our fair value
estimates were: (i) present value factors used in
determining the fair value of the reporting units and trade
names; (ii) royalty rates used in our trade name
valuations; (iii) projected average revenue growth rates
used in the reporting unit and trade name models; and
(iv) projected long-term growth rates used in the
derivation of terminal year values. These and other assumptions
are impacted by economic
36
conditions and expectations of management and will change in the
future based on period specific facts and circumstances.
Inventories
Inventories are stated at the lower of cost or market, the
majority of which are based on the
first-in,
first-out method of accounting. Reserves for excess and obsolete
inventory are based on a variety of factors, including product
changes and improvements, changes in active ingredient
availability and regulatory acceptance, new product
introductions and estimated future demand. The adequacy of our
reserves could be materially affected by changes in the demand
for our products or regulatory actions.
Contingencies
As described more fully in Note 17 to the Consolidated
Financial Statements included in this Annual Report on
Form 10-K,
we are involved in significant environmental and legal matters,
which have a high degree of uncertainty associated with them. We
continually assess the likely outcomes of these matters and the
adequacy of amounts, if any, provided for their resolution.
There can be no assurance that the ultimate outcomes will not
differ materially from our assessment of them. There can also be
no assurance that all matters that may be brought against us are
known at any point in time.
Income
Taxes
Our annual effective tax rate is established based on our
income, statutory tax rates and the tax impacts of items treated
differently for tax purposes than for financial reporting
purposes. We record income tax liabilities utilizing known
obligations and estimates of potential obligations. A deferred
tax asset or liability is recognized whenever there are future
tax effects from existing temporary differences and operating
loss and tax credit carryforwards. Valuation allowances are used
to reduce deferred tax assets to the balance that is more likely
than not to be realized. We must make estimates and judgments on
future taxable income, considering feasible tax planning
strategies and taking into account existing facts and
circumstances, to determine the proper valuation allowance. When
we determine that deferred tax assets could be realized in
greater or lesser amounts than recorded, the asset balance and
consolidated statement of operations reflect the change in the
period such determination is made. Due to changes in facts and
circumstances and the estimates and judgments that are involved
in determining the proper valuation allowance, differences
between actual future events and prior estimates and judgments
could result in adjustments to this valuation allowance. We use
an estimate of our annual effective tax rate at each interim
period based on the facts and circumstances available at that
time, while the actual effective tax rate is calculated at
year-end.
Associate
Benefits
We sponsor various post-employment benefit plans. These include
pension plans, both defined contribution plans and defined
benefit plans, and other post-employment benefit (OPEB) plans,
consisting primarily of health care for retirees. For accounting
purposes, the defined benefit pension and OPEB plans are
dependent on a variety of assumptions to estimate the projected
and accumulated benefit obligations determined by actuarial
valuations. These assumptions include the following: discount
rate; expected salary increases; certain employee-related
factors, such as turnover, retirement age and mortality;
expected return on plan assets; and health care cost trend
rates. These and other assumptions affect the annual expense
recognized for these plans.
Assumptions are reviewed annually for appropriateness and
updated as necessary. We base the discount rate assumption on
investment yields available at year-end on corporate long-term
bonds rated AA or the equivalent. The salary growth assumption
reflects our long-term actual experience, the near-term outlook
and assumed inflation. The expected return on plan assets
assumption reflects asset allocation, investment strategy and
the views of investment managers regarding the market.
Retirement and mortality rates are based primarily on actual and
expected plan experience. The effects of actual results
differing from our assumptions are accumulated and amortized
over future periods.
Changes in the discount rate and investment returns can have a
significant effect on the funded status of our pension plans and
shareholders equity. We cannot predict these discount
rates or investment returns with certainty and, therefore,
cannot determine whether adjustments to our shareholders
equity for minimum pension liability in subsequent years will be
significant.
37
Accruals for
Self-Insurance
We maintain insurance for certain risks, including workers
compensation, general liability and vehicle liability, and are
self-insured for employee-related health care benefits. We
establish reserves for losses based on our claims experience and
industry actuarial estimates of the ultimate loss amount
inherent in the claims, including losses for claims incurred but
not reported. Our estimate of self-insured liabilities is
subject to change as new events or circumstances develop which
might materially impact the ultimate cost to settle these losses.
Other Significant
Accounting Policies
Other significant accounting policies, primarily those with
lower levels of uncertainty than those discussed above, are also
critical to understanding the consolidated financial statements.
The Notes to the Consolidated Financial Statements included in
this Annual Report on
Form 10-K
contain additional information related to our accounting
policies, including recent accounting pronouncements, and should
be read in conjunction with this discussion.
|
|
ITEM 7A.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
As part of our ongoing business, we are exposed to certain
market risks, including fluctuations in interest rates, foreign
currency exchange rates and commodity prices. Financial
derivative and other instruments are used to manage these risks.
These instruments are not used for speculative purposes.
Interest Rate
Risk
The Company had variable-rate debt instruments outstanding at
September 30, 2007 and 2006 that are impacted by changes in
interest rates. As a means of managing our interest rate risk on
these debt instruments, the Company enters into interest rate
swap agreements to effectively convert certain variable-rate
debt obligations to fixed rates.
At September 30, 2007, the Company had outstanding interest
rate swaps with major financial institutions that effectively
convert a portion of our variable-rate debt to a fixed rate. The
swap agreements had a total U.S. dollar equivalent notional
amount of $720.0 million. At September 30, 2006, the
Company had outstanding interest rate swaps with major financial
institutions that effectively converted a portion of our British
pound (GBP) and Euro denominated variable-rate debt to a fixed
rate. The swap agreements have a total U.S. dollar
equivalent notional amount of $120.0 million with
three-year terms expiring November 2008. Under the terms of
these swaps, we paid fixed rates of 2.98% on Euro denominated
swaps and 4.76% on GBP denominated swaps.
The following table summarizes information about our derivative
financial instruments and debt instruments that are sensitive to
changes in interest rates as of September 30, 2007 and
2006. For debt instruments, the table presents principal cash
flows and related weighted-average interest rates by expected
maturity dates. For interest rate swaps, the table presents
expected cash flows based on notional amounts and
weighted-average interest rates by contractual maturity dates.
Weighted-average variable rates are based on implied forward
rates in the yield curve at September 30, 2007 and 2006. A
change in our variable interest rate of 1% would have a
$4.3 million impact on interest expense assuming the
$434.0 million of our variable-rate debt that had not been
hedged via an interest rate swap at September 30, 2007 was
outstanding for the entire fiscal year. The information is
presented in U.S. dollars (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Maturity Date
|
|
|
|
|
|
Fair
|
|
2007
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
2011
|
|
|
After
|
|
|
Total
|
|
|
Value
|
|
|
|
|
Long-term debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variable rate debt
|
|
$
|
82.6
|
|
|
$
|
84.0
|
|
|
$
|
154.0
|
|
|
$
|
193.2
|
|
|
$
|
578.4
|
|
|
$
|
1,092.2
|
|
|
$
|
1,092.2
|
|
Average rate
|
|
|
6.5
|
%
|
|
|
6.5
|
%
|
|
|
6.5
|
%
|
|
|
6.5
|
%
|
|
|
6.5
|
%
|
|
|
6.5
|
%
|
|
|
|
|
Interest rate derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps based on U.S. Dollar, Euro and GBP LIBOR
|
|
$
|
1.9
|
|
|
$
|
(0.9
|
)
|
|
$
|
(1.4
|
)
|
|
$
|
|
|
|
$
|
(3.7
|
)
|
|
$
|
(4.1
|
)
|
|
$
|
(4.1
|
)
|
Average rate
|
|
|
3.87
|
%
|
|
|
4.90
|
%
|
|
|
4.87
|
%
|
|
|
|
|
|
|
5.20
|
%
|
|
|
4.71
|
%
|
|
|
|
|
38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Maturity Date
|
|
|
|
|
|
Fair
|
|
|
|
|
2006
|
|
2008
|
|
|
2010
|
|
|
After
|
|
|
Total
|
|
|
Value
|
|
|
|
|
|
|
|
Long-term debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed rate debt
|
|
|
|
|
|
$
|
|
|
|
$
|
200.0
|
|
|
$
|
200.0
|
|
|
$
|
194.0
|
|
|
|
|
|
Average rate
|
|
|
|
|
|
|
|
|
|
|
6.625
|
%
|
|
|
6.625
|
%
|
|
|
|
|
|
|
|
|
Variable rate debt
|
|
|
|
|
|
$
|
253.8
|
|
|
$
|
|
|
|
$
|
253.8
|
|
|
$
|
253.8
|
|
|
|
|
|
Average rate
|
|
|
|
|
|
|
4.4
|
%
|
|
|
|
|
|
|
4.4
|
%
|
|
|
|
|
|
|
|
|
Interest rate derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps based on Euro and GBP LIBOR
|
|
$
|
1.3
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1.3
|
|
|
$
|
1.3
|
|
|
|
|
|
Average rate
|
|
|
3.87
|
%
|
|
|
|
|
|
|
|
|
|
|
3.87
|
%
|
|
|
|
|
|
|
|
|
Excluded from the information provided above are
$25.6 million and $27.4 million at September 30,
2007 and 2006, respectively, of miscellaneous debt instruments.
Other Market
Risks
Our market risk associated with foreign currency rates is not
considered to be material. Through fiscal 2007, we had only
minor amounts of transactions that were denominated in
currencies other than the currency of the country of origin. We
use foreign currency swap contracts to manage the exchange rate
risk associated with intercompany loans with foreign
subsidiaries that are denominated in U.S. dollars. At
September 30, 2007, the notional amount of outstanding
contracts was $101.5 million with a fair value of
$(1.3) million. At September 30, 2006, the notional
amount of outstanding contracts was $66.7 million with a
fair value of $0.4 million. We are subject to market risk
from fluctuating market prices of certain raw materials,
including urea, resins, grass seed, and wild bird food
components. Our objectives surrounding the procurement of these
materials are to ensure continuous supply and to minimize costs.
We seek to achieve these objectives through negotiation of
contracts with favorable terms directly with vendors. In
addition, we have entered into arrangements to partially
mitigate the effect of fluctuating direct and indirect fuel
costs on our North America and Scotts
LawnService®
businesses and hedged a portion of our urea needs for fiscal
2008. We had outstanding a strip of collars for approximately
0.5 million and 3.2 million gallons of fuel with fair
values of $0 and $0.2 million at September 30, 2007
and 2006, respectively. We also had hedging arrangements for
45,000 and 69,000 aggregate tons of urea at September 30,
2007 and 2006, respectively. The fair value of the 45,000
aggregate tons at September 30, 2007 was $1.0 million,
while the fair value of the 69,000 aggregate tons at
September 30, 2006 was $o.
|
|
ITEM 8.
|
FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA
|
The financial statements and other information required by this
Item are contained in the consolidated financial statements,
notes thereto and schedule listed in the Index to
Consolidated Financial Statements and Financial Statement
Schedule on page 53 of this Annual Report on
Form 10-K
herein.
|
|
ITEM 9.
|
CHANGES IN AND
DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
|
None
|
|
ITEM 9A.
|
CONTROLS AND
PROCEDURES
|
Evaluation of
Disclosure Controls and Procedures
With the participation of the principal executive officer and
the principal financial officer of The Scotts Miracle-Gro
Company (the Registrant), the Registrants
management has evaluated the effectiveness of the
Registrants disclosure controls and procedures (as defined
in
Rule 13a-15(e)
under the Securities Exchange Act of 1934 (the Exchange
Act), as of the end of the fiscal year covered by this
39
Annual Report on
Form 10-K.
Based upon that evaluation, the Registrants principal
executive officer and principal financial officer have concluded
that:
|
|
|
|
|
information required to be disclosed by the Registrant in this
Annual Report on
Form 10-K
and the other reports that the Registrant files or submits under
the Exchange Act would be accumulated and communicated to the
Registrants management, including its principal executive
officer and principal financial officer, as appropriate to allow
timely decisions regarding required disclosure;
|
|
|
|
information required to be disclosed by the Registrant in this
Annual Report on
Form 10-K
and the other reports that the Registrant files or submits under
the Exchange Act would be recorded, processed, summarized and
reported within the time periods specified in the SECs
rules and forms; and
|
|
|
|
the Registrants disclosure controls and procedures were
effective as of the end of the fiscal year covered by this
Annual Report on
Form 10-K.
|
Managements
Annual Report on Internal Control Over Financial
Reporting
The Annual Report of Management on Internal Control Over
Financial Reporting required by Item 308(a) of SEC
Regulation S-K
is included on page 54 of this Annual Report on
Form 10-K.
Attestation
Report of Independent Registered Public Accounting
Firm
The Report of Independent Registered Public Accounting
Firm required by Item 308(b) of SEC
Regulation S-K
is included on page 56 of this Annual Report on
Form 10-K.
Changes in
Internal Control Over Financial Reporting
There were no changes in the Registrants internal control
over financial reporting (as defined in
Rule 13a-15(f)
under the Exchange Act) that occurred during the
Registrants fiscal quarter ended September 30, 2007,
that have materially affected, or are reasonably likely to
materially affect, the Registrants internal control over
financial reporting.
|
|
ITEM 9B.
|
OTHER
INFORMATION
|
None.
40
PART III
|
|
ITEM 10.
|
DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
Directors,
Executive Officers and Persons Nominated or Chosen to Become
Directors or Executive Officers
The information required by Item 401 of SEC
Regulation S-K
concerning the directors of The Scotts Miracle-Gro Company
(Scotts Miracle-Gro or the Registrant)
and the nominees for re-election as directors of Scotts
Miracle-Gro at the Annual Meeting of Shareholders to be held on
January 31, 2008 (the 2008 Annual Meeting) is
incorporated herein by reference from the disclosure which will
be included under the caption ELECTION OF DIRECTORS
in Scotts Miracle-Gros definitive Proxy Statement relating
to the 2008 Annual Meeting (Scotts Miracle-Gros
Definitive Proxy Statement), which will be filed pursuant
to SEC Regulation 14A not later than 120 days after
the end of Scotts Miracle-Gros fiscal year ended
September 30, 2007.
The information required by Item 401 of SEC
Regulation S-K
concerning the executive officers of Scotts Miracle-Gro is
incorporated herein by reference from the disclosure included
under the caption SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF
THE REGISTRANT in Part I of the Annual Report on
Form 10-K.
Compliance with
Section 16(a) of the Securities Exchange Act of
1934
The information required by Item 405 of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the caption SECTION 16(a)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE in Scotts
Miracle-Gros Definitive Proxy Statement.
Procedures for
Recommending Director Nominees
The information required by Item 407(c)(3) of SEC
Regulation S-K
is incorporated herein by reference from the disclosure to be
included under the captions CORPORATE
GOVERNANCE Nominations of Directors and
MEETINGS AND COMMITTEES OF THE BOARD
Committees of the Board Governance and Nominating
Committee in Scotts Miracle-Gros Definitive Proxy
Statement.
Audit
Committee
The information required by Items 407(d)(4) and 407(d)(5)
of SEC
Regulation S-K
is incorporated herein by reference from the disclosure to be
included under the caption MEETINGS AND COMMITTEES OF THE
BOARD Committees of the Board Audit
Committee in Scotts Miracle-Gros Definitive Proxy
Statement.
Committee
Charters; Code of Business Conduct and Ethics; Corporate
Governance Guidelines
The Board of Directors of the Registrant has adopted charters
for each of the Audit Committee, the Governance and Nominating
Committee, the Compensation and Organization Committee, the
Finance Committee and the Innovation & Technology
Committee.
In accordance with the requirements of Section 303A.10 of
the New York Stock Exchanges Listed Company Manual, the
Board of Directors of the Registrant has adopted a Code of
Business Conduct and Ethics covering the members of the
Registrants Board of Directors and associates (employees)
of the Registrant and its subsidiaries, including, without
limitation, the Registrants principal executive officer,
principal financial officer and principal accounting officer.
The Registrant intends to disclose the following events, if they
occur, on its Internet website located at
http://investor.scotts.com within four business days following
their occurrence: (A) the date and nature of any amendment
to a provision of Scotts Miracle-Gros Code of Business
Conduct and Ethics that (i) applies to the
Registrants principal executive officer, principal
financial officer, principal accounting officer or controller,
or persons performing similar functions, (ii) relates to
any element of the code of ethics definition enumerated in
Item 406(b) of SEC
Regulation S-K,
and (iii) is not a technical, administrative or other
non-substantive amendment; and (B) a description (including
the nature of the waiver, the name of the person to whom the
waiver was granted and the date of the waiver) of any waiver,
including an implicit waiver, from a provision of the Code of
Business Conduct and Ethics to the Registrants principal
executive officer, principal financial officer, principal
accounting officer or controller, or persons performing similar
41
functions, that relates to one or more of the elements of the
code of ethics definition set forth in Item 406(b) of SEC
Regulation S-K.
The text of the Code of Business Conduct and Ethics, the
Registrants Corporate Governance Guidelines, the Audit
Committee charter, the Governance and Nominating Committee
charter, the Compensation and Organization Committee charter,
the Finance Committee charter and the Innovation &
Technology Committee charter are posted under the
governance link on the Registrants Internet
website located at http://investor.scotts.com. Interested
persons may also obtain copies of each of these documents
without charge by writing to The Scotts Miracle-Gro Company,
Attention: Corporate Secretary, 14111 Scottslawn Road,
Marysville, Ohio 43041. In addition, a copy of the Code of
Business Conduct and Ethics, as amended on November 2,
2006, is incorporated by reference in Exhibit 14 to this
Annual Report on
Form 10-K.
|
|
ITEM 11.
|
EXECUTIVE
COMPENSATION
|
The information required by Item 402 of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the captions EXECUTIVE
COMPENSATION and NON-EMPLOYEE DIRECTOR
COMPENSATION in Scotts Miracle-Gros Definitive Proxy
Statement.
The information required by Item 407(e)(4) of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the caption MEETINGS AND COMMITTEES
OF THE BOARD Committees of the Board
Compensation and Organization Committee Interlocks and Insider
Participation in Scotts Miracle-Gros Definitive
Proxy Statement.
The information required by Item 407(e)(5) of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the caption COMPENSATION AND
ORGANIZATION COMMITTEE REPORT in Scotts Miracle-Gros
Definitive Proxy Statement.
|
|
ITEM 12.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
|
Ownership of
Common Shares of Scotts Miracle-Gro
The information required by Item 403 of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the caption BENEFICIAL OWNERSHIP OF
SECURITIES OF THE COMPANY in Scotts Miracle-Gros
Definitive Proxy Statement.
Equity
Compensation Plan Information
The information required by Item 201(d) of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the caption EQUITY COMPENSATION
PLAN INFORMATION in Scotts Miracle-Gros Definitive
Proxy Statement.
|
|
ITEM 13.
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
|
Certain
Relationships and Related Person Transactions
The information required by Item 404 of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the captions ELECTION OF
DIRECTORS, BENEFICIAL OWNERSHIP OF SECURITIES OF THE
COMPANY and CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS in Scotts Miracle-Gros Definitive Proxy
Statement.
Director
Independence
The information required by Item 407(a) of SEC
Regulation S-K
is incorporated herein by reference from the disclosure which
will be included under the captions CORPORATE
GOVERNANCE Director Independence and
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS in
Scotts Miracle-Gros Definitive Proxy Statement.
|
|
ITEM 14.
|
PRINCIPAL
ACCOUNTANT FEES AND SERVICES
|
The information required by this Item 14 is incorporated
herein by reference from the disclosure which will be included
under the captions AUDIT COMMITTEE MATTERS
Fees of the Independent
42
Registered Public Accounting Firm and AUDIT
COMMITTEE MATTERS Pre-Approval of Services Performed
by the Independent Registered Public Accounting Firm in
Scotts Miracle-Gros Definitive Proxy Statement.
PART IV
|
|
ITEM 15.
|
EXHIBITS AND
FINANCIAL STATEMENT SCHEDULES
|
(a) LIST OF DOCUMENTS FILED AS PART OF THIS REPORT
1 and 2. Financial Statements and Financial Statement
Schedule:
The response to this portion of Item 15 is submitted as a
separate section of this Annual Report on
Form 10-K.
Reference is made to the Index to Consolidated Financial
Statements and Financial Statement Schedule on
page 53 herein.
3. Exhibits:
The exhibits listed on the Index to Exhibits
beginning on page 102 of this Annual Report on
Form 10-K
are filed with this Annual Report on
Form 10-K
or incorporated herein by reference as noted in the Index
to Exhibits. The following table provides certain
information concerning each management contract or compensatory
plan or arrangement required to be filed as an exhibit to this
Annual Report on
Form 10-K
or incorporated herein by reference.
43
MANAGEMENT
CONTRACTS AND COMPENSATORY PLANS AND ARRANGEMENTS
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(a)(1)
|
|
The O.M. Scott & Sons Company Excess Benefit Plan,
effective October 1, 1993
|
|
Incorporated herein by reference to the Annual Report on
Form 10-K
for the fiscal year ended September 30, 1993 of The Scotts
Company, a Delaware corporation (File
No. 0-19768)
[Exhibit 10(h)]
|
10(a)(2)
|
|
First Amendment to The O.M. Scott & Sons Company Excess
Benefit Plan, effective as of January 1, 1998
|
|
Incorporated herein by reference to the Annual Report on
Form 10-K
for the fiscal year ended September 30, 2001 of The Scotts
Company, an Ohio corporation (Scotts) (File
No. 1-13292)
[Exhibit 10(a)(2)]
|
10(a)(3)
|
|
Second Amendment to The O.M. Scott & Sons Company Excess
Benefit Plan, effective as of January 1, 1999
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2001 (File
No. 1-13292)
[Exhibit 10(a)(3)]
|
10(a)(4)
|
|
Third Amendment to The O.M. Scott & Sons Company Excess
Benefit Plan, effective as of March 18, 2005 (amended title of
plan to be The Scotts Company LLC Excess Benefit Plan)
|
|
Incorporated herein by reference to the Quarterly Report on
Form 10-Q
for the quarterly period ended April 2, 2005 of The Scotts
Miracle-Gro Company (the Registrant) (File
No. 1-13292)
[Exhibit 10(CC)]
|
10(b)(1)
|
|
The Scotts Company LLC Executive/Management Incentive Plan (as
approved by the shareholders of The Scotts Miracle-Gro Company
on January 26, 2006)
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed February 2, 2006 (File
No. 1-13292)
[Exhibit 10.4]
|
10(b)(2)
|
|
The Scotts Company LLC Amended and Restated Executive/Management
Incentive Plan (effective as of November 7, 2007)
|
|
*
|
10(c)(1)
|
|
Specimen form of Employee Confidentiality, Noncompetition,
Nonsolicitation Agreement for employees participating in The
Scotts Company LLC Executive/Management Incentive Plan (now
known as The Scotts Company LLC Amended and Restated
Executive/Management Incentive Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended July 1, 2006 (File
No. 1-13292)
[Exhibit 10.1]
|
10(c)(2)
|
|
Executive Officers of The Scotts Miracle-Gro Company who are
parties to form of Employee Confidentiality, Noncompetition,
Nonsolicitation Agreement for employees participating in The
Scotts Company LLC Executive/Management Incentive Plan (now
known as The Scotts Company LLC Amended and Restated
Executive/Management Incentive Plan)
|
|
*
|
44
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(d)(1)
|
|
The Scotts Company 1996 Stock Option Plan (as amended through
May 15, 2000)
|
|
Incorporated herein by reference to Scotts Quarterly
Report on
Form 10-Q
for the quarterly period ended April 1, 2000 (File
No. 1-13292)
[Exhibit 10(d)]
|
10(d)(2)
|
|
The Scotts Company 1996 Stock Option Plan (2002 Amendment)
|
|
Incorporated herein by reference to Scotts Quarterly
Report on
Form 10-Q
for the quarterly period ended December 28, 2002 (File
No. 1-13292)
[Exhibit 10(d)(i)]
|
10(d)(3)
|
|
Amendment to The Scotts Company 1996 Stock Option
Plan 2005 Amendment, effective as of March 18, 2005
(amended title of plan to be The Scotts Miracle-Gro Company 1996
Stock Option Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended April 2, 2005 (File
No. 1-13292)
[Exhibit 10(z)]
|
10(d)(4)
|
|
The Scotts Miracle-Gro Company Amended and Restated 1996 Stock
Option Plan (effective as of October 30, 2007)
|
|
*
|
10(e)
|
|
Form of 1996 Stock Option Plan Stock Option
Agreement Non-Qualified Stock Option
|
|
Incorporated herein by reference to Scotts Current Report
on
Form 8-K
filed November 19, 2004 (File
No. 1-13292)
[Exhibit 10.7]
|
10(f)
|
|
Specimen form of Stock Option Agreement (as amended through
October 23, 2001) for Non-Qualified Stock Options granted to
employees under The Scotts Company 1996 Stock Option Plan (now
known as The Scotts Miracle-Gro Company Amended and Restated
1996 Stock Option Plan), French specimen
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2001 (File
No. 1-13292)
[Exhibit 10(f)]
|
10(g)(1)
|
|
The Scotts Company Executive Retirement Plan
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 1998 (File
No. 1-11593)
[Exhibit 10(j)]
|
10(g)(2)
|
|
First Amendment to The Scotts Company Executive Retirement Plan,
effective as of January 1, 1999
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2001 (File
No. 1-13292)
[Exhibit 10(g)(2)]
|
10(g)(3)
|
|
Second Amendment to The Scotts Company Executive Retirement
Plan, effective as of January 1, 2000
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2001 (File
No. 1-13292)
[Exhibit 10(g)(3)]
|
10(g)(4)
|
|
Third Amendment to The Scotts Company Executive Retirement Plan,
effective as of January 1, 2003
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2003 (File
No. 1-13292)
[Exhibit 10(g)(4)]
|
45
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(g)(5)
|
|
Fourth Amendment to The Scotts Company Executive Retirement
Plan, effective as of January 1, 2004
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2004 (File
No. 1-13292)
[Exhibit 10(g)(5)]
|
10(g)(6)
|
|
Fifth Amendment to The Scotts Company Executive Retirement Plan,
effective as of March 18, 2005 (amended title of plan to be The
Scotts Company LLC Executive Retirement Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended April 2, 2005 (File
No. 1-13292)
[Exhibit 10(DD)]
|
10(h)
|
|
Employment Agreement, dated as of May 19, 1995, between The
Scotts Company and James Hagedorn
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 1995 (File
No. 1-11593)
[Exhibit 10(p)]
|
10(i)(1)
|
|
Letter agreement, dated June 8, 2000, between The Scotts Company
and Patrick J. Norton
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2000 (File
No. 1-13292)
[Exhibit 10(q)]
|
10(i)(2)
|
|
Letter agreement, dated November 5, 2002, and accepted by Mr.
Norton on November 22, 2002, pertaining to the terms of
employment of Patrick J. Norton through December 31, 2005, and
superseding certain provisions of the letter agreement, dated
June 8, 2000, between The Scotts Company and Mr. Norton
|
|
Incorporated herein by reference to Scotts Annual Report
on
Form 10-K
for the fiscal year ended September 30, 2002 (File
No. 1-13292)
[Exhibit 10(q)]
|
10(i)(3)
|
|
Letter of Extension, dated October 25, 2005, between The Scotts
Miracle-Gro Company and Patrick J. Norton
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed December 14, 2005 (File
No. 1-13292)
[Exhibit 10.3]
|
10(j)(1)
|
|
The Scotts Company 2003 Stock Option and Incentive Equity Plan
(as approved by shareholders of The Scotts Company on January
30, 2003)
|
|
Incorporated herein by reference to Scotts Quarterly
Report on
Form 10-Q
for the quarterly period ended December 28, 2002 (File
No. 1-13292)
[Exhibit 10(w)]
|
10(j)(2)
|
|
First Amendment to The Scotts Company 2003 Stock Option and
Incentive Equity Plan, effective as of March 18, 2005 (amended
title of plan to be The Scotts Miracle-Gro Company 2003 Stock
Option and Incentive Equity Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended April 2, 2005 (File
No. 1-13292)
[Exhibit 10(AA)]
|
10(j)(3)
|
|
The Scotts Miracle-Gro Company Amended and Restated 2003 Stock
Option and Incentive Equity Plan (effective as of October 30,
2007)
|
|
*
|
46
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(k)(1)
|
|
Specimen form of Award Agreement for Nondirectors used to
evidence Incentive Stock Options, Nonqualified Stock Options,
Stock Appreciation Rights, Restricted Stock and Performance
Shares which may be granted under The Scotts-Miracle Gro Company
2003 Stock Option and Incentive Equity Plan (now known as The
Scotts Miracle-Gro Company Amended and Restated 2003 Stock
Option and Incentive Equity Plan)
|
|
Incorporated herein by reference to the Registrants Annual
Report on
Form 10-K
for the fiscal year ended September 30, 2005 (File
No. 1-13292)
[Exhibit 10(u)]
|
10(k)(2)
|
|
Form of letter agreement amending Restricted Stock awards
granted under The Scotts Miracle-Gro Company 2003 Stock Option
and Incentive Equity Plan, as amended (effective as of October
30, 2007)
|
|
*
|
10(l)
|
|
Specimen form of Award Agreement for Directors used to evidence
Nonqualified Stock Options granted under The Scotts Miracle-Gro
Company 2003 Stock Option and Incentive Equity Plan (now known
as The Scotts Miracle-Gro Company Amended and Restated 2003
Stock Option and Incentive Equity Plan)
|
|
Incorporated herein by reference to the Registrants Annual
Report on
Form 10-K
for the fiscal year ended September 30, 2005 (File
No. 1-13292)
[Exhibit 10(v)]
|
10(m)
|
|
Employment Agreement effective as of October 1, 2007, between
The Scotts Company LLC and Barry W. Sanders
|
|
*
|
10(n)
|
|
Employment Agreement effective as of July 1, 2001, between The
Scotts Company LLC and Claude Lopez [English
Translation Original in French]
|
|
*
|
10(o)
|
|
Employment Agreement for Christopher Nagel, entered into
effective as of October 1, 2006, by and between Christopher
Nagel and The Scotts Miracle-Gro Company (voluntarily terminated
effective July 18, 2007)
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed December 7, 2006 (File
No. 1-13292)
[Exhibit 10.1]
|
10(p)
|
|
The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan
Award Agreement for Employees, evidencing Restricted Stock Award
of 38,000 Restricted Stock Awarded to Christopher Nagel on
October 1, 2006 by The Scotts Miracle-Gro Company (forfeited as
a result of voluntary termination effective July 18, 2007)
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed December 7, 2006 (File
No. 1-13292)
[Exhibit 10.2]
|
10(q)
|
|
Separation Agreement and General Release, entered into and
effective as of July 18, 2007, by and between The Scotts
Miracle-Gro Company and Christopher L. Nagel
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed July 18, 2007 (File
No. 1-13292)
[Exhibit 10.1]
|
10(r)(1)
|
|
The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (as
approved by the shareholders of The Scotts Miracle-Gro Company
on January 26, 2006)
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed February 2, 2006 (File
No. 1-13292)
[Exhibit 10.2]
|
10(r)(2)
|
|
The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan (effective as of October 30, 2007)
|
|
*
|
47
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(s)
|
|
Specimen form of Award Agreement used to evidence Time-Based
Nonqualified Stock Options for Non-Employee Directors under The
Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (now
known as The Scotts Miracle-Gro Company Amended and Restated
2006 Long-Term Incentive Plan)
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed February 2, 2006 (File
No. 1-13292)
[Exhibit 10.3]
|
10(t)(1)
|
|
Specimen form of Award Agreement used to evidence awards of
Restricted Stock Units, Performance Shares, Nonqualified Stock
Options, Incentive Stock Options, Restricted Stock and Stock
Appreciation Rights which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan), used prior to October 30, 2007
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 31, 2005 (File
No. 1-13292)
[Exhibit 10(b)]
|
10(t)(2)
|
|
Form of letter agreement amending Restricted Stock awards
granted under The Scotts Miracle-Gro Company 2006 Long-Term
Incentive Plan, as amended (effective as of October 30, 2007)
|
|
*
|
10(t)(3)
|
|
Specimen form of Nonqualified Stock Option Award Agreement for
Employees to evidence grants of Nonqualified Stock Options which
may be made under The Scotts Miracle-Gro Company [Amended and
Restated] 2006 Long-Term Incentive Plan (used after October 30,
2007)
|
|
*
|
10(t)(4)
|
|
Specimen form of Restricted Stock Award Agreement for Employees
to evidence grants of Restricted Stock which may be made under
The Scotts Miracle-Gro Company [Amended and Restated] 2006
Long-Term Incentive Plan (used after October 30, 2007)
|
|
*
|
10(t)(5)
|
|
Specimen form of Performance Share Award Agreement for Employees
(with Related Dividend Equivalents) to evidence grants of
Performance Shares which may be made under The Scotts
Miracle-Gro Company [Amended and Restated] 2006 Long-Term
Incentive Plan (used after October 30, 2007)
|
|
*
|
10(u)
|
|
Specimen form of Award Agreement for Third Party Service
Providers used to evidence awards which may be granted under The
Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (now
known as The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) to third party service providers
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended July 1, 2006 (File
No. 1-13292)
[Exhibit 10.3]
|
10(v)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options, Restricted Stock and Restricted
Stock Units which may be granted under The Scotts Miracle-Gro
Company 2006 Long-Term Incentive Plan (now known as The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) (Standard International Specimen covering
Australian, Canadian and The Netherlands)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 30, 2006 (File
No. 1-13292)
[Exhibit 10.1]
|
48
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(w)
|
|
Specimen form of Award Agreement for Employees used to evidence
Stock Options, Restricted Stock and Restricted Stock Units which
may be granted under The Scotts Miracle-Gro Company 2006
Long-Term Incentive Plan (now known as The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) (Austrian Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 30, 2006 (File
No. 1-13292)
[Exhibit 10.2]
|
10(x)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) (Belgian Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 30, 2006 (File
No. 1-13292)
[Exhibit 10.3]
|
10(y)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options, Restricted Stock, Restricted Stock
Units and Performance Shares which may be granted under The
Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (now
known as The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) (French Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 30, 2006 (File
No. 1-13292)
[Exhibit 10.4]
|
10(z)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) (German Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 30, 2006 (File
No. 1-13292)
[Exhibit 10.5]
|
10(aa)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) (Polish Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 30, 2006 (File
No. 1-13292)
[Exhibit 10.6]
|
10(bb)
|
|
Specimen form of Award Agreement for United Kingdom Employees
used to evidence Nonqualified Stock Options, Restricted Stock
and Restricted Stock Units which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts
Miracle-Gro
Company Amended and Restated 2006
Long-Term
Incentive Plan) (United Kingdom Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on
Form 10-Q
for the quarterly period ended December 30, 2006 (File
No. 1-13292)
[Exhibit 10.7]
|
10(cc)
|
|
The Scotts Miracle-Gro Company Discounted Stock Purchase Plan
(As Amended and Restated as of January 26, 2006; Reflects
2-for-1 Stock Split Distributed on November 9, 2005)
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed February 2, 2006 (File
No. 1-13292)
[Exhibit 10.1]
|
10(dd)
|
|
Summary of Compensation for Directors of The Scotts Miracle-Gro
Company
|
|
*
|
10(ee)
|
|
Separation Agreement and General Release, entered into and
effective as of July 17, 2007 by and between The Scotts
Miracle-Gro Company and David M. Aronowitz
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed July 17, 2007 (File
No. 1-13292)
[Exhibit 10.1]
|
49
The exhibits listed on the Index to Exhibits
beginning on page 102 of this Annual Report on
Form 10-K
are filed with this Annual Report on
Form 10-K
or incorporated herein by reference as noted in the Index
to Exhibits.
|
|
(c)
|
FINANCIAL STATEMENT
SCHEDULE
|
The financial statement schedule filed with this Annual Report
on
Form 10-K
is submitted in a separate section hereof. For a description of
such financial statement schedule, see Index to
Consolidated Financial Statements and Financial Statement
Schedule on page 53 of this Annual Report on
Form 10-K.
50
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this Report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
THE SCOTTS MIRACLE-GRO COMPANY
|
Dated: November 29, 2007
|
|
By: /s/ James
Hagedorn
James
Hagedorn, President, Chief Executive
Officer and Chairman of the Board
|
Pursuant to the requirements of the Securities Exchange Act of
1934, this Report has been signed below by the following persons
on behalf of the Registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
/s/ Mark
R.
Baker*
Mark
R. Baker
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Gordon
F.
Brunner*
Gordon
F. Brunner
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Arnold
W.
Donald*
Arnold
W. Donald
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ David
C. Evans
David
C. Evans
|
|
Executive Vice President and Chief Financial Officer (Principal
Financial Officer and Principal Accounting Officer)
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Joseph
P.
Flannery*
Joseph
P. Flannery
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ James
Hagedorn
James
Hagedorn
|
|
President, Chief Executive Officer, Chairman of the Board and
Director (Principal Executive Officer)
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Thomas
N. Kelly
Jr.*
Thomas
N. Kelly Jr.
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Katherine
Hagedorn
Littlefield*
Katherine
Hagedorn Littlefield
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Karen
G.
Mills*
Karen
G. Mills
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Nancy
G.
Mistretta*
Nancy
G. Mistretta
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ Patrick
J.
Norton*
Patrick
J. Norton
|
|
Director
|
|
November 29, 2007
|
51
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
/s/ Stephanie
M.
Shern*
Stephanie
M. Shern
|
|
Director
|
|
November 29, 2007
|
|
|
|
|
|
/s/ John
S.
Shiely*
John
S. Shiely
|
|
Director
|
|
November 29, 2007
|
|
|
|
* |
|
The undersigned, by signing his name hereto, does hereby sign
this Report on behalf of each of the directors of the Registrant
identified above pursuant to Powers of Attorney executed by the
directors identified above, which Powers of Attorney are filed
with this Report as exhibits. |
David C. Evans,
Attorney-in-Fact
52
INDEX TO
CONSOLIDATED FINANCIAL STATEMENTS
AND FINANCIAL STATEMENT SCHEDULE
|
|
|
|
|
|
|
Page
|
|
Consolidated Financial Statements of The Scotts Miracle-Gro
Company and Subsidiaries:
|
|
|
|
|
|
|
|
54
|
|
|
|
|
55
|
|
|
|
|
57
|
|
|
|
|
58
|
|
|
|
|
59
|
|
|
|
|
60
|
|
|
|
|
61
|
|
Schedule Supporting the Consolidated Financial Statements:
|
|
|
|
|
|
|
|
100
|
|
|
|
|
101
|
|
Schedules other than the schedule listed above are omitted since
they are not required or are not applicable, or the required
information is shown in the Consolidated Financial Statements or
Notes thereto.
53
ANNUAL
REPORT OF MANAGEMENT ON INTERNAL
CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining
adequate internal control over financial reporting to provide
reasonable assurance regarding the reliability of our financial
reporting and the preparation of financial statements for
external purposes in accordance with accounting principles
generally accepted in the United States of America. Internal
control over financial reporting includes those policies and
procedures that (i) pertain to the maintenance of records
that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of The Scotts
Miracle-Gro Company and our consolidated subsidiaries;
(ii) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial
statements in accordance with accounting principles generally
accepted in the United States of America, and that receipts and
expenditures of The Scotts Miracle-Gro Company and our
consolidated subsidiaries are being made only in accordance with
authorizations of management and directors of The Scotts
Miracle-Gro Company and our consolidated subsidiaries, as
appropriate; and (iii) provide reasonable assurance
regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the assets of The Scotts
Miracle-Gro Company and our consolidated subsidiaries that could
have a material effect on the consolidated financial statements.
Management, with the participation of our principal executive
officer and principal financial officer, assessed the
effectiveness of our internal control over financial reporting
as of September 30, 2007, the end of our fiscal year.
Management based its assessment on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission. Managements assessment included evaluation of
such elements as the design and operating effectiveness of key
financial reporting controls, process documentation, accounting
policies and our overall control environment. This assessment is
supported by testing and monitoring performed under the
direction of management.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluations of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
Accordingly, even an effective system of internal control over
financial reporting will provide only reasonable assurance with
respect to financial statement preparation.
Based on our assessment, management has concluded that our
internal control over financial reporting was effective as of
September 30, 2007, to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external reporting
purposes in accordance with accounting principles generally
accepted in the United States of America. We reviewed the
results of managements assessment with the Audit Committee
of The Scotts Miracle-Gro Company.
Our independent registered public accounting firm,
Deloitte & Touche LLP, independently audited our
internal control over financial reporting and has issued their
report which appears herein.
|
|
|
/s/ James
Hagedorn
|
|
/s/ David
C. Evans
|
James Hagedorn
|
|
David C. Evans
|
President, Chief Executive Officer
|
|
Executive Vice President
|
and Chairman of the Board
|
|
and Chief Financial Officer
|
Dated: November 29, 2007
|
|
Dated: November 29, 2007
|
54
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
The Scotts Miracle-Gro Company
Marysville, Ohio
We have audited the accompanying consolidated balance sheets of
The Scotts Miracle-Gro Company and Subsidiaries (the
Company) as of September 30, 2007 and 2006, and
the related consolidated statements of operations,
shareholders equity, and cash flows for each of the three
years in the period ended September 30, 2007. These
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of the
Company as of September 30, 2007 and 2006, and the results
of its operations and its cash flows for each of the three years
in the period ended September 30, 2007, in conformity with
accounting principles generally accepted in the United States of
America.
As discussed in Note 1 to the financial statements on
September 30, 2007 the Company adopted Statement of
Financial Accounting Standards No. 158, Employers
Accounting for Defined Benefit Pension and Other Postretirement
Plans.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
Companys internal control over financial reporting as of
September 30, 2007, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission and our report dated November 29, 2007 expressed
an unqualified opinion on the Companys internal control
over financial reporting.
/s/ Deloitte &
Touche LLP
Columbus, Ohio
November 29, 2007
55
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of
The Scotts Miracle-Gro Company
Marysville, Ohio
We have audited the internal control over financial reporting of
The Scotts Miracle-Gro Company and Subsidiaries (the
Company) as of September 30, 2007, based on
criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission. The Companys
management is responsible for maintaining effective internal
control over financial reporting and for its assessment of the
effectiveness of internal control over financial reporting,
included in the accompanying Annual Report of Management on
Internal Control Over Financial Reporting. Our responsibility is
to express an opinion on the Companys internal control
over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed by, or under the supervision of, the
companys principal executive and principal financial
officers, or persons performing similar functions, and effected
by the companys board of directors, management, and other
personnel to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of the inherent limitations of internal control over
financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements
due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the
effectiveness of the internal control over financial reporting
to future periods are subject to the risk that the controls may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.
In our opinion, the Company maintained, in all material
respects, effective internal control over financial reporting as
of September 30, 2007, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated financial statements as of and for the year ended
September 30, 2007 of the Company and our report dated
November 29, 2007 expressed an unqualified opinion on those
financial statements, and included an explanatory paragraph
relating to the Companys adoption of Statement of
Financial Accounting Standards No. 158, Employers
Accounting for Defined Benefit Pension and Other Postretirement
Plans on September 30, 2007.
/s/ Deloitte & Touche LLP
Columbus, Ohio
November 29, 2007
56
The Scotts
Miracle-Gro Company
Consolidated
Statements of Operations
for the fiscal years ended September 30, 2007, 2006 and
2005
(in millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Net sales
|
|
$
|
2,871.8
|
|
|
$
|
2,697.1
|
|
|
$
|
2,369.3
|
|
Cost of sales
|
|
|
1,867.3
|
|
|
|
1,741.1
|
|
|
|
1,509.2
|
|
Restructuring and other charges
|
|
|
|
|
|
|
0.1
|
|
|
|
(0.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
1,004.5
|
|
|
|
955.9
|
|
|
|
860.4
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
700.9
|
|
|
|
636.9
|
|
|
|
633.8
|
|
Impairment, restructuring and other charges
|
|
|
38.0
|
|
|
|
75.7
|
|
|
|
33.2
|
|
Other income, net
|
|
|
(11.5
|
)
|
|
|
(9.2
|
)
|
|
|
(7.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations
|
|
|
277.1
|
|
|
|
252.5
|
|
|
|
200.9
|
|
Costs related to refinancings
|
|
|
18.3
|
|
|
|
|
|
|
|
1.3
|
|
Interest expense
|
|
|
70.7
|
|
|
|
39.6
|
|
|
|
41.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
188.1
|
|
|
|
212.9
|
|
|
|
158.1
|
|
Income taxes
|
|
|
74.7
|
|
|
|
80.2
|
|
|
|
57.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
113.4
|
|
|
|
132.7
|
|
|
|
100.4
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
113.4
|
|
|
$
|
132.7
|
|
|
$
|
100.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.74
|
|
|
$
|
1.97
|
|
|
$
|
1.51
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.74
|
|
|
$
|
1.97
|
|
|
$
|
1.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.69
|
|
|
$
|
1.91
|
|
|
$
|
1.47
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.69
|
|
|
$
|
1.91
|
|
|
$
|
1.47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
57
The Scotts
Miracle-Gro Company
Consolidated
Statements of Cash Flows
for the fiscal years ended September 30, 2007, 2006 and
2005
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
113.4
|
|
|
$
|
132.7
|
|
|
$
|
100.6
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment and other charges
|
|
|
38.0
|
|
|
|
66.4
|
|
|
|
23.4
|
|
Costs related to refinancings
|
|
|
18.3
|
|
|
|
|
|
|
|
1.3
|
|
Stock-based compensation expense
|
|
|
13.3
|
|
|
|
15.7
|
|
|
|
10.7
|
|
Depreciation
|
|
|
51.4
|
|
|
|
51.0
|
|
|
|
49.6
|
|
Amortization
|
|
|
16.1
|
|
|
|
16.0
|
|
|
|
17.6
|
|
Deferred taxes
|
|
|
6.3
|
|
|
|
(0.4
|
)
|
|
|
(13.6
|
)
|
Gain on sale of property, plant and equipment
|
|
|
(0.4
|
)
|
|
|
(0.5
|
)
|
|
|
|
|
Changes in assets and liabilities, net of acquired businesses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(4.2
|
)
|
|
|
(37.6
|
)
|
|
|
(37.9
|
)
|
Inventories
|
|
|
13.2
|
|
|
|
(60.6
|
)
|
|
|
(15.8
|
)
|
Prepaid and other current assets
|
|
|
(6.9
|
)
|
|
|
(3.6
|
)
|
|
|
8.1
|
|
Accounts payable
|
|
|
(3.5
|
)
|
|
|
34.3
|
|
|
|
10.3
|
|
Accrued taxes and liabilities
|
|
|
(2.0
|
)
|
|
|
(33.4
|
)
|
|
|
27.9
|
|
Restructuring reserves
|
|
|
(5.0
|
)
|
|
|
(9.2
|
)
|
|
|
10.3
|
|
Other non-current items
|
|
|
6.8
|
|
|
|
2.0
|
|
|
|
6.6
|
|
Other, net
|
|
|
(8.2
|
)
|
|
|
9.6
|
|
|
|
27.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
246.6
|
|
|
|
182.4
|
|
|
|
226.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Redemption of available for sale securities
|
|
|
|
|
|
|
|
|
|
|
57.2
|
|
Proceeds from sale of property, plant and equipment
|
|
|
0.5
|
|
|
|
1.3
|
|
|
|
|
|
Investment in property, plant and equipment
|
|
|
(54.0
|
)
|
|
|
(57.0
|
)
|
|
|
(40.4
|
)
|
Investments in acquired businesses, net of cash acquired
|
|
|
(18.7
|
)
|
|
|
(118.4
|
)
|
|
|
(77.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(72.2
|
)
|
|
|
(174.1
|
)
|
|
|
(60.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Borrowings under revolving and bank lines of credit and term
loans
|
|
|
2,519.2
|
|
|
|
746.9
|
|
|
|
924.2
|
|
Repayments under revolving and bank lines of credit and term
loans
|
|
|
(1,710.5
|
)
|
|
|
(691.7
|
)
|
|
|
(736.4
|
)
|
Repayment of term loans
|
|
|
|
|
|
|
|
|
|
|
(399.0
|
)
|
Repayment of
65/8% senior
subordinated notes
|
|
|
(209.6
|
)
|
|
|
|
|
|
|
|
|
Financing and issuance fees
|
|
|
(13.0
|
)
|
|
|
|
|
|
|
(3.6
|
)
|
Dividends paid
|
|
|
(543.6
|
)
|
|
|
(33.5
|
)
|
|
|
(8.6
|
)
|
Payments on sellers notes
|
|
|
(2.7
|
)
|
|
|
(4.5
|
)
|
|
|
(6.9
|
)
|
Purchase of common shares
|
|
|
(246.8
|
)
|
|
|
(87.9
|
)
|
|
|
|
|
Excess tax benefits from share-based payment arrangements
|
|
|
19.0
|
|
|
|
6.2
|
|
|
|
|
|
Cash received from exercise of stock options
|
|
|
29.2
|
|
|
|
17.6
|
|
|
|
32.2
|
|
Proceeds from termination of interest rate swaps
|
|
|
|
|
|
|
|
|
|
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities
|
|
|
(158.8
|
)
|
|
|
(46.9
|
)
|
|
|
(195.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes
|
|
|
4.2
|
|
|
|
6.5
|
|
|
|
(6.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
19.8
|
|
|
|
(32.1
|
)
|
|
|
(35.4
|
)
|
Cash and cash equivalents, beginning of year
|
|
|
48.1
|
|
|
|
80.2
|
|
|
|
115.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of year
|
|
$
|
67.9
|
|
|
$
|
48.1
|
|
|
$
|
80.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid, net of interest capitalized
|
|
|
(75.9
|
)
|
|
|
(38.2
|
)
|
|
|
(39.9
|
)
|
Income taxes paid
|
|
|
(65.2
|
)
|
|
|
(60.3
|
)
|
|
|
(64.0
|
)
|
See Notes to Consolidated Financial Statements.
58
The Scotts
Miracle-Gro Company
Consolidated
Balance Sheets
September 30, 2007 and 2006
(in millions except per share data)
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
67.9
|
|
|
$
|
48.1
|
|
Accounts receivable, less allowances of $11.4 in 2007 and $11.3
in 2006
|
|
|
248.3
|
|
|
|
380.4
|
|
Accounts receivable pledged
|
|
|
149.5
|
|
|
|
|
|
Inventories, net
|
|
|
405.9
|
|
|
|
409.2
|
|
Prepaid and other assets
|
|
|
127.7
|
|
|
|
104.3
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
999.3
|
|
|
|
942.0
|
|
Property, plant and equipment, net
|
|
|
365.9
|
|
|
|
367.6
|
|
Goodwill
|
|
|
462.9
|
|
|
|
458.1
|
|
Intangible assets, net
|
|
|
418.8
|
|
|
|
424.7
|
|
Other assets
|
|
|
30.3
|
|
|
|
25.2
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
2,277.2
|
|
|
$
|
2,217.6
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Current portion of debt
|
|
$
|
86.4
|
|
|
$
|
6.0
|
|
Accounts payable
|
|
|
202.5
|
|
|
|
200.4
|
|
Accrued liabilities
|
|
|
286.8
|
|
|
|
269.1
|
|
Accrued taxes
|
|
|
10.9
|
|
|
|
20.7
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
586.6
|
|
|
|
496.2
|
|
Long-term debt
|
|
|
1,031.4
|
|
|
|
475.2
|
|
Other liabilities
|
|
|
179.9
|
|
|
|
164.5
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
1,797.9
|
|
|
|
1,135.9
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Notes 15, 16 and 17)
|
|
|
|
|
|
|
|
|
Shareholders equity:
|
|
|
|
|
|
|
|
|
Common shares and capital in excess of $.01 stated value
per share; shares issued and outstanding of 64.1 in 2007 and
66.6 in 2006
|
|
|
480.3
|
|
|
|
509.1
|
|
Retained earnings
|
|
|
260.5
|
|
|
|
690.7
|
|
Treasury shares, at cost; 4.0 shares in 2007 and
1.5 shares in 2006
|
|
|
(219.5
|
)
|
|
|
(66.5
|
)
|
Accumulated other comprehensive loss
|
|
|
(42.0
|
)
|
|
|
(51.6
|
)
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
479.3
|
|
|
|
1,081.7
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
2,277.2
|
|
|
$
|
2,217.6
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
59
The Scotts
Miracle-Gro Company
Consolidated
Statements of Shareholders Equity
for the fiscal years ended September 30, 2007, 2006 and
2005
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
Common Stock
|
|
|
Excess of
|
|
|
Deferred
|
|
|
Retained
|
|
|
Treasury Stock
|
|
|
Comprehensive
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Stated Value
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Shares
|
|
|
Amount
|
|
|
Income/(loss)
|
|
|
Total
|
|
|
|
|
Balance, September 30, 2004
|
|
|
65.7
|
|
|
$
|
0.3
|
|
|
$
|
443.0
|
|
|
$
|
(10.4
|
)
|
|
$
|
499.5
|
|
|
|
|
|
|
$
|
|
|
|
$
|
(57.8
|
)
|
|
$
|
874.6
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.6
|
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.1
|
|
|
|
4.1
|
|
Unrecognized gain on derivatives, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.1
|
|
|
|
2.1
|
|
Minimum pension liability, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5.0
|
)
|
|
|
(5.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.8
|
|
Stock-based compensation awarded
|
|
|
|
|
|
|
|
|
|
|
15.1
|
|
|
|
(15.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation forfeitures
|
|
|
|
|
|
|
|
|
|
|
(2.6
|
)
|
|
|
2.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.7
|
|
Cash dividends paid ($0.125 per share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.6
|
)
|
Issuance of common shares
|
|
|
2.1
|
|
|
|
|
|
|
|
47.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2005
|
|
|
67.8
|
|
|
|
0.3
|
|
|
|
503.2
|
|
|
|
(12.2
|
)
|
|
|
591.5
|
|
|
|
|
|
|
|
|
|
|
|
(56.6
|
)
|
|
|
1,026.2
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
132.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
132.7
|
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1.5
|
)
|
|
|
(1.5
|
)
|
FAS 123(R) reclassification
|
|
|
|
|
|
|
|
|
|
|
(12.2
|
)
|
|
|
12.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum pension liability, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.5
|
|
|
|
6.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
137.7
|
|
Stock-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
15.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.7
|
|
Cash dividends paid ($0.50 per share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(33.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(33.5
|
)
|
Treasury stock purchases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.0
|
|
|
|
(87.9
|
)
|
|
|
|
|
|
|
(87.9
|
)
|
Treasury stock issuances
|
|
|
|
|
|
|
|
|
|
|
(21.4
|
)
|
|
|
|
|
|
|
|
|
|
|
(0.5
|
)
|
|
|
21.4
|
|
|
|
|
|
|
|
|
|
Issuance of common shares
|
|
|
0.3
|
|
|
|
|
|
|
|
23.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2006
|
|
|
68.1
|
|
|
|
0.3
|
|
|
|
508.8
|
|
|
|
|
|
|
|
690.7
|
|
|
|
1.5
|
|
|
|
(66.5
|
)
|
|
|
(51.6
|
)
|
|
|
1,081.7
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
113.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
113.4
|
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.9
|
|
|
|
4.9
|
|
Unrecognized gain (loss) on derivatives, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2.4
|
)
|
|
|
(2.4
|
)
|
Minimum pension liability, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.4
|
|
|
|
20.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
136.3
|
|
Adjustment to initially apply SFAS 158, net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13.3
|
)
|
|
|
(13.3
|
)
|
Stock-based compensation expense (non cash)
|
|
|
|
|
|
|
|
|
|
|
13.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.3
|
|
Cash dividends paid ($8.50 per share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(543.6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(543.6
|
)
|
Treasury stock purchases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.5
|
|
|
|
(246.8
|
)
|
|
|
|
|
|
|
(246.8
|
)
|
Treasury stock issuances
|
|
|
|
|
|
|
|
|
|
|
(42.1
|
)
|
|
|
|
|
|
|
|
|
|
|
(2.0
|
)
|
|
|
93.8
|
|
|
|
|
|
|
|
51.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2007
|
|
|
68.1
|
|
|
$
|
0.3
|
|
|
$
|
480.0
|
|
|
$
|
|
|
|
$
|
260.5
|
|
|
|
4.0
|
|
|
$
|
(219.5
|
)
|
|
$
|
(42.0
|
)
|
|
$
|
479.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
60
The Scotts
Miracle-Gro Company
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 1.
|
SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES
|
Nature of
Operations
The Scotts Miracle-Gro Company (Scotts Miracle-Gro)
and its subsidiaries (collectively, the Company) are
engaged in the manufacture, marketing and sale of lawn and
garden care products. The Companys major customers include
home improvement centers, mass merchandisers, warehouse clubs,
large hardware chains, independent hardware stores, nurseries,
garden centers, food and drug stores, commercial nurseries and
greenhouses, and specialty crop growers. The Companys
products are sold primarily in North America and the European
Union. We also operate the Scotts
LawnService®
business which provides lawn and tree and shrub fertilization,
insect control and other related services in the United States
and Smith &
Hawken®,
a leading brand in the outdoor living and gardening lifestyle
category. Effective November 18, 2005, the Company entered
the North America wild bird food category with the acquisition
of Gutwein & Co., Inc. (Gutwein).
Due to the nature of the lawn and garden business, the majority
of shipments to retailers occur in the Companys second and
third fiscal quarters. On a combined basis, net sales for the
second and third fiscal quarters generally represent 70% to 75%
of annual net sales.
Organization
and Basis of Presentation
The Companys consolidated financial statements are
presented in accordance with accounting principles generally
accepted in the United States of America. The consolidated
financial statements include the accounts of Scotts Miracle-Gro
and all wholly-owned and majority-owned subsidiaries. All
intercompany transactions and accounts are eliminated in
consolidation. The Companys criteria for consolidating
entities is based on majority ownership (as evidenced by a
majority voting interest in the entity) and an objective
evaluation and determination of effective management control.
Revenue
Recognition
Revenue is recognized when title and risk of loss transfer,
which generally occurs when products are received by the
customer. Provisions for estimated returns and allowances are
recorded at the time revenue is recognized based on historical
rates and are periodically adjusted for known changes in return
levels. Shipping and handling costs are included in cost of
sales. Scotts
LawnService®
revenues are recognized at the time service is provided to the
customer.
Under the terms of the Amended and Restated Exclusive Agency and
Marketing Agreement (the Marketing Agreement)
between the Company and Monsanto Company (Monsanto),
the Company, in its role as exclusive agent, performs certain
functions, such as sales support, merchandising, distribution
and logistics, and incurs certain costs in support of the
consumer
Roundup®
business. The actual costs incurred by the Company on behalf of
Roundup®
are recovered from Monsanto through the terms of the Marketing
Agreement. The reimbursement of costs for which the Company is
considered the primary obligor is included in net sales.
Promotional
Allowances
The Company promotes its branded products through cooperative
advertising programs with retailers. Retailers also are offered
in-store promotional allowances and rebates based on sales
volumes. Certain products are promoted with direct consumer
rebate programs and special purchasing incentives. Promotion
costs (including allowances and rebates) incurred during the
year are expensed to interim periods in relation to revenues and
are recorded as a reduction of net sales. Accruals for expected
payouts under the programs are included in the Accrued
liabilities line in the Consolidated Balance Sheets.
Advertising
The Company advertises its branded products through national and
regional media. Advertising costs incurred during the year are
expensed to interim periods in relation to revenues. All
advertising costs, except for external production costs, are
expensed within the fiscal year in which such costs are
61
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
incurred. External production costs for advertising programs are
deferred until the period in which the advertising is first
aired.
Scotts
LawnService®
promotes its service offerings primarily through direct mail
campaigns. External costs associated with these campaigns that
qualify as direct response advertising costs are deferred and
recognized as advertising expense in proportion to revenues over
a period not beyond the end of the subsequent calendar year.
Costs that are not direct advertising costs are expensed within
the fiscal year incurred on a monthly basis in proportion of net
sales. The costs deferred at September 30, 2007 and 2006
were $5.7 million and $5.6 million, respectively.
Advertising expenses were $150.9 million in fiscal 2007,
$137.3 million in fiscal 2006 and $122.5 million in
fiscal 2005.
Research and
Development
All costs associated with research and development are charged
to expense as incurred. Expense for fiscal 2007, 2006 and 2005
was $38.8 million, $35.1 million and
$38.0 million including registrations of $9.3 million,
$8.2 million and $7.5 million, respectively.
Environmental
Costs
The Company recognizes environmental liabilities when conditions
requiring remediation are probable and the amounts can be
reasonably estimated. Expenditures which extend the life of the
related property or mitigate or prevent future environmental
contamination are capitalized. Environmental liabilities are not
discounted or reduced for possible recoveries from insurance
carriers.
Stock-Based
Compensation Awards
In fiscal 2003, the Company began expensing prospective grants
of employee stock-based compensation awards in accordance with
SFAS 123, Accounting for Stock-Based
Compensation. The Company adopted SFAS 123(R),
Share-Based Payment effective October 1, 2005,
following the modified prospective application approach. The
Company was already in substantial compliance with
SFAS 123(R) at the adoption date as SFAS 123(R)
closely parallels SFAS 123. The fair value of awards is
expensed ratably over the vesting period, generally three years,
except for grants to members of the Board of Directors of Scotts
Miracle-Gro that have a shorter vesting period. The Company uses
a binomial model to fair value its option grants.
Earnings per
Common Share
Basic earnings per common share is computed based on the
weighted-average number of common shares outstanding each
period. Diluted earnings per common share is computed based on
the weighted-average number of common shares and dilutive
potential common shares (stock options, restricted stock,
performance shares and stock appreciation rights) outstanding
each period.
Cash and Cash
Equivalents
The Company considers all highly liquid financial instruments
with original maturities of three months or less to be cash
equivalents. The Company maintains cash deposits in banks which
from time to time exceed the amount of deposit insurance
available. Management periodically assesses the financial
condition of the institutions and believes that any potential
credit loss is minimal.
Accounts
Receivable and Allowances
Trade accounts receivable are recorded at the invoiced amount
and do not bear interest. Allowances reflect our best estimate
of amounts in our existing accounts receivable that may not be
collected due to customer claims, the return of goods, or
customer inability or unwillingness to pay. We determine the
allowance based on customer risk assessment and historical
experience. We review our allowances monthly. Past due balances
over 90 days and in excess of a specified amount are
reviewed individually for collectibility. All other balances are
reviewed on a pooled basis by type of receivable. Account
62
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
balances are charged off against the allowance when we feel it
is probable the receivable will not be recovered. We do not have
any off-balance-sheet credit exposure related to our customers.
Inventories
Inventories are stated at the lower of cost or market,
principally determined by the FIFO method. Certain growing media
inventories are accounted for by the LIFO method. Approximately
5% of inventories were valued at the lower of LIFO cost or
market at September 30, 2007 and 2006. Inventories include
the cost of raw materials, labor, manufacturing overhead, and
freight and in-bound handling costs incurred to pre-position
goods in the Companys warehouse network. The Company makes
provisions for obsolete or slow-moving inventories as necessary
to properly reflect inventory at the lower of cost or market
value. Reserves for excess and obsolete inventories were
$15.6 million and $15.1 million at September 30,
2007 and 2006, respectively.
Goodwill and
Indefinite-lived Intangible Assets
In accordance with SFAS 142, Goodwill and Other
Intangible Assets, goodwill and intangible assets
determined to have indefinite lives are not subject to
amortization. Goodwill and indefinite-lived intangible assets
are reviewed for impairment by applying a fair-value based test
on an annual basis or more frequently if circumstances indicate
a potential impairment. If it is determined that an impairment
has occurred, an impairment loss is recognized for the amount by
which the carrying amount of the asset exceeds its estimated
fair value and classified as Impairment, restructuring and
other charges in the Consolidated Statement of Operations.
During the third quarter of fiscal 2007, the Company changed the
timing of its annual goodwill impairment testing from the last
day of the fiscal first quarter to the first day of the fiscal
fourth quarter. As such, the annual impairment test was
performed as of December 30, 2006 and was performed again
as of July 1, 2007. This accounting is preferable in the
circumstances as moving the timing of our annual goodwill
impairment testing better aligns with the seasonal nature of the
business and the timing of the annual strategic planning
process. The Company believes that this change in accounting
principle will not delay, accelerate, or avoid an impairment
charge. In addition, the Company also changed the date of its
annual indefinite life intangible impairment testing to the
first day of the fiscal fourth quarter for the current year. The
Company determined that the change in accounting principle
related to the annual testing date does not result in
adjustments to the financial statements applied retrospectively.
Long-lived
Assets
Property, plant and equipment are stated at cost. Interest
capitalized on capital projects amounted to $0.4 million,
$0.5 million and $0.3 million during fiscal 2007,
fiscal 2006 and fiscal 2005, respectively. Expenditures for
maintenance and repairs are charged to expense as incurred. When
properties are retired or otherwise disposed of, the cost of the
asset and the related accumulated depreciation are removed from
the accounts with the resulting gain or loss being reflected in
income from operations.
Depreciation of property, plant and equipment is provided on the
straight-line method and is based on the estimated useful
economic lives of the assets as follows:
|
|
|
|
|
Land improvements
|
|
|
10 25 years
|
|
Buildings
|
|
|
10 40 years
|
|
Machinery and equipment
|
|
|
3 15 years
|
|
Furniture and fixtures
|
|
|
6 10 years
|
|
Software
|
|
|
3 8 years
|
|
Intangible assets with finite lives, and therefore subject to
amortization, include technology (e.g., patents), customer
accounts, and certain tradenames. These intangible assets are
being amortized on the straight-line method over periods
typically ranging from 10 to 25 years. The Companys
fixed assets and intangible assets subject to amortization are
required to be tested for recoverability under SFAS 144,
Accounting for the Impairment or Disposal of Long-Lived
Assets, whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable.
63
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Internal Use
Software
The Company accounts for the costs of internal use software in
accordance with Statement of Position
98-1,
Accounting for the Costs of Computer Software Developed or
Obtained for Internal Use. Accordingly, costs are expensed
or capitalized depending on whether they are incurred in the
preliminary project stage, application development stage or the
post-implementation/operation stage. As of September 30,
2007 and 2006, the Company had $31.1 million and
$29.4 million, respectively, in unamortized capitalized
internal use computer software costs. Amortization of these
costs was $12.1 million, $10.7 million and
$9.6 million during fiscal 2007, 2006 and 2005,
respectively.
Accruals for
Self-Insured Losses
The Company maintains insurance for certain risks, including
workers compensation, general liability and vehicle
liability, and is self-insured for employee related health care
benefits. The Company accrues for the expected costs associated
with these risks by considering historical claims experience,
demographic factors, severity factors, and other relevant
information. Costs are recognized in the period the claim is
incurred, and the financial statement accruals include an
actuarially determined estimate of claims incurred but not yet
reported.
Translation of
Foreign Currencies
For all foreign operations, the functional currency is the local
currency. Assets and liabilities of these operations are
translated at the exchange rate in effect at each year-end.
Income and expense accounts are translated at the average rate
of exchange prevailing during the year. Translation gains and
losses arising from the use of differing exchange rates from
period to period are included in other comprehensive income, a
component of shareholders equity. Foreign currency
transaction gains and losses are included in the determination
of net income and amounted to a loss of $0.2 million, a
loss of $0.7 million and a gain of $2.1 million in
fiscal years 2007, 2006 and 2005, respectively.
Derivative
Instruments
In the normal course of business, the Company is exposed to
fluctuations in interest rates, the value of foreign currencies,
and the cost of commodities. A variety of financial instruments,
including forward and swap contracts, are used to manage these
exposures. The Companys objective in managing these
exposures is to better control these elements of cost and
mitigate the earnings and cash flow volatility associated with
changes in the applicable rates and prices.
The Company has established policies and procedures that
encompass risk-management philosophy and objectives, guidelines
for derivative-instrument usage, counterparty credit approval,
and the monitoring and reporting of derivative activity. The
Company does not enter into derivative instruments for the
purpose of speculation.
Use of
Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions
that affect the amounts reported in the consolidated financial
statements and accompanying disclosures. Although these
estimates are based on managements best knowledge of
current events and actions the Company may undertake in the
future, actual results ultimately may differ from the estimates.
Variable
Interest Entities
Financial Accounting Standards Board (FASB) Interpretation
46(R), Consolidation of Variable Interest Entities, an
Interpretation of ARB No. 51 (FIN 46(R))
provides a framework for identifying variable interest entities
(VIEs) and determining when a company should include the assets,
liabilities, noncontrolling interests, and results of operations
of a VIE in its consolidated financial statements. In general, a
VIE is a corporation, partnership, limited liability company,
trust, or any other legal structure used to conduct activities
or hold assets that either (1) has an insufficient amount
of equity to carry out its principal activities without
additional subordinated financial support, (2) has a group
of equity owners that are
64
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
unable to make significant decisions about its activities, or
(3) has a group of equity owners that do not have the
obligation to absorb losses or the right to receive returns
generated by its operations.
FIN 46(R) requires a VIE to be consolidated if a party with
an ownership, contractual or other financial interest in the VIE
(a variable interest holder) is obligated to absorb a majority
of the risk of loss from the VIEs activities, is entitled
to receive a majority of the VIEs residual returns (if no
party absorbs a majority of the VIEs losses), or both. A
variable interest holder that consolidates the VIE is called the
primary beneficiary. Upon consolidation, the primary beneficiary
generally must initially record all of the VIEs assets,
liabilities and noncontrolling interests at fair value and
subsequently account for the VIE as if it were consolidated
based on majority voting interest. FIN 46(R) also requires
disclosures about VIEs that the variable interest holder is not
required to consolidate but in which it has a significant
variable interest.
The Companys Scotts
LawnService®
business sells new franchise territories, primarily in small to
mid-size markets, under arrangements where a portion of the
franchise fee is paid in cash with the balance due under a
promissory note. The Company believes that it may be the primary
beneficiary for certain of its franchisees initially, but ceases
to be the primary beneficiary as the franchisees develop their
businesses and the promissory notes are repaid. At
September 30, 2007, the Company had approximately
$2.3 million in notes receivable from such franchisees. The
effect of consolidating the entities where the Company may be
the primary beneficiary for a limited period of time is not
material to either the Consolidated Statements of Operations or
the Consolidated Balance Sheets.
New Accounting
Pronouncements
Statement of
Financial Accounting Standards No. 158
Employers Accounting For Defined Benefit Pension And Other
Postretirement Plans
In September 2006, the Financial Accounting Standards Board
issued SFAS 158, Employers Accounting for
Defined Benefit Pension and Other Postretirement Plans, an
amendment of FASB Statements No. 87, 88, 106, and
132(R). The Company adopted the recognition and disclosure
provisions of SFAS 158 as required on September 30,
2007. SFAS 158 requires the Company to record non-cash
adjustments to recognize the funded status of each of its
defined pension and postretirement benefit plans, measured as
the difference between the plan assets and the benefit
obligation, as a net asset or liability in its statement of
financial position with an offsetting amount in accumulated
other comprehensive income or loss, and to recognize changes in
that funded status in the year in which changes occur through
comprehensive income or loss. The Company was already in
compliance with the SFAS 158 requirement to measure plan
assets and liabilities as of the Companys fiscal year end.
The adoption of SFAS 158 had no effect on the
Companys Consolidated Statement of Operations for any
period presented, and it will not affect the Companys
operating results in future periods. SFAS 158 does not
change the way the Company measures plan assets and benefit
obligations or the determination of net periodic benefit cost.
The following table reflects the effects of the adoption of
SFAS 158 on the Companys Consolidated Balance Sheet
as of September 30, 2007. See the related footnote
disclosures in Note 8, Retirement Plans and Note 9,
Associate Medical Benefits.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior to Adopting
|
|
|
Effect of Adopting
|
|
|
As Reported under
|
|
|
|
SFAS 158
|
|
|
SFAS 158
|
|
|
SFAS 158
|
|
|
|
|
|
(In millions)
|
|
|
Prepaid and other assets
|
|
$
|
136.8
|
|
|
$
|
(9.1
|
)
|
|
$
|
127.7
|
|
Accrued liabilities
|
|
|
283.1
|
|
|
|
3.7
|
|
|
|
286.8
|
|
Other liabilities
|
|
|
179.4
|
|
|
|
0.5
|
|
|
|
179.9
|
|
Total liabilities
|
|
|
1,793.7
|
|
|
|
4.2
|
|
|
|
1,797.9
|
|
Accumulated other comprehensive gain (loss)
|
|
|
(28.7
|
)
|
|
|
(13.3
|
)
|
|
|
(42.0
|
)
|
65
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Statement of
Financial Accounting Standards No. 157 Fair
Value Measurements
In September 2006, the Financial Accounting Standards Board
issued SFAS 157, Fair Value Measurements.
SFAS 157 defines fair value, establishes a framework for
measuring fair value, and expands disclosures about fair value
measurements. The Company will be required to adopt
SFAS 157 no later than October 1, 2008, the beginning
of its 2009 fiscal year. The provisions of SFAS 157 should
be applied prospectively to the beginning of the fiscal year in
which SFAS 157 is initially applied, except with respect to
certain financial instruments as defined by SFAS 157. The
Company has not yet determined the effect, if any, that the
adoption of SFAS 157 will have on its consolidated
financial statements.
Statement of
Financial Accounting Standards No. 159 -The Fair Value
Option for Financial Assets and Financial
Liabilities
In February 2007, the Financial Accounting Standards Board
issued SFAS 159, The Fair Value Option for Financial
Assets and Financial Liabilities, which allows an entity
the irrevocable option to elect fair value for the initial and
subsequent measurement for certain financial assets and
liabilities on a
contract-by-contract
basis. Subsequent changes in fair value of these financial
assets and liabilities would be recognized in earnings when they
occur. SFAS 159 further establishes certain additional
disclosure requirements. SFAS 159 is effective for the
Companys financial statements for the fiscal year
beginning on October 1, 2008, with earlier adoption
permitted. No entity is permitted to apply SFAS 159
retrospectively to fiscal years preceding the effective date
unless the entity chooses early adoption. Management is
currently evaluating the impact and timing of the adoption of
SFAS 159 on the Companys consolidated financial
statements.
FIN 48
Accounting For Uncertainty In Income Taxes An
Interpretation of FASB Statement No. 109
In July 2006, the Financial Accounting Standards Board has
issued Interpretation (FIN) 48, Accounting for Uncertainty
in Income Taxes an interpretation of FASB Statement
No. 109. This Interpretation clarifies the accounting
for uncertainty in income taxes recognized in an
enterprises financial statements in accordance with
SFAS 109, Accounting for Income Taxes.
FIN 48 prescribes a recognition threshold and measurement
attribute for the financial statement recognition and
measurement of a tax position taken or expected to be taken in a
tax return. This Interpretation also provides guidance on
derecognition, classification, interest and penalties,
accounting in interim periods, disclosure, and transition.
The evaluation of a tax position in accordance with FIN 48
is a two-step process. The first step is recognition. The
enterprise determines whether it is more-likely-than-not that a
tax position will be sustained upon examination, including
resolution of any related appeals or litigation processes, based
on the technical merits of the position. In evaluating whether a
tax position has met the more-likely-than-not recognition
threshold, the enterprise should presume that the position will
be examined by the appropriate taxing authority that would have
full knowledge of all relevant information. The second step is
measurement. A tax position that meets the more-likely-than-not
recognition threshold is measured to determine the amount of
benefit to recognize in the financial statements. The tax
position is measured at the largest amount of benefit that is
greater than 50 percent likely of being realized upon
ultimate settlement.
Tax positions that previously failed to meet the
more-likely-than-not recognition threshold should be recognized
in the first subsequent financial reporting period in which that
threshold is met. Previously recognized tax positions that no
longer meet the more-likely-than-not recognition threshold
should be derecognized in the first subsequent financial
reporting period in which that threshold is no longer met.
The Company is required to adopt the provisions of FIN 48
in respect of all the Companys tax positions as of
October 1, 2007, the beginning of fiscal 2008. The
cumulative effect of applying the provisions of the
Interpretation will be reported as an adjustment to the opening
balance of retained earnings for fiscal 2008. The Company is
completing its evaluation of FIN 48 and does not expect its
adoption in the first quarter of fiscal 2008 to have a material
impact on its financial position or results of operations.
66
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
On December 12, 2006, the Company announced a
recapitalization plan to return $750 million to the
Companys shareholders. This plan expanded and accelerated
the previously announced five-year $500 million share
repurchase program (which was canceled) under which the Company
repurchased $87.9 million of its common shares during
fiscal 2006. Pursuant to the recapitalization plan, on
February 14, 2007, the Company completed a modified
Dutch auction tender offer, resulting in the
repurchase of 4.5 million of the Companys common
shares for an aggregate purchase price of $245.5 million
($54.50 per share). On February 16, 2007, the
Companys Board of Directors declared a special one-time
cash dividend of $8.00 per share ($508 million in the
aggregate), which was paid on March 5, 2007, to
shareholders of record on February 26, 2007.
In order to fund these transactions, the Company entered into
new credit facilities aggregating $2.15 billion and
terminated its prior credit facility. As part of this debt
restructuring, the Company also conducted a cash tender offer
for any and all of its outstanding
65/8% senior
subordinated notes in an aggregate principal amount of
$200 million. Reference should be made to Note 10,
Debt for further information as to the new credit
facilities and the repayment and termination of the prior credit
facility and the
65/8% senior
subordinated notes.
The payment of the special one-time cash dividend required the
Company to adjust the number of common shares subject to stock
options and stock appreciation rights outstanding under the
Companys share-based awards programs, as well as the price
at which the awards may be exercised. Reference should be made
to Note 11, Shareholders Equity for further
information. The Companys interest expense will be
significantly higher for periods subsequent to the
recapitalization transactions as a result of the borrowings
incurred to fund the cash returned to shareholders. The
following pro forma financial information has been compiled as
if the Company had completed the recapitalization transactions
as of October 1, 2005 for fiscal 2006 and as of
October 1, 2006 for fiscal 2007. Borrowing rates in effect
as of March 30, 2007 were used to compute pro forma
interest expense. As the recapitalization involved a share
repurchase, pro forma diluted common shares are also provided.
67
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
Pro Forma Financial Information (Unaudited)
|
|
|
|
Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
(In millions, except per share data)
|
|
|
Income before income taxes, as reported
|
|
$
|
188.1
|
|
|
$
|
212.9
|
|
Add back reported interest expense
|
|
|
70.7
|
|
|
|
39.6
|
|
Add back costs related to refinancing
|
|
|
18.3
|
|
|
|
|
|
Deduct pro forma interest expense
|
|
|
(94.3
|
)
|
|
|
(100.8
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma income before income taxes
|
|
$
|
182.8
|
|
|
$
|
151.7
|
|
Pro forma income taxes
|
|
|
72.5
|
|
|
|
57.3
|
|
|
|
|
|
|
|
|
|
|
Pro forma net income
|
|
$
|
110.3
|
|
|
$
|
94.4
|
|
|
|
|
|
|
|
|
|
|
Pro forma basic net income per common share
|
|
$
|
1.74
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
|
Pro forma diluted net income per common share
|
|
$
|
1.68
|
|
|
$
|
1.45
|
|
|
|
|
|
|
|
|
|
|
Reported interest expense
|
|
$
|
70.7
|
|
|
$
|
39.6
|
|
Incremental interest on recapitalization borrowings
|
|
|
21.8
|
|
|
|
53.0
|
|
New credit facilities interest rate differential
|
|
|
1.5
|
|
|
|
7.4
|
|
Incremental amortization of new credit facilities fees
|
|
|
0.3
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
Pro forma interest expense
|
|
$
|
94.3
|
|
|
$
|
100.8
|
|
|
|
|
|
|
|
|
|
|
Pro forma effective tax rates
|
|
|
39.7
|
%
|
|
|
37.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
Pro Forma Shares
|
|
|
|
Year Ended
|
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
(In millions)
|
|
|
Weighted-average common shares outstanding during the period
|
|
|
65.2
|
|
|
|
67.5
|
|
Incremental full period impact of repurchased common shares
|
|
|
(1.8
|
)
|
|
|
(4.5
|
)
|
|
|
|
|
|
|
|
|
|
Pro forma basic common shares
|
|
|
63.4
|
|
|
|
63.0
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding during the period
plus dilutive potential common shares
|
|
|
67.0
|
|
|
|
69.4
|
|
Incremental full period impact of repurchased common shares
|
|
|
(1.8
|
)
|
|
|
(4.5
|
)
|
Impact on dilutive potential common shares
|
|
|
0.3
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
Pro forma diluted common shares
|
|
|
65.5
|
|
|
|
65.2
|
|
|
|
|
|
|
|
|
|
|
68
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 3.
|
DETAIL OF CERTAIN
FINANCIAL STATEMENT ACCOUNTS
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
(In millions)
|
|
|
INVENTORIES, NET:
|
|
|
|
|
|
|
|
|
Finished goods
|
|
$
|
289.9
|
|
|
$
|
267.4
|
|
Work-in-progress
|
|
|
28.3
|
|
|
|
36.0
|
|
Raw materials
|
|
|
87.7
|
|
|
|
105.8
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
405.9
|
|
|
$
|
409.2
|
|
|
|
|
|
|
|
|
|
|
PROPERTY, PLANT AND EQUIPMENT, NET:
|
|
|
|
|
|
|
|
|
Land and improvements
|
|
$
|
58.9
|
|
|
$
|
49.8
|
|
Buildings
|
|
|
162.8
|
|
|
|
144.6
|
|
Machinery and equipment
|
|
|
417.4
|
|
|
|
401.8
|
|
Furniture and fixtures
|
|
|
39.2
|
|
|
|
39.2
|
|
Software
|
|
|
88.6
|
|
|
|
79.7
|
|
Construction in progress
|
|
|
17.8
|
|
|
|
22.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
784.7
|
|
|
|
737.6
|
|
Less: accumulated depreciation
|
|
|
(418.8
|
)
|
|
|
(370.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
365.9
|
|
|
$
|
367.6
|
|
|
|
|
|
|
|
|
|
|
ACCRUED LIABILITIES:
|
|
|
|
|
|
|
|
|
Payroll and other compensation accruals
|
|
$
|
44.0
|
|
|
$
|
53.7
|
|
Advertising and promotional accruals
|
|
|
138.8
|
|
|
|
126.8
|
|
Restructuring accruals
|
|
|
2.5
|
|
|
|
6.4
|
|
Other
|
|
|
101.5
|
|
|
|
82.2
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
286.8
|
|
|
$
|
269.1
|
|
|
|
|
|
|
|
|
|
|
OTHER NON-CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Accrued pension and postretirement liabilities
|
|
$
|
79.8
|
|
|
$
|
93.8
|
|
Legal and environmental reserves
|
|
|
4.2
|
|
|
|
4.2
|
|
Deferred tax liability
|
|
|
67.9
|
|
|
|
49.2
|
|
Other
|
|
|
28.0
|
|
|
|
17.3
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
179.9
|
|
|
$
|
164.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
|
(In millions)
|
|
|
ACCUMULATED OTHER COMPREHENSIVE LOSS:
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized gain (loss) on derivatives, net of tax of $0.4,
$(0.9) and $(1.2)
|
|
$
|
(0.6
|
)
|
|
$
|
1.8
|
|
|
$
|
1.8
|
|
Minimum pension liability, net of tax of $0, $19.5 and $23.7
|
|
|
|
|
|
|
(34.1
|
)
|
|
|
(40.6
|
)
|
Pension liability under FAS 158, net of tax of $15.9
|
|
|
(27.0
|
)
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment
|
|
|
(14.4
|
)
|
|
|
(19.3
|
)
|
|
|
(17.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(42.0
|
)
|
|
$
|
(51.6
|
)
|
|
$
|
(56.6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 4.
|
MARKETING
AGREEMENT
|
The Company is Monsantos exclusive agent for the domestic
and international marketing and distribution of consumer
Roundup®
herbicide products. Under the terms of the Marketing Agreement
with Monsanto, the Company is entitled to receive an annual
commission from Monsanto in consideration for the performance of
the Companys duties as agent. The annual gross commission
under the Marketing Agreement is calculated as a percentage of
the actual earnings before interest and income taxes (EBIT) of
the consumer
Roundup®
business, as defined in the Marketing Agreement. Each
years percentage varies in accordance with the terms of
the Marketing Agreement based on the achievement of two earnings
thresholds and on commission rates that vary by threshold and
program year.
The Marketing Agreement also requires the Company to make annual
payments to Monsanto as a contribution against the overall
expenses of the consumer
Roundup®
business. The annual contribution payment is defined in the
Marketing Agreement as $20 million; however, portions of
the annual contribution payments for the first three years of
the Marketing Agreement were deferred with no expense recorded
as payment of the deferred amount was considered to be
contingent. During fiscal 2005, the Company updated its
assessment of this contingent obligation and concluded that it
was probable that the deferred amount totaling
$45.7 million as of July 2, 2005 would be paid. Since
the recognition of this contingent obligation was for previously
deferred contribution payments, the Company recorded this
liability with a charge to net sales in the quarter ended
July 2, 2005. This amount bore interest at 8% until it was
paid in October 2005.
Under the terms of the Marketing Agreement, the Company performs
certain functions, primarily manufacturing conversion, selling
and marketing support, on behalf of Monsanto in the conduct of
the consumer
Roundup®
business. The actual costs incurred for these activities are
charged to and reimbursed by Monsanto, for which the Company
recognizes no gross profit or net income. The Company records
costs incurred under the Marketing Agreement for which the
Company is the primary obligor on a gross basis, recognizing
such costs in Cost of sales and the reimbursement of
these costs in Net sales, with no effect on gross
profit or net income. The related net sales and cost of sales
were $47.7 million, $37.6 million and
$40.7 million for fiscal 2007, 2006 and 2005, respectively.
The elements of the net commission earned under Marketing
Agreement and included in Net sales for each of the
three years in the period ended September 30, 2007 are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Gross commission
|
|
$
|
62.7
|
|
|
$
|
60.7
|
|
|
$
|
67.0
|
|
Contribution expenses
|
|
|
(20.0
|
)
|
|
|
(20.0
|
)
|
|
|
(23.8
|
)
|
Deferred contribution charge
|
|
|
|
|
|
|
|
|
|
|
(45.7
|
)
|
Amortization of marketing fee
|
|
|
(0.8
|
)
|
|
|
(0.8
|
)
|
|
|
(2.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net commission income (expense)
|
|
|
41.9
|
|
|
|
39.9
|
|
|
|
(5.3
|
)
|
Reimbursements associated with Marketing Agreement
|
|
|
47.7
|
|
|
|
37.6
|
|
|
|
40.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales associated with Marketing Agreement
|
|
$
|
89.6
|
|
|
$
|
77.5
|
|
|
$
|
35.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In consideration for the rights granted to the Company under the
Marketing Agreement for North America, the Company was required
to pay a marketing fee of $33 million to Monsanto. The
Company has deferred this amount on the basis that the payment
will provide a future benefit through commissions that will be
earned under the Marketing Agreement. Based on managements
current assessment of the likely term of the Marketing
Agreement, the useful life over which the marketing fee is being
amortized is 20 years.
The Marketing Agreement has no definite term except as it
relates to the European Union countries. With respect to the
European Union countries, the term of the Marketing Agreement
has been extended through September 30, 2008 and may be
renewed at the option of both parties for two additional
successive terms ending on September 30, 2015 and 2018,
with a separate determination being made by the parties at least
six months prior to the expiration of each such term as to
whether to commence a subsequent renewal term. If Monsanto does
not agree to the renewal term with respect to the European Union
countries, the commission structure will be renegotiated within
the terms of the
70
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Marketing Agreement. For countries outside of the European
Union, the Marketing Agreement continues indefinitely unless
terminated by either party.
The Marketing Agreement provides Monsanto with the right to
terminate the Marketing Agreement for an event of default (as
defined in the Marketing Agreement) by the Company or a change
in control of Monsanto or the sale of the consumer
Roundup®
business. The Marketing Agreement provides the Company with the
right to terminate the Marketing Agreement in certain
circumstances including an event of default by Monsanto or the
sale of the consumer
Roundup®
business. Unless Monsanto terminates the Marketing Agreement for
an event of default by the Company, Monsanto is required to pay
a termination fee to the Company that varies by program year. If
Monsanto terminates the Marketing Agreement upon a change of
control of Monsanto or the sale of the consumer
Roundup®
business prior to September 30, 2008, the Company will be
entitled to a termination fee in excess of $100 million. If
the Company terminates the Marketing Agreement upon an uncured
material breach, material fraud or material willful misconduct
by Monsanto, the Company will be entitled to receive a
termination fee in excess of $100 million if the
termination occurs prior to September 30, 2008. The
termination fee declines over time from $100 million to a
minimum of $16 million for terminations between
September 30, 2008 and September 30, 2018. If Monsanto
was to terminate the Marketing Agreement for cause, the Company
would not be entitled to any termination fee, and would lose
all, or a significant portion, of the significant source of
earnings and overhead expense absorption the Marketing Agreement
provides. Monsanto may also be able to terminate the Marketing
Agreement within a given region, including North America,
without paying the Company a termination fee if sales to
consumers in that region decline: (1) over a cumulative
three fiscal year period; or (2) by more than 5% for each
of two consecutive years.
|
|
NOTE 5.
|
IMPAIRMENT,
RESTRUCTURING AND OTHER CHARGES
|
The Company recorded net restructuring and other charges of
$2.7 million, $9.4 million and $9.5 million in
fiscal 2007, fiscal 2006 and fiscal 2005, respectively. Other
charges in fiscal 2007 relate to certain assets and ongoing
monitoring and remediation costs associated with the
Companys turfgrass biotechnology program. Substantially
all costs in fiscal 2006 and $26.3 million in fiscal 2005
were for severance and related costs, including curtailment
charges relating to a pension plan and the retiree medical plan,
related primarily to a strategic improvement plan designed to
reduce general and administrative costs. Offsetting the fiscal
2005 charges was a reserve reversal of $7.9 million related
to the collection of outstanding accounts receivable due from
Central Garden & Pet Company (Central Garden), and a
net settlement gain of $8.9 million related to the lawsuit
against Aventis.
Goodwill and intangible asset impairment charges of
$35.3 million, $66.4 million and $23.4 million
were recorded in fiscal 2007, fiscal 2006 and fiscal 2005,
respectively. The nature of the impairment charges are discussed
further in Note 6, Goodwill and Intangible Assets, Net.
71
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The following table details impairment, restructuring and other
charges and rolls forward the cash portion of the restructuring
and other charges accrued in fiscal 2007, 2006 and 2005 (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Restructuring and other charges:
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance
|
|
$
|
|
|
|
$
|
8.5
|
|
|
$
|
15.9
|
|
Facility exit costs
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
Curtailment of pension and retiree medical plans
|
|
|
|
|
|
|
|
|
|
|
4.9
|
|
Other related costs
|
|
|
2.7
|
|
|
|
0.9
|
|
|
|
5.4
|
|
Central Garden litigation
|
|
|
|
|
|
|
|
|
|
|
(7.9
|
)
|
Aventis litigation
|
|
|
|
|
|
|
|
|
|
|
(8.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net restructuring and other charges
|
|
|
2.7
|
|
|
|
9.4
|
|
|
|
9.5
|
|
Goodwill and intangible asset impairment
|
|
|
35.3
|
|
|
|
66.4
|
|
|
|
23.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total impairment, restructuring and other charges
|
|
$
|
38.0
|
|
|
$
|
75.8
|
|
|
$
|
32.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts reserved for restructuring and other charges at
beginning of year
|
|
$
|
6.4
|
|
|
$
|
15.6
|
|
|
$
|
5.3
|
|
Restructuring and other charges
|
|
|
2.7
|
|
|
|
9.4
|
|
|
|
9.5
|
|
Receipts, payments and other
|
|
|
(6.6
|
)
|
|
|
(18.6
|
)
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts reserved for restructuring and other charges at end of
year
|
|
$
|
2.5
|
|
|
$
|
6.4
|
|
|
$
|
15.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The activities to which these costs apply are expected to be
largely completed in fiscal 2008. The balance of the accrued
charges at September 30, 2007 and 2006, are included in
Accrued liabilities on the Consolidated Balance
Sheets.
|
|
NOTE 6.
|
GOODWILL AND
INTANGIBLE ASSETS, NET
|
In accordance with SFAS 142, goodwill and indefinite-lived
intangible assets are not subject to amortization. Goodwill and
indefinite-lived intangible assets are reviewed for impairment
by applying a
fair-value
based test on an annual basis or more frequently if
circumstances indicate a potential impairment. As discussed in
Note 1, Summary of Significant Accounting Policies, during
the third quarter of fiscal 2007, the Company changed the timing
of its annual goodwill impairment testing from the last day of
the fiscal first quarter to the first day of the fiscal fourth
quarter. As such, annual impairment testing for fiscal 2007 was
performed as of December 30, 2006 and again as of
July 1, 2007.
Management engages an independent valuation firm to assist in
its impairment assessment reviews. The value of all
indefinite-lived tradenames was determined using a royalty
savings methodology similar to that employed when the associated
businesses were acquired but using updated estimates of sales,
cash flow and profitability. The fair value of the
Companys reporting units for purposes of goodwill testing
was determined primarily by employing a discounted cash flow
methodology.
At December 30, 2006, the Company completed its impairment
analysis and determined that a charge for impairment was not
required.
The Companys fourth quarter fiscal 2007 impairment review
resulted in a non-cash goodwill and intangible asset impairment
charge of $35.3 million. In part as a result of the
disappointing 2007 lawn and garden season, management undertook
a comprehensive strategic update of the Companys business
initiatives in the fourth quarter of fiscal 2007. One outcome of
this update was a decision to increase the focus of resources on
the Companys core consumer lawn and garden do-it-yourself
businesses. This process also involved a re-evaluation of the
strategy and cash flow projections surrounding the
Companys Smith &
Hawken®
business, which has consistently performed below expectations
since it was acquired in early fiscal 2005. While the Company
remains committed to the outdoor living category and intends to
more vigorously leverage the Smith &
Hawken®
brand in other lawn and garden categories, management revised
its Smith &
Hawken®
strategy to reflect a scaled back retail expansion plan, with an
increased focus on aggressively expanding the wholesale aspect
of this business. This resulted in a decrease in the prior cash
flow projections for this business, resulting in a
$24.6 million goodwill impairment charge and a
$4.6 million impairment charge for an indefinite-lived
tradename. The goodwill impairment charge is an estimate, as the
appraisals necessary to complete the required SFAS 142
evaluation of the Smith &
Hawken®
goodwill remain in process as of
72
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
the date of this report. The Company will finalize this
evaluation in the first quarter of fiscal 2008 and, if
necessary, update the impairment charge for Smith &
Hawken®
goodwill in that reporting period.
Managements fiscal 2007 fourth quarter strategic update
also encompassed other areas. The Company remains strongly
committed to the development of turfgrass varieties that could
one day require less mowing, less water and fewer treatments to
resist insects, weeds and disease. The Companys efforts to
develop such turfgrass varieties include conventional breeding
programs, as well as research and development involving
biotechnology. Efforts to develop turfgrass varieties involving
biotechnology have yielded positive results; however, the
required regulatory approval process is taking longer than
anticipated, impacting the Companys ability to
commercialize such innovations. As a result of managements
fiscal 2007 fourth quarter strategic update, the Company
recorded a $2.2 million goodwill impairment charge related
to its turfgrass biotechnology program. Similarly, a strategic
update of certain information technology initiatives in the
Companys Scotts
LawnService®
segment resulted in a $3.9 million impairment charge.
The Companys fiscal 2006 annual impairment analysis
resulted in an impairment charge of $1.0 million associated
with a tradename no longer in use in the European consumer
business. Subsequent to the fiscal 2006 first quarter impairment
analysis, the European consumer business of the International
reporting segment and Smith &
Hawken®
experienced significant off plan performance. Management
believes the off plan performance of the European consumer
business was driven largely by category declines in the European
consumer markets. The off plan performance of these two
businesses was an indication that, more-likely-than-not, the
fair values of the related reporting units and indefinite-lived
intangibles have declined below their carrying amount.
Accordingly, an interim impairment test was performed for the
goodwill and indefinite-lived tradenames of these reporting
units during the fourth quarter of fiscal 2006. As a result of
the interim impairment test, the Company recorded a
$65.4 million non-cash impairment charge,
$62.3 million of which was associated with indefinite-lived
tradenames that continue to be employed in the consumer portion
of the International reporting segment. The balance of the
fiscal 2006 fourth quarter impairment charge was in the North
America segment and consisted of $1.3 million for a
Canadian tradename being phased out and $1.8 million
related to goodwill of a pottery business being exited. The
interim impairment testing of the Smith &
Hawken®
goodwill and indefinite-lived tradename did not indicate
impairment.
The following table presents goodwill and intangible assets as
of September 30, 2007 and 2006 (dollars in millions).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2007
|
|
|
September 30, 2006
|
|
|
|
Weighted
|
|
|
Gross
|
|
|
|
|
|
Net
|
|
|
Gross
|
|
|
|
|
|
Net
|
|
|
|
Average
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
Carrying
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
Carrying
|
|
|
|
Life
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
|
|
|
|
Amortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
|
|
|
14
|
|
|
$
|
56.7
|
|
|
$
|
(37.1
|
)
|
|
$
|
19.6
|
|
|
$
|
54.3
|
|
|
$
|
(34.3
|
)
|
|
$
|
20.0
|
|
Customer relationships
|
|
|
16
|
|
|
|
89.0
|
|
|
|
(29.6
|
)
|
|
|
59.4
|
|
|
|
80.5
|
|
|
|
(17.9
|
)
|
|
|
62.6
|
|
Tradenames
|
|
|
17
|
|
|
|
11.3
|
|
|
|
(5.6
|
)
|
|
|
5.7
|
|
|
|
11.3
|
|
|
|
(4.9
|
)
|
|
|
6.4
|
|
Other
|
|
|
15
|
|
|
|
117.7
|
|
|
|
(82.0
|
)
|
|
|
35.7
|
|
|
|
111.2
|
|
|
|
(75.6
|
)
|
|
|
35.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortizable intangible assets, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
120.4
|
|
|
|
|
|
|
|
|
|
|
|
124.6
|
|
Unamortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tradenames
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
298.4
|
|
|
|
|
|
|
|
|
|
|
|
300.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
418.8
|
|
|
|
|
|
|
|
|
|
|
|
424.7
|
|
Goodwill
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
462.9
|
|
|
|
|
|
|
|
|
|
|
|
458.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total goodwill and intangible assets, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
881.7
|
|
|
|
|
|
|
|
|
|
|
$
|
882.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
73
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The changes to the net carrying value of goodwill by segment for
the fiscal years ended September 30, 2007 and 2006, are as
follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North
|
|
|
Scotts
|
|
|
|
|
|
Other/
|
|
|
|
|
|
|
America
|
|
|
LawnService®
|
|
|
International
|
|
|
Corporate
|
|
|
Total
|
|
|
|
|
Balance as of September 30, 2005
|
|
$
|
190.9
|
|
|
$
|
105.0
|
|
|
$
|
112.4
|
|
|
$
|
24.6
|
|
|
$
|
432.9
|
|
Increases due to acquisitions
|
|
|
16.6
|
|
|
|
3.6
|
|
|
|
|
|
|
|
|
|
|
|
20.2
|
|
Impairment
|
|
|
(1.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1.8
|
)
|
Other, primarily cumulative translation
|
|
|
|
|
|
|
|
|
|
|
6.8
|
|
|
|
|
|
|
|
6.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30, 2006
|
|
$
|
205.7
|
|
|
$
|
108.6
|
|
|
$
|
119.2
|
|
|
$
|
24.6
|
|
|
$
|
458.1
|
|
Increases due to acquisitions
|
|
|
4.3
|
|
|
|
14.9
|
|
|
|
|
|
|
|
|
|
|
|
19.2
|
|
Impairment
|
|
|
(2.2
|
)
|
|
|
|
|
|
|
|
|
|
|
(24.6
|
)
|
|
|
(26.8
|
)
|
Other, primarily cumulative translation
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
12.5
|
|
|
|
|
|
|
|
12.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30, 2007
|
|
$
|
207.7
|
|
|
$
|
123.5
|
|
|
$
|
131.7
|
|
|
$
|
|
|
|
$
|
462.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total amortization expense for the years ended
September 30, 2007, 2006 and 2005 was $16.1 million,
$16.0 million and $17.6 million, respectively.
Amortization expense is estimated to be as follows for the years
ending September 30 (in millions):
|
|
|
|
|
2008
|
|
$
|
16.6
|
|
2009
|
|
|
15.0
|
|
2010
|
|
|
13.6
|
|
2011
|
|
|
12.9
|
|
2012
|
|
|
11.9
|
|
74
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The Company continues to view strategic acquisitions as a means
to enhance our strong core businesses. The following recaps key
acquisitions made during fiscal 2006:
|
|
|
|
|
|
|
Date of Acquisition
|
|
Assets Acquired
|
|
Consideration
|
|
Reasons for the Acquisition
|
|
|
June 2006
|
|
Certain brands and assets of Landmark Seed Company, a leading
producer and distributor of quality professional seed and
turfgrasses.
|
|
Cash of $6.2 million with an additional $1 million deferred to
future periods.
|
|
Transaction enhances the Companys position in the global
turfgrass seed industry and compliments the acquisition from
Turf-Seed, Inc.
|
May 2006
|
|
Certain brands and assets of Turf-Seed, Inc., a leading producer
of quality commercial turfgrasses, including 49% equity interest
in Turf-Seed Europe, which distributes Turf-Seeds grass
varieties throughout the European Union and other countries in
the region.
|
|
Cash of $10.0 million plus assumed liabilities of $4.5 million.
Contingent consideration based on future performance of the
business due in 2012 that may approximate $15 million which
would be recorded as additional purchase price.
|
|
Integration of Turf-Seeds extensive professional seed
sales and distribution network with the Companys existing
presence and industry leading brands in the consumer seed market
will strengthen the Companys overall global position in
the seed category.
|
November 2005
|
|
All the outstanding shares of Gutwein & Co., Inc.
(Gutwein), a leader in the growing North America
wild bird food category.
|
|
$78.3 million in cash plus assumed liabilities of $4.7 million.
|
|
Gutweins Morning
Song®
branded products are sold at leading mass retailers, grocery,
pet and general merchandise stores. This acquisition gives the
Company its entry into the North America wild bird food
category, a large, growing, fragmented category with tremendous
opportunity for branding and innovation.
|
October 2005
|
|
All the outstanding shares of Rod McLellan Company
(RMC), a leading branded producer and marketer of
soil and landscape products in the western U.S.
|
|
$20.5 million in cash plus assumed liabilities of $6.8 million.
|
|
RMC compliments our existing line of growing media products and
has been integrated into that business.
|
On a pro forma basis, net sales for the year ended
September 30, 2005 would have been $2.48 billion (an
increase of $114.5 million) had the acquisitions of RMC and
Gutwein, and the brands and assets from Turf-Seed and Landmark
Seed occurred as of October 1, 2004. The pro forma reported
net income for the year ended September 30, 2005 would have
increased by approximately $6.5 million or 0.09 cents per
diluted common share. Due to the timing of these acquisitions in
fiscal 2006, pro forma results would not be materially different
from actual results for the year ended September 30, 2006.
75
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Scotts
LawnService®
From fiscal 2005 through 2007, the Companys Scotts
LawnService®
segment acquired 19 individual lawn service entities for a total
cost of approximately $33.3 million. The following table
summarizes the details of these transactions by fiscal year
(dollar amounts in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Number of individual acquisitions
|
|
|
11
|
|
|
|
5
|
|
|
|
3
|
|
Total cost
|
|
$
|
22.5
|
|
|
$
|
4.4
|
|
|
$
|
6.4
|
|
Portion of cost paid in cash
|
|
|
18.7
|
|
|
|
3.4
|
|
|
|
4.1
|
|
Notes issued and liabilities assumed
|
|
|
3.8
|
|
|
|
1.0
|
|
|
|
2.3
|
|
Goodwill
|
|
|
14.9
|
|
|
|
3.5
|
|
|
|
4.7
|
|
Other intangible assets
|
|
|
6.3
|
|
|
|
0.7
|
|
|
|
0.9
|
|
Working capital and property, plant and equipment
|
|
|
1.3
|
|
|
|
0.2
|
|
|
|
0.8
|
|
Pro forma results would not be materially different from actual
results for the year ended September 30, 2007.
The Company sponsors a defined contribution profit sharing and
401(k) plan for substantially all U.S. associates. The
Company provides a base contribution equal to 2% of compensation
up to 50% of the Social Security taxable wage base plus 4% of
remaining compensation. Associates also may make pretax
contributions from compensation that are matched by the Company
at 100% of the associates initial 3% contribution and 50%
of their remaining contribution up to 5%. The Company recorded
charges of $10.7 million, $10.3 million and
$10.8 million under the plan in fiscal 2007, 2006 and 2005,
respectively.
The Company sponsors two defined benefit plans for certain
U.S. associates. Benefits under these plans have been
frozen and closed to new associates since 1997. The benefits
under the primary plan are based on years of service and the
associates average final compensation or stated amounts.
The Companys funding policy, consistent with statutory
requirements and tax considerations, is based on actuarial
computations using the Projected Unit Credit method. The second
frozen plan is a non-qualified supplemental pension plan. This
plan provides for incremental pension payments so that total
pension payments equal amounts that would have been payable from
the Companys pension plan if it were not for limitations
imposed by the income tax regulations.
The Company sponsors defined benefit pension plans associated
with its International businesses in the United Kingdom, the
Netherlands, Germany, and France. These plans generally cover
all associates of the respective businesses with retirement
benefits primarily based on years of service and compensation
levels. During fiscal 2004, the U.K. plans were closed to new
participants, but existing participants continue to accrue
benefits. All newly hired associates of the U.K. business now
participate in a new defined contribution plan in lieu of the
defined benefit plans.
76
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The following tables present information about benefit
obligations, plan assets, annual expense, assumptions and other
information about the Companys defined benefit pension
plans (in millions), including the disclosures required by
SFAS 158 which was adopted by the Company on
September 30, 2007. The incremental effect of applying
SFAS 158 on individual line items in the Consolidated
Balance Sheet at September 30, 2007 is discussed in
Note 1, Summary of Significant Accounting Policies. The
defined benefit plans are valued using a September 30
measurement date.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailed Defined
|
|
|
International
|
|
|
|
Benefit Plans
|
|
|
Benefit Plans
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
|
|
Change in projected benefit obligation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation at beginning of year
|
|
$
|
93.4
|
|
|
$
|
96.1
|
|
|
$
|
178.7
|
|
|
$
|
158.2
|
|
Service cost
|
|
|
|
|
|
|
|
|
|
|
3.9
|
|
|
|
4.2
|
|
Interest cost
|
|
|
5.3
|
|
|
|
5.2
|
|
|
|
9.2
|
|
|
|
7.7
|
|
Plan participants contributions
|
|
|
|
|
|
|
|
|
|
|
0.9
|
|
|
|
0.9
|
|
Plan amendments
|
|
|
|
|
|
|
|
|
|
|
(0.8
|
)
|
|
|
|
|
Curtailment /settlement gain
|
|
|
|
|
|
|
|
|
|
|
(0.6
|
)
|
|
|
(1.1
|
)
|
Actuarial loss (gain)
|
|
|
(1.5
|
)
|
|
|
(1.7
|
)
|
|
|
(23.8
|
)
|
|
|
3.4
|
|
Benefits paid
|
|
|
(6.4
|
)
|
|
|
(6.2
|
)
|
|
|
(6.0
|
)
|
|
|
(4.7
|
)
|
Other
|
|
|
|
|
|
|
|
|
|
|
0.2
|
|
|
|
|
|
Special termination benefits
|
|
|
|
|
|
|
|
|
|
|
0.5
|
|
|
|
|
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
17.3
|
|
|
|
10.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligation at end of year
|
|
$
|
90.8
|
|
|
$
|
93.4
|
|
|
$
|
179.5
|
|
|
$
|
178.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated benefit obligation at end of year
|
|
$
|
90.8
|
|
|
$
|
93.4
|
|
|
$
|
158.6
|
|
|
$
|
154.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at beginning of year
|
|
$
|
70.9
|
|
|
$
|
72.5
|
|
|
$
|
116.1
|
|
|
$
|
96.4
|
|
Actual return on plan assets
|
|
|
9.3
|
|
|
|
4.4
|
|
|
|
10.4
|
|
|
|
9.8
|
|
Employer contribution
|
|
|
4.1
|
|
|
|
0.2
|
|
|
|
9.6
|
|
|
|
7.2
|
|
Plan participants contributions
|
|
|
|
|
|
|
|
|
|
|
0.9
|
|
|
|
0.9
|
|
Benefits paid
|
|
|
(6.4
|
)
|
|
|
(6.2
|
)
|
|
|
(6.0
|
)
|
|
|
(4.7
|
)
|
Foreign currency translation
|
|
|
|
|
|
|
|
|
|
|
11.9
|
|
|
|
6.5
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of year
|
|
$
|
77.9
|
|
|
$
|
70.9
|
|
|
$
|
142.7
|
|
|
$
|
116.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded status at end of year
|
|
$
|
12.9
|
|
|
$
|
22.5
|
|
|
$
|
36.8
|
|
|
$
|
62.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Information for pension plans with an accumulated benefit
obligation in excess of plan assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligation
|
|
$
|
90.8
|
|
|
$
|
93.4
|
|
|
$
|
28.1
|
|
|
$
|
178.7
|
|
Accumulated benefit obligation
|
|
|
90.8
|
|
|
|
93.4
|
|
|
|
26.5
|
|
|
|
154.5
|
|
Fair value of plan assets
|
|
|
77.9
|
|
|
|
70.9
|
|
|
|
7.0
|
|
|
|
116.1
|
|
Amounts recognized in the Consolidated Balance Sheets consist
of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
$
|
0.2
|
|
|
$
|
|
|
|
$
|
1.0
|
|
|
$
|
|
|
Noncurrent liabilities
|
|
|
12.7
|
|
|
|
22.5
|
|
|
|
35.8
|
|
|
|
40.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amount accrued
|
|
$
|
12.9
|
|
|
$
|
22.5
|
|
|
$
|
36.8
|
|
|
$
|
40.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailed Defined
|
|
|
International
|
|
|
|
Benefit Plans
|
|
|
Benefit Plans
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
|
|
Amounts recognized in accumulated other comprehensive loss
consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss
|
|
$
|
22.0
|
|
|
|
|
|
|
$
|
21.7
|
|
|
|
|
|
Prior service cost
|
|
|
|
|
|
|
|
|
|
|
(1.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net amount recognized
|
|
$
|
22.0
|
|
|
|
|
|
|
$
|
20.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in accumulated other comprehensive loss expected to
be recognized as components of net periodic benefit cost in
fiscal 2008 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial loss
|
|
$
|
1.3
|
|
|
|
|
|
|
$
|
0.6
|
|
|
|
|
|
Prior service cost
|
|
|
|
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount to be amortized into net periodic benefit cost
|
|
$
|
1.3
|
|
|
|
|
|
|
$
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average assumptions used in development of projected
benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
6.11
|
%
|
|
|
5.93
|
%
|
|
|
5.67
|
%
|
|
|
4.86
|
%
|
Rate of compensation increase
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
3.5
|
%
|
|
|
3.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailed Defined
|
|
|
International
|
|
|
|
Benefit Plan
|
|
|
Benefit Plans
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
3.9
|
|
|
$
|
4.2
|
|
|
$
|
3.3
|
|
Interest cost
|
|
|
5.3
|
|
|
|
5.2
|
|
|
|
5.2
|
|
|
|
9.2
|
|
|
|
7.7
|
|
|
|
7.1
|
|
Expected return on plan assets
|
|
|
(5.6
|
)
|
|
|
(5.5
|
)
|
|
|
(5.4
|
)
|
|
|
(8.2
|
)
|
|
|
(7.0
|
)
|
|
|
(6.3
|
)
|
Net amortization
|
|
|
2.1
|
|
|
|
2.2
|
|
|
|
2.6
|
|
|
|
2.1
|
|
|
|
2.0
|
|
|
|
1.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost
|
|
|
1.8
|
|
|
|
1.9
|
|
|
|
2.4
|
|
|
|
7.0
|
|
|
|
6.9
|
|
|
|
5.5
|
|
Curtailment /settlement loss (gain)
|
|
|
|
|
|
|
|
|
|
|
2.3
|
|
|
|
0.6
|
|
|
|
(1.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefit cost
|
|
$
|
1.8
|
|
|
$
|
1.9
|
|
|
$
|
4.7
|
|
|
$
|
7.6
|
|
|
$
|
5.8
|
|
|
$
|
5.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailed Defined
|
|
|
International
|
|
|
|
Benefit Plan
|
|
|
Benefit Plans
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Weighted average assumptions used in development of net
periodic benefit cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
5.93
|
%
|
|
|
5.63
|
%
|
|
|
5.75
|
%
|
|
|
4.86
|
%
|
|
|
4.68
|
%
|
|
|
5.35
|
%
|
Expected return on plan assets
|
|
|
8.0
|
%
|
|
|
8.0
|
%
|
|
|
8.0
|
%
|
|
|
6.6
|
%
|
|
|
6.9
|
%
|
|
|
7.5
|
%
|
Rate of compensation increase
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
3.5
|
%
|
|
|
3.5
|
%
|
|
|
3.7
|
%
|
78
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Other
Information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
International
|
|
|
|
Curtailed Defined
|
|
|
Benefit
|
|
|
|
Benefit Plans
|
|
|
Plans
|
|
|
|
|
Plan asset allocations:
|
|
|
|
|
|
|
|
|
Target for September 30, 2008:
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
60
|
%
|
|
|
50
|
%
|
Debt securities
|
|
|
40
|
%
|
|
|
50
|
%
|
September 30, 2007:
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
61
|
%
|
|
|
50
|
%
|
Debt securities
|
|
|
38
|
%
|
|
|
49
|
%
|
Other
|
|
|
1
|
%
|
|
|
1
|
%
|
September 30, 2006:
|
|
|
|
|
|
|
|
|
Equity securities
|
|
|
66
|
%
|
|
|
56
|
%
|
Debt securities
|
|
|
34
|
%
|
|
|
43
|
%
|
Other
|
|
|
|
|
|
|
1
|
%
|
Expected contributions in fiscal 2008:
|
|
|
|
|
|
|
|
|
Company
|
|
|
4.9
|
|
|
|
9.4
|
|
Employee
|
|
|
|
|
|
|
0.9
|
|
Expected future benefit payments:
|
|
|
|
|
|
|
|
|
2008
|
|
|
6.5
|
|
|
|
5.1
|
|
2009
|
|
|
6.5
|
|
|
|
5.2
|
|
2010
|
|
|
6.6
|
|
|
|
5.7
|
|
2011
|
|
|
6.6
|
|
|
|
5.8
|
|
2012
|
|
|
6.7
|
|
|
|
6.4
|
|
Total 2013 to 2017
|
|
|
33.9
|
|
|
|
37.2
|
|
Investment
Strategy:
Target allocation percentages among various asset classes are
maintained based on an individual investment policy established
for each of the various pension plans. Asset allocations are
designed to achieve long term objectives of return, while
mitigating against downside risk and considering expected cash
requirements to fund benefit payments.
Basis for
Long-Term Rate of Return on Asset Assumptions:
The Companys expected long-term rate of return on asset
assumptions are derived from studies conducted by third parties.
The studies include a review of anticipated future long-term
performance of individual asset classes and consideration of the
appropriate asset allocation strategy given the anticipated
requirements of the plan to determine the average rate of
earnings expected. While the studies give appropriate
consideration to recent fund performance and historical returns,
the assumptions primarily represent expectations about future
rates of return over the long term.
|
|
NOTE 9.
|
ASSOCIATE MEDICAL
BENEFITS
|
The Company provides comprehensive major medical benefits to
certain of its retired associates and their dependents.
Substantially all of the Companys domestic associates who
were hired before January 1, 1998 become eligible for these
benefits if they retire at age 55 or older with more than
ten years of service. The plan requires certain minimum
contributions from retired associates and includes provisions to
limit the overall cost increases the Company is required to
cover. The Company funds its portion of retiree medical benefits
on a pay-as-you-go basis.
79
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The following table sets forth the information about the retiree
medical plan for domestic associates (in millions) including the
disclosures required by SFAS 158 which was adopted by the
Company on September 30, 2007. The incremental effect of
applying SFAS 158 on individual line items in the
Consolidated Balance Sheet at September 30, 2007 is
discussed in Note 1, Summary of Significant Accounting
Policies. The retiree medical plan is valued using a September
30 measurement date.
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
Change in Accumulated Plan Benefit Obligation (APBO)
|
|
|
|
|
|
|
|
|
Benefit obligation at beginning of year
|
|
$
|
33.2
|
|
|
$
|
34.7
|
|
Service cost
|
|
|
0.6
|
|
|
|
0.7
|
|
Interest cost
|
|
|
1.8
|
|
|
|
1.9
|
|
Plan participants contributions
|
|
|
0.9
|
|
|
|
0.7
|
|
Actuarial gain
|
|
|
(3.4
|
)
|
|
|
(2.3
|
)
|
Benefits paid (net of federal subsidy of $0.3 and $0.2)
|
|
|
(2.7
|
)
|
|
|
(2.5
|
)
|
|
|
|
|
|
|
|
|
|
Benefit obligation at end of year
|
|
$
|
30.4
|
|
|
$
|
33.2
|
|
|
|
|
|
|
|
|
|
|
Change in plan assets
|
|
|
|
|
|
|
|
|
Fair value of plan assets at beginning of year
|
|
$
|
|
|
|
$
|
|
|
Employer contribution
|
|
|
2.1
|
|
|
|
2.0
|
|
Plan participants contributions
|
|
|
0.9
|
|
|
|
0.7
|
|
Gross benefits paid
|
|
|
(3.0
|
)
|
|
|
(2.7
|
)
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded status at end of year
|
|
$
|
(30.4
|
)
|
|
$
|
(33.2
|
)
|
|
|
|
|
|
|
|
|
|
Amounts recognized in the Consolidated Balance Sheets consist
of:
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
$
|
(2.5
|
)
|
|
$
|
|
|
Noncurrent liabilities
|
|
|
(27.9
|
)
|
|
|
(29.5
|
)
|
|
|
|
|
|
|
|
|
|
Total amount accrued
|
|
$
|
(30.4
|
)
|
|
$
|
(29.5
|
)
|
|
|
|
|
|
|
|
|
|
Reconciliation of funded status and accrued amounts:
|
|
|
|
|
|
|
|
|
Funded status as of September 30 measurement date
|
|
$
|
(30.4
|
)
|
|
$
|
(33.2
|
)
|
Unrecognized prior loss
|
|
|
|
|
|
|
3.7
|
|
|
|
|
|
|
|
|
|
|
Accrued benefit cost
|
|
$
|
(30.4
|
)
|
|
$
|
(29.5
|
)
|
|
|
|
|
|
|
|
|
|
Amounts recognized in accumulated other comprehensive loss
consist of:
|
|
|
|
|
|
|
|
|
Actuarial loss
|
|
$
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The estimated actuarial loss that will be amortized from
accumulated other comprehensive income into net periodic benefit
cost over the next fiscal year is $0.
|
|
|
|
|
|
|
|
|
Discount rate used in development of APBO
|
|
|
6.22
|
%
|
|
|
5.86
|
%
|
|
|
|
|
|
|
|
|
|
80
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
0.6
|
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
Interest cost
|
|
|
1.8
|
|
|
|
1.9
|
|
|
|
2.0
|
|
Amortization of actuarial loss
|
|
|
|
|
|
|
0.1
|
|
|
|
0.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic postretirement benefit cost
|
|
|
2.4
|
|
|
|
2.7
|
|
|
|
3.3
|
|
Curtailment charge
|
|
|
|
|
|
|
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total postretirement benefit cost
|
|
$
|
2.4
|
|
|
$
|
2.7
|
|
|
$
|
5.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate used in development of net periodic benefit
cost
|
|
|
5.86
|
%
|
|
|
5.51
|
%
|
|
|
5.75
|
%
|
On December 8, 2003, the Medicare Prescription Drug,
Improvement and Modernization Act (the Act) became
law. The Act provides for a federal subsidy to sponsors of
retiree health care benefit plans that provide a prescription
drug benefit that is at least actuarially equivalent to the
benefit established by the Act. On May 19, 2004, the FASB
issued Staff Position
No. 106-2,
Accounting and Disclosure Requirements Related to the
Medicare Prescription Drug, Improvement and Modernization Act of
2003 (the FSP). The FSP provides guidance on
accounting for the effects of the Act, which the Company adopted
at the beginning of its fourth quarter of fiscal 2004. The APBO
at September 30, 2007, has been reduced by a deferred
actuarial gain in the amount of $5.6 million to reflect the
effect of the subsidy related to benefits attributed to past
service. The amortization of the actuarial gain and reduction of
service and interest costs served to reduce net periodic post
retirement benefit cost for fiscal years 2007, 2006 and 2005 by
$0.7 million, $0.9 million and $0.2 million,
respectively.
For measurement as of September 30, 2007, management has
assumed that health care costs will increase at an annual rate
of 7.5% in fiscal 2008, decreasing 0.50% per year to an ultimate
trend of 5.00% in 2013. A 1% increase in health cost trend rate
assumptions would increase the APBO as of September 30,
2007 and 2006 by $0 and $0.1 million, respectively. A 1%
decrease in health cost trend rate assumptions would decrease
the APBO as of September 30, 2007 and 2006 by
$0.1 million and $0.2 million, respectively. A 1%
increase or decrease in the same rate would not have a material
effect on service or interest costs.
Estimated Future
Benefit Payments
The following benefit payments under the plan are expected to be
paid by the Company and the retirees for the fiscal years
indicated (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
|
|
|
|
|
|
Medicare
|
|
|
Net
|
|
|
|
Benefit
|
|
|
Retiree
|
|
|
Part D
|
|
|
Company
|
|
|
|
Payments
|
|
|
Contributions
|
|
|
Subsidy
|
|
|
Payments
|
|
|
|
|
2008
|
|
$
|
3.7
|
|
|
$
|
(0.9
|
)
|
|
$
|
(0.3
|
)
|
|
$
|
2.5
|
|
2009
|
|
|
3.9
|
|
|
|
(1.1
|
)
|
|
|
(0.3
|
)
|
|
|
2.5
|
|
2010
|
|
|
4.1
|
|
|
|
(1.2
|
)
|
|
|
(0.4
|
)
|
|
|
2.5
|
|
2011
|
|
|
4.3
|
|
|
|
(1.4
|
)
|
|
|
(0.4
|
)
|
|
|
2.5
|
|
2012
|
|
|
4.6
|
|
|
|
(1.6
|
)
|
|
|
(0.5
|
)
|
|
|
2.5
|
|
2013-2017
|
|
|
26.9
|
|
|
|
(11.6
|
)
|
|
|
(2.9
|
)
|
|
|
12.4
|
|
The Company also provides comprehensive major medical benefits
to its associates. The Company is self-insured for certain
health benefits up to $0.3 million per occurrence per
individual. The cost of such benefits is recognized as expense
in the period the claim is incurred. This cost was
$21.4 million, $21.8 million and $17.9 million in
fiscal 2007, 2006 and 2005, respectively.
81
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
(In millions)
|
|
|
Credit Facilities:
|
|
|
|
|
|
|
|
|
Revolving loans
|
|
$
|
469.2
|
|
|
$
|
253.8
|
|
Term loans
|
|
|
558.6
|
|
|
|
|
|
Master Accounts Receivable Purchase Agreement
|
|
|
64.4
|
|
|
|
|
|
65/8% Senior
Subordinated Notes
|
|
|
|
|
|
|
200.0
|
|
Notes due to sellers
|
|
|
15.1
|
|
|
|
15.4
|
|
Foreign bank borrowings and term loans
|
|
|
|
|
|
|
2.8
|
|
Other
|
|
|
10.5
|
|
|
|
9.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,117.8
|
|
|
|
481.2
|
|
Less current portions
|
|
|
86.4
|
|
|
|
6.0
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,031.4
|
|
|
$
|
475.2
|
|
|
|
|
|
|
|
|
|
|
The Companys debt matures as follows for each of the next
five fiscal years and thereafter (in millions):
|
|
|
|
|
|
|
|
|
2008
|
|
|
|
|
|
$
|
86.4
|
|
2009
|
|
|
|
|
|
|
87.4
|
|
2010
|
|
|
|
|
|
|
157.0
|
|
2011
|
|
|
|
|
|
|
193.6
|
|
2012
|
|
|
|
|
|
|
589.4
|
|
Thereafter
|
|
|
|
|
|
|
4.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,117.8
|
|
|
|
|
|
|
|
|
|
|
In connection with the recapitalization transactions discussed
in Note 2, Scotts Miracle-Gro and certain of its
subsidiaries have entered into the following loan facilities
totaling up to $2.15 billion in the aggregate: (a) a
senior secured five-year term loan in the principal amount of
$560 million and (b) a senior secured five-year
revolving loan facility in the aggregate principal amount of up
to $1.59 billion. Under the terms of the loan facilities,
the Company may request an additional $200 million in
revolving credit
and/or term
credit commitments, subject to approval from the lenders.
Borrowings may be made in various currencies including
U.S. dollars, Euros, British pounds sterling, Australian
dollars and Canadian dollars. The new $2.15 billion senior
secured credit facilities replaced the Companys former
$1.05 billion senior credit facility.
The terms of the new senior secured credit facilities provide
for customary representations and warranties and affirmative
covenants similar to the prior senior credit facility. The new
senior secured credit facilities also contain customary negative
covenants providing limitations, subject to negotiated
carve-outs, on liens; contingent obligations; fundamental
changes; acquisitions, investments, loans and advances;
indebtedness; restrictions on subsidiary distributions;
transactions with affiliates and officers; sales of assets; sale
and leaseback transactions; changing the Companys fiscal
year end; modifications of certain debt instruments; negative
pledge clauses; entering into new lines of business; and
restricted payments (including dividend payments restricted to
$55 million annually based on the current Leverage Ratio
(as defined) of the Company). The new senior secured credit
facilities are secured by collateral that includes the capital
stock of specified subsidiaries of Scotts Miracle-Gro,
substantially all domestic accounts receivable (exclusive of any
sold receivables), inventory, and equipment. The new
senior secured credit facilities also require the maintenance of
a specified Leverage Ratio and Interest Coverage Ratio (both as
defined), and are guaranteed by substantially all of Scotts
Miracle-Gros domestic subsidiaries.
82
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The new senior secured credit facilities have several borrowing
options, including interest rates that are based on (i) a
LIBOR rate plus a margin based on a Leverage Ratio (as defined)
or (ii) the greater of the prime rate or the Federal Funds
Effective Rate (as defined) plus
1/2
of 1% plus a margin based on a Leverage Ratio (as defined).
Commitment fees are paid quarterly and are calculated as an
amount equal to the product of a rate based on a Leverage Ratio
(as defined) and the average daily unused portion of both the
revolving and term credit facilities. Amounts outstanding under
the new senior secured credit facilities at September 30,
2007 were at interest rates based on LIBOR applicable to the
borrowed currencies plus 125 basis points. The weighted
average interest rates on amounts outstanding under the credit
facilities were 6.5% and 4.4% at September 30, 2007 and
2006, respectively. As of September 30, 2007, there was
$1,098.1 million of availability under the new senior
secured credit facilities. Under the new senior secured credit
facilities, the Company has the ability to issue letter of
credit commitments up to $65.0 million. At
September 30, 2007, the Company had letters of credit in
the amount of $22.2 million outstanding.
On January 10, 2007, the Company also launched a cash
tender offer for any and all of its outstanding
65/8% senior
subordinated notes due 2013 in an aggregate principal amount of
$200 million. Substantially all of the
65/8% senior
subordinated notes were repurchased under the terms of the
tender offer on February 14, 2007. The remaining senior
subordinated notes not tendered were subsequently called and
repurchased on March 26, 2007. Proceeds from the new senior
secured credit facilities were used to fund the repurchase of
the
65/8% senior
subordinated notes, at an aggregate cost of $209.6 million
including an early redemption premium.
At September 30, 2007, the Company had outstanding interest
rate swaps with major financial institutions that effectively
converted a portion of variable-rate debt denominated in the
Euro, British pound and U.S. dollar to a fixed rate. The
swap agreements have a total U.S. dollar equivalent
notional amount of $720.0 million. The term, expiration
date and rates of these swaps are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional
|
|
|
|
|
|
|
|
|
|
|
Currency
|
|
Amount in USD
|
|
|
Term
|
|
|
Expiration Date
|
|
|
Fixed Rate
|
|
|
|
|
|
(In millions)
|
|
|
British pound
|
|
$
|
59.0
|
|
|
|
3 years
|
|
|
|
11/17/2008
|
|
|
|
4.76
|
%
|
Euro
|
|
|
61.0
|
|
|
|
3 years
|
|
|
|
11/17/2008
|
|
|
|
2.98
|
%
|
U.S. dollar
|
|
|
200.0
|
|
|
|
2 years
|
|
|
|
3/31/2009
|
|
|
|
4.90
|
%
|
U.S. dollar
|
|
|
200.0
|
|
|
|
3 years
|
|
|
|
3/31/2010
|
|
|
|
4.87
|
%
|
U.S. dollar
|
|
|
200.0
|
|
|
|
5 years
|
|
|
|
2/14/2012
|
|
|
|
5.20
|
%
|
The Company has recorded a charge of $18.3 million
(including approximately $8.0 million of noncash charges
associated with the write-off of deferred financing costs)
during fiscal 2007 relating to the refinancing of the former
$1.05 billion senior credit facility and the repurchase of
the
65/8% senior
subordinated notes.
Master Accounts
Receivable Purchase Agreement
On April 11, 2007, the Company entered into a Master
Accounts Receivable Purchase Agreement (the MARP
Agreement). The facility terminates on April 10,
2008, or such later date as may be extended by mutual consent of
the Company and lenders. The Company currently intends to
request an extension. The MARP Agreement provides for the
discounted sale, on a revolving basis, of accounts receivable
generated by specified account debtors, with seasonally adjusted
monthly aggregate limits ranging from $55 million to
$300 million. The MARP Agreement also provides for
specified account debtor sublimit amounts, which provide limits
on the amount of receivables owed by individual account debtors
that can be sold.
The MARP Agreement provides that although the specified
receivables are sold, the purchaser has the right to require the
Company to repurchase uncollected receivables if certain events
occur, including the breach of certain covenants, warranties or
representations made by the Company with respect to such
receivables. However, the purchaser does not have the right to
require the Company to repurchase any uncollected receivables if
nonpayment is due to the account debtors financial
inability to pay. Under certain specified conditions, the
Company has the right to repurchase receivables which have been
sold pursuant to the MARP Agreement. The purchase price paid by
the purchaser reflects a discount
83
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
on the adjusted amount (primarily reflecting historical dilution
and potential trade credits) of the receivables purchased, which
effectively is equal to the
30-day LIBOR
rate plus a margin of .65% per annum. The Company continues to
be responsible for the servicing and administration of the
receivables purchased.
The Company accounts for the sale of receivables under the MARP
Agreement as short-term debt and continues to carry the
receivables on its Consolidated Balance Sheet, in accordance
with SFAS 140, Accounting for Transfers and Servicing
of Financial Assets and Extinguishments of Liabilities,
primarily as a result of the Companys right to repurchase
receivables sold. The caption Accounts receivable pledged
under MARP Agreement in the amount of $149.5 on the
accompanying Consolidated Balance Sheet as of September 30,
2007, represents the pool of receivables that have been
designated as sold and serve as collateral for
short-term debt in the amount of $64.4 million as of that
date.
The Company was in compliance with the terms of all borrowing
agreements at September 30, 2007.
|
|
NOTE 11.
|
SHAREHOLDERS
EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
(In millions)
|
|
|
Preferred shares, no par value:
|
|
|
|
|
|
|
|
|
Authorized
|
|
|
0.2 shares
|
|
|
|
0.2 shares
|
|
Issued
|
|
|
0.0 shares
|
|
|
|
0.0 shares
|
|
Common shares, no par value, $.01 stated value per share
|
|
|
|
|
|
|
|
|
Authorized
|
|
|
100.0 shares
|
|
|
|
100.0 shares
|
|
Issued
|
|
|
68.1 shares
|
|
|
|
68.1 shares
|
|
In fiscal 1995, The Scotts Company merged with Sterns
Miracle-Gro Products, Inc. (Miracle-Gro). At September 30,
2007, the former shareholders of Miracle-Gro, including Hagedorn
Partnership, L.P., owned approximately 33% of Scotts
Miracle-Gros outstanding common shares and, thus, have the
ability to significantly influence the election of directors and
approval of other actions requiring the approval of Scotts
Miracle-Gros shareholders.
Under the terms of the Miracle-Gro merger agreement, the former
shareholders of Miracle-Gro may not collectively acquire,
directly or indirectly, beneficial ownership of Voting Stock (as
that term is defined in the Miracle-Gro merger agreement)
representing more than 49% of the total voting power of the
outstanding Voting Stock, except pursuant to a tender offer for
100% of that total voting power, which tender offer is made at a
price per share which is not less than the market price per
share on the last trading day before the announcement of the
tender offer and is conditioned upon the receipt of at least 50%
of the Voting Stock beneficially owned by shareholders of Scotts
Miracle-Gro other than the former shareholders of Miracle-Gro
and their affiliates and associates.
Scotts Miracle-Gro reacquired 4.5 million and
2.0 million common shares during fiscal 2007 and fiscal
2006, respectively, to be held in treasury. Common shares held
in treasury totaling 2.0 million and 0.5 million have
been reissued in support of share-based compensation awards and
employee purchases under the employee stock purchase plan during
fiscal 2007 and fiscal 2006, respectively. See Note 2 for a
discussion of the Companys fiscal 2007 recapitalization
transactions.
Share-Based
Awards
Scotts Miracle-Gro grants share-based awards annually to
officers and other key employees of the Company and non-employee
directors. The Companys share-based awards typically
consist of stock options and restricted stock, although
performance share awards have been made. Stock appreciation
rights (SARs) also have been granted, though not in
recent years. SARs result in less dilution than stock options as
the SAR holder receives a net share settlement upon exercise.
These share-based awards have been made under plans approved by
the shareholders. Generally, employee share-based awards provide
for three-year cliff vesting, while awards to non-employee
directors typically vest in one year or less. Share-based awards
are forfeited if a holder terminates employment or service with
the Company prior to the vesting date. The Company estimates
that 10% of its share-based awards will be forfeited based on an
analysis of historical trends. This assumption is re-evaluated
on an annual basis
84
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
by grant and adjusted as appropriate. Stock options and SAR
awards have exercise prices equal to the market price of the
underlying common shares on the date of grant with a term of
10 years. If available, the Company will typically use
treasury shares, or if not available, newly issued common shares
in satisfaction of its share-based awards.
A maximum of 18 million common shares are available for
issuance under share-based award plans. At September 30,
2007, approximately 3.3 million common shares were not
subject to outstanding awards and were available to underlie the
grant of new share-based awards. Subsequent to
September 30, 2007, awards covering 1.0 million common
shares were granted to key employees with an estimated fair
value of $17.6 million on the date of grant.
The following is a recap of the share-based awards granted over
the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Key employees
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
|
821,200
|
|
|
|
835,640
|
|
|
|
965,600
|
|
Restricted stock
|
|
|
193,550
|
|
|
|
184,595
|
|
|
|
101,000
|
|
Performance shares
|
|
|
|
|
|
|
30,000
|
|
|
|
|
|
Board of Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
|
127,000
|
|
|
|
126,000
|
|
|
|
147,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,141,750
|
|
|
|
1,176,235
|
|
|
|
1,213,600
|
|
Options and SARs due to recapitalization
|
|
|
1,074,796
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total share-based awards
|
|
|
2,216,546
|
|
|
|
1,176,235
|
|
|
|
1,213,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate fair value at grant dates (in millions), excluding
additional options and SARs issued due to the recapitalization
|
|
$
|
22.3
|
|
|
$
|
20.9
|
|
|
$
|
15.1
|
|
As discussed in Note 2, the Company consummated a series of
transactions as part of a recapitalization plan in the quarter
ended March 31, 2007. The payment of a special dividend is
a recapitalization or adjustment event under the Companys
share-based award programs. As such, it was necessary to adjust
the number of common shares subject to stock options and SARs
outstanding at the time of the dividend, as well as the price at
which such awards may be exercised. The adjustments to the
outstanding awards resulted in an increase in the number of
common shares subject to outstanding stock options and SAR
awards in an aggregate amount of 1.1 million common shares.
The methodology used to adjust the awards was consistent with
Internal Revenue Code (IRC) Section 409A and the then
proposed regulations promulgated thereunder and IRC
Section 424 and the regulations promulgated thereunder,
compliance with which was necessary to avoid adverse tax
consequences for the holder of an award. Such methodology also
resulted in a fair value for the adjusted awards post-dividend
equal to that of the unadjusted awards pre-dividend, with the
result that there was no additional compensation expense in
accordance with the accounting for modifications to awards under
SFAS 123(R).
Total share-based compensation and the deferred tax benefit
recognized were as follows for the periods indicated (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30,
|
|
|
2007
|
|
2006
|
|
2005
|
|
|
Share-based compensation
|
|
$
|
15.5
|
|
|
$
|
15.7
|
|
|
$
|
10.7
|
|
Tax benefit recognized
|
|
|
6.2
|
|
|
|
5.9
|
|
|
|
3.9
|
|
85
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Stock
Options/SARs
Aggregate stock option and SARs activity consisted of the
following for the year ended September 30, 2007
(options/SARs in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WTD.
|
|
|
|
|
|
|
Avg.
|
|
|
|
No. of
|
|
|
Exercise
|
|
|
|
Options/SARs
|
|
|
Price
|
|
|
|
|
Beginning balance
|
|
|
6.2
|
|
|
$
|
26.09
|
|
Granted
|
|
|
2.0
|
|
|
$
|
32.33
|
|
Exercised
|
|
|
(2.1
|
)
|
|
$
|
19.17
|
|
Forfeited
|
|
|
(0.3
|
)
|
|
$
|
35.26
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
|
5.8
|
|
|
$
|
26.63
|
|
|
|
|
|
|
|
|
|
|
Exercisable
|
|
|
3.4
|
|
|
$
|
20.25
|
|
The following summarizes certain information pertaining to stock
option and SAR awards outstanding and exercisable at
September 30, 2007 (options/SARs in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards Outstanding
|
|
|
Awards Exercisable
|
|
|
|
No. of
|
|
|
WTD. Avg.
|
|
|
WTD. Avg.
|
|
|
No. of
|
|
|
|
|
|
WTD Avg
|
|
Range of
|
|
Options/
|
|
|
Remaining
|
|
|
Exercise
|
|
|
Options/
|
|
|
|
|
|
Remaining
|
|
Exercise Price
|
|
SARs
|
|
|
Life
|
|
|
Price
|
|
|
SARS
|
|
|
Exercise Price
|
|
|
Life
|
|
|
|
|
$11.14 $14.95
|
|
|
0.8
|
|
|
|
1.95
|
|
|
$
|
13.66
|
|
|
|
0.8
|
|
|
$
|
13.66
|
|
|
|
1.95
|
|
$15.03 $19.82
|
|
|
0.9
|
|
|
|
3.55
|
|
|
|
16.84
|
|
|
|
0.9
|
|
|
|
16.84
|
|
|
|
3.55
|
|
$20.12 $28.97
|
|
|
1.6
|
|
|
|
5.90
|
|
|
|
23.55
|
|
|
|
1.6
|
|
|
|
23.51
|
|
|
|
5.89
|
|
$29.01 $31.62
|
|
|
0.7
|
|
|
|
7.20
|
|
|
|
29.07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$33.25 $37.48
|
|
|
0.7
|
|
|
|
8.13
|
|
|
|
35.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$38.00 $39.95
|
|
|
0.8
|
|
|
|
8.99
|
|
|
|
38.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$40.53 $46.70
|
|
|
0.3
|
|
|
|
8.92
|
|
|
|
43.38
|
|
|
|
0.1
|
|
|
|
41.66
|
|
|
|
8.33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.8
|
|
|
|
6.06
|
|
|
$
|
26.63
|
|
|
|
3.4
|
|
|
$
|
20.25
|
|
|
|
4.48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The intrinsic value of the stock option and SAR awards
outstanding and exercisable at September 30, were as
follows (in millions):
|
|
|
|
|
|
|
2007
|
|
|
Outstanding
|
|
$
|
93.5
|
|
Exercisable
|
|
|
76.5
|
|
The grant date fair value of stock option awards are estimated
using a binomial model and the assumptions in the following
table. Expected market price volatility is based on implied
volatilities from traded options on Scotts Miracle-Gros
common shares and historical volatility specific to the common
shares. Historical data, including demographic factors impacting
historical exercise behavior, is used to estimate option
exercise and employee termination within the valuation model.
The risk-free rate for periods within the contractual life
(normally ten years) of the option is based on the
U.S. Treasury yield curve in effect at the time of grant.
The expected life of stock options is based on historical
experience and expectations for grants outstanding. The weighted
average assumptions for awards granted are as follows for the
periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Expected market price volatility
|
|
|
26.3
|
%
|
|
|
23.0
|
%
|
|
|
23.9
|
%
|
Risk-free interest rates
|
|
|
4.8
|
%
|
|
|
4.4
|
%
|
|
|
3.7
|
%
|
Expected dividend yield
|
|
|
1.1
|
%
|
|
|
1.2
|
%
|
|
|
0.0
|
%
|
Expected life of stock options in years
|
|
|
5.83
|
|
|
|
6.19
|
|
|
|
6.15
|
|
Estimated weighted-average fair value per stock option
|
|
$
|
11.42
|
|
|
$
|
12.04
|
|
|
$
|
10.57
|
|
86
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Restricted
Stock
Restricted stock award activity was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WTD Avg.
|
|
|
|
|
|
|
Grant Date
|
|
|
|
No. of
|
|
|
Fair Value
|
|
|
|
Shares
|
|
|
per Share
|
|
|
|
|
Awards outstanding at September 30, 2006
|
|
|
302,795
|
|
|
$
|
39.26
|
|
Granted
|
|
|
193,550
|
|
|
|
45.69
|
|
Vested
|
|
|
(114,665
|
)
|
|
|
35.67
|
|
Forfeited
|
|
|
(104,600
|
)
|
|
|
43.23
|
|
|
|
|
|
|
|
|
|
|
Awards outstanding at September 30, 2007
|
|
|
277,080
|
|
|
$
|
43.74
|
|
As of September 30, 2007, total unrecognized compensation
cost related to non-vested share-based awards amounted to
$15.4 million. This cost is expected to be recognized over
a weighted-average period of 1.8 years. Unearned
compensation cost is amortized by grant on the straight-line
method over the vesting period with the amortization expense
classified as a component of Selling, general and
administrative expense within the Consolidated Statements
of Operations.
The total intrinsic value of stock options exercised was
$65.5 million, $23.2 million and $41.7 million
during fiscal 2007, fiscal 2006 and fiscal 2005, respectively.
The total fair value of restricted stock vested was
$5.5 million, $0.4 million and $0.1 million
during fiscal 2007, fiscal 2006 and fiscal 2005, respectively.
Cash received from the exercise of stock options for fiscal 2007
was $29.2 million. The tax benefit realized from the tax
deductions from the exercise of share-based awards and the
vesting of restricted stock totaled $25.2 million for
fiscal 2007.
87
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 12.
|
EARNINGS PER
COMMON SHARE
|
The following table (in millions, except per share data)
presents information necessary to calculate basic and diluted
earnings per common share. Basic earnings per common share are
computed by dividing net income by the weighted average number
of common shares outstanding. Diluted earnings per common share
are computed by dividing net income by the weighted average
number of common shares outstanding plus all potentially
dilutive securities. Options to purchase 0.17 million,
0.15 million and 0.4 million common shares for the
years ended September 30, 2007, 2006 and 2005,
respectively, were not included in the computation of diluted
earnings per common share. These options were excluded from the
calculation because the exercise price of these options was
greater than the average market price of the common shares in
the respective periods, and therefore, they were anti-dilutive.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Income from continuing operations
|
|
$
|
113.4
|
|
|
$
|
132.7
|
|
|
$
|
100.4
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
113.4
|
|
|
$
|
132.7
|
|
|
$
|
100.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC EARNINGS PER COMMON SHARE:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding during the period
|
|
|
65.2
|
|
|
|
67.5
|
|
|
|
66.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.74
|
|
|
$
|
1.97
|
|
|
$
|
1.51
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.74
|
|
|
$
|
1.97
|
|
|
$
|
1.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DILUTED EARNINGS PER COMMON SHARE:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding during the period
|
|
|
65.2
|
|
|
|
67.5
|
|
|
|
66.8
|
|
Potential common shares
|
|
|
1.8
|
|
|
|
1.9
|
|
|
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of common shares outstanding and
dilutive potential common shares
|
|
|
67.0
|
|
|
|
69.4
|
|
|
|
68.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.69
|
|
|
$
|
1.91
|
|
|
$
|
1.47
|
|
Income from discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.69
|
|
|
$
|
1.91
|
|
|
$
|
1.47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
88
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The provision for income taxes consists of the following (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Currently payable:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
54.5
|
|
|
$
|
68.3
|
|
|
$
|
55.9
|
|
State
|
|
|
5.4
|
|
|
|
6.0
|
|
|
|
7.0
|
|
Foreign
|
|
|
8.5
|
|
|
|
6.3
|
|
|
|
8.4
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
6.5
|
|
|
|
(0.5
|
)
|
|
|
(11.8
|
)
|
State
|
|
|
(0.6
|
)
|
|
|
1.6
|
|
|
|
(1.8
|
)
|
Foreign
|
|
|
0.4
|
|
|
|
(1.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
74.7
|
|
|
$
|
80.2
|
|
|
$
|
57.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The domestic and foreign components of income before taxes are
as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Domestic
|
|
$
|
175.3
|
|
|
$
|
253.6
|
|
|
$
|
170.0
|
|
Foreign
|
|
|
12.8
|
|
|
|
(40.7
|
)
|
|
|
(11.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes
|
|
$
|
188.1
|
|
|
$
|
212.9
|
|
|
$
|
158.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the federal corporate income tax rate and
the effective tax rate on income before income taxes from
continuing operations is summarized below (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Statutory income tax rate
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
Effect of goodwill and other permanent differences
|
|
|
4.8
|
|
|
|
|
|
|
|
|
|
Effect of foreign operations
|
|
|
(0.5
|
)
|
|
|
(0.5
|
)
|
|
|
0.2
|
|
State taxes, net of federal benefit
|
|
|
1.6
|
|
|
|
2.3
|
|
|
|
1.8
|
|
Change in state NOL and credit carryforwards
|
|
|
(0.2
|
)
|
|
|
0.1
|
|
|
|
1.9
|
|
Other
|
|
|
(1.0
|
)
|
|
|
0.8
|
|
|
|
(2.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
39.7
|
%
|
|
|
37.7
|
%
|
|
|
36.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The net current and non-current components of deferred income
taxes recognized in the Consolidated Balance Sheets are (in
millions):
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
Net current deferred tax asset (classified with prepaid and
other assets)
|
|
$
|
69.6
|
|
|
$
|
52.6
|
|
Net non-current deferred tax liability (classified with other
liabilities)
|
|
|
(67.9
|
)
|
|
|
(49.2
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
$
|
1.7
|
|
|
$
|
3.4
|
|
|
|
|
|
|
|
|
|
|
89
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The components of the net deferred tax asset/(liability) are as
follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
DEFERRED TAX ASSETS
|
|
|
|
|
|
|
|
|
Inventories
|
|
$
|
12.0
|
|
|
$
|
13.0
|
|
Accrued liabilities
|
|
|
56.0
|
|
|
|
39.0
|
|
Postretirement benefits
|
|
|
26.5
|
|
|
|
33.9
|
|
Accounts receivable
|
|
|
3.4
|
|
|
|
3.3
|
|
Federal NOL carryovers
|
|
|
0.1
|
|
|
|
0.1
|
|
State NOL carryovers
|
|
|
5.4
|
|
|
|
4.5
|
|
Foreign NOL carryovers
|
|
|
38.6
|
|
|
|
33.2
|
|
Other
|
|
|
19.1
|
|
|
|
16.4
|
|
|
|
|
|
|
|
|
|
|
Gross deferred tax assets
|
|
|
161.1
|
|
|
|
143.4
|
|
Valuation allowance
|
|
|
(41.0
|
)
|
|
|
(35.4
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
120.1
|
|
|
|
108.0
|
|
|
|
|
|
|
|
|
|
|
DEFERRED TAX LIABILITIES
|
|
|
|
|
|
|
|
|
Property, plant and equipment
|
|
|
(38.4
|
)
|
|
|
(44.5
|
)
|
Intangible assets
|
|
|
(72.5
|
)
|
|
|
(52.1
|
)
|
Other
|
|
|
(7.5
|
)
|
|
|
(8.0
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax liability
|
|
|
(118.4
|
)
|
|
|
(104.6
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
$
|
1.7
|
|
|
$
|
3.4
|
|
|
|
|
|
|
|
|
|
|
Tax benefits relating to state net operating loss carryforwards
were $5.4 million and $4.5 million at
September 30, 2007 and 2006, respectively. State net
operating loss carryforward periods range from 5 to
20 years. Any losses not utilized within a specific
states carryforward period will expire. State net
operating loss carryforwards include $2.4 million of tax
benefits relating to Smith &
Hawken®.
As these losses may only be used against income of
Smith &
Hawken®,
and cannot be used to offset income of the consolidated group, a
full valuation allowance has been recorded against this tax
asset. Tax benefits associated with state tax credits will
expire if not utilized and amounted to $0.1 million and
$0.3 million at September 30, 2007 and 2006,
respectively.
In accordance with APB 23, deferred taxes have not been provided
on unremitted earnings approximating $93 million of certain
foreign subsidiaries and foreign corporate joint ventures as
such earnings have been permanently reinvested. The Company has
also elected to treat certain foreign entities as disregarded
entities for U.S. tax purposes, which results in their net
income or loss being recognized currently in the Companys
U.S. tax return. As such, the tax benefit of net operating
losses available for foreign statutory tax purposes has already
been recognized for U.S. purposes. Accordingly, a full
valuation allowance is required on the tax benefit of these net
operating losses on global consolidation. Statutory tax benefit
of these net operating loss carryovers amounted to $38.6 million
and $33.2 million for the fiscal years ended
September 30, 2007, and September 30, 2006,
respectively. A full valuation allowance has been placed on
these assets for worldwide tax purposes.
The American Jobs Creation Act (the AJCA) provides
for a domestic production activities deduction (IRC
§ 199) calculated as a percentage of qualified income
from manufacturing in the United States. The percentage
deduction increases from 3% to 9% over a
6-year
period that began with the Companys 2006 fiscal year. A
FASB staff position provides that this deduction be treated as a
special deduction, as opposed to a tax rate reduction, in
accordance with SFAS 109. The benefit of this deduction did
not have a material impact on the Companys effective tax
rate in fiscal 2007 or fiscal 2006.
Management judgment is required in determining tax provisions
and evaluating tax positions. Management believes its tax
positions and related provisions reflected in the consolidated
financial
90
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
statements are fully supportable and appropriate. We establish
reserves for additional income taxes that may become due if our
tax positions are challenged and not sustained. Our tax
provision includes the impact of recording reserves and changes
thereto. The reserves for additional income taxes are based on
managements best estimate of the ultimate resolution of
the tax matter. Based on currently available information, we
believe that the ultimate outcomes of any challenges to our tax
positions will not have a material adverse effect on our
financial position, results of operations or cash flows. Our tax
provision includes the impact of recording reserves and
adjusting existing reserves.
|
|
NOTE 14.
|
FINANCIAL
INSTRUMENTS
|
A description of the Companys financial instruments and
the methods and assumptions used to estimate their fair values
is as follows:
Long-Term
Debt
The carrying amounts of borrowings under the revolving credit
and term loan facilities are considered to approximate their
fair values.
Accounts
Receivable Pledged
The carrying amounts of short-term debt associated with accounts
receivable pledged under the MARP Agreement are considered to
approximately their fair values.
Derivatives
and Hedging
The Company is exposed to market risks, such as changes in
interest rates, currency exchange rates and commodity prices. To
manage the volatility related to these exposures, the Company
enters into various financial transactions, which are accounted
for under SFAS 133, Accounting for Derivative
Instruments and Hedging Activities, as amended and
interpreted. The utilization of these financial transactions is
governed by policies covering acceptable counterpart exposure,
instrument types and other hedging practices. The Company does
not hold or issue derivative financial instruments for
speculative trading purposes.
The Company formally designates and documents qualifying
instruments as hedges of underlying exposures at inception. The
Company formally assesses, both at inception and at least
quarterly on an ongoing basis, whether the financial instruments
used in hedging transactions are effective at offsetting changes
in either the fair value or cash flows of the related underlying
exposure. Fluctuations in the value of these instruments
generally are offset by changes in the fair value or cash flows
of the underlying exposures being hedged. This offset is driven
by the high degree of effectiveness between the exposure being
hedged and the hedging instrument. Any ineffective portion of a
change in the fair value of a qualifying instrument is
immediately recognized in earnings. There were no amounts
excluded from the assessment of effectiveness for derivatives
designated as either fair value or cash flow hedges for the
years ended September 30, 2007 and 2006.
Foreign
Currency Swap Agreements
The Company uses foreign currency swap contracts to manage the
exchange rate risk associated with intercompany loans with
foreign subsidiaries that are denominated in U.S. dollars.
At September 30, 2007, the notional amount of outstanding
contracts was $101.5 million with a fair value of
$(1.3) million. The unrealized loss on the contracts
approximates the unrealized gain on the intercompany loans
recognized by our foreign subsidiaries.
Interest Rate
Swap Agreements
At September 30, 2007 and 2006, the Company had outstanding
interest rate swaps with major financial institutions that
effectively convert a portion of our variable-rate debt to a
fixed rate. The objective of the interest rates swaps was to
eliminate the variability of cash flows attributable to
fluctuations in interest rates. The swap agreements had a total
U.S. dollar equivalent notional amount of
$720.0 million and $108.2 million at
September 30, 2007 and 2006, respectively. Reference should
be made to Note 10, Debt for the terms, expiration dates,
and rates of the swaps outstanding at
91
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2007. The Euro and British pound denominated
swaps included in the table in Note 10 in the notional
amount of $120.0 million were also outstanding at
September 30, 2006. The change in notional amounts for the
Euro and British pounds denominated swaps is due to foreign
exchange movement. During the next 12 months,
$1.1 million of the September 30, 2007 other
comprehensive income balance will be reclassified to earnings
consistent with the timing of the underlying hedged transactions.
The Company enters into interest rate swap agreements as a means
to hedge its variable interest rate exposure on debt
instruments. Since the interest rate swaps have been designated
as hedging instruments, their fair values are reflected in the
Companys Consolidated Balance Sheets. Net amounts to be
received or paid under the swap agreements are reflected as
adjustments to interest expense. Unrealized gains or losses
resulting from adjusting these swaps to fair value are recorded
as elements of accumulated other comprehensive income or loss
within the Consolidated Balance Sheets. The fair value of the
swap agreements was determined based on the present value of the
estimated future net cash flows using implied rates in the
applicable yield curve as of the valuation date.
Commodity
Hedges
The Company has outstanding a strip of collars for approximately
546,000 gallons of fuel at September 30, 2007. The collars
are designed to partially mitigate the effect of fluctuating
fuel costs on the operating results of the Scotts
LawnService®
business through December 31, 2007. The collars do not
qualify for hedge accounting treatment under SFAS 133, and
are being marked-to-market with unrealized gains and losses on
open contracts and realized gains or losses on settled contracts
recorded as an element of cost of sales. Amounts included in
cost of sales relating to these collars at September 30,
2007 and 2006 were not significant.
The Company also has hedging arrangements designed to fix the
price of a portion of its urea needs through March 31,
2008. The contracts are designated as hedges of the
Companys exposure to future cash flows associated with the
cost of urea. The objective of the hedge is to eliminate the
variability of cash flows attributable to the risk of change.
Unrealized gains or losses in the fair value of these contracts
are recorded to the accumulated other comprehensive loss
component of shareholders equity. Gains or losses upon
realization remain as a component of accumulated other
comprehensive loss until the related inventory is sold. Upon
sale of the underlying inventory, the gain or loss is
reclassified to cost of sales. The fair value of the 45,000
aggregate tons hedged at September 30, 2007 was
$1.0 million. During the next 12 months,
$1.0 million of the September 30, 2007 other
comprehensive income balance will be reclassified to earnings
consistent with the timing of the underlying hedged transactions.
Estimated Fair
Values
The estimated fair values of the Companys financial
instruments are as follows for the fiscal years ended September
30 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
Carrying
|
|
|
Fair
|
|
|
Carrying
|
|
|
Fair
|
|
|
|
Amount
|
|
|
Value
|
|
|
Amount
|
|
|
Value
|
|
|
|
|
Revolving loans
|
|
$
|
469.2
|
|
|
$
|
469.2
|
|
|
$
|
253.8
|
|
|
$
|
253.8
|
|
Senior Subordinated Notes
|
|
|
|
|
|
|
|
|
|
|
200.0
|
|
|
|
194.0
|
|
Foreign bank borrowings and term loans
|
|
|
|
|
|
|
|
|
|
|
2.8
|
|
|
|
2.8
|
|
Term loans
|
|
|
558.6
|
|
|
|
558.6
|
|
|
|
|
|
|
|
|
|
Master Accounts Receivable Purchase Agreement
|
|
|
64.4
|
|
|
|
64.4
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) on foreign currency swap agreements
|
|
|
(1.3
|
)
|
|
|
(1.3
|
)
|
|
|
0.4
|
|
|
|
0.4
|
|
Unrealized gain (loss) on interest rate swap agreements
|
|
|
(4.1
|
)
|
|
|
(4.1
|
)
|
|
|
1.3
|
|
|
|
1.3
|
|
Unrealized gain (loss) on commodity hedging instruments
|
|
|
1.0
|
|
|
|
1.0
|
|
|
|
(0.2
|
)
|
|
|
(0.2
|
)
|
92
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Certain miscellaneous instruments included in the Companys
total debt balances for which fair value determinations are not
ascertainable have been excluded from the fair value table
above. The excluded items at September 30, 2007 and 2006
(in millions) are as follows:
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
2006
|
|
|
Notes due to sellers
|
|
$
|
15.1
|
|
|
$
|
15.4
|
|
Other
|
|
|
10.5
|
|
|
|
9.2
|
|
|
|
NOTE 15.
|
OPERATING
LEASES
|
The Company leases certain property and equipment from third
parties under various non-cancelable operating lease agreements.
Certain lease agreements contain renewal and purchase options.
The lease agreements generally provide that the Company pay
taxes, insurance and maintenance expenses related to the leased
assets. Future minimum lease payments for non-cancelable
operating leases at September 30, 2007, are as follows (in
millions):
|
|
|
|
|
2008
|
|
$
|
37.5
|
|
2009
|
|
|
32.7
|
|
2010
|
|
|
25.6
|
|
2011
|
|
|
22.6
|
|
2012
|
|
|
20.4
|
|
Thereafter
|
|
|
55.4
|
|
|
|
|
|
|
Total future minimum lease payments
|
|
$
|
194.2
|
|
|
|
|
|
|
The Company also leases certain vehicles (primarily cars and
light trucks) under agreements that are cancelable after the
first year, but typically continue on a month-to-month basis
until canceled by the Company. The vehicle leases and certain
other non-cancelable operating leases contain residual value
guarantees that create a contingent obligation on the part of
the Company to compensate the lessor if the leased asset cannot
be sold for an amount in excess of a specified minimum value at
the conclusion of the lease term. If all such vehicle leases had
been canceled as of September 30, 2007, the Companys
residual value guarantee would have approximated
$8.4 million. Other residual value guarantee amounts that
apply at the conclusion of the non-cancelable lease term are as
follows:
|
|
|
|
|
|
|
|
|
|
|
Amount of
|
|
Lease
|
|
|
Guarantee
|
|
Termination Date
|
|
|
Scotts
LawnService®
vehicles
|
|
$
|
15.9 million
|
|
|
|
2011
|
|
Corporate aircraft
|
|
|
15.7 million
|
|
|
|
2010 and 2012
|
|
Rent expense for fiscal 2007, fiscal 2006 and fiscal 2005
totaled $74.9 million, $63.3 million, and
$57.9 million, respectively.
The Company has the following unconditional purchase obligations
due during each of the next five fiscal years that have not been
recognized on the Consolidated Balance Sheet at
September 30, 2007 (in millions):
|
|
|
|
|
2008
|
|
$
|
292.0
|
|
2009
|
|
|
144.8
|
|
2010
|
|
|
66.8
|
|
2011
|
|
|
45.9
|
|
2012
|
|
|
12.2
|
|
Thereafter
|
|
|
7.5
|
|
|
|
|
|
|
|
|
$
|
569.2
|
|
|
|
|
|
|
93
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Purchase obligations primarily represent outstanding purchase
orders for materials used in the Companys manufacturing
processes. Purchase obligations also include commitments for
warehouse services, grass seed, and out-sourced information
services.
Management continually evaluates the Companys
contingencies, including various lawsuits and claims which arise
in the normal course of business, product and general
liabilities, workers compensation, property losses and
other fiduciary liabilities for which the Company is
self-insured or retains a high exposure limit. Self-insurance
reserves are established based on loss estimates for specific
individual claims plus actuarial estimated amounts for incurred
but not reported claims and adverse development factors for
existing claims. Legal costs incurred in connection with the
resolution of claims, lawsuits and other contingencies generally
are expensed as incurred. In the opinion of management, its
assessment of contingencies is reasonable and related reserves,
in the aggregate, are adequate; however, there can be no
assurance that future quarterly or annual operating results will
not be materially affected by the final resolution of these
matters. The following are the more significant of the
Companys identified contingencies.
Environmental
Matters
In 1997, the Ohio Environmental Protection Agency (the
Ohio EPA) initiated an enforcement action against
the Company with respect to alleged surface water violations and
inadequate treatment capabilities at the Marysville, Ohio
facility and seeking corrective action under the federal
Resource Conservation and Recovery Act. The action related to
discharges from
on-site
waste water treatment and several discontinued
on-site
disposal areas.
Pursuant to a Consent Order entered by the Union County Common
Pleas Court in 2002, the Company is actively engaged in
restoring the site to eliminate exposure to waste materials from
the discontinued
on-site
disposal areas.
At September 30, 2007, $4.6 million was accrued for
environmental and regulatory matters, primarily related to the
Marysville facility. Most of the accrued costs are expected to
be paid in fiscal 2008; however, payments could be made for a
period thereafter. While the amounts accrued are believed to be
adequate to cover known environmental exposures based on current
facts and estimates of likely outcome, the adequacy of these
accruals is based on several significant assumptions:
|
|
|
|
|
that all significant sites that must be remediated have been
identified;
|
|
|
|
that there are no significant conditions of contamination that
are unknown to us; and
|
|
|
|
that with respect to the agreed judicial Consent Order in Ohio,
the potentially contaminated soil can be remediated in place
rather than having to be removed and only specific stream
segments will require remediation as opposed to the entire
stream.
|
If there is a significant change in the facts and circumstances
surrounding these assumptions, it could have a material impact
on the ultimate outcome of these matters and our results of
operations, financial position and cash flows.
During fiscal 2007, fiscal 2006, and fiscal 2005, we expensed
approximately $1.5 million, $2.4 million, and
$3.7 million, respectively, for environmental matters.
U.S. Horticultural
Supply, Inc. (F/K/A E.C. Geiger, Inc.)
On November 5, 2004, U.S. Horticultural Supply, Inc.
(Geiger) filed suit against the Company in the
U.S. District Court for the Eastern District of
Pennsylvania. This complaint alleges that the Company conspired
with another distributor, Griffin Greenhouse Supplies, Inc., to
restrain trade in the horticultural products market, in
violation of Section 1 of the Sherman Antitrust Act. On
June 2, 2006, the Court denied the Companys motion to
dismiss the complaint. Fact discovery ended on March 8,
2007. The Company is currently engaged in expert discovery, the
deadline for completion of which is December 7, 2007.
Geigers damages expert quantifies Geigers alleged
damages at approximately $3.3 million, which could be
trebled under the antitrust laws. The deadline for dispositive
motions is January 17, 2008.
94
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The Company continues to vigorously defend against Geigers
claims. The Company believes that Geigers claims are
without merit and that the likelihood of an unfavorable outcome
is remote. Therefore, no accrual has been established related to
this matter. However, the Company cannot predict the ultimate
outcome with certainty. If the above action is determined
adversely to the Company, the result could have a material
adverse effect on the Companys results of operations,
financial position and cash flows. The Company had previously
sued and obtained a judgment against Geiger on April 25,
2005, based on Geigers default on obligations to the
Company, and the Company is proceeding to collect that judgment.
Other
The Company has been named a defendant in a number of cases
alleging injuries that the lawsuits claim resulted from exposure
to asbestos-containing products, apparently based on the
Companys historic use of vermiculite in certain of its
products. The complaints in these cases are not specific about
the plaintiffs contacts with the Company or its products.
The Company in each case is one of numerous defendants and none
of the claims seeks damages from the Company alone. The Company
believes that the claims against it are without merit and is
vigorously defending them. It is not currently possible to
reasonably estimate a probable loss, if any, associated with the
cases and, accordingly, no accrual or reserves have been
recorded in the Companys consolidated financial
statements. There can be no assurance that these cases, whether
as a result of adverse outcomes or as a result of significant
defense costs, will not have a material adverse effect on the
Companys financial condition, results of operations or
cash flows.
The Company is reviewing agreements and policies that may
provide insurance coverage or indemnity as to these claims and
is pursuing coverage under some of these agreements and
policies, although there can be no assurance of the results of
these efforts.
On April 27, 2007, the Company received a proposed Order On
Consent from the New York State Department of Environmental
Conservation (the Proposed Order) alleging that
during the calendar year 2003, the Company and James Hagedorn,
individually and as Chairman of the Board and the Chief
Executive Officer of the Company, unlawfully donated to a Port
Washington, New York youth sports organization forty bags of
Scotts®
LawnPro Annual Program Step 3 Insect Control Plus Fertilizer
which, while federally registered, was allegedly not registered
in the state of New York. The Proposed Order requests penalties
totaling $695,000. The Company has made its position clear to
the New York State Department of Environmental Conservation and
is awaiting a response.
On November 26, 2007, the United States Department of
Agriculture issued an administrative complaint alleging that
Scotts LLC had violated the Plant Protection Act and the
regulations promulgated thereunder, related to the testing of
genetically-modified Glyphosate-tolerant creeping bentgrass.
Without admitting or denying that it violated the law, on
November 26, 2007, Scotts LLC entered into a Consent
Decision and Order with the USDA resolving this matter. The
Company has agreed to pay a civil penalty of $500,000, which had
previously been accrued, and conduct three public workshops.
We are involved in other lawsuits and claims which arise in the
normal course of our business. In our opinion, these claims
individually and in the aggregate are not expected to result in
a material adverse effect on our results of operations,
financial position or cash flows.
Former Litigation
Impacting Financial Results for Fiscal 2005
AgrEvo
Environmental Health, Inc. v. The Scotts Company (Southern
District of New York)
The Scotts
Company v. Aventis S.A. and Starlink Logistics, Inc.
(Southern District of Ohio)
On September 30, 2005, all litigation among the
aforementioned companies had been concluded with the Company
receiving a payment of approximately $10 million, of which
amount $8.9 million is recorded in Impairment,
restructuring and other charges within the Consolidated
Statements of Operations (see Note 5).
95
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Central
Garden & Pet Company
The Scotts
Company v. Central Garden, Southern District of
Ohio
Central
Garden v. Scotts & Pharmacia, Northern District
of California
All litigation with Central Garden & Pet Company
(Central Garden) has been concluded. On
July 15, 2005, the Company received approximately
$15 million in satisfaction of the judgment against Central
Garden. The Company has recognized the satisfaction of this
judgment in its financial results for fiscal 2005 as follows (in
millions):
|
|
|
|
|
Reversal of reserve against outstanding receivables due from
Central Garden. The reserve was initially established through a
charge to restructuring and other charges within selling,
general and administrative expenses; therefore, the reversal of
the reserve has been classified in a like manner. (See
Note 5)
|
|
$
|
7.9
|
|
Portion of judgment classified with other income, net
|
|
|
4.1
|
|
|
|
|
|
|
Total amount included in income from operations
|
|
|
12.0
|
|
Portion of judgment applied to unreserved accounts receivable
due from Central Garden
|
|
|
3.0
|
|
|
|
|
|
|
Total judgment
|
|
$
|
15.0
|
|
|
|
|
|
|
All pending litigation brought by Central Garden against the
Company has been concluded including the previously pending
antitrust case in the Northern District of California in which
the Company prevailed.
|
|
NOTE 18.
|
CONCENTRATIONS OF
CREDIT RISK
|
Financial instruments which potentially subject the Company to
concentration of credit risk consist principally of trade
accounts receivable. The Company sells its consumer products to
a wide variety of retailers, including mass merchandisers, home
centers, independent hardware stores, nurseries, garden outlets,
warehouse clubs and local and regional chains. Professional
products are sold to commercial nurseries, greenhouses,
landscape services, and growers of specialty agriculture crops.
Concentrations of accounts receivable at September 30, net
of accounts receivable pledged under the terms of the MARP
Agreement whereby the purchaser has assumed the risk associated
with the debtors financial inability to pay
($149.5 million and $0 for 2007 and 2006, respectively),
were as follows:
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
Due from customers geographically located in North America
|
|
|
52
|
%
|
|
|
76
|
%
|
Applicable to the consumer business
|
|
|
54
|
%
|
|
|
79
|
%
|
Applicable to Scotts
LawnService®,
the professional businesses (primarily distributors),
Smith &
Hawken®,
and Morning
Song®
|
|
|
46
|
%
|
|
|
21
|
%
|
Top 3 customers within consumer business as a percent of total
consumer accounts receivable
|
|
|
0
|
%
|
|
|
53
|
%
|
The remainder of the Companys accounts receivable at
September 30, 2007 and 2006, were generated from customers
located outside of North America, primarily retailers,
distributors, nurseries and growers in Europe. No concentrations
of customers or individual customers within this group account
for more than 10% of the Companys accounts receivable at
either balance sheet date.
The Companys three largest customers are reported within
the North America segment, and are the only customers that
individually represent more than 10% of reported consolidated
net sales for each of the last three fiscal years. These three
customers accounted for the following percentages of
consolidated net sales for the fiscal years ended September 30:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Largest
|
|
|
2nd Largest
|
|
|
3rd Largest
|
|
|
|
Customer
|
|
|
Customer
|
|
|
Customer
|
|
|
|
|
2007
|
|
|
20.2
|
%
|
|
|
10.9
|
%
|
|
|
10.2
|
%
|
2006
|
|
|
21.5
|
%
|
|
|
11.2
|
%
|
|
|
10.5
|
%
|
2005
|
|
|
23.5
|
%
|
|
|
11.9
|
%
|
|
|
9.7
|
%
|
96
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
|
|
NOTE 19.
|
OTHER (INCOME)
EXPENSE
|
Other (income) expense consisted of the following for the fiscal
years ended September 30 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Royalty income
|
|
$
|
(9.9
|
)
|
|
$
|
(6.8
|
)
|
|
$
|
(6.5
|
)
|
Gain from peat transaction
|
|
|
(1.0
|
)
|
|
|
(0.9
|
)
|
|
|
(0.8
|
)
|
Franchise fees
|
|
|
(0.2
|
)
|
|
|
(0.2
|
)
|
|
|
(0.3
|
)
|
Foreign currency (gains) losses
|
|
|
(0.2
|
)
|
|
|
(0.7
|
)
|
|
|
2.1
|
|
Legal settlement
|
|
|
|
|
|
|
|
|
|
|
(4.0
|
)
|
Other, net
|
|
|
(0.2
|
)
|
|
|
(0.6
|
)
|
|
|
2.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(11.5
|
)
|
|
$
|
(9.2
|
)
|
|
$
|
(7.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTE 20.
|
SEGMENT
INFORMATION
|
The Company is divided into the following segments
North America, International, Scotts
LawnService®,
and Corporate & Other. This division of reportable
segments is consistent with how the segments report to and are
managed by senior management of the Company. Certain
reclassifications were made to prior period amounts to reflect
the inclusion of biotech costs and certain other items in the
Corporate & Other segment instead of the North America
segment to be consistent with fiscal 2007 reporting.
The North America segment primarily consists of the Lawns,
Gardens, Growing Media,
Ortho®
(Controls), Canada and North American Professional business
groups as well as the North American portion of the
Roundup®
commission. This segment manufactures, markets and sells dry,
granular slow-release lawn fertilizers, combination lawn
fertilizer and control products, grass seed, spreaders,
water-soluble, liquid and continuous-release garden and indoor
plant foods, plant care products, potting, garden and lawn
soils, mulches and other growing media products, pesticide
products, wild bird food, and a full line of horticulture
products.
Products are marketed to mass merchandisers, home improvement
centers, large hardware chains, warehouse clubs, distributors,
nurseries, garden centers and specialty crop growers in the
United States, Canada, Latin America, South America, Australia,
and Asia/Pacific.
The International segment provides products similar to those
described above for the North America segment to retail
consumers and professional customers primarily in Europe. The
Scotts
LawnService®
segment provides lawn fertilization, disease and insect control
and other related services such as core aeration and tree and
shrub fertilization primarily to residential consumers through
company-owned branches and franchises. In our larger branches,
an exterior barrier pest control service also is offered. The
Corporate & Other segment consists of the Smith &
Hawken®
business and corporate general and administrative expenses.
97
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
The following table (dollars in millions) presents segment
financial information in accordance with SFAS 131,
Disclosures about Segments of an Enterprise and Related
Information. Pursuant to SFAS 131, the presentation
of the segment financial information is consistent with the
basis used by management (i.e., certain costs not allocated to
business segments for internal management reporting purposes are
not allocated for purposes of this presentation).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
1,988.3
|
|
|
$
|
1,914.5
|
|
|
$
|
1,668.1
|
|
International
|
|
|
469.8
|
|
|
|
408.5
|
|
|
|
430.3
|
|
Scotts
LawnService®
|
|
|
230.5
|
|
|
|
205.7
|
|
|
|
159.8
|
|
Corporate & Other
|
|
|
184.0
|
|
|
|
169.2
|
|
|
|
159.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
2,872.6
|
|
|
|
2,697.9
|
|
|
|
2,417.8
|
|
Roundup®
deferred contribution charge
|
|
|
|
|
|
|
|
|
|
|
(45.7
|
)
|
Roundup®
amortization
|
|
|
(0.8
|
)
|
|
|
(0.8
|
)
|
|
|
(2.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,871.8
|
|
|
$
|
2,697.1
|
|
|
$
|
2,369.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
375.4
|
|
|
$
|
391.2
|
|
|
$
|
355.4
|
|
International
|
|
|
35.0
|
|
|
|
28.5
|
|
|
|
34.3
|
|
Scotts
LawnService®
|
|
|
11.3
|
|
|
|
15.6
|
|
|
|
13.1
|
|
Corporate & Other
|
|
|
(90.5
|
)
|
|
|
(91.0
|
)
|
|
|
(105.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment total
|
|
|
331.2
|
|
|
|
344.3
|
|
|
|
297.1
|
|
Roundup®
deferred contribution charge
|
|
|
|
|
|
|
|
|
|
|
(45.7
|
)
|
Roundup®
amortization
|
|
|
(0.8
|
)
|
|
|
(0.8
|
)
|
|
|
(2.8
|
)
|
Amortization
|
|
|
(15.3
|
)
|
|
|
(15.2
|
)
|
|
|
(14.8
|
)
|
Impairment of intangibles and goodwill
|
|
|
(35.3
|
)
|
|
|
(66.4
|
)
|
|
|
(23.4
|
)
|
Restructuring and other charges
|
|
|
(2.7
|
)
|
|
|
(9.4
|
)
|
|
|
(9.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
277.1
|
|
|
$
|
252.5
|
|
|
$
|
200.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation & amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
30.7
|
|
|
$
|
30.7
|
|
|
$
|
30.9
|
|
International
|
|
|
12.0
|
|
|
|
13.1
|
|
|
|
11.5
|
|
Scotts
LawnService®
|
|
|
4.1
|
|
|
|
3.8
|
|
|
|
3.9
|
|
Corporate & Other
|
|
|
20.7
|
|
|
|
19.4
|
|
|
|
20.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
67.5
|
|
|
$
|
67.0
|
|
|
$
|
67.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures:
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
26.3
|
|
|
$
|
24.8
|
|
|
$
|
22.6
|
|
International
|
|
|
12.7
|
|
|
|
11.4
|
|
|
|
3.5
|
|
Scotts
LawnService®
|
|
|
3.8
|
|
|
|
3.0
|
|
|
|
2.1
|
|
Corporate & Other
|
|
|
11.2
|
|
|
|
17.8
|
|
|
|
12.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
54.0
|
|
|
$
|
57.0
|
|
|
$
|
40.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
752.2
|
|
|
$
|
760.3
|
|
|
|
|
|
International
|
|
|
259.6
|
|
|
|
235.0
|
|
|
|
|
|
Scotts
LawnService®
|
|
|
141.1
|
|
|
|
120.3
|
|
|
|
|
|
Corporate & Other
|
|
|
94.7
|
|
|
|
134.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,247.6
|
|
|
$
|
1,250.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
$
|
1,328.3
|
|
|
$
|
1,331.7
|
|
|
|
|
|
International
|
|
|
531.6
|
|
|
|
450.9
|
|
|
|
|
|
Scotts
LawnService®
|
|
|
189.2
|
|
|
|
161.6
|
|
|
|
|
|
Corporate & Other
|
|
|
228.1
|
|
|
|
273.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,277.2
|
|
|
$
|
2,217.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income (loss) represents earnings before
amortization of intangible assets, interest and taxes, since
this is the measure of profitability used by management.
Accordingly, the
98
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS
Corporate & Other operating loss includes unallocated
corporate general and administrative expenses and certain other
income/expense not allocated to the business segments.
Long-lived assets reported for the Companys operating
segments include goodwill and intangible assets as well as
property, plant and equipment within each segment. Total assets
reported for the Companys operating segments include the
intangible assets for the acquired businesses within those
segments. Corporate & Other assets primarily include
deferred financing and debt issuance costs, corporate intangible
assets as well as deferred tax assets and Smith &
Hawken®
assets.
|
|
NOTE 21.
|
QUARTERLY
CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED)
|
The following is a summary of the unaudited quarterly results of
operations for fiscal 2007 and fiscal 2006 (in millions, except
per share data).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First
|
|
|
Second
|
|
|
Third
|
|
|
Fourth
|
|
|
|
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Full Year
|
|
|
|
|
FISCAL 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
271.2
|
|
|
$
|
993.3
|
|
|
$
|
1,098.4
|
|
|
$
|
508.9
|
|
|
$
|
2,871.8
|
|
Gross profit
|
|
|
55.3
|
|
|
|
368.4
|
|
|
|
422.7
|
|
|
|
158.1
|
|
|
|
1,004.5
|
|
Net income (loss)
|
|
|
(59.4
|
)
|
|
|
83.4
|
|
|
|
129.7
|
|
|
|
(40.3
|
)
|
|
|
113.4
|
|
Basic earnings (loss) per common share
|
|
$
|
(0.88
|
)
|
|
$
|
1.26
|
|
|
$
|
2.04
|
|
|
$
|
(0.63
|
)
|
|
$
|
1.74
|
|
Common shares used in basic EPS calculation
|
|
|
67.2
|
|
|
|
66.1
|
|
|
|
63.6
|
|
|
|
63.9
|
|
|
|
65.2
|
|
Diluted earnings (loss) per common share
|
|
$
|
(0.88
|
)
|
|
$
|
1.23
|
|
|
$
|
1.98
|
|
|
$
|
(0.63
|
)
|
|
$
|
1.69
|
|
Common shares and dilutive potential common shares used in
diluted EPS calculation
|
|
|
67.2
|
|
|
|
67.8
|
|
|
|
65.4
|
|
|
|
63.9
|
|
|
|
67.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First
|
|
|
Second
|
|
|
Third
|
|
|
Fourth
|
|
|
|
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Quarter
|
|
|
Full Year
|
|
|
|
|
FISCAL 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
249.5
|
|
|
$
|
907.5
|
|
|
$
|
1,048.0
|
|
|
$
|
492.1
|
|
|
$
|
2,697.1
|
|
Gross profit
|
|
|
53.5
|
|
|
|
346.4
|
|
|
|
406.0
|
|
|
|
150.0
|
|
|
|
955.9
|
|
Net income (loss)
|
|
|
(52.7
|
)
|
|
|
94.8
|
|
|
|
133.3
|
|
|
|
(42.7
|
)
|
|
|
132.7
|
|
Basic earnings (loss) per common share
|
|
$
|
(0.78
|
)
|
|
$
|
1.40
|
|
|
$
|
1.97
|
|
|
$
|
(0.64
|
)
|
|
$
|
1.97
|
|
Common shares used in basic EPS calculation
|
|
|
68.0
|
|
|
|
67.5
|
|
|
|
67.5
|
|
|
|
66.8
|
|
|
|
67.5
|
|
Diluted earnings (loss) per common share
|
|
$
|
(0.78
|
)
|
|
$
|
1.36
|
|
|
$
|
1.92
|
|
|
$
|
(0.64
|
)
|
|
$
|
1.91
|
|
Common shares and dilutive potential common shares used in
diluted EPS calculation
|
|
|
68.0
|
|
|
|
69.6
|
|
|
|
69.4
|
|
|
|
66.8
|
|
|
|
69.4
|
|
Common share equivalents, such as stock awards, are excluded
from the diluted loss per share calculation in periods where
there is a net loss because their effect is anti-dilutive.
The Companys business is highly seasonal with 70% to 75%
of net sales occurring in the second and third fiscal quarters
combined.
Unusual items during fiscal 2007 consisted of impairment,
restructuring and other charges and charges incurred to execute
the Companys recapitalization plan. These items are
reflected in the quarterly financial information as follows:
second quarter refinancing expense due to the recapitalization
plan of $18.3 million, fourth quarter impairment of
intangible assets and goodwill of $35.3 million and
restructuring and other charges of $2.7 million.
Unusual items during fiscal 2006 consisted of impairment
charges, restructuring and other costs, and an insurance
recovery. These items are reflected in the quarterly financial
information as follows: first quarter restructuring and other
charges of $4.7 million and impairment of intangible assets
of $1.0 million; second quarter restructuring and other
charges of $1.1 million; third quarter restructuring and
other charges of $1.1 million; and fourth quarter
restructuring and other charges of $2.5 million and
impairment of intangible assets of $65.4 million. Also
included in the first and second quarters are a
$1.0 million and $9.1 million benefit, respectively,
from an insurance recovery.
99
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of The Scotts
Miracle-Gro Company
Marysville, OH
We have audited the consolidated financial statements of The
Scotts Miracle-Gro Company and Subsidiaries (the
Company) as of September 30, 2007 and 2006, and
for each of the three years in the period ended
September 30, 2007, and the Companys internal control
over financial reporting as of September 30, 2007, and have
issued our reports thereon dated November 29, 2007 (which
report expressed an unqualified opinion and includes an
explanatory paragraph relating to the Companys adoption of
Statement of Financial Accounting Standards No. 158,
Employers Accounting for Defined Benefit Pension and
Other Postretirement Plans on September 30, 2007); such
consolidated financial statements and reports are included
elsewhere in this
Form 10-K.
Our audits also included the consolidated financial statement
schedules of the Company listed in the Index to Consolidated
Financial Statements and Financial Statement Schedules. These
consolidated financial statement schedules are the
responsibility of the Companys management. Our
responsibility is to express an opinion based on our audits. In
our opinion, such consolidated financial statement schedules,
when considered in relation to the basic consolidated financial
statements taken as a whole, present fairly, in all material
respects, the information set forth therein.
/s/ Deloitte &
Touche LLP
Columbus, Ohio
November 29, 2007
100
The
Scotts Miracle-Gro Company
Schedule II
Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2007
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Column A
|
|
Column B
|
|
|
Column C
|
|
|
Column D
|
|
|
Column E
|
|
|
Column F
|
|
|
|
Balance
|
|
|
|
|
|
Additions
|
|
|
Deductions
|
|
|
|
|
|
|
at
|
|
|
|
|
|
Charged
|
|
|
Credited
|
|
|
Balance
|
|
|
|
Beginning
|
|
|
Reserves
|
|
|
to
|
|
|
and
|
|
|
at End of
|
|
Classification
|
|
of Period
|
|
|
Acquired
|
|
|
Expense
|
|
|
Write-Offs
|
|
|
Period
|
|
|
|
|
Valuation and qualifying accounts deducted from the assets to
which they apply:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory reserve
|
|
$
|
15.1
|
|
|
$
|
|
|
|
$
|
9.6
|
|
|
$
|
(9.1
|
)
|
|
$
|
15.6
|
|
Allowance for doubtful accounts
|
|
|
11.3
|
|
|
|
4.1
|
|
|
|
1.3
|
|
|
|
(5.3
|
)
|
|
|
11.4
|
|
Income tax valuation allowance
|
|
|
35.4
|
|
|
|
|
|
|
|
8.5
|
|
|
|
(2.9
|
)
|
|
|
41.0
|
|
Schedule II
Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2006
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Column A
|
|
Column B
|
|
|
Column C
|
|
|
Column D
|
|
|
Column E
|
|
|
Column F
|
|
|
|
Balance
|
|
|
|
|
|
Additions
|
|
|
Deductions
|
|
|
|
|
|
|
at
|
|
|
|
|
|
Charged
|
|
|
Credited
|
|
|
Balance
|
|
|
|
Beginning
|
|
|
Reserves
|
|
|
to
|
|
|
and
|
|
|
at End of
|
|
Classification
|
|
of Period
|
|
|
Acquired
|
|
|
Expense
|
|
|
Write-Offs
|
|
|
Period
|
|
|
|
|
Valuation and qualifying accounts deducted from the assets to
which they apply:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory reserve
|
|
$
|
16.3
|
|
|
$
|
0.3
|
|
|
$
|
9.4
|
|
|
$
|
(10.9
|
)
|
|
$
|
15.1
|
|
Allowance for doubtful accounts
|
|
|
11.4
|
|
|
|
0.5
|
|
|
|
3.5
|
|
|
|
(4.1
|
)
|
|
|
11.3
|
|
Income tax valuation allowance
|
|
|
33.0
|
|
|
|
|
|
|
|
5.1
|
|
|
|
(2.7
|
)
|
|
|
35.4
|
|
Schedule II
Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2005
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Column A
|
|
Column B
|
|
|
Column C
|
|
|
Column D
|
|
|
Column E
|
|
|
Column F
|
|
|
|
Balance
|
|
|
|
|
|
Additions
|
|
|
Deductions
|
|
|
|
|
|
|
at
|
|
|
|
|
|
Charged
|
|
|
Credited
|
|
|
Balance
|
|
|
|
Beginning
|
|
|
Reserves
|
|
|
to
|
|
|
and
|
|
|
at End of
|
|
Classification
|
|
of Period
|
|
|
Acquired
|
|
|
Expense
|
|
|
Write-Offs
|
|
|
Period
|
|
|
|
|
Valuation and qualifying accounts deducted from the assets to
which they apply:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventory reserve
|
|
$
|
21.3
|
|
|
$
|
|
|
|
$
|
11.4
|
|
|
$
|
(16.4
|
)
|
|
$
|
16.3
|
|
Allowance for doubtful accounts
|
|
|
29.0
|
|
|
|
|
|
|
|
1.9
|
|
|
|
(19.5
|
)
|
|
|
11.4
|
|
Income tax valuation allowance
|
|
|
28.8
|
|
|
|
2.4
|
|
|
|
1.8
|
|
|
|
|
|
|
|
33.0
|
|
101
The Scotts
Miracle-Gro Company
Index
to Exhibits
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
2(a)
|
|
Amended and Restated Agreement and Plan of Merger, dated as of
May 19, 1995, among Sterns Miracle-Gro Products,
Inc., Sterns Nurseries, Inc., Miracle-Gro Lawn Products
Inc., Miracle-Gro Products Limited, Hagedorn Partnership, L.P.,
the general partners of Hagedorn Partnership, L.P., Horace
Hagedorn, Community Funds, Inc., and John Kenlon, The Scotts
Company and ZYX Corporation
|
|
Incorporated herein by reference to the Current Report on Form
8-K of The Scotts Company, a Delaware corporation, filed
June 2, 1995 (File No. 0-19768) [Exhibit 2(b)]
|
|
|
|
|
|
|
|
|
|
|
2(b)
|
|
First Amendment to Amended and Restated Agreement and Plan of
Merger, made and entered into as of October 1, 1999, among
The Scotts Company, Scotts Miracle-Gro Products, Inc. (as
successor to ZYX Corporation and Sterns Miracle-Gro
Products, Inc.), Miracle-Gro Lawn Products Inc., Miracle-Gro
Products Limited, Hagedorn Partnership, L.P., Community Funds,
Inc., Horace Hagedorn and John Kenlon, and James Hagedorn,
Katherine Hagedorn Littlefield, Paul Hagedorn, Peter Hagedorn,
Robert Hagedorn and Susan Hagedorn
|
|
Incorporated herein by reference to the Current Report on Form
8-K of The Scotts Company, an Ohio corporation
(Scotts) filed October 5, 1999 (File No. 1-11593)
[Exhibit 2]
|
|
|
|
|
|
|
|
|
|
|
2(c)
|
|
Agreement and Plan of Merger, dated as of December 13,
2004, by and among The Scotts Company, The Scotts Company LLC
and The Scotts Miracle-Gro Company
|
|
Incorporated herein by reference to Scotts Current Report
on Form 8-K filed February 2, 2005 (File
No. 1-13292))
[Exhibit 2.1]
|
|
|
|
|
|
|
|
|
|
|
3(a)
|
|
Initial Articles of Incorporation of The Scotts Miracle-Gro
Company as filed with Ohio Secretary of State on
November 22, 2004
|
|
Incorporated herein by reference to the Current Report on Form
8-K of The Scotts Miracle-Gro Company (the
Registrant) filed March 24, 2005 (File No. 1-13292)
[Exhibit 3.1]
|
|
|
|
|
|
|
|
|
|
|
3(b)
|
|
Certificate of Amendment by Shareholders to Articles of
Incorporation of The Scotts Miracle-Gro Company as filed with
Ohio Secretary of State on March 18, 2005
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed March 24, 2005 (File No.
1-13292) [Exhibit 3.2]
|
|
|
|
|
|
|
|
|
|
|
3(c)
|
|
Code of Regulations of The Scotts Miracle-Gro Company
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed March 24, 2005 (File No.
1-13292) [Exhibit 3.3]
|
|
|
|
|
|
|
|
|
|
|
4(a)
|
|
Amended and Restated Credit Agreement, dated as of
February 7, 2007, by and among The Scotts Miracle-Gro
Company as the Borrower; the Subsidiary Borrowers
(as defined in the Amended and Restated Credit Agreement); the
several banks and other financial institutions from time to time
parties to the Amended and Restated Credit Agreement; Bank of
America, N.A., as Syndication Agent; The Bank of
Tokyo-Mitsubushi UFJ, Ltd, BNP Paribas, CoBank, ACB, BMO Capital
Markets Financing, Inc., LaSalle Bank N.A., Cooperatieve
Centrale Raiffeisen Boerenleenbank, B.A. Rabobank
Nederland, New York Branch, Citicorp North America, Inc.
and The Bank of Nova Scotia, as Documentation Agents; and
JPMorgan Chase Bank, N.A., as Administrative Agent
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2007 (File
No. 1-13292)
[Exhibit 4(a)]
|
|
|
|
|
|
102
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
4(b)
|
|
First Amendment, dated as of April 10, 2007, to the Amended
and Restated Credit Agreement, dated as of February 7,
2007, by and among The Scotts Miracle-Gro Company as the
Borrower; the Subsidiary Borrowers (as defined in
the Amended and Restated Credit Agreement); the several banks
and other financial institutions from time to time parties to
the Amended and Restated Credit Agreement; the Syndication Agent
and the Documentation Agents named in the Amended and Restated
Credit Agreement and JPMorgan Chase Bank, N.A., as
Administrative Agent
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2007 (File
No. 1-13292)
[Exhibit 4(b)]
|
|
|
|
|
|
|
|
|
|
|
4(c)
|
|
Amended and Restated Guarantee and Collateral Agreement, dated
as of February 7, 2007, made by The Scotts Miracle-Gro
Company and each Subsidiary Borrower (and certain of the
Subsidiary Borrowers domestic subsidiaries) under the
Amended and Restated Credit Agreement in favor of JPMorgan Chase
Bank, N.A., as Administrative Agent
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2007 (File
No. 1-13292)
[Exhibit 4(c)]
|
|
|
|
|
|
|
|
|
|
|
4(d)
|
|
Foreign Pledge Agreement Acknowledgement and Confirmation, dated
as of March 30, 2007, entered into by Scotts Sierra
Investments, Inc. and OMS Investments, Inc. in favor of JPMorgan
Chase Bank, N.A., as Administrative Agent
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2007 (File
No. 1-13292)
[Exhibit 4(d)]
|
|
|
|
|
|
|
|
|
|
|
4(e)
|
|
Agreement to furnish copies of instruments and agreements
defining rights of holders of long-term debt
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(a)(1)
|
|
The O.M. Scott & Sons Company Excess Benefit Plan,
effective October 1, 1993
|
|
Incorporated herein by reference to the Annual Report on Form
10-K for the fiscal year ended September 30, 1993 of The Scotts
Company, a Delaware corporation (File
No. 0-19768)
[Exhibit 10(h)]
|
|
|
|
|
|
|
|
|
|
|
10(a)(2)
|
|
First Amendment to The O.M. Scott & Sons Company
Excess Benefit Plan, effective as of January 1, 1998
|
|
Incorporated herein by reference to the Annual Report on Form
10-K for the fiscal year ended September 30, 2001 of The Scotts
Company, an Ohio corporation (Scotts) (File No.
1-13292) [Exhibit 10(a)(2)]
|
|
|
|
|
|
|
|
|
|
|
10(a)(3)
|
|
Second Amendment to The O.M. Scott & Sons Company
Excess Benefit Plan, effective as of January 1, 1999
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2001 (File
No. 1-13292) [Exhibit 10(a)(3)]
|
|
|
|
|
|
|
|
|
|
|
10(a)(4)
|
|
Third Amendment to The O.M. Scott & Sons Company
Excess Benefit Plan, effective as of March 18, 2005
(amended title of plan to be The Scotts Company LLC Excess
Benefit Plan)
|
|
Incorporated herein by reference to the Quarterly Report on Form
10-Q for the quarterly period ended April 2, 2005 of The Scotts
Miracle-Gro Company (the Registrant) (File
No. 1-13292)
[Exhibit 10(CC)]
|
|
|
|
|
|
|
|
|
|
|
10(b)(1)
|
|
The Scotts Company LLC Executive/Management Incentive Plan (as
approved by the shareholders of The Scotts Miracle-Gro Company
on January 26, 2006)
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed February 2, 2006 (File No.
1-13292) [Exhibit 10.4]
|
|
|
|
|
|
103
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(b)(2)
|
|
The Scotts Company LLC Amended and Restated Executive/Management
Incentive Plan (effective as of November 7, 2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(c)(1)
|
|
Specimen form of Employee Confidentiality, Noncompetition,
Nonsolicitation Agreement for employees participating in The
Scotts Company LLC Executive/Management Incentive Plan (now
known as The Scotts Company LLC Amended and Restated
Executive/Management Incentive Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
July 1, 2006 (File No. 1-13292) [Exhibit 10.1]
|
|
|
|
|
|
|
|
|
|
|
10(c)(2)
|
|
Executive Officers of The Scotts Miracle-Gro Company who are
parties to form of Employee Confidentiality, Noncompetition,
Nonsolicitation Agreement for employees participating in The
Scotts Company LLC Executive/Management Incentive Plan (now
known as The Scotts Company LLC Amended and Restated
Executive/Management Incentive Plan)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(d)(1)
|
|
The Scotts Company 1996 Stock Option Plan (as amended through
May 15, 2000)
|
|
Incorporated herein by reference to Scotts Quarterly
Report on Form 10-Q for the quarterly period ended April 1, 2000
(File No. 1-13292) [Exhibit 10(d)]
|
|
|
|
|
|
|
|
|
|
|
10(d)(2)
|
|
The Scotts Company 1996 Stock Option Plan (2002 Amendment)
|
|
Incorporated herein by reference to Scotts Quarterly
Report on Form 10-Q for the quarterly period ended December 28,
2002 (File No. 1-13292) [Exhibit 10(d)(i)]
|
|
|
|
|
|
|
|
|
|
|
10(d)(3)
|
|
Amendment to The Scotts Company 1996 Stock Option
Plan 2005 Amendment, effective as of March 18,
2005 (amended title of plan to be The Scotts Miracle-Gro Company
1996 Stock Option Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
April 2, 2005 (File No. 1-13292) [Exhibit 10(z)]
|
|
|
|
|
|
|
|
|
|
|
10(d)(4)
|
|
The Scotts Miracle-Gro Company Amended and Restated 1996 Stock
Option Plan (effective as of October 30, 2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(e)
|
|
Form of 1996 Stock Option Plan Stock Option
Agreement Non-Qualified Stock Option
|
|
Incorporated herein by reference to Scotts Current Report
on Form 8-K filed November 19, 2004 (File No. 1-13292) [Exhibit
10.7]
|
|
|
|
|
|
|
|
|
|
|
10(f)
|
|
Specimen form of Stock Option Agreement (as amended through
October 23, 2001) for Non-Qualified Stock Options
granted to employees under The Scotts Company 1996 Stock Option
Plan (now known as The Scotts Miracle-Gro Company Amended and
Restated 1996 Stock Option Plan), French specimen
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2001 (File
No. 1-13292) [Exhibit 10(f)]
|
|
|
|
|
|
|
|
|
|
|
10(g)(1)
|
|
The Scotts Company Executive Retirement Plan
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 1998 (File
No. 1-11593) [Exhibit 10(j)]
|
|
|
|
|
|
|
|
|
|
|
10(g)(2)
|
|
First Amendment to The Scotts Company Executive Retirement Plan,
effective as of January 1, 1999
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2001 (File
No. 1-13292) [Exhibit 10(g)(2)]
|
|
|
|
|
|
104
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(g)(3)
|
|
Second Amendment to The Scotts Company Executive Retirement
Plan, effective as of January 1, 2000
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2001 (File
No. 1-13292) [Exhibit 10(g)(3)]
|
|
|
|
|
|
|
|
|
|
|
10(g)(4)
|
|
Third Amendment to The Scotts Company Executive Retirement Plan,
effective as of January 1, 2003
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2003 (File
No. 1-13292) [Exhibit 10(g)(4)]
|
|
|
|
|
|
|
|
|
|
|
10(g)(5)
|
|
Fourth Amendment to The Scotts Company Executive Retirement
Plan, effective as of January 1, 2004
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2004 (File
No. 1-13292) [Exhibit 10(g)(5)]
|
|
|
|
|
|
|
|
|
|
|
10(g)(6)
|
|
Fifth Amendment to The Scotts Company Executive Retirement Plan,
effective as of March 18, 2005 (amended title of plan to be
The Scotts Company LLC Executive Retirement Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
April 2, 2005 (File No. 1-13292) [Exhibit 10(DD)]
|
|
|
|
|
|
|
|
|
|
|
10(h)
|
|
Employment Agreement, dated as of May 19, 1995, between The
Scotts Company and James Hagedorn
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 1995 (File
No. 1-11593) [Exhibit 10(p)]
|
|
|
|
|
|
|
|
|
|
|
10(i)(1)
|
|
Letter agreement, dated June 8, 2000, between The Scotts
Company and Patrick J. Norton
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2000 (File
No. 1-13292) [Exhibit 10(q)]
|
|
|
|
|
|
|
|
|
|
|
10(i)(2)
|
|
Letter agreement, dated November 5, 2002, and accepted by
Mr. Norton on November 22, 2002, pertaining to the
terms of employment of Patrick J. Norton through
December 31, 2005, and superseding certain provisions of
the letter agreement, dated June 8, 2000, between The
Scotts Company and Mr. Norton
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 2002 (File
No. 1-13292) [Exhibit 10(q)]
|
|
|
|
|
|
|
|
|
|
|
10(i)(3)
|
|
Letter of Extension, dated October 25, 2005, between The
Scotts Miracle-Gro Company and Patrick J. Norton
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed December 14, 2005 (File No.
1-13292) [Exhibit 10.3]
|
|
|
|
|
|
|
|
|
|
|
10(j)(1)
|
|
The Scotts Company 2003 Stock Option and Incentive Equity Plan
(as approved by shareholders of The Scotts Company on
January 30, 2003)
|
|
Incorporated herein by reference to Scotts Quarterly
Report on Form 10-Q for the quarterly period ended December 28,
2002 (File No. 1-13292) [Exhibit 10(w)]
|
|
|
|
|
|
|
|
|
|
|
10(j)(2)
|
|
First Amendment to The Scotts Company 2003 Stock Option and
Incentive Equity Plan, effective as of March 18, 2005
(amended title of plan to be The Scotts Miracle-Gro Company 2003
Stock Option and Incentive Equity Plan)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
April 2, 2005 (File No. 1-13292) [Exhibit 10(AA)]
|
|
|
|
|
|
|
|
|
|
|
10(j)(3)
|
|
The Scotts Miracle-Gro Company Amended and Restated 2003 Stock
Option and Incentive Equity Plan (effective as of
October 30, 2007)
|
|
*
|
|
|
|
|
|
105
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(k)(1)
|
|
Specimen form of Award Agreement for Nondirectors used to
evidence Incentive Stock Options, Nonqualified Stock Options,
Stock Appreciation Rights, Restricted Stock and Performance
Shares which may be granted under The Scotts-Miracle Gro Company
2003 Stock Option and Incentive Equity Plan (now known as The
Scotts Miracle-Gro Company Amended and Restated 2003 Stock
Option and Incentive Equity Plan)
|
|
Incorporated herein by reference to the Registrants Annual
Report on Form 10-K for the fiscal year ended September 30, 2005
(File No. 1-13292) [Exhibit 10(u)]
|
|
|
|
|
|
|
|
|
|
|
10(k)(2)
|
|
Form of letter agreement amending Restricted Stock awards
granted under The Scotts Miracle-Gro Company 2003 Stock Option
and Incentive Equity Plan, as amended (effective as of
October 30, 2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(l)
|
|
Specimen form of Award Agreement for Directors used to evidence
Nonqualified Stock Options granted under The Scotts Miracle-Gro
Company 2003 Stock Option and Incentive Equity Plan (now known
as The Scotts Miracle-Gro Company Amended and Restated 2003
Stock Option and Incentive Equity Plan)
|
|
Incorporated herein by reference to the Registrants Annual
Report on
Form 10-K
for the fiscal year ended September 30, 2005 (File No.
1-13292) [Exhibit 10(v)]
|
|
|
|
|
|
|
|
|
|
|
10(m)
|
|
Employment Agreement effective as of October 1, 2007,
between The Scotts Company LLC and Barry W. Sanders
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(n)
|
|
Employment Agreement effective as of July 1, 2001, between
The Scotts Company LLC and Claude Lopez [English
Translation Original in French]
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(o)
|
|
Employment Agreement for Christopher Nagel, entered into
effective as of October 1, 2006, by and between Christopher
Nagel and The Scotts Miracle-Gro Company (voluntarily terminated
effective July 18, 2007)
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed December 7, 2006 (File No.
1-13292) [Exhibit 10.1]
|
|
|
|
|
|
|
|
|
|
|
10(p)
|
|
The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan
Award Agreement for Employees, evidencing Restricted Stock Award
of 38,000 Restricted Stock Awarded to Christopher Nagel on
October 1, 2006 by The Scotts Miracle-Gro Company
(forfeited as a result of voluntary termination effective
July 18, 2007)
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed December 7, 2006 (File No.
1-13292) [Exhibit 10.2]
|
|
|
|
|
|
|
|
|
|
|
10(q)
|
|
Separation Agreement and General Release, entered into and
effective as of July 18, 2007, by and between The Scotts
Miracle-Gro Company and Christopher L. Nagel
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed July 18, 2007 (File No.
1-13292) [Exhibit 10.1]
|
|
|
|
|
|
|
|
|
|
|
10(r)(1)
|
|
The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (as
approved by the shareholders of The Scotts Miracle-Gro Company
on January 26, 2006)
|
|
Incorporated herein by reference to the Registrants
Current Report on
Form 8-K
filed February 2, 2006 (File No. 1-13292)
[Exhibit 10.2]
|
|
|
|
|
|
|
|
|
|
|
10(r)(2)
|
|
The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan (effective as of October 30, 2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(s)
|
|
Specimen form of Award Agreement used to evidence Time-Based
Nonqualified Stock Options for Non-Employee Directors under The
Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (now
known as The Scotts Miracle-Gro Company Amended and Restated
2006 Long-Term Incentive Plan)
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed February 2, 2006 (File No.
1-13292) [Exhibit 10.3]
|
|
|
|
|
|
106
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(t)(1)
|
|
Specimen form of Award Agreement used to evidence awards of
Restricted Stock Units, Performance Shares, Nonqualified Stock
Options, Incentive Stock Options, Restricted Stock and Stock
Appreciation Rights which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan), used prior to October 30, 2007
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 31, 2005 (File
No. 1-13292)
[Exhibit 10(b)]
|
|
|
|
|
|
|
|
|
|
|
10(t)(2)
|
|
Form of letter agreement amending Restricted Stock awards
granted under The Scotts Miracle-Gro Company 2006 Long-Term
Incentive Plan, as amended (effective as of October 30,
2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(t)(3)
|
|
Specimen form of Nonqualified Stock Option Award Agreement for
Employees to evidence grants of Nonqualified Stock Options which
may be made under The Scotts Miracle-Gro Company [Amended and
Restated] 2006 Long-Term Incentive Plan (used after
October 30, 2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(t)(4)
|
|
Specimen form of Restricted Stock Award Agreement for Employees
to evidence grants of Restricted Stock which may be made under
The Scotts Miracle-Gro Company [Amended and Restated] 2006
Long-Term Incentive Plan (used after October 30, 2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(t)(5)
|
|
Specimen form of Performance Share Award Agreement for Employees
(with Related Dividend Equivalents) to evidence grants of
Performance Shares which may be made under The Scotts
Miracle-Gro Company [Amended and Restated] 2006 Long-Term
Incentive Plan (used after October 30, 2007)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(u)
|
|
Specimen form of Award Agreement for Third Party Service
Providers used to evidence awards which may be granted under The
Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (now
known as The Scotts Miracle-Gro Company Amended and Restated
2006 Long-Term Incentive Plan) to third party service providers
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
July 1, 2006 (File No. 1-13292) [Exhibit 10.3]
|
|
|
|
|
|
|
|
|
|
|
10(v)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options, Restricted Stock and Restricted
Stock Units which may be granted under The Scotts Miracle-Gro
Company 2006 Long-Term Incentive Plan (now known as The Scotts
Miracle-Gro Company Amended and Restated 2006 Long-Term
Incentive Plan) (Standard International Specimen covering
Australian, Canadian and The Netherlands)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 30, 2006 (File
No. 1-13292)
[Exhibit 10.1]
|
|
|
|
|
|
|
|
|
|
|
10(w)
|
|
Specimen form of Award Agreement for Employees used to evidence
Stock Options, Restricted Stock and Restricted Stock Units which
may be granted under The Scotts Miracle-Gro Company 2006
Long-Term Incentive Plan (now known as The Scotts Miracle-Gro
Company Amended and Restated 2006 Long-Term Incentive Plan)
(Austrian Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 30, 2006 (File
No. 1-13292)
[Exhibit 10.2]
|
|
|
|
|
|
107
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(x)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan) (Belgian Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 30, 2006 (File
No. 1-13292)
[Exhibit 10.3]
|
|
|
|
|
|
|
|
|
|
|
10(y)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options, Restricted Stock, Restricted Stock
Units and Performance Shares which may be granted under The
Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (now
known as The Scotts Miracle-Gro Company Amended and Restated
2006 Long-Term Incentive Plan) (French Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 30, 2006 (File
No. 1-13292)
[Exhibit 10.4]
|
|
|
|
|
|
|
|
|
|
|
10(z)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan) (German Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 30, 2006 (File
No. 1-13292)
[Exhibit 10.5]
|
|
|
|
|
|
|
|
|
|
|
10(aa)
|
|
Specimen form of Award Agreement for Employees used to evidence
Nonqualified Stock Options which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan) (Polish Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 30, 2006 (File
No. 1-13292)
[Exhibit 10.6]
|
|
|
|
|
|
|
|
|
|
|
10(bb)
|
|
Specimen form of Award Agreement for United Kingdom Employees
used to evidence Nonqualified Stock Options, Restricted Stock
and Restricted Stock Units which may be granted under The Scotts
Miracle-Gro Company 2006 Long-Term Incentive Plan (now known as
The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan) (United Kingdom Specimen)
|
|
Incorporated herein by reference to the Registrants
Quarterly Report on Form 10-Q for the quarterly period ended
December 30, 2006 (File
No. 1-13292)
[Exhibit 10.7]
|
|
|
|
|
|
|
|
|
|
|
10(cc)
|
|
The Scotts Miracle-Gro Company Discounted Stock Purchase Plan
(As Amended and Restated as of January 26, 2006; Reflects
2-for-1
Stock Split Distributed on November 9, 2005)
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed February 2, 2006 (File No.
1-13292) [Exhibit 10.1]
|
|
|
|
|
|
|
|
|
|
|
10(dd)
|
|
Summary of Compensation for Directors of The Scotts Miracle-Gro
Company
|
|
*
|
|
|
|
|
|
|
|
|
|
|
10(ee)
|
|
Separation Agreement and General Release, entered into and
effective as of July 17, 2007 by and between The Scotts
Miracle-Gro Company and David M. Aronowitz
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed July 17, 2007 (File
No. 1-13292)
[Exhibit 10.1]
|
|
|
|
|
|
|
|
|
|
|
10(ff)
|
|
Exclusive Distributor Agreement Horticulture,
effective as of June 22, 1998, between The Scotts Company
and AgrEvo USA Company
|
|
Incorporated herein by reference to Scotts Annual Report
on Form 10-K for the fiscal year ended September 30, 1998 (File
No. 1-11593)
[Exhibit 10(v)]
|
|
|
|
|
|
108
|
|
|
|
|
Exhibit
|
|
|
|
|
No.
|
|
Description
|
|
Location
|
|
|
10(gg)
|
|
Amended and Restated Exclusive Agency and Marketing Agreement,
dated as of September 30, 1998, between Monsanto Company
and The Scotts Company LLC (as successor to The Scotts Company)
|
|
Incorporated herein by reference to the Registrants Annual
Report on Form 10-K for the fiscal year ended September 30, 2005
(File
No. 1-13292)
[Exhibit 10(x)]
|
|
|
|
|
|
|
|
|
|
|
10(hh)
|
|
Master Accounts Receivable Purchase Agreement, dated as of
April 11, 2007, by and among The Scotts Company LLC as
seller, The Scotts Miracle-Gro Company as guarantor and LaSalle
Bank National Association as purchaser
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed April 17, 2007 (File
No. 1-13292)
[Exhibit 10.1]
|
|
|
|
|
|
|
|
|
|
|
14
|
|
Code of Business Conduct and Ethics of The Scotts Miracle-Gro
Company, as amended on November 2, 2006
|
|
Incorporated herein by reference to the Registrants
Current Report on Form 8-K filed November 8, 2006 (File
No. 1-13292))
[Exhibit 14]
|
|
|
|
|
|
|
|
|
|
|
21
|
|
Subsidiaries of The Scotts Miracle-Gro Company
|
|
*
|
|
|
|
|
|
|
|
|
|
|
23
|
|
Consent of Independent Registered Public Accounting
Firm Deloitte & Touche LLP
|
|
*
|
|
|
|
|
|
|
|
|
|
|
24
|
|
Powers of Attorney of Executive Officers and Directors of The
Scotts Miracle-Gro Company
|
|
*
|
|
|
|
|
|
|
|
|
|
|
31(a)
|
|
Rule 13a-14(a)/15d-14(a)
Certification (Principal Executive Officer)
|
|
*
|
|
|
|
|
|
|
|
|
|
|
31(b)
|
|
Rule 13a-14(a)/15d-14(a)
Certification (Principal Financial Officer)
|
|
*
|
32
|
|
Section 1350 Certification (Principal Executive Officer and
Principal Financial Officer)
|
|
*
|
109
EX-4(E)
Exhibit 4(e)
November 29, 2007
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
|
|
|
Re: |
|
The Scotts Miracle-Gro Company Annual Report on Form 10-K
for the fiscal year ended September 30, 2007 |
Ladies and Gentlemen:
The Scotts Miracle-Gro Company, an Ohio corporation (Scotts Miracle-Gro), is today filing
its Annual Report on Form 10-K for the fiscal year ended September 30, 2007 (the Form 10-K).
Neither Scotts Miracle-Gro nor any of its consolidated subsidiaries has outstanding any
instrument or agreement with respect to its long-term debt, other than those filed or incorporated
by reference as an exhibit to the Form 10-K, under which the total amount of long-term debt
authorized exceeds ten percent (10%) of the total assets of Scotts Miracle-Gro and its subsidiaries
on a consolidated basis. In accordance with the provisions of Item 601(b)(4)(iii) of SEC
Regulation S-K, Scotts Miracle-Gro hereby agrees to furnish to the SEC, upon request, a copy of
each such instrument or agreement defining the rights of holders of long-term debt of Scotts
Miracle-Gro or the rights of holders of long-term debt of one of Scotts Miracle-Gros consolidated
subsidiaries, in each case which is not being filed or incorporated by reference as an exhibit to
the Form 10-K.
Very truly yours,
THE SCOTTS MIRACLE-GRO COMPANY
/s/ David C. Evans
David C. Evans
Executive Vice President and Chief Financial Officer
14111 Scottslawn Road Marysville, OH 43041 937-644-0011
www.scotts.com
EX-10(B)(2)
EXHIBIT 10(b)(2)
THE SCOTTS COMPANY LLC
AMENDED AND RESTATED
EXECUTIVE/MANAGEMENT INCENTIVE PLAN (THE PLAN or EMIP)
TERMS AND CONDITIONS
|
1.1 |
|
Provide meaningful financial incentives consistent with and supportive of
corporate strategies and objectives. |
|
|
1.2 |
|
Encourage team effort toward achievement of corporate financial and strategic
goals aligned with shareholders of The Scotts Miracle-Gro Company and our customers. |
|
|
1.3 |
|
Contribute toward a competitive compensation program for all associates
participating in the Plan (Participants). |
|
2.1 |
|
All managers and more senior level associates of The Scotts Company LLC (the
Company) and all Affiliates and Subsidiaries (as defined below) are eligible to
participate upon recommendation by management and in the case of covered employees (as
defined in Code §162(m)) approval by the Compensation and Organization Committee of The
Scotts Miracle-Gro Company (the Committee). For purposes of this Plan: |
|
(a) |
|
Code means the Internal Revenue Code of 1986, as amended. |
|
|
(b) |
|
Affiliates and Subsidiaries mean all persons with whom the
Company would be considered a single employer under Code §§414(b) and (c). |
|
2.2 |
|
Except as otherwise provided by the Committee and, in the case of covered
employees, permitted under Code §162(m), Participants must be actively employed in an
eligible job/position for at least 13 consecutive weeks during the Plan Year (the
Companys fiscal year). |
|
|
2.3 |
|
Participant eligibility is based on active status during the Plan Year.
Periods of inactive status such as short-term disability and other leaves will be
reflected in the eligible earnings and payout calculation. |
|
|
2.4 |
|
Except as otherwise provided by the Committee and, in the case of covered
employees, permitted under Code §162(m), Participants must be employed on the last day
of the Plan Year to be eligible for an incentive payment. |
|
|
2.5 |
|
Except as otherwise provided by the Committee and, in the case of covered
employees, permitted under Code §162(m), participants whose employment terminates
during the Plan Year, except in cases of retirement, will not be eligible for an
incentive payment, prorated or otherwise. |
|
|
2.6 |
|
Participants who retire during the Plan Year will be eligible for a prorated
incentive payment. |
|
|
2.7 |
|
Participants who hold an eligible position on a part-time basis are eligible
for the EMIP. All other terms and conditions apply. |
|
2.8 |
|
Participants who move to a different EMIP eligible position or otherwise become
eligible for a different target percentage during the Plan Year will be pro-rated based
on new metrics/target (if applicable) only if the move is for an eligible period of at
least 13 weeks in the Plan Year. |
|
|
2.9 |
|
Participants who move to a non-EMIP eligible position during the Plan Year will
be eligible for a pro-rated incentive payment (based on Plan Year earnings) provided
other eligibility requirements are met. |
|
|
2.10 |
|
Participants shall not have any right with respect to any award until an award
shall, in fact, be paid to them. |
|
|
2.11 |
|
The Plan confers no rights upon any associate to participate in the Plan or
remain in the employ of the Company or any Affiliate or Subsidiary. Neither the
adoption of the Plan nor its operation shall in any way affect the right of the
associate or the Company or any Affiliate or Subsidiary to terminate the employment
relationship at any time. |
3. |
|
Plan Design, Performance Measures, and Payouts |
|
3.1 |
|
The Plan is designed to recognize and reward performance against established
financial targets. The Plan is comprised of: |
|
(a) |
|
A corporate net income funding trigger below which no
incentives will be paid to any Participant; |
|
|
(b) |
|
Up to five standard Performance Measures from the list of
available Performance Measures, below; |
|
|
(c) |
|
An earnings multiplier that will reinforce the importance of
earnings by modifying the performance results against all of the other goals;
and |
|
|
(d) |
|
The ability to tailor incentive measure weights to each
particular group or unit reflecting the relative contribution that group or
unit can make to those results. |
|
3.2 |
|
Available Performance Measures under the Plan shall be measured over the
period established by the Committee and be limited to the following: |
|
(a) |
|
Net earnings or net income (before or after taxes); |
|
|
(b) |
|
Earnings per share (basic or diluted); |
|
|
(c) |
|
Net sales or revenue growth; |
|
|
(d) |
|
Net operating profit; |
|
|
(e) |
|
Return measures (including, but not limited to, return on
assets, capital, invested capital, equity, sales, or revenue); |
|
|
(f) |
|
Cash flow (including, but not limited to, operating cash flow,
free cash flow, cash flow return on equity, and cash flow return on
investment); |
|
|
(g) |
|
Earnings before or after taxes, interest, depreciation, and/or amortization; |
|
|
(h) |
|
Gross or operating margins; |
2
|
(i) |
|
Productivity ratios; |
|
|
(j) |
|
Share price (including, but not limited to, growth measures and
total shareholder return); |
|
|
(k) |
|
Expense targets; |
|
|
(1) |
|
Margins; |
|
|
(m) |
|
Operating efficiency; |
|
|
(n) |
|
Market share; |
|
|
(o) |
|
Customer satisfaction/service; |
|
|
(p) |
|
Product Fill Rate percent (% of orders filled on first
delivery) or All-In Fill Rate percent (% calculated dollar fill based on
potential) times Inventory Turns; |
|
|
(q) |
|
Working capital targets; |
|
|
(r) |
|
Economic value added or EVA(R)(net operating profit after tax
minus the sum of capital multiplied by the cost of capital); |
|
|
(s) |
|
Developing new products and lines of revenue; |
|
|
(t) |
|
Reducing operating expenses; |
|
|
(u) |
|
Developing new markets; |
|
|
(v) |
|
Meeting completion schedules; |
|
|
(w) |
|
Developing and managing relationships with regulatory and other
governmental agencies; |
|
|
(x) |
|
Managing cash; |
|
|
(y) |
|
Managing claims against the Company, including litigation; and |
|
|
(z) |
|
Identifying and completing strategic acquisitions. |
|
|
(aa) |
|
Any Performance Measure(s) may be used to measure the
performance of the Company, Subsidiary, and/or Affiliate as a whole or any
business unit of the Company, Subsidiary, and/or Affiliate or any combination
thereof, as the Committee may deem appropriate, or any of the above Performance
Measures as compared to the performance of a group of comparator companies, or
published or special index that the Committee, in its sole discretion, deems
appropriate. |
|
3.3 |
|
Performance above and below target performance goals will be incrementally
calculated so Participants will receive a payout calculated on a straight-line basis;
provided, however, that the Committee may determine, in its sole discretion, that no
payouts will be made for performance below target performance goals. Notwithstanding
the foregoing or any other provision in the Plan to the contrary, the Committee shall
have the right, in its sole discretion, to reduce the amount otherwise payable to a
Participant based on the Participants individual performance or any other factors that
the Committee deems appropriate. |
3
|
3.4 |
|
The maximum amount of compensation that could be paid to any Participant in any
Plan Year from this Plan is $2.5 million. |
|
|
3.5 |
|
Unless a Participant has made a valid election under a deferred compensation
plan maintained by the Company, an Affiliate or a Subsidiary no later than the date
permitted under such plan, all awards under the Plan, including any prorated amounts
described in Section 2.6, will be paid by the 15th day of the third month following the
close of the applicable Plan Year. |
4. |
|
Employee Agreement and Forfeiture of Payment |
|
4.1 |
|
Regardless of any other provision of this section and unless the Incentive
Review Committee (as defined in Section 5.2) specifies otherwise, in order to
participate in the Plan, a Participant must execute an Employee Confidentiality,
Noncompetition, Nonsolicitation Agreement. |
|
|
4.2 |
|
Furthermore, regardless of any other provision of this section and unless the
Incentive Review Committee specifies otherwise, a Participant who breaches any part of
that Employee Confidentiality, Noncompetition, Nonsolicitation Agreement will forfeit
any future payment under the Plan and will also return to the Company or any Affiliate
or Subsidiary any monies paid out to Participant under this Plan within the three years
prior to said breach. |
|
|
4.3 |
|
By participating in this Plan, a Participant hereby consents to a deduction
from any amount the Company or any Affiliate or Subsidiary may owe the Participant
(including amounts owed to the Participant as wages or other compensation, fringe
benefits, or vacation pay as well as any other amounts owed to the Participant by the
Company or any Affiliate or Subsidiary), to the extent of the amounts owed the Company,
Affiliate or Subsidiary under this Section 4, whether or not it elects to make any
set-off in whole or in part. If the Company or any Affiliate or Subsidiary does not
recover the full amount the Participant owes it by means of set-off, calculated as set
forth above in Section 4.2, the Participant agrees to pay immediately the unpaid
balance to the Company, Affiliate or Subsidiary, as applicable. |
|
5.1 |
|
The Plan is to be administered by the Vice President, Global Total Rewards or
the Committee designee, who will be responsible for: |
|
(a) |
|
Recommending changes in the Plan as appropriate; |
|
|
(b) |
|
Recommending payout targets; and |
|
|
(c) |
|
Recommending additions or deletions to the list of eligible associates. |
|
5.2 |
|
The Incentive Review Committee (comprised of the Chief Executive Officer,
Executive Vice President, Human Resources and the Chief Financial Officer) is
responsible for: |
4
|
(a) |
|
Approving the percentages by which financial measurements vary
from approved budgets and business unit financial performance results; |
|
|
(b) |
|
Adjudicating changes and adjustments; and |
|
|
(c) |
|
Recommending Plan payouts. |
|
5.3 |
|
The Committee approves: |
|
(a) |
|
Changes in the Plan design; |
|
|
(b) |
|
The payout percentage; |
|
|
(c) |
|
Additions or deletions of eligible associates; and |
|
|
(e) |
|
Payouts to all Participants after written certification that
Performance Measures have been met. |
|
5.4 |
|
The Committee shall approve the Performance Measures within 90 days of the
beginning of the performance period but no later than 25% of the performance period.
Material terms of the Plan, including the Plan measures, were approved by shareholders
on January 26, 2006. The foregoing qualifies payments under the Plan as qualified
performance-based compensation under Treasury Regulation §1.162-27(e). The Plan is
amended and restated effective October 30, 2007 for purposes of Code §409A and to make
certain other changes. |
|
|
5.5 |
|
The Committee shall review the operation of the Plan and (subject to
restrictions imposed in Code §162(m)), if at any time the continuation of the Plan or
any of its provisions becomes inappropriate or inadvisable, the Committee shall revise
or modify Plan provisions or recommend to the Board of Directors of The Scotts
Miracle-Gro Company (the Board) that the Plan be suspended or withdrawn. In
addition, the Committee reserves the right to modify incentive formulas to reflect
unusual circumstances. |
|
|
5.6 |
|
The Board reserves to itself the right to suspend the Plan, to withdraw the
Plan, and, to the extent allowed without shareholder approval, make alterations in Plan
concept. |
|
|
5.7 |
|
It is intended that this Plan comply with the short-term deferral requirements
under Treasury Regulation §1.409A-1(a)(4), and this Plan will be interpreted,
administered and operated in good faith accordingly. Nothing herein shall be construed
as an entitlement to or guarantee of any particular tax treatment to a Participant. |
5
EX-10(C)(2)
Exhibit 10(c)
(2)
Executive
Officers of
The Scotts Miracle-Gro Company
who are parties to form of
Employee Confidentiality, Noncompetition,
Nonsolicitation Agreement for employees
participating in The Scotts Company LLC
Executive/Management Incentive Plan
|
|
|
Name and Principal Position |
|
Date of Employee Confidentiality, |
with The Scotts Miracle-Gro Company |
|
Noncompetition, Nonsolicitation Agreement |
|
|
|
Denise
S. Stump, Executive Vice President, Global
Human Resources
|
|
August 8, 2006 |
|
|
|
David
C. Evans,
Executive Vice President,
Chief Financial Officer
|
|
May 20, 2006 |
|
|
|
Barry
W. Sanders, Executive Vice President, North America
|
|
April 22, 2005 |
EX-10(D)(4)
Exhibit 10(d)(4)
THE SCOTTS MIRACLE-GRO COMPANY
AMENDED AND RESTATED
1996 STOCK OPTION PLAN
(EFFECTIVE AS OF OCTOBER 30, 2007)
(Does Not Reflect Any Stock Splits or Stock Dividends)
THE SCOTTS MIRACLE-GRO COMPANY
AMENDED AND RESTATED
1996 STOCK OPTION PLAN
(EFFECTIVE AS OF OCTOBER 30, 2007)
(Does Not Reflect Any Stock Splits or Stock Dividends)
SECTION 1.
PURPOSE AND EFFECTIVE DATE
1.1 Purpose. The purpose of the Plan is to foster and promote the long-term financial success
of the Company and materially increase shareholder value by (a) encouraging and providing for the
acquisition of an ownership interest in the Company by Employees and Eligible Directors, and (b)
enabling the Company to attract and retain the services of an outstanding management team upon
whose judgment, interest, and special effort the successful conduct of its operations is largely
dependent.
1.2. Effective Date. The Plan was originally adopted by the Board on February 12, 1996 and is
hereby amended and restated effective as of October 30, 2007.
SECTION 2.
DEFINITIONS
2.1 Definitions. Whenever used herein, the following terms shall have the respective meanings
set forth below:
(a) Act means the Securities Exchange Act of 1934, as amended.
(b) Annual Meeting means the annual meeting of the shareholders of the Company.
(c) Annual Retainer means the annual retainer fee, established by the Board, paid to an
Eligible Director for services on the Board.
(d) Award means any Option or Stock Unit.
(e) Board means the Board of Directors of the Company.
(f) Cause means (i) the willful failure by a Participant to perform substantially the
Participants duties as an Employee of the Company (other than due to physical or mental illness)
after reasonable notice to the Participant of such failure, (ii) the Participants engaging in
serious misconduct that is injurious to the Company or any Subsidiary, (iii) the Participants
having been convicted of, or entered a plea of nolo contendere to, a crime that constitutes
a felony or (iv) the breach by the Participant of any written covenant or agreement with the
Company or any Subsidiary not to disclose any information pertaining to the Company or any
Subsidiary or not to compete or interfere with the Company or any Subsidiary.
2
(g) Change in Control means the occurrence of any of the following events:
(i) the members of the Board (Incumbent Directors) cease for any reason other than
death to constitute at least a majority of the members of the Board, provided that any
director whose election, or nomination for election by the Companys shareholders, was
approved by a vote of at least a majority of the then Incumbent Directors also will be
treated as an Incumbent Director; or
(ii) any person, including a group [as such terms are used in Sections 13(d) and
14(d)(2) of the Act, but excluding the Company, any of its Subsidiaries, any employee
benefit plan of the Company or any of its Subsidiaries or Hagedorn Partnership, L.P. or any
party related to Hagedorn Partnership, L.P. as determined by the Committee] becomes the
beneficial owner [as defined in Rule 13d-3 under the Act], directly or indirectly, of
securities of the Company representing more than 30 percent of the combined voting power of
the Companys then outstanding securities; or
(iii) the adoption or authorization by the shareholders of the Company of a definitive
agreement or a series of related agreements (1) for the merger or other business combination
of the Company with or into another entity in which the shareholders of the Company
immediately before the effective date of such merger or other business combination own less
than 50 percent of the voting power in such entity or (2) for the sale or other disposition
of all or substantially all of the assets of the Company;
(iv) the adoption by the shareholders of the Company of a plan relating to the
liquidation or dissolution of the Company; or
(v) for any reason, Hagedorn Partnership, L.P. or any party related to Hagedorn
Partnership, L.P. as determined by the Committee, becomes the beneficial owner [as defined
in Rule 13d-3 under the Act], directly or indirectly, of securities of the Company
representing more than 49 percent of the combined voting power of the Companys then
outstanding securities.
(h) Change in Control Price means the price per share of Stock paid in conjunction with any
transaction resulting in a Change in Control (as determined in good faith by the Committee if any
part of the price offered is payable other than in cash) or, in the case of a Change in Control
occurring solely by reason of events not related to a transfer of Stock, the highest Fair Market
Value of a share of Stock on any of the 30 consecutive trading days ending on the last trading day
before the Change in Control occurs.
(i) Code means the Internal Revenue Code of 1986, as amended.
3
(j) Committee means the Compensation and Organization Committee of the Board which shall
have the meaning ascribed to a compensation committee in Section 1.162-27(c)(4) of the final
regulations promulgated under Section 162(m) of the Code and which shall consist of three or more
members, each of whom shall be (i) a person from time to time permitted by the rules promulgated
under Section 16 of the Act in order for grants of Awards to be exempt transactions under said
Section 16 and (ii) receiving remuneration in no other capacity than as a director, except as
permitted under Section 1.162-27(e)(3) of the final regulations promulgated under Section 162(m) of
the Code and the rulings thereunder.
(k) Company means The Scotts Miracle-Gro Company, an Ohio corporation, and any successor
thereto.
(l) Director Option means a nonstatutory stock option (NSO) granted to each Eligible
Director pursuant to Section 6.6 without any action by the Board or the Committee.
(m) Disability means the inability of the Participant to perform the Participants duties
for a period of at least six months due to a physical or medical infirmity. Notwithstanding the
foregoing, with respect to Incentive Stock Options, the term Disability shall be defined as such
term is defined in Section 22(e)(3) of the Code.
(n) Eligible Director means, on any date, a person who is serving as a member of the Board
and who is not an Employee.
(o) Employee means any officer or other key executive and management employee of the Company
or of any of its Subsidiaries.
(p) Fair Market Value means, on any date, the closing price of the Stock as reported on the
New York Stock Exchange (or on such other recognized market or quotation system on which the
trading prices of the Stock are traded or quoted at the relevant time) on such date. In the event
that there are no Stock transactions reported on the New York Stock Exchange (or such other market
or system) on such date, Fair Market Value shall mean the closing price on the immediately
preceding date on which Stock transactions were so reported.
(q) Non-Grandfathered Option means an NSO that was not earned and vested (within the meaning
of Treasury Regulation §1.409A-6) as of December 31, 2004.
(r) Option means the right to purchase Stock at a stated price for a specified period of
time. For purposes of the Plan, an Option may be either (i) an Incentive Stock Option (ISO)
within the meaning of Section 422 of the Code or (ii) an NSO which does not qualify for treatment
as an Incentive Stock Option.
(s) Participant means any Employee designated by the Committee to participate in the Plan.
4
(t) Plan means The Scotts Miracle-Gro Company Amended and Restated 1996 Stock Option Plan,
as in effect from time to time.
(u) Retirement means, unless the Committee specifies otherwise, the date:
(i) a Participant terminates employment on or after the earlier of (1) reaching age 62
or, (2) with the Committees approval, reaching age 55 and completing at least 10 years of
service as an Employee; or
(ii) an Eligible Director terminates service as a Board member after having been a
Board member for at least one full term.
(v) Stock means the Common Shares, without par value, of the Company.
(w) Stock Unit means a right to receive payment, in accordance with the provisions hereof,
of the Fair Market Value of a share of Stock.
(x) Subsidiary means any corporation or partnership in which the Company owns, directly or
indirectly, 50% or more of the total combined voting power of all classes of stock of such
corporation or of the capital interest or profits interest of such partnership.
2.2 Gender and Number. Except when otherwise indicated by the context, words in the masculine
gender used in the Plan shall include the feminine gender, the singular shall include the plural,
and the plural shall include the singular.
SECTION 3.
ELIGIBILITY AND PARTICIPATION
Except as otherwise provided in Sections 6.6 and 6.7, the only persons eligible to participate
in the Plan shall be those Employees selected by the Committee as Participants.
SECTION 4.
POWERS OF THE COMMITTEE
4.1 Power to Grant. The Committee shall determine the Participants to whom Options shall be
granted, the type or types of Options to be granted and the terms and conditions of any and all
such Options. The Committee may establish different terms and conditions for different types of
Options, for different Participants receiving the same type of Option and for the same Participant
for each Option such Participant may receive, whether or not granted at different times.
4.2 Administration. The Committee shall be responsible for the administration of the Plan.
The Committee, by majority action thereof, is authorized to prescribe, amend, and rescind rules and
regulations relating to the Plan, to provide for conditions deemed necessary or advisable to
protect the interests of the Company, and to make all other determinations (including, without
limitation, whether a Participant has incurred a Disability) necessary or
5
advisable for the administration and interpretation of the Plan in order to carry out its
provisions and purposes. Determinations, interpretations, or other actions made or taken by the
Committee pursuant to the provisions of the Plan shall be final, binding, and conclusive for all
purposes and upon all persons.
SECTION 5.
STOCK SUBJECT TO PLAN
5.1 Number. Subject to the provisions of Section 5.3, the number of shares of Stock subject
to Awards under the Plan may not exceed 5,500,000 shares of Stock. Subject to the provisions of
Section 5.3, no Participant shall receive Options for more than 150,000 shares of Stock over any
one-year period. For this purpose, to the extent that any Option is canceled (as described in
Section 1.162-27(e)(2)(vi)(B) of the final regulations promulgated under Section 162(m) of the
Code), such canceled Option shall continue to be counted against the maximum number of shares of
Stock for which Options may be granted to a Participant under the Plan. The shares of Stock to be
delivered under the Plan may consist, in whole or in part, of treasury Stock or authorized but
unissued Stock, not reserved for any other purpose.
5.2 Canceled, Terminated, or Forfeited Awards. Except as provided in Section 5.1, any shares
of Stock subject to an Award which for any reason is canceled, terminated or otherwise settled
without the issuance of any Stock shall again be available for Awards under the Plan.
5.3 Adjustment in Capitalization. In the event of any Stock dividend or Stock split,
recapitalization (including, without limitation, the payment of an extraordinary dividend), merger,
consolidation, combination, spin-off, distribution of assets to shareholders, exchange of shares,
or other similar corporate change, the aggregate number of shares of Stock available for Awards
under Section 5.1 or subject to outstanding Awards and the respective prices and/or limitations
applicable to outstanding Awards shall be appropriately adjusted by the Committee, whose
determination shall be conclusive. A corresponding adjustment shall be made to the number of
shares subject to outstanding Director Options and Stock Units, and a corresponding adjustment
shall also be made to the number of shares subject to each Director Option and each Stock Unit
thereafter granted pursuant to Section 6.6 or Section 6.7. Notwithstanding anything to the
contrary in this Section 5.3, an adjustment to a Non-Grandfathered Option shall be made only to the
extent such adjustment complies with the requirements of Section 409A of the Code.
6
SECTION 6.
OPTIONS AND STOCK UNITS
6.1 Grant of Options. Options may be granted to Participants at such time or times as shall
be determined by the Committee. Options granted under the Plan may be of two types: (i) Incentive
Stock Options and (ii) NSOs. The Committee shall have complete discretion in determining the
number of Options, if any, to be granted to a Participant. Without limiting the foregoing, the
Committee may grant Options containing provisions for the issuance to the Participant, upon
exercise of such Option and payment of the exercise price therefor with previously owned shares of
Stock, of an additional Option for the number of shares so delivered, having such other terms and
conditions not inconsistent with the Plan as the Committee shall determine. Each Option shall be
evidenced by an Option agreement that shall specify the type of Option granted, the exercise price,
the duration of the Option, the number of shares of Stock to which the Option pertains, and such
other terms and conditions not inconsistent with the Plan as the Committee shall determine.
6.2 Option Price. NSOs and Incentive Stock Options granted pursuant to the Plan shall have an
exercise price which is not less than the Fair Market Value of the Stock on the date the Option is
granted. To the extent that an Incentive Stock Option is granted to a Participant who owns
(actually or constructively under the provisions of Section 424(d) of the Code) Stock possessing
more than 10% of the total combined voting power of all classes of Stock of the Company or of any
Subsidiary, such Incentive Stock Option shall have an exercise price which is not less than 110% of
the Fair Market Value on the date the Option is granted.
6.3 Exercise of Options. Options granted to a Participant under the Plan shall be exercisable
at such times and shall be subject to such restrictions and conditions including the performance of
a minimum period of service, as the Committee may impose, either at or after the time of grant of
such Options; provided, however, that if the Committee does not specify another exercise schedule
at the time of grant, each Option shall become exercisable on the third anniversary of the date of
grant, subject to the Committees right to accelerate the exercisability of such Option in its
discretion. Notwithstanding the foregoing, no Option shall be exercisable for more than ten years
after the date on which it is granted; provided, however, in the case of an Incentive Stock Option
granted to a Participant who owns (actually or constructively under the provisions of Section
424(d) of the Code) Stock possessing more than 10% of total combined voting power of all classes of
Stock of the Company or any Subsidiary, such Incentive Stock Option shall not be exercisable for
more than five years after the date on which it is granted.
6.4 Payment. The Committee shall establish procedures governing the exercise of Options,
which shall require that written notice of exercise be given and that the Option price be paid in
full in cash or equivalents, including by personal check, at the time of exercise or pursuant to
any arrangement that the Committee shall approve. The Committee may, in its discretion, permit a
Participant or an Eligible Director to tender Stock already owned by the Participant or the
Eligible Director, either by actual delivery of the shares of Stock or by attestation, valued at
its Fair Market Value on the date of exercise, as partial or full payment of the exercise price.
As soon as practicable after receipt of a written exercise notice and full
7
payment of the exercise price, the Company shall deliver to the Participant or the Eligible
Director a certificate or certificates representing the acquired shares of Stock.
6.5 Incentive Stock Options. Notwithstanding anything in the Plan to the contrary, no term of
this Plan relating to Incentive Stock Options shall be interpreted, amended or altered, nor shall
any discretion or authority granted under the Plan be so exercised, so as to disqualify the Plan
under Section 422 of the Code, or, without the consent of any Participant affected thereby, to
cause any Incentive Stock Option previously granted to fail to qualify for the Federal income tax
treatment afforded under Section 421 of the Code. Further, the aggregate Fair Market Value
(determined as of the time an Incentive Stock Option is granted) of the Stock with respect to which
Incentive Stock Options are exercisable for the first time by any Participant during any calendar
year (under all option plans of the Company and all Subsidiaries of the Company) shall not exceed
$100,000.
6.6 Director Options. Notwithstanding anything else contained herein to the contrary, prior
to January 29, 2002, on the first
business day following the date of each annual meeting of shareholders during the term of the Plan,
each Eligible Director shall receive a Director Option to purchase 5,000 shares of Stock at an
exercise price per share equal to the Fair Market Value of the Stock on the date of grant. An
Eligible Director who is a member of one or more Board committees, shall receive an additional
grant covering 500 shares of Stock for each committee of which the Eligible Director is a member.
An Eligible Director who chairs one or more Board committees shall receive (over and above that
additional grant covering 500 shares for each committee membership) an additional grant covering
1,000 shares of Stock for each committee the Eligible Director chairs. Each Director Option shall
be exercisable six months after the date of grant and shall remain exercisable until the earlier to
occur of (a) the tenth anniversary of the date of grant or (b) the first anniversary of the date
the Eligible Director ceases to be a member of the Board, except that (i) if the Eligible Director
ceases to be a member of the Board after having been convicted of, or pled guilty or nolo
contendere to, a felony, the Eligible Directors Director Options shall be canceled on the date
the Eligible Director ceases to be a director, or (ii) if the Eligible Director ceases to be a
member of the Board due to Retirement, any Director Options granted to such Eligible Director which
are then outstanding (whether or not exercisable prior to the date of such Retirement), may be
exercised at any time prior to the expiration of the term of the Director Options or within five
years following the Retirement, whichever period is shorter. An Eligible Director may exercise a
Director Option in the manner described in Section 6.3.
6.7 Stock Units. Effective beginning in the calendar year 2000 and ending in calendar year
2002, each
Eligible Director shall be provided with the opportunity to elect to receive all or a portion, in
25% increments, of the Eligible Directors Annual Retainer: (a) in cash or (b) in Stock Units. An
Eligible Directors first such election shall be made on a form provided by the Committee at least
two weeks in advance of the 2000 Annual Meeting. Such election shall be effective until the next
Annual Meeting. Elections for annual periods thereafter shall be made on an annual basis, at least
two weeks in advance of the applicable Annual Meeting. In the event no election is received from
an Eligible Director for an applicable period, the Eligible Director shall
8
be deemed to have elected payment of the Eligible Directors Annual Retainer in cash. Any
portion of an Eligible Directors Annual Retainer which is elected to be paid in cash shall be paid
in accordance with the Companys regular practice for such payments. To the extent that the
Eligible Director elects to receive Stock Units in lieu of all or a portion of the Eligible
Directors Annual Retainer, the Eligible Director shall receive a number of Stock Units (including
fractional Stock Units) determined by dividing the dollar amount of Annual Retainer elected by the
Fair Market Value of a share of Stock on the next business day following the date of the Annual
Meeting; provided that for the calendar year 2000, the Fair Market Value as of March 31, 2000 shall
be the value used. All payments in respect of Stock Units shall be settled as soon as practicable
after the earlier of (a) the occurrence of a Change in Control or (b) the Eligible Directors
cessation of service on the Board; provided, however, that if the Eligible Director has elected on
a form provided by the Committee at least one year prior to the commencement of payment of the
value of the Eligible Directors Stock Units, payment thereof shall be made over a period of up to
ten years, as elected by the Eligible Director. All such payments to the Eligible Director shall
be made in cash or in Stock, as elected by the Eligible Director on the deferral form provided by
the Committee. If distributions are made in cash pursuant to such Eligible Directors election,
distribution shall be made at Fair Market Value determined as of the date immediately preceding the
date of distribution. Upon the death of an Eligible Director, the value of any unpaid Stock Units
shall be paid in a lump sum in cash in accordance with the provisions of Section 10.2.
6.8 Restriction on Repricing. Regardless of any other provision of this Plan, neither the
Company nor the Committee may reprice (as defined under rules issued by the exchange on which the
Stock then is traded) any Option without the prior approval of the shareholders.
SECTION 7.
TERMINATION OF EMPLOYMENT
7.1 Termination of Employment Due to Retirement. Unless otherwise determined by the Committee
at the time of grant, in the event a Participants employment terminates by reason of Retirement,
any Options granted to such Participant which are then outstanding (whether or not exercisable
prior to the date of such termination) may be exercised at any time prior to the expiration of the
term of the Options or within five years (or such shorter period as the Committee shall determine
at the time of grant) following the Participants termination of employment, whichever period is
shorter. Notwithstanding any provision contained herein, with respect to any Incentive Stock
Option, a Participant who terminates the Participants employment by reason of Retirement may
exercise such Incentive Stock Option at any time prior to the expiration of the term of the Option
or within three months following the Participants termination of employment, whichever period is
shorter.
7.2 Termination of Employment Due to Death or Disability. Unless otherwise determined by the
Committee at the time of grant, in the event a Participants employment terminates by reason of
death or Disability, any Options granted to such Participant which are
9
then outstanding (whether or not exercisable prior to the date of such termination) may be
exercised by the Participant or the Participants designated beneficiary, and if none is named, in
accordance with Section 10.2, at any time prior to the expiration date of the term of the Options
or within five years (or such shorter period as the Committee shall determine at the time of grant)
following the Participants termination of employment, whichever period is shorter.
Notwithstanding any provision contained herein, with respect to any Incentive Stock Option, a
Participant whose employment terminates by reason of death or Disability may exercise (or the
Participants designated beneficiary may exercise, in the case of death) such Incentive Stock
Option at any time prior to the expiration of the term of the Option or within one year following
the Participants termination of employment, whichever period is shorter.
7.3 Termination of Employment For Cause. Unless otherwise determined by the Committee at the
time of grant, in the event a Participants employment is terminated for Cause, any Options granted
to such Participant which are then outstanding (whether or not exercisable prior to the date of
such termination) shall be forfeited.
7.4 Termination of Employment for Any Other Reason. Unless otherwise determined by the
Committee at or after the time of grant, in the event the employment of the Participant shall
terminate for any reason other than one described in Section 7.1, 7.2 or 7.3, any Options granted
to such Participant which are exercisable at the date of the Participants termination of
employment, or on such accelerated basis as the Committee may have determined in its discretion,
shall remain exercisable until the earlier to occur of (a) the expiration of the term of such
Options or (b) the ninetieth day following the Participants termination of employment, whichever
period is shorter.
7.5 Limitations on Exercisability Following Termination of Employment. No Options shall be
exercisable after termination of employment unless the Participant shall have, during the time
period in which the Options are exercisable, (a) refrained from serving as an officer, director or
employee of any individual, partnership or corporation, or the owner of a business, or a member of
a partnership which conducts business in competition with the Company or renders any service
(including, without limitation, advertising agencies and business consultants) to competitors with
any portion of the business of the Company, (b) been available, if so requested by the Company, at
reasonable times and upon a reasonable basis, to consult with, supply information to, and otherwise
cooperate with, the Company, and (c) refrained from engaging in a deliberate action which has been
determined by the Committee to cause substantial harm to the interests of the Company. If any of
these conditions is not fulfilled, the Committee may require the Participant to forfeit all rights
to any Options which have not been exercised prior to the date of the breach of the condition.
10
SECTION 8.
CHANGE IN CONTROL
8.1 Accelerated Vesting and Payment. Subject to the provisions of Section 8.2 below, in the
event of a Change in Control, each Participant shall be permitted, in the Participants discretion,
to surrender any Option (excluding any Director Option) or portion thereof in exchange for (a) a
payment in cash of an amount equal to the excess of the Change in Control Price over the exercise
price of the Option or (b) at the Committees discretion, whole shares of Stock with a Fair Market
Value equal to the excess of the Change in Control Price over the exercise price of the Option and
the Fair Market Value of any fractional share of Stock will be distributed in cash. However, the
Committee, in its sole discretion, may offer the holders of the Options to be surrendered a
reasonable opportunity (not longer than 15 days beginning on the date of the Change in Control) to
exercise all their outstanding Options (whether or not otherwise then exercisable) by following the
exercise procedures described in Section 6. Such right to surrender an Option in exchange for a
payment in cash or, if appropriate, in shares of Stock (or to exercise an Option) as provided in
the two preceding sentences shall remain in effect only during the fifteen-day period commencing
with the day following the date of a Change in Control. Thereafter, the Option shall only be
exercisable in accordance with the terms and conditions of the Stock Option Agreement and the
provisions of the Plan.
8.2 Alternative Awards. Notwithstanding Section 8.1, no cancellation or cash settlement or
other payment or exercise shall occur under the circumstances described in Section 8.1 with respect
to any Option or any class of Options if the Committee reasonably determines in good faith prior to
the occurrence of a Change in Control that such Option or Options shall be honored or assumed, or
new rights substituted therefor (such honored, assumed or substituted award hereinafter called an
Alternative Award), by a Participants employer (or the parent or a subsidiary of such employer)
immediately following the Change in Control, provided that any such Alternative Award must:
(a) be based on stock which is traded on an established securities market, or which
will be so traded within 60 days of the Change in Control;
(b) provide such Participant (or each Participant in a class of Participants) with
rights and entitlements substantially equivalent to or better than the rights, terms and
conditions applicable under such Option, including, but not limited to, an identical or
better exercise or vesting schedule and identical or better timing and methods of payment;
(c) have substantially equivalent economic value to such Option (determined at the time
of the Change in Control); and
(d) have terms and conditions which provide that in the event that the Participants
employment is involuntarily terminated or constructively terminated, any conditions on a
Participants rights under, or any restrictions on transfer or exercisability applicable to,
each such Alternative Award shall be waived or shall lapse, as the case may be.
11
For this purpose, a constructive termination shall mean a termination by a Participant
following a material reduction in the Participants compensation, a material reduction in the
Participants responsibilities or the relocation of the Participants principal place of employment
to another location, in each case without the Participants written consent.
Notwithstanding anything herein to the contrary, no Alternative Award shall be made with
respect to an Option if it would cause the Option to become deferred compensation subject to
Section 409A of the Code or fail to comply with the requirements of Section 409A of the Code.
8.3 Director Options and Stock Units. Upon a Change in Control, each Director Option granted
to an Eligible Director and all Stock Units credited to an Eligible Director shall be canceled in
exchange for (a) a payment in cash or, (b) in the case of Director Options and at the Committees
discretion, whole shares of Stock with a Fair Market Value equal to the excess of the Change in
Control Price over the exercise price associated with the cancelled Director Options and the Fair
Market Value of any fractional share of Stock will be distributed in cash. Alternatively, the
Committee, in its sole discretion, may offer the holders of the Director Options to be cancelled a
reasonable opportunity (not longer than 15 days beginning on the date of the Change in Control) to
exercise all their outstanding Director Options (whether or not otherwise then exercisable) by
following the exercise procedures described in Section 6. The amount of cash (or the Fair Market
Value of shares of Stock plus the cash distributed in lieu of a fractional share of Stock)
exchanged for each Director Option shall be the excess of the Change in Control Price over the
exercise price for such Director Option unless (a) the Stock remains traded on an established
securities market following the Change in Control and (b) such Eligible Director remains on the
Board following the Change in Control. The amount of cash exchanged for each Stock Unit shall be
the Change in Control Price.
8.4 Options Granted Within Six Months of the Change in Control. If any Option (including a
Director Option) granted within six months of the date on which a Change in Control occurs (a) is
held by a person subject to the reporting requirements of Section 16(a) of the Act and (b) is to be
cashed out pursuant to Section 8.1 or 8.3, such cash out shall not occur unless and until, in the
opinion of the Companys counsel, such cash out could occur without such reporting person being
potentially subject to liability under Section 16(b) of the Act by reason of such cash out.
SECTION 9.
AMENDMENT, MODIFICATION, AND TERMINATION OF PLAN
The Board or the Committee may at any time terminate or suspend the Plan, and from time to
time may amend or modify the Plan. Any such amendment, termination or suspension may be made
without the approval of the shareholders of the Company except as such shareholder approval may be
required (a) to satisfy the requirements of Rule 16b-3 under the Act, or any successor rule or
regulation, (b) to satisfy applicable requirements of the Code or (c)
12
to satisfy applicable requirements of any securities exchange on which are listed any of the
Companys equity securities. No amendment of the Plan shall result in any loss of a Committee
members status as a non-employee director as defined in Rule 16b-3 under the Act, or any
successor rule or regulation, with respect to any employee benefit plan of the Company or result in
the Plan losing its status as a plan satisfying the requirements of said Rule 16b-3. No amendment,
modification, or termination of the Plan shall in any manner adversely affect any Award theretofore
made under the Plan, without the consent of the Participant.
SECTION 10.
MISCELLANEOUS PROVISIONS
10.1. Assignability.
(a) With the permission of the Committee, a Participant or a specified group of
Participants who has or have been granted an NSO under the Plan may transfer it to a
revocable inter vivos trust as to which the Participant is the settlor or may transfer it to
a Permissible Transferee. A Permissible Transferee shall be defined as any member of the
immediate family of the Participant; any trust, whether revocable or irrevocable, solely for
the benefit of members of the Participants immediate family; any partnership or limited
liability company whose only partners or members are members of the Participants immediate
family; or an organization described in Section 501(c)(3) of the Code. Any such transferee
shall remain subject to all of the terms and conditions applicable to such NSO and subject
to the rules and regulations prescribed by the Committee. A Permissible Transferee [other
than an organization described in Section 501(c)(3) of the Code] may not retransfer an NSO
except by will or the laws of descent and distribution and then only to another Permissible
Transferee. Other than as described above, an NSO granted under the Plan may not be
transferred except by will or the laws of descent and distribution and, during the lifetime
of the Participant to whom granted, may be exercised only by the Participant or the
Participants guardian or legal representative.
(b) With the permission of the Committee, an Eligible Director who has been granted a
Director Option or has received a Stock Unit under the Plan may transfer such Director
Option or Stock Unit to a revocable inter vivos trust as to which the Eligible Director is
the settlor or may transfer such Director Option or Stock Unit to a Permissible
Transferee. A Permissible Transferee shall be defined as any member of the immediate
family of the Eligible Director; any trust, whether revocable or irrevocable, solely for the
benefit of members of the Eligible Directors immediate family; any partnership or limited
liability company whose only partners or members are members of the Eligible Directors
immediate family; or an organization described in Section 501(c)(3) of the Code. Any such
transferee shall remain subject to all of the terms and conditions applicable to such
Director Option or Stock Unit and subject to the rules and regulations prescribed by the
Committee. A Permissible Transferee [other than an organization described in Section
501(c)(3) of the Code] may not retransfer a Director Option or Stock Unit except by will or
the laws of descent and distribution and then only to another Permissible Transferee. Other
than as described above, a Director Option
13
granted or Stock Unit received under the Plan may not be transferred except by will or
the laws of descent and distribution and, during the lifetime of the Eligible Director to
whom granted or by whom received, may be exercised only by the Eligible Director or the
Eligible Directors guardian or legal representative.
10.2 Beneficiary Designation. Each Participant and each Eligible Director may from time to
time name a beneficiary or beneficiaries (who may be named contingently or successively) to whom
any benefit under the Plan is to be paid or by whom any right under the Plan is to be exercised in
case of the Participants or Eligible Directors death. Each designation shall revoke all prior
designations by the same Participant or Eligible Director, shall be in a form prescribed by the
Committee, and shall be effective only when filed in writing with the Committee. In the absence of
any such designation, benefits remaining unpaid at the Participants or Eligible Directors death
shall be paid to the Participant or Eligible Directors surviving spouse, if any, or otherwise to
the Participants or Eligible Directors estate and Options outstanding at the Eligible Directors
death shall be exercised by the Participant or Eligible Directors surviving spouse, if any, or
otherwise by the Participants or Eligible Directors estate.
10.3 No Guarantee of Employment or Participation. Nothing in the Plan shall interfere with or
limit in any way the right of the Company or any Subsidiary to terminate any Participants
employment at any time, nor confer upon any Participant any right to continue in the employ of the
Company or any Subsidiary. No Employee shall have a right to be selected as a Participant, or,
having been so selected, to receive any future Awards. Nothing in the Plan shall confer upon an
Eligible Director a right to continue to serve on the Board or to be nominated for reelection to
the Board.
10.4 Tax Withholding. The Company shall have the power to withhold, or require a Participant
or Eligible Director to remit to the Company, an amount sufficient to satisfy Federal, state, and
local withholding tax requirements on any Award under the Plan, and the Company may defer payment
of cash or issuance of Stock until such requirements are satisfied. The Committee may, in its
discretion, permit a Participant or an Eligible Director to elect, subject to such conditions as
the Committee shall impose, (a) to have shares of Stock otherwise issuable under the Plan withheld
by the Company or (b) to deliver to the Company previously acquired shares of Stock having a Fair
Market Value sufficient to satisfy all or part of the Participants or the Eligible Directors
estimated total Federal, state, and local tax obligation associated with the transaction.
10.5 Indemnification. Each person who is or shall have been a member of the Committee or of
the Board shall be indemnified and held harmless by the Company against and from any loss, cost,
liability, or expense that may be imposed upon or reasonably incurred by such person in connection
with or resulting from any claim, action, suit, or proceeding to which such person may be made a
party or in which such person may be involved by reason of any action taken or failure to act under
the Plan and against and from any and all amounts paid by such person in settlement thereof, with
the Companys approval, or paid by such person in
14
satisfaction of any judgment in any such action, suit, or proceeding against such person
provided such person shall give the Company an opportunity, at its own expense, to handle and
defend the same before such person undertakes to handle and defend it on such persons own behalf.
The foregoing right of indemnification shall not be exclusive and shall be independent of any other
rights of indemnification to which such persons may be entitled under the Companys articles of
incorporation or code of regulations, by contract, as a matter of law, or otherwise.
10.6 No Limitation on Compensation. Nothing in the Plan shall be construed to limit the right
of the Company to establish other plans or to pay compensation to its Employees or directors, in
cash or property, in a manner which is not expressly authorized under the Plan.
10.7 International Employees. It is the Companys desire to provide the same motivation to
materially increase shareholder value and to enable the Company to attract and retain the services
of outstanding managers in the international locations where the Company maintains facilities and
employs people. To this end, the Company will adopt incentives in its foreign locations that
provide as closely as possible the same motivational effect as Options provide to domestic
Participants. The Committee may grant Options to employees who are subject to the tax laws of
nations other than the United States, which Options may have terms and conditions that differ from
other Options granted under the Plan for the purposes of complying with foreign tax laws.
10.8 Requirements of Law. The making of Awards and the issuance of shares of Stock shall be
subject to all applicable laws, rules, and regulations, and to such approvals by any governmental
agencies or national securities exchanges as may be required. Notwithstanding the foregoing, no
Stock shall be issued under the Plan unless the Company is satisfied that such issuance will be in
compliance with applicable federal and state securities laws. Certificates for Stock delivered
under the Plan may be subject to such stock transfer orders and other restrictions as the Committee
may deem advisable under the rules, regulations and other requirements of the Securities and
Exchange Commission, any stock exchange upon which the Stock is then listed or traded, The NASDAQ
Stock Market or any applicable federal or state securities law. The Committee may cause a legend
or legends to be placed on any such certificates to make appropriate reference to such
restrictions.
10.9 Term of Plan. The Plan was effective upon its adoption by the Committee, subject to
approval by the Board and approval by the affirmative vote of the holders of a majority of the
shares of voting stock present in person or represented by proxy at the 1996 Annual Meeting. After
January 26, 2006, no Award is permitted to be granted under the Plan, but all Awards outstanding as
of such date may extend beyond such date in accordance with their respective terms.
10.10 Governing Law. The Plan, and all agreements hereunder, shall be construed in accordance
with and governed by the laws of the State of Ohio.
10.11 No Impact On Benefits. Plan Awards are not compensation for purposes of calculating an
Employees rights under any employee benefit plan.
15
EX-10(J)(3)
Exhibit 10(j)(3)
THE SCOTTS MIRACLE-GRO COMPANY
AMENDED AND RESTATED
2003 STOCK OPTION AND INCENTIVE EQUITY PLAN
(EFFECTIVE AS OF OCTOBER 30, 2007)
(Does Not Reflect Any Stock Splits or Stock Dividends)
1.00 PURPOSE
This Plan is intended to foster and promote the long-term financial success of the Company and to
materially increase shareholder value by [1] providing Key Employees and Eligible Directors an
opportunity to acquire an ownership interest in the Company, and [2] enabling the Company to
attract and retain the services of outstanding Employees and Eligible Directors upon whose
judgment, interest and special efforts the successful conduct of the Companys business is largely
dependent.
2.00 DEFINITIONS
When used in this Plan, the following terms have the meanings given to them in this section unless
another meaning is expressly provided elsewhere in this document or clearly required by the
context. When applying these definitions, the form of any term or word will include any of its
other forms.
2.01 Act. The Securities Exchange Act of 1934, as amended.
2.02 Annual Meeting. The annual meeting of the Companys shareholders.
2.03 Annual Retainer. The annual cash retainer and any other fees paid to each Eligible Director
for service as a member of the Board and as a member of any Board committees.
2.04 Annual Retainer Deferral Form. The form each Eligible Director must complete to defer all or
a portion of his or her Annual Retainer.
2.05 Award. Any Incentive Stock Option, Nonstatutory Stock Option, Performance Share, Performance
Unit, Restricted Stock, Stock Appreciation Right and Stock Unit issued under the Plan. During any
single Plan Year, no Participant may be granted SARs affecting more than 150,000 shares of Stock
(adjusted as provided in Section 5.03) and Options affecting more than 150,000 shares of Stock
(adjusted as provided in Section 5.03), including Options and SARs that are cancelled [or deemed to
have been cancelled under Treas. Reg. §1.162-27(e)(2)(vi)(B)] during the Plan Year issued.
2.06 Award Agreement. The written agreement between the Company and each Participant that
describes the terms and conditions of each Award.
2.07 Beneficiary. The person a Member designates to receive (or exercise) any Plan benefits (or
rights) that are unpaid (or unexercised) when he or she dies. A Beneficiary may be designated only
by following the procedures described in Section 14.02; neither the Company nor the Committee is
required to infer a Beneficiary from any other source.
2.08 Board. The Companys Board of Directors.
2.09 Cause. Unless the Committee specifies otherwise in the Award Agreement, with respect to any
Participant:
[1] Willful failure to substantially perform his or her duties as an Employee (for reasons
other than physical or mental illness) or director after reasonable notice to the
Participant of that failure;
[2] Misconduct that materially injures the Company or any Subsidiary;
[3] Conviction of, or entering into a plea of nolo contendere to, a felony; or
[4] Breach of any written covenant or agreement with the Company or any Subsidiary.
2.10 Change in Control.
The occurrence of any of the following events:
[1] The members of the Board on November 8, 2002 (Incumbent Directors) cease for any
reason other than death to constitute at least a majority of the members of the Board,
provided that any director whose election, or nomination for election by the Companys
shareholders, was approved by a vote of at least a majority of the then Incumbent Directors
also will be treated as an Incumbent Director; or
[2] Any person, including a group [as such terms are used in Act §§13(d) and 14(d)(2),
but excluding the Company, any of its Subsidiaries, any employee benefit plan of the Company
or any of its Subsidiaries or Hagedorn Partnership, L.P. or any party related to Hagedorn
Partnership, L.P. as determined by the Committee] becomes the beneficial owner (as defined
in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company
representing more than 30 percent of the combined voting power of the Companys then
outstanding securities; or
[3] The adoption or authorization by the shareholders of the Company of a definitive
agreement or a series of related agreements [a] for the merger or other business combination
of the Company with or into another entity in which the shareholders of the Company
immediately before the effective date of such merger or other business combination own less
than 50 percent of the voting power in such entity; or [b] for the sale or other disposition
of all or substantially all of the assets of the Company; or
[4] The adoption by the shareholders of the Company of a plan relating to the liquidation or
dissolution of the Company; or
-2-
[5] For any reason, Hagedorn Partnership, L. P. or any party related to Hagedorn
Partnership, L.P. as determined by the Committee becomes the beneficial owner (as defined
in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company
representing more than 49 percent of the combined voting power of the Companys then
outstanding securities.
2.11 Change in Control Price. The price per share of Stock paid in conjunction with any
transaction resulting in a Change in Control (as determined in good faith by the Committee if any
part of the offered price is payable other than in cash) or, in the case of a Change in Control
occurring solely by reason of events not related to a transfer of Stock, the highest Fair Market
Value of a share of Stock on any of the 30 consecutive trading days ending on the last trading day
before the Change in Control occurs.
2.12 Code. The Internal Revenue Code of 1986, as amended, and any regulations issued under the
Code (sometimes referred to as Treas. Reg.) and any applicable rulings issued under the Code.
2.13 Committee. The Boards Compensation and Organization Committee which also constitutes a
compensation committee within the meaning of Treas. Reg. §1.162-27(c)(4). The Committee will be
comprised of at least three persons [a] each of whom is [i] an outside director, as defined in
Treas. Reg. §1.162-27(e)(3)(i) and [ii] a non-employee director within the meaning of Rule 16b-3
under the Act and [b] none of whom may receive remuneration from the Company or any Subsidiary in
any capacity other than as a director, except as permitted under Treas. Reg. §1.162-27(e)(3)(ii).
2.14 Company. The Scotts Miracle-Gro Company, an Ohio corporation, and any and all successors to
it.
2.15 Director Option. A Nonstatutory Stock Option granted to an Eligible Director under Section
6.05.
2.16 Disability. Unless the Committee specifies otherwise in the Award Agreement:
[1] With respect to any Award other than an Incentive Stock Option, the Participants
inability to perform his or her normal duties for a period of at least six months due to a
physical or mental infirmity; or
[2] With respect to an Incentive Stock Option, as defined in Code §22(e)(3).
-3-
2.17 Eligible Director. A person who, on an applicable Grant Date [1] is an elected member of the
Board (or has been appointed to the Board to fill an unexpired term and will continue to serve at
the expiration of that term only if elected by shareholders) and [2] is not an Employee. For
purposes of applying this definition, an Eligible Directors status will be determined as of the
Grant Date applicable to each affected Award.
2.18 Employee. Any person who, on an applicable Grant Date, is a common law employee of the
Company or any Subsidiary. A worker who is classified as other than a common law employee but who
is subsequently reclassified as a common law employee of the Company for any reason and on any
basis will be treated as a common law employee only from the date of that determination and will
not retroactively be reclassified as an Employee for any purpose of this Plan.
2.19 Exercise Price. The price at which a Member may exercise an Award.
2.20 Fair Market Value. The value of one share of Stock on any relevant date, determined under the
following rules:
[1] If the Stock is traded on an exchange, the reported closing price on the relevant
date, if it is a trading day, otherwise on the next trading day;
[2] If the Stock is traded over-the-counter with no reported closing price, the mean between
the lowest bid and the highest asked prices on that quotation system on the relevant date if
it is a trading day, otherwise on the next trading day; or
[3] If neither Section 2.20[1] nor Section 2.20[2] applies, the value as determined by the
Committee through the reasonable application of a reasonable valuation method, taking into
account all information material to the value of the Company, within the meaning of
Code §409A and the Treasury Regulations promulgated thereunder.
2.21 Freestanding SAR. An SAR that is not associated with an Option and is granted under Section
10.00.
2.22 Grandfathered Stock Unit. A Stock Unit that was earned and vested (within the meaning of
Treas. Reg. §1.409A-6) as of December 31, 2004.
2.23 Grant Date. The date an Award is granted to a Participant.
2.24 Key Employee. Any Employee who, on any applicable Grant Date, is performing services the
Committee concludes are essential to the Companys business success and to whom the Committee has
granted an Award.
2.25 Member. Each Participant and Terminated Participant to whom an Award has been granted and
which has not expired under the terms of the Award Agreement or as provided in Section 11.00.
-4-
2.26 Non-Grandfathered NSO. A Nonstatutory Stock Option that (1) was not earned and vested (within
the meaning of Treas. Reg. §1.409A-6) as of December 31, 2004 or (2) was granted on or after
January 1, 2005.
2.27 Non-Grandfathered SAR. A Stock Appreciation Right that (1) was not earned and vested (within
the meaning of Treas. Reg. § 1.409A-6) as of December 31, 2004 or (2) was granted on or after
January 1, 2005.
2.28 Non-Grandfathered Stock Unit. A Stock Unit that is not a Grandfathered Stock Unit.
2.29 Nonstatutory Stock Option. Any Option granted under Section 6.00 that is not an Incentive
Stock Option.
2.30 Option. The right granted under the Plan to purchase a share of Stock at a stated price for a
specified period of time. An Option may be either [1] an Incentive Stock Option or [2] a
Nonstatutory Stock Option.
2.31 Participant. Any Key Employee or Eligible Director who has not Terminated.
2.32 Performance Goal. The conditions that must be met before a Key Employee will earn a
Performance Share or Performance Unit.
2.33 Performance Period. The period over which the Committee will determine if applicable
Performance Goals have been met.
2.34 Performance Share. An Award granted under Section 9.00.
2.35 Performance Unit. An Award granted under Section 9.00.
2.36 Plan. The Scotts Miracle-Gro Company Amended and Restated 2003 Stock Option and Incentive
Equity Plan.
2.37 Plan Year. The Companys fiscal year.
2.38 Restricted Stock. An Award granted under Section 8.00.
2.39 Restriction Period. The period over which the Committee will determine if a Key Employee has
met conditions placed on Restricted Stock; provided such period will be at least three years.
2.40 Retirement. Unless, the Committee specifies otherwise in the Award Agreement, the date:
[1] A Key Employee Terminates on or after the earlier of [a] reaching age 62 or [b] with the
Committees approval, reaching age 55 and completing at least 10 years of service as an
Employee; or
[2] An Eligible Director Terminates as a Board member after having been a Board member for
at least one full term.
-5-
For purposes of applying this definition, a Participants status will be determined as of the Grant
Date applicable to each affected Award.
2.41 Stock. A common share, without par value, issued by the Company.
2.42 Stock Appreciation Right (or SAR). An Award granted under Section 10.00 that is a Tandem
SAR or a Freestanding SAR.
2.43 Stock Unit. A right to receive payment of the Fair Market Value of a share of Stock as
provided in Section 7.00.
2.44 Subsidiary. Any corporation, partnership or other form of unincorporated entity of which the
Company owns, directly or indirectly, 50 percent or more of the total combined voting power of all
classes of stock, if the entity is a corporation; or of the capital or profits interest, if the
entity is a partnership or another form of unincorporated entity.
2.45 Tandem SAR. An SAR that is associated with an Option and which expires when that Option
expires or is exercised, as described in Section 10.00.
2.46 Termination or Terminated. Unless the Committee specifies otherwise in the Award Agreement,
[1] cessation of the employee-employer relationship between a Key Employee and the Company and all
Subsidiaries for any reason or [2] cessation of an Eligible Directors service on the Board for any
reason; provided, however, that, with respect to any Award subject to Code §409A, such cessation
also must constitute a separation from service as defined under Treas. Reg. §1.409A-1(h).
3.00 PARTICIPATION
3.01 Key Employees.
[1] Consistent with the terms of the Plan and subject to Section 3.02, the Committee will:
[a] Decide which Key Employees may become Participants;
[b] Decide which Key Employees will be granted Awards; and
[c] Specify the type of Award to be granted and the terms upon which an Award will
be granted.
[2] The Committee may establish different terms and conditions:
[a] For each type of Award;
-6-
[b] For each Key Employee receiving the same type of Award; and
[c] For the same Key Employees for each Award the Key Employee receives, whether or
not those Awards are granted at different times.
3.02 Eligible Directors. Each Eligible Director will [1] become a Participant on the date he or
she becomes an Eligible Director and [2] receive the Awards described in Sections 6.05 and 7.00
without any further action by the Committee. However, as of the date an Award is made, the
Committee will complete and deliver an Award Agreement to each affected Eligible Director
describing the terms of the Award.
3.03 Conditions of Participation. Each Participant receiving an Award agrees:
[1]
To sign an Award Agreement;
[2]
To be bound by the terms of the Award Agreement and the Plan; and
[3]
To comply with other conditions imposed by the Committee.
4.00 ADMINISTRATION
4.01 Committee Duties. The Committee is responsible for administering the Plan and has all powers
appropriate and necessary to that purpose. Consistent with the Plans objectives, the Committee
may adopt, amend and rescind rules and regulations relating to the Plan, to the extent appropriate
to protect the Companys interests and has complete discretion to make all other decisions
(including whether a Participant has incurred a Disability) necessary or advisable for the
administration and interpretation of the Plan. Any action by the Committee will be final, binding
and conclusive for all purposes and upon all persons.
4.02 Delegation of Ministerial Duties. In its sole discretion, the Committee may delegate any
ministerial duties associated with the Plan to any person (including employees) that it deems
appropriate.
4.03 Award Agreement. At the time any Award is made, the Committee will prepare and deliver an
Award Agreement to each affected Participant. The Award Agreement:
[1] Will describe:
[a] The type of Award and when and how it may be exercised;
[b] The effect of exercising the Award; and
[c] Any Exercise Price associated with each Award.
[2] To the extent different from the terms of the Plan, will describe:
[a] Any conditions that must be met before the Award may be exercised;
-7-
[b] Any objective restrictions placed on Restricted Stock, Performance Shares and
Performance Units and any performance related conditions and Performance Goals that
must be met before those restrictions will be released;
[c] When and how an Award may be exercised; and
[d] Any other applicable terms and conditions affecting the Award.
4.04 Restriction on Repricing. Regardless of any other provision of this Plan, neither the Company
nor the Committee may reprice (as defined under rules issued by the exchange on which the Stock
then is traded) any Option without the prior approval of the shareholders.
5.00 STOCK SUBJECT TO PLAN
5.01 Number of Shares of Stock. Subject to Section 5.03, the number of shares of Stock subject to
Awards under the Plan may not be larger than 1,800,000 of which up to 300,000 may be issued as
Restricted Stock. The shares of Stock to be delivered under the Plan may consist, in whole or in
part, of treasury Stock or authorized but unissued Stock not reserved for any other purpose.
5.02 Cancelled, Terminated or Forfeited Awards. Any Stock subject to an Award that, for any
reason, is cancelled, terminated or otherwise settled without the issuance of any Stock or cash may
again be granted under the Plan. Any Performance Share or share of Restricted Stock that has been
issued to a Participant under the Plan and is subsequently forfeited pursuant to the terms of the
Plan or the applicable Award Agreement will be forfeited to and acquired by the Company as treasury
Stock and may again be granted under the terms of the Plan.
5.03 Adjustment in Capitalization. If there is a Stock dividend or Stock split, recapitalization
(including payment of an extraordinary dividend), merger, consolidation, combination, spin-off,
distribution of assets to shareholders, exchange of shares, or other similar corporate change
affecting Stock, the Committee will appropriately adjust [1] the number of Awards that may or will
be issued to Participants during a Plan Year, [2] the aggregate number of shares of Stock available
for Awards under Section 5.01 or subject to outstanding Awards (as well as any share-based limits
imposed under this Plan), [3] the respective Exercise Price, number of shares and other limitations
applicable to outstanding or subsequently issued Awards and [4] any other factors, limits or terms
affecting any outstanding or subsequently issued Awards. Notwithstanding anything to the contrary
in this Section 5.03, an adjustment to a Non-Grandfathered NSO, a Non-Grandfathered SAR or a
Non-Grandfathered Stock Unit shall be made only to the extent such adjustment complies with the
requirements of Code §409A.
-8-
6.00 OPTIONS
6.01 Grant of Options. The Committee may grant Options to Key Employees at any time during the
term of this Plan. Options may be either [1] Incentive Stock Options or [2] Nonstatutory Stock
Options.
6.02 Option Price. Each Option will bear the Exercise Price the Committee specifies in the Award
Agreement. However, [1] in the case of a Nonstatutory Stock Option, the Exercise Price will not be
less than the Fair Market Value of a share of Stock on the Grant Date and [2] in the case of an
Incentive Stock Option, the Exercise Price [a] will not be less than the Fair Market Value of a
share of Stock on the Grant Date and [b] will be at least 110 percent of the Fair Market Value of a
share of Stock on the Grant Date with respect to any Incentive Stock Options issued to a Key
Employee who, on the Grant Date, owns [as defined in Code §424(d)] Stock possessing more than
10 percent of the total combined voting power of all classes of Stock.
6.03 Exercise of Options. Subject to Section 11.00 and any other restrictions and conditions
specified in the Award Agreement and unless the Committee specifies otherwise in the Award
Agreement, Options will be exercisable according to the following schedule:
|
|
|
Number of Full Years Beginning
After Grant Date
|
|
Cumulative Percentage
Vested |
|
|
|
Less than 3
3 or more
|
|
0 percent
100 percent |
However:
[1] Any fractional share of Stock will be rounded down.
[2] Unless the Committee specifies otherwise in the Award Agreement, no Key Employee may
exercise Options for fewer than the smaller of:
[a] 100 shares of Stock; or
[b] The number of full shares of Stock for which Options are then exercisable.
-9-
[3] No Option may be exercised more than ten years after it is granted (five years in
respect of an Incentive Stock Option, if the Key Employee owns [as defined in Code §424(d)]
Stock possessing more than 10 percent of total combined voting power of all classes of Stock
on the Grant Date).
6.04 Incentive Stock Options. Notwithstanding anything in the Plan to the contrary:
[1] No provision of this Plan relating to Incentive Stock Options will be interpreted,
amended or altered, nor will any discretion or authority granted under the Plan be
exercised, in a manner that is inconsistent with Code §422 or, without the consent of any
affected Member, to cause any Incentive Stock Option to fail to qualify for the federal
income tax treatment afforded under Code §421;
[2] The aggregate Fair Market Value of the Stock (determined as of the Grant Date) with
respect to which Incentive Stock Options are exercisable for the first time by any Member
during any calendar year (under all option plans of the Company and all Subsidiaries of the
Company) will not exceed $100,000 [or other amount specified in Code §422(d)]; and
[3] No Incentive Stock Option will be granted to any person who is not a Key Employee on the
Grant Date.
6.05 Director Options.
[1] Prior to the 2006 Annual Meeting, on the first business day after each Annual Meeting,
each Eligible Director was issued Director Options to purchase [a] 5,000 shares of Stock
plus [b] 500 shares of Stock, multiplied by the number of Board committees of which he or
she was then a member, plus [c] 1,000 shares of Stock, multiplied by the number of Board
committees of which he or she was then chairperson. The Director Options issued under this
section were reduced (but not below zero) by any options issued for the same purpose under
any other Company equity plan or program.
[2] Subject to Section 6.05[3], each Director Option may be exercised [a] no earlier than
six months after the Grant Date and [b] no later than the earlier of [i] ten years after the
Grant Date, or [ii] one year after the Eligible Director Terminates (five years if
Termination is because of Retirement).
[3] However:
[a] Any fractional share of Stock will be rounded down; and
[b] Unless the Committee specifies otherwise in the Award Agreement, no Eligible
Director may exercise Director Options for fewer than the smaller of:
|
|
|
[i] 100 shares of Stock; or |
-10-
|
|
|
[ii] The number of full shares of Stock for which
Director Options are then exercisable. |
6.06 Payment for Options. Unless the Committee specifies otherwise in the Award Agreement, the
Exercise Price associated with each Option must be paid in cash. However, the Committee may, in
its discretion, develop, and extend to some or all Members, procedures through which Members may
pay an Options Exercise Price, including allowing a Member to tender Stock he or she already has
owned for at least six months before the exercise date, either by actual delivery of the previously
owned Stock or by attestation, valued at its Fair Market Value on the exercise date, as partial or
full payment of the Exercise Price.
6.07 Transferability of Stock. Unless the Committee specifies otherwise in the Award Agreement,
Stock acquired through an Option will be transferable, subject to applicable federal securities
laws, the requirements of any national securities exchange or system on which shares of Stock are
then listed or traded or any blue sky or state securities laws.
7.00 STOCK UNITS
7.01 Granting Stock Units. Each Eligible Director was permitted to elect, prior to January 1,
2005, to receive all or a portion of his or her Annual Retainer in cash or Stock Units under this
Plan by returning to the Committee an Annual Retainer Deferral Form specifying:
[1] The portion (stated in 25 percent increments) of the Annual Retainer to be converted to
Stock Units;
[2] The date Stock Units are to be settled;
[3] Whether Stock Units are to be settled in cash or Stock; and
[4] The period (which may not be longer than 10 years) over which the value of Stock Units
is to be distributed.
If a completed Annual Retainer Deferral Form was not timely received, the Eligible Directors
Annual Retainer was paid in cash through the Companys regular procedures for paying Annual
Retainers. Each Eligible Director that effectively elected to receive Stock Units in lieu of all
or a portion of his or her Annual Retainer received a number of Stock Units calculated by dividing
the dollar amount of Annual Retainer to be received in Stock Units by the Fair Market Value of a
share of Stock on the first trading day following the date of the Annual Meeting for which the
deferred value of the Annual Retainer otherwise would have been paid and rounded to the next
highest whole share of Stock.
7.02 Settling Stock Units.
[1] All Stock Units will be settled as of the earlier of:
[a] The date the Eligible Director Terminates; or
-11-
[b] The date the Eligible Director specifies on an Annual Retainer Deferral Form.
[2] If Stock Units are to be settled in cash, the amount distributed will be calculated by
multiplying the number of Stock Units to be settled in cash by the Fair Market Value of a
share of Stock on the date the Stock Units are settled.
[3] If Stock Units are to be settled in shares of Stock, the number of shares distributed
will equal the whole number of Stock Units to be settled in Stock, with the Fair Market
Value of any fractional share of Stock on the date the Stock Units are settled distributed
in cash.
[4] If an Eligible Director dies before all of his or her Stock Units have been settled, the
value of any unpaid Stock Units will be paid in a lump sum in cash to his or her
Beneficiary.
7.03 Change to Election.
[1] Grandfathered Stock Units. Once filed, elections made on an Annual Retainer Deferral
Form with respect to Grandfathered Stock Units will remain in effect until changed. Any
change to an earlier election relating to Grandfathered Stock Units must be made by
completing and returning another completed Annual Retainer Deferral Form to the Committee:
[a] If the change relates to the time Grandfathered Stock Units are to be settled,
no later than 12 months before the previously established settlement date relating
to the affected Grandfathered Stock Units; or
[b] If the change relates to the form in which Grandfathered Stock Units are to be
settled, no later than 12 months before the settlement date relating to the affected
Grandfathered Stock Units.
[2] Non-Grandfathered Stock Units.
[a] An Eligible Director may change the time and period over which the
Non-Grandfathered Stock Units are to be settled (based on the choices available
under Section 7.01[2] and [4]) by completing and returning a new Annual Retainer
Deferral Form to the Committee; provided that such change is irrevocable and
-12-
meets the following requirements: [i] the change may not take effect until at least
12 months after the date on which such election is made; [ii] the settlement date of
the Non-Grandfathered Stock Units must be deferred (other than in respect of a
distribution upon death) for a period of not less than five years from the date the
Non-Grandfathered Stock Units were scheduled to be settled; and [iii] any change
affecting a distribution at a specified time (or pursuant to a fixed schedule) may
not be made less than 12 months before the date the Non-Grandfathered Stock Units
were scheduled to be settled.
[b] Once payments relating to Non-Grandfathered Stock Units begin, no changes to the
Eligible Directors distribution election shall be permitted.
[c] For purposes of this Section 7.03[2], the right to a series of installment
payments shall be treated as the right to a series of separate payments.
8.00 RESTRICTED STOCK
8.01 Restricted Stock Grants. The Committee may grant Restricted Stock to Key Employees at any
time during the term of this Plan.
8.02 Transferability. Shares of Restricted Stock may not be sold, transferred, pledged, assigned
or otherwise alienated or hypothecated until the end of the applicable Restriction Period.
Restricted Stock normally will be held by the Company as escrow agent during the Restriction Period
and will be distributed as described in Section 8.03. However, at any time during the Restriction
Period, the Committee may, in its sole discretion, issue the Restricted Stock to the Key Employee
in the form of certificates containing a legend describing restrictions imposed on the Restricted
Stock.
8.03 Removal of Restrictions. Shares of Restricted Stock will be:
[1] Forfeited, if all restrictions have not been met at the end of the Restriction Period,
and again become available to be granted under the Plan; or
[2] Released from escrow and distributed to the affected Key Employee (or any restrictions
imposed on the distributed certificate removed) as soon as practicable, but no later than 60
days, after the last day of the Restriction Period, if all restrictions have then been met.
8.04 Rights Associated with Restricted Stock. During the Restriction Period:
[1] Key Employees may exercise full voting rights associated with their Restricted Stock;
and
[2] All dividends and other distributions paid with respect to any Restricted Stock will be
held in escrow during the Restriction Period and subject to the same restrictions on
transferability and forfeitability as the shares of Restricted Stock with respect to which
they were paid. A reasonable rate of interest, as determined by the Committee in its sole
discretion, will be credited to the Key Employee and held in escrow during the
-13-
Restriction Period with respect to any such cash dividends that were or are declared and
paid during the period beginning on December 20, 2006 and ending on the last day of the
Restriction Period. At the end of the Restriction Period, any such dividends and interest
thereon will be distributed to the Key Employee or forfeited as provided in Section 8.03.
9.00. PERFORMANCE SHARES AND PERFORMANCE UNITS
9.01 Performance Shares and Performance Unit Grants. The Committee may grant Performance Shares or
Performance Units to Key Employees at any time during the term of this Plan.
9.02 Performance Criteria.
[1] For each Performance Period, the Committee will establish the Performance Goal that will
be applied to determine the Performance Shares or Performance Units that will be distributed
at the end of the Performance Period.
[2] In establishing each Participants Performance Goal, the Committee will consider the
relevance of each Participants assigned duties and responsibilities to factors that
preserve and increase the Companys value. These factors will include:
[a] Increasing sales;
[b] Developing new products and lines of revenue;
[c] Reducing operating expenses;
[d] Increasing customer satisfaction;
[e] Developing new markets and increasing the Companys share of existing markets;
[f] Meeting completion schedules;
[g] Increasing standardized pricing;
[h] Developing and managing relationships with regulatory and other governmental
agencies;
[i]
Managing cash;
[j]
Managing claims against the Company, including litigation;
[k]
Identifying and completing strategic acquisitions; and
[l]
Increasing the Companys book value.
-14-
[3] The Committee will make appropriate adjustments to reflect:
[a] The effect on any Performance Goal of any Stock dividend or Stock split,
recapitalization (including, without limitation, the payment of an extraordinary
dividend), merger, consolidation, combination, spin-off, distribution of assets to
shareholders, exchange of shares or similar corporate change. This adjustment to
the Performance Goal will be made [i] to the extent the Performance Goal is based on
Stock, [ii] as of the effective date of the event and [iii] for the Performance
Period in which the event occurs. Also, the Committee will make a similar
adjustment to any portion of a Performance Goal that is not based on Stock but which
is affected by an event having an effect similar to those just described.
[b] A substantive change in a Participants job description or assigned duties and
responsibilities.
[4] Performance Goals will be established and communicated to each affected Participant in
an Award Agreement no later than the earlier of:
[a] 90 days after the beginning of the applicable Performance Period; or
[b] The expiration of 25 percent of the applicable Performance Period.
9.03 Earning Performance Shares and Performance Units. As of the end of each Performance Period,
the Committee will certify to the Board the extent to which each Participant has or has not met his
or her Performance Goal. Performance Shares or Performance Units will be:
[1] Forfeited, to the extent that Performance Goals have not been met at the end of the
Performance Period, and again become available to be granted under the Plan; or
[2] Valued and distributed, in a single lump sum, to Key Employees, in the form of cash,
Stock or a combination of both (as determined by the Committee) as soon as practicable, but
no later than 60 days, after the last day of the Performance Period, to the extent that
related Performance Goals have been met.
9.04 Rights Associated with Performance Shares and Performance Units. During the Performance
Period, and unless the Award Agreement provides otherwise:
[1] Key Employees may exercise full voting rights associated with their Performance Shares
or Performance Units; and
[2] All dividends and other distributions paid with respect to any Performance Shares or
Performance Units will be held in escrow during the Performance Period. At the end of the
Performance Period, these dividends will be distributed to the Key Employee or
-15-
forfeited as provided in Section 9.03. No interest or other accretion will be credited with
respect to any dividends held in escrow. If any dividends or other distributions are paid
in shares of Stock, those shares will be subject to the same restrictions on transferability
and forfeitability as the shares of Restricted Stock with respect to which they were paid.
10.00 STOCK APPRECIATION RIGHTS
10.01 SAR Grants. Subject to the terms of the Plan, the Committee may grant Freestanding SARs and
Tandem SARs (or a combination of each) to Key Employees at any time during the term of this Plan.
10.02 Exercise Price. The Exercise Price of a SAR will not be less than 100 percent of the Fair
Market Value of a share of Stock on the Grant Date.
10.03 Exercise of Freestanding SARs. Freestanding SARs will be exercisable subject to the terms
specified in the Award Agreement.
10.04 Exercise of Tandem SARs. Tandem SARs may be exercised with respect to all or part of the
shares of Stock subject to the related Option by surrendering the right to exercise the equivalent
portion of the related Option. A Tandem SAR may be exercised only with respect to the shares of
Stock for which its related Option is then exercisable. However:
[1] A Tandem SAR will expire no later than the date the related Option expires;
[2] The value of the payout with respect to the Tandem SAR will not be more than 100 percent
of the difference between the Exercise Price of the SAR and the Fair Market Value of a share
of Stock on the date the Tandem SAR is exercised; and
[3] A Tandem SAR may be exercised only if the Fair Market Value of a share of Stock subject
to the Option is larger than the Exercise Price of the related Option.
10.05 Settling SARs. A Member exercising a Tandem SAR or a Freestanding SAR will receive an amount
equal to:
[1] The difference between the Fair Market Value of a share of Stock on the exercise date
and the Exercise Price; multiplied by
[2] The number of shares of Stock with respect to which the Tandem SAR or Freestanding SAR
is exercised.
-16-
At the discretion of the Committee, the value of any Tandem SAR or Freestanding SAR being exercised
will be settled in cash, shares of Stock or any combination of both.
11.00 TERMINATION/BUY OUT
11.01 Retirement. Unless otherwise specified in the Award Agreement, all Awards that are
outstanding (whether or not then exercisable) when a Participant Retires may be exercised at any
time before the earlier of [1] the expiration date specified in the Award Agreement or [2] 60
months (three months in the case of Incentive Stock Options) beginning on the Retirement date (or
any shorter period specified in the Award Agreement).
11.02 Death or Disability. Unless otherwise specified in the Award Agreement, all Awards that are
outstanding (whether or not then exercisable) when a Participant Terminates because of death or
Disability may be exercised by the Participant or the Participants Beneficiary at any time before
the earlier of [1] the expiration date specified in the Award Agreement or [2] 60 months (12 months
in the case of an Incentive Stock Option) beginning on the date of death or Termination because of
Disability (or any shorter period specified in the Award Agreement).
11.03 Termination for Cause. Unless otherwise specified in the Award Agreement, all Awards that
are outstanding (whether or not then exercisable) if a Participant Terminates for Cause will be
forfeited.
11.04 Termination for any Other Reason. Unless otherwise specified in the Award Agreement or
subsequently, any Awards that are outstanding when an Employee Participant Terminates for any
reason not described in Sections 11.01 through 11.03 and which are then exercisable, or which the
Committee has, in its sole discretion, decided to make exercisable, may be exercised at any time
before the earlier of [1] the expiration date specified in the Award Agreement or [2] 90 days
beginning on the date the Employee Participant Terminates.
11.05 Limits on Exercisability/Forfeiture of Exercised Awards. Regardless of any other provision
of this section or the Plan and unless the Committee specifies otherwise in the Award Agreement, a
Member who fails to comply with Sections 11.05[3] through [9] will:
[1] Forfeit all outstanding Awards; and
[2] Forfeit all shares of Stock or cash (including dividends held in escrow under Sections
8.04[2] and 9.04[2]) acquired or received by the exercise of any Award, lapse of any
restrictions or attainment of any Performance Goals on the date of Termination or within 180
days before and 730 days after Terminating, including any amounts received under a buy out
as described in Section 11.06 but excluding amounts received as a consequence of a Change in
Control as described in Section 12.00.
The forfeiture described in Sections 11.05[1] and [2] will apply if the Member:
-17-
[3] Without the Committees written consent, which may be withheld for any reason or for no
reason, serves (or agrees to serve) as an officer, director, consultant or employee of any
proprietorship, partnership or corporation or becomes the owner of a business or a member of
a partnership that competes with any portion of the Companys (or a Subsidiarys) business
with which the Member has been involved anytime within five years before Termination or
renders any service (including, without limitation, advertising or business consulting) to
entities that compete with any portion of the Companys (or a Subsidiarys) business with
which the Member has been involved anytime within five years before Termination;
[4] Refuses or fails to consult with, supply information to or otherwise cooperate with the
Company after having been requested to do so;
[5] Deliberately engages in any action that the Committee concludes has caused substantial
harm to the interests of the Company or any Subsidiary;
[6] Without the Committees written consent, which may be withheld for any reason or for no
reason, on his or her own behalf or on behalf of any other person, partnership, association,
corporation or other entity, solicits or in any manner attempts to influence or induce any
employee of the Company or a Subsidiary to leave the Companys or Subsidiarys employment or
uses or discloses to any person, partnership, association, corporation or other entity any
information obtained while an employee or director of the Company or any Subsidiary
concerning the names and addresses of the Companys and any Subsidiaries employees;
[7] Without the Committees written consent, which may be withheld for any reason or for no
reason, discloses confidential and proprietary information relating to the Companys and its
Subsidiaries business affairs (Trade Secrets), including technical information, product
information and formulae, processes, business and marketing plans, strategies, customer
information and other information concerning the Companys and Subsidiaries products,
promotions, development, financing, expansion plans, business policies and practices,
salaries and benefits and other forms of information considered by the Company to be
proprietary and confidential and in the nature of Trade Secrets;
[8] Fails to return all property (other than personal property), including keys, notes,
memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks,
cards, surveys, maps, logs, machines, technical data, formulae or any other tangible
property or document and any and all copies, duplicates or reproductions that have been
produced by, received by or otherwise been submitted to the Member in the course of his or
her service with the Company or a Subsidiary; or
[9] Engaged in conduct that the Committee reasonably concludes would have given rise to a
Termination for Cause had it been discovered before the Participant Terminated.
-18-
11.06 Buy Out of Awards. At any time before a Change in Control or the commencement of activity
that may reasonably be expected to result in a Change in Control, to the extent permitted by
applicable law, the Committee, in its sole discretion and without the consent of the affected
Member, may cancel any or all outstanding Awards, other than an Award that is subject to
Code §409A, held by that Member, whether or not exercisable, by providing to that Member written
notice (Buy Out Notice) of its intention to exercise the rights reserved in this section. If a
Buy Out Notice is given, in the case of an Option or a SAR (other than an Option or a SAR that is
subject to Code §409A), the Company also will pay to each affected Participant the difference
between [1] the Fair Market Value of the Stock underlying each exercisable Option (or portion
thereof) or SAR (or portion thereof) to be cancelled and [2] the Exercise Price associated with
each exercisable Option or SAR to be cancelled. With respect to any Award other than an Option, a
SAR or an Award that is subject to Code §409A, the Company will pay to each affected Participant
the Fair Market Value of the Stock subject to the Award. However, unless otherwise specified in
the Award Agreement, no payment will be made with respect to any Awards that are not exercisable
when cancelled under this section. The Company will complete any buy out made under this section
as soon as administratively possible after the date of the Buy Out Notice. At the Committees
option, payment of the buy out amount may be made in cash, in whole shares of Stock or partly in
cash and partly in shares of Stock. The number of whole shares of Stock, if any, included in the
buy out amount will be determined by dividing the amount of the payment to be made in shares of
Stock by the Fair Market Value as of the date of the Buy Out Notice.
12.00 CHANGE IN CONTROL
12.01 Accelerated Vesting and Settlement. Subject to Section 12.02, on the date of any Change in
Control:
[1] [a] Each Option (other than Directors Options) outstanding on the date of a Change in
Control (whether or not exercisable) will be cancelled in exchange [i] for cash equal to the
excess of the Change in Control Price over the Exercise Price associated with the cancelled
Option or, [ii] at the Committees discretion, for whole shares of Stock with a Fair Market
Value equal to the excess of the Change in Control Price over the Exercise Price associated
with the cancelled Option and the Fair Market Value of any fractional share of Stock will be
distributed in cash, and [b] all related Tandem SARs will be cancelled. However, the
Committee, in its sole discretion, may offer the holders of the Options to be cancelled a
reasonable opportunity (not longer than 15 days beginning on the date of the Change in
Control) to exercise all their outstanding Options (whether or not otherwise then
exercisable) by following the exercise procedures described in Section 6.00;
[2] All Performance Goals associated with Performance Shares or Performance Units will be
deemed to have been met on the date of the Change in Control, all Performance Periods
accelerated to the date of the Change in Control and all outstanding Performance Shares and
Performance Units (including those subject to the acceleration described in this
-19-
subsection) will be distributed in a single lump sum cash payment within 30 days following
such Change in Control; and
[3] Each Freestanding SAR will be deemed to be exercisable and will be liquidated in a
single lump sum cash payment equal to [a] the difference between the Change in Control Price
and the Exercise Price; multiplied by [b] the number of shares of Stock with respect to
which the Freestanding SAR is deemed exercised.
12.02 Alternative Awards. Section 12.01 will not apply to the extent that the Committee reasonably
concludes in good faith before the Change in Control occurs that Awards will be honored or assumed
or new rights substituted for the Award (collectively Alternative Awards) by the Key Employees
employer (or the parent or a subsidiary of that employer) immediately after the Change in Control,
provided that any Alternative Award must:
[1] Be based on stock that is (or, within 60 days of the Change in Control, will be) traded
on an established securities market;
[2] Provide the Key Employee (or each Key Employee in a class of Key Employees) rights and
entitlements substantially equivalent to or better than the rights, terms and conditions of
each Award for which it is substituted, including an identical or better exercise or vesting
schedule and identical or, in the case of an Award that is not subject to Code §409A, better
timing and methods of payment;
[3] Have substantially equivalent economic value to the Award (determined at the time of the
Change in Control) for which it is substituted; and
[4] Provide that, if the Key Employees employment is involuntarily Terminated without Cause
or constructively Terminated by the Key Employee, any conditions on the Key Employees
rights under, or any restrictions on transfer or exercisability applicable to, each
Alternative Award will be waived or lapse.
For purposes of this section, a constructive Termination means a Termination by a Key Employee
following a material reduction in the Key Employees compensation or job responsibilities (when
compared to the Key Employees compensation and job responsibilities on the date of the Change in
Control) or the relocation of the Key Employees principal place of employment to a location at
least 50 miles from his or her principal place of employment on the date of the Change in Control
(or other location to which the Key Employee has been reassigned with his or her written consent),
in each case without the Key Employees written consent.
Notwithstanding anything herein to the contrary, no Alternative Award shall be made with respect to
an Option or SAR if it would cause the Option or SAR to become deferred compensation subject to
Code §409A or fail to comply with the requirements of Code §409A.
-20-
12.03 Directors Options and Stock Units. Upon a Change in Control, outstanding:
[1] Director Options will be cancelled unless [a] the Stock continues to be traded on an
established securities market after the Change in Control or [b] the Eligible Director
continues to be a Board member after the Change in Control. In the situations just
described, the Director Option will be unaffected by a Change in Control. Any Director
Option to be cancelled under the first sentence of this Section 12.03[1] will be exchanged
[c] for cash equal to the excess of the Change in Control Price over the Exercise Price
associated with the cancelled Director Option or, [d] at the Committees discretion, for
whole shares of Stock with a Fair Market Value equal to the excess of the Change in Control
Price over the Exercise Price associated with the cancelled Director Option and the Fair
Market Value of any fractional share of Stock will be distributed in cash. However, the
Committee, in its sole discretion, may offer the holders of the Director Options to be
cancelled a reasonable opportunity (not longer than 15 days beginning on the date of the
Change in Control) to exercise all their outstanding Director Options (whether or not
otherwise then exercisable) by following the exercise procedures described in Section 6.00.
[2] Stock Units will be settled within 30 days following the Change in Control for a lump
sum cash payment equal to [a] the Change in Control Price, multiplied by [b] the number of
Stock Units to be settled. Notwithstanding the foregoing, Non-Grandfathered Stock Units
will not be settled under this Section 12.03[2] unless the Change in Control also
constitutes a change in control event under Code §409A and the Treasury Regulations
promulgated thereunder. If the Change in Control does not constitute a change in control
event under Code §409A, the Non-Grandfathered Stock Units will be settled as described in
Section 7.02.
13.00 AMENDMENT, MODIFICATION AND TERMINATION OF PLAN
The Board or the Committee may terminate, suspend or amend the Plan at any time without shareholder
approval except to the extent that shareholder approval is required to satisfy applicable
requirements imposed by [1] Rule 16b-3 under the Act, or any successor rule or regulation,
[2] applicable requirements of the Code or [3] any securities exchange, market or other quotation
system on or through on which the Companys securities are listed or traded. Also, no Plan
amendment may [4] result in the loss of a Committee members status as a non-employee director as
defined in Rule 16b-3 under the Act, or any successor rule or regulation, with respect to any
employee benefit plan of the Company, [5] cause the Plan to fail to meet requirements imposed by
Rule 16b-3 or [6] without the consent of the affected Member adversely affect any Award issued
before the amendment, modification or termination. However, nothing in this section will restrict
the Committees right to exercise the discretion retained in Section 11.06.
14.00 MISCELLANEOUS
14.01 Assignability. Except as described in this Section 14.01, an Award may not be transferred
except by will or the laws of descent and distribution and, during the Members lifetime, may be
exercised only by the Member, the Members guardian or legal representative. However, with the
permission of the Committee, a Member or a specified group of Members may transfer Awards
-21-
(other than Incentive Stock Options) to a revocable inter vivos trust, of which the Member is the
settlor, or may transfer Awards (other than an Incentive Stock Option) to any member of the
Members immediate family, any trust, whether revocable or irrevocable, established solely for the
benefit of the Members immediate family, any partnership or limited liability company whose only
partners or members are members of the Members immediate family or an organization described in
Code §501(c)(3) (Permissible Transferees). Any Award transferred to a Permissible Transferee
will continue to be subject to all of the terms and conditions that applied to the Award before the
transfer and to any other rules prescribed by the Committee. A Permissible Transferee [other than
an organization described in Code §501(c)(3)] may not retransfer an Award except by will or the
laws of descent and distribution and then only to another Permissible Transferee.
14.02 Beneficiary Designation. Each Member may name a Beneficiary or Beneficiaries (who may be
named contingently or successively) to receive or to exercise any vested Award that is unpaid or
unexercised at the Members death. Each designation made will revoke all prior designations made
by the same Member, must be made on a form prescribed by the Committee and will be effective only
when filed in writing with the Committee. If a Member has not made an effective Beneficiary
designation, the deceased Members Beneficiary will be his or her surviving spouse or, if none, the
deceased Members estate. The identity of a Members designated Beneficiary will be based only on
the information included in the latest beneficiary designation form completed by the Member and
will not be inferred from any other evidence.
14.03 No Guarantee of Employment or Participation. Nothing in the Plan may be construed as:
[1] Interfering with or limiting the right of the Company or any Subsidiary to Terminate any
Key Employees employment at any time;
[2] Conferring on any Participant any right to continue as an Employee or director of the
Company or any Subsidiary;
[3]
Guaranteeing that any Employee will be selected to be a Key Employee; or
[4]
Guaranteeing that any Member will receive any future Awards.
14.04 Tax Withholding.
[1] The Company will withhold from other amounts owed to the Member, or require a Member to
remit to the Company, an amount sufficient to satisfy federal, state and local withholding
tax requirements on any Award, exercise or cancellation of an Award or purchase of Stock.
If these amounts are not to be withheld from other payments due to the Member (or if there
are no other payments due to the Member), the Company will defer payment of cash or issuance
of shares of Stock until the earlier of:
[a] Thirty days after the settlement date; or
-22-
[b] The date the Member remits the required amount.
[2] If the Member has not remitted the required amount within 30 days after the settlement
date, the Company will permanently withhold from the value of the Awards to be distributed
the minimum amount required to be withheld to comply with applicable federal, state and
local income, wage and employment taxes and distribute the balance to the Member.
[3] In its sole discretion, which may be withheld for any reason or for no reason, the
Committee may permit a Member to elect, subject to conditions the Committee establishes, to
reimburse the Company for this tax withholding obligation through one or more of the
following methods:
[a] By having shares of Stock otherwise issuable under the Plan withheld by the
Company (but only to the extent of the minimum amount that must be withheld to
comply with applicable state, federal and local income, employment and wage tax
laws);
[b] By delivering to the Company previously acquired shares of Stock that the Member
has owned for at least six months;
[c] By remitting cash to the Company; or
[d] By remitting a personal check immediately payable to the Company.
14.05 Indemnification. Each individual who is or was a member of the Committee or of the Board
will be indemnified and held harmless by the Company against and from any loss, cost, liability or
expense that may be imposed upon or reasonably incurred by him or her in connection with or
resulting from any claim, action, suit or proceeding to which he or she may be made a party or in
which he or she may be involved by reason of any action taken or failure to take action under the
Plan as a Committee member and against and from any and all amounts paid, with the Companys
approval, by him or her in settlement of any matter related to or arising from the Plan as a
Committee member or paid by him or her in satisfaction of any judgment in any action, suit or
proceeding relating to or arising from the Plan against him or her as a Committee member, but only
if he or she gives the Company an opportunity, at its own expense, to handle and defend the matter
before he or she undertakes to handle and defend it in his or her own behalf. The right of
indemnification described in this section is not exclusive and is independent of any other rights
of indemnification to which the individual may be entitled under the Companys organizational
documents, by contract, as a matter of law or otherwise. The foregoing right of indemnification is
not exclusive and is independent of any other rights of indemnification to which the person may be
entitled under the Companys organizational documents, by contract, as a matter of law or
otherwise.
14.06 No Limitation on Compensation. Nothing in the Plan is to be construed to limit the right of
the Company to establish other plans or to pay compensation to its employees or directors, in cash
or property, in a manner not expressly authorized under the Plan.
-23-
14.07 International Employees. To provide the same motivation to materially increase shareholder
value and to enable the Company to attract and retain the services of outstanding managers at its
international locations, the Company will adopt incentives for its foreign locations that provide,
as closely as possible, the same motivational effect as Awards provided to domestic Participants.
Also, the Committee may grant Awards to Employees who are subject to the tax laws of nations other
than the United States under terms and conditions that differ from other Awards granted under the
Plan but which are required to comply with applicable foreign tax laws.
14.08 Requirements of Law. The grant of Awards and the issuance of shares of Stock will be subject
to all applicable laws, rules and regulations and to all required approvals of any governmental
agencies or national securities exchange, market or other quotation system. Also, no shares of
Stock will be issued under the Plan unless the Company is satisfied that the issuance of those
shares of Stock will comply with applicable federal and state securities laws. Certificates for
shares of Stock delivered under the Plan may be subject to any stock transfer orders and other
restrictions that the Committee believes to be advisable under the rules, regulations and other
requirements of the Securities and Exchange Commission, any stock exchange or other recognized
market or quotation system upon which the Stock is then listed or traded, or any other applicable
federal or state securities law. The Committee may cause a legend or legends to be placed on any
certificates issued under the Plan to make appropriate reference to restrictions within the scope
of this section.
14.09 Term of Plan. The Plan was originally effective upon its adoption by the Board and approval
by the affirmation vote of the holders of a majority of the shares of voting stock present in
person or represented by proxy at the first Annual Meeting occurring after the Board approved the
Plan and is hereby amended and restated effective as of October 30, 2007. Subject to
Section 13.00, the Plan will continue until November 8, 2012. After January 26, 2006, no Award is
permitted to be granted under this Plan, but all Awards outstanding as of such date may extend
beyond such date in accordance with their respective terms.
14.10 Governing Law. The Plan, and all agreements hereunder, will be construed in accordance with
and governed by the laws (other than laws governing conflicts of laws) of the State of Ohio.
14.11 No Impact on Benefits. Plan Awards are incentives designed to promote the objectives
described in Section 1.00. Also, Awards are not compensation for purposes of calculating a
Members rights under any employee benefit plan.
-24-
EX-10(K)(2)
Exhibit 10(k)(2)
[Grantee]
[Address]
[Address]
Dear [Grantee]:
This letter agreement amends the Restricted Stock award granted to you on [Grant Date]
pursuant to the terms of The Scotts Miracle-Gro Company 2003 Stock Option and Incentive Equity
Plan, as amended from time to time (the Plan), and The Scotts Miracle-Gro Company 2003 Stock
Option and Incentive Equity Plan Award Agreement for Nondirectors (the Award Agreement). This
amendment shall be effective as of October 30, 2007 (the Amendment Effective Date). Unless
otherwise defined in this letter agreement, capitalized terms used herein shall have the meanings
provided to them in the Award Agreement.
As provided in your Award Agreement, your Restricted Stock will vest on [vesting date] (the
Vesting Date), subject to the terms of the Plan and the Award Agreement, as amended by this
letter agreement. This letter agreement clarifies that, if your employment terminates (as defined
in the Plan) for any reason prior to the Vesting Date, any unvested shares of your Restricted Stock
will be forfeited as of the date of your termination, and supersedes in its entirety
Section 1.01[1] of your Award Agreement.
Additionally, the Committee has determined, and the Plan has been amended to provide, that a
reasonable rate of interest will be calculated with respect to certain cash dividends held in
escrow during the Restriction Period (as defined in the Plan) relating to your shares of Restricted
Stock. Accordingly, the following paragraph is hereby added to the Award Agreement:
A reasonable rate of interest, as determined by the Committee in its sole discretion, will
be credited to you and held by the Company in escrow during the Restriction Period (as
defined in the Plan) with respect to any cash dividends that were or are declared and paid
in respect of your shares of Restricted Stock during the period that began on December 20,
2006 and that ends on the Vesting Date. At the end of the Restriction Period, such interest
will be distributed to you if all restrictions and conditions relating to your shares of
Restricted Stock are met or will be forfeited if those restrictions and conditions have not
been met.
|
|
|
|
|
|
|
|
|
THE SCOTTS MIRACLE-GRO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
|
|
|
Acknowledged and agreed,
effective as of the Amendment
Effective Date:
EX-10.M
Exhibit 10(m)
Employment Agreement for
Barry Sanders
The Scotts Company LLC
October 1, 2007
Contents
|
|
|
|
|
|
Article 1. Term of Employment |
|
|
1 |
|
|
|
|
|
|
Article 2. Definitions |
|
|
2 |
|
|
|
|
|
|
Article 3. Position and Responsibilities |
|
|
5 |
|
|
|
|
|
|
Article 4. Standard of Care |
|
|
5 |
|
|
|
|
|
|
Article 5. Compensation |
|
|
6 |
|
|
|
|
|
|
Article 6. Expenses |
|
|
7 |
|
|
|
|
|
|
Article 7. Employment Terminations |
|
|
7 |
|
|
|
|
|
|
Article 8. Assignment |
|
|
11 |
|
|
|
|
|
|
Article 9. Notice |
|
|
12 |
|
|
|
|
|
|
Article 10. Confidentiality, Noncompetition, and Nonsolicitation |
|
|
12 |
|
|
|
|
|
|
Article 11. Miscellaneous |
|
|
12 |
|
|
|
|
|
|
Article 12. Governing Law |
|
|
14 |
|
|
|
|
|
|
Article 13. Indemnification |
|
|
14 |
|
The Scotts Company LLC
Employment Agreement for Barry Sanders
This EMPLOYMENT AGREEMENT is made, entered into, and is effective as of the first day of
October, 2007 (herein referred to as the Effective Date), by and between The Scotts Company LLC
(Company), an Ohio corporation and Barry Sanders (Executive).
WHEREAS, the Company and the Executive intend that the Executive shall serve the Company as
Executive Vice President North America.
WHEREAS, the Executive possesses considerable experience and an intimate knowledge of the
business, and, as such, the Executive has demonstrated unique qualifications to act in an executive
capacity for the Company.
WHEREAS, the Company is desirous of assuring the employment of the Executive in the above
stated capacity, and the Executive is desirous of such assurance.
WHEREAS, the Company and Executive desire to enter into an agreement embodying the terms of
such employment.
NOW THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements of
the parties set forth in this Agreement, and of other good and valuable consideration the receipt
and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally
bound, agree as follows:
ARTICLE 1. TERM OF EMPLOYMENT
The Company hereby agrees to employ the Executive and the Executive agrees to serve the
Company, in accordance with the terms and conditions set forth herein, for an initial period of
three (3) years commencing as of the Effective Date; subject, however, to earlier termination as
expressly provided herein.
The initial three (3) year period of employment shall be extended for one (1) additional year
at the end of the initial three (3) year term and then again after each successive year thereafter.
However, either party may terminate this Agreement at the end of the initial three (3) year term,
or at the end of any successive one (1) year term thereafter, by delivering to the other party
written notice of its intent not to renew at least sixty (60) days prior to the end of such initial
three (3) year term or successive term.
In the event such notice of intent not to renew is properly delivered, this Agreement
automatically shall expire at the end of the initial three (3) year term or successive term then in
progress.
Notwithstanding the foregoing, if at any time during the initial three (3) year term of the
Agreement or any successive term, a Change in Control occurs, then the term of this Agreement shall
be the later of the remainder of the initial three (3) year term or two (2) years beyond the month
in which the effective date of such Change in Control occurs.
ARTICLE 2. DEFINITIONS
|
2.1 |
|
Agreement means this Employment Agreement for Barry Sanders. |
|
|
2.2 |
|
Annual Bonus Award means the annual bonus to be paid to the Executive in accordance
with the Companys annual bonus program as described in Section 5.2 herein. |
|
|
2.3 |
|
Award Period means the performance period applicable to Long-Term Incentive Awards
granted under the relevant Company long-term incentive plan. |
|
|
2.4 |
|
Base Salary means the salary of record paid to the Executive as annual salary,
pursuant to Section 5.1, excluding all other amounts received including under incentive or
other bonus plans, whether or not deferred. |
|
|
2.5 |
|
Beneficiary means the individuals or entities designated or deemed designated by
the Executive pursuant to Section 11.6 herein. |
|
|
2.6 |
|
Board or Board of Directors means the Board of Directors of Scotts. |
|
|
2.7 |
|
Cause means the Executives: |
|
(a) |
|
Continued failure to substantially perform his duties with the Company,
Scotts or any of their affiliates after a written demand for substantial
performance is delivered to the Executive that specifically identifies the manner
in which the Company believes that the Executive has failed to substantially
perform his duties, and after the Executive has failed to resume substantial
performance of his duties on a continuous basis within thirty (30) calendar days of
receiving such demand; or |
|
|
(b) |
|
Conviction of a felony; or |
|
|
(c) |
|
Engagement in illegal conduct, an act of dishonesty, violation of
Scotts policies or other similar conduct, that in the Companys sole discretion,
which shall be exercised in good faith, is injurious to the Company, Scotts or any
of their affiliates; or |
|
|
(d) |
|
Material breach of any provision of this Agreement; provided, however,
that the Executives willful and material breach of Article 4 shall not constitute
Cause unless the Executive has first been provided with written notice detailing
such breach and a thirty (30) day period to cure such breach; or |
|
|
(e) |
|
Breach of Scotts code of business conduct or ethics as determined in
good faith by the Company; or |
|
|
(f) |
|
Violation of Scotts insider-trading policies as determined in good
faith by the Company; or |
2
|
(g) |
|
Material breach of his fiduciary duties to the Company, Scotts or any
of their affiliates as determined in good faith by the Company. |
For purposes of determining Cause, no act or omission by the Executive shall be
considered willful unless it is done or omitted in bad faith or without reasonable
belief that the Executives action or omission was in the best interests of the Company.
Any act or failure to act based upon: (i) authority given pursuant to a resolution duly
adopted by the Board; or (ii) advice of counsel for the Company, shall be conclusively
presumed to be done or omitted to be done by the Executive in good faith and in the best
interests of the Company.
|
2.8 |
|
Change in Control means the occurrence of any of the following events after the
Effective Date of this Agreement: |
|
(a) |
|
Any person or group (as such terms are used in Sections 13(d) and
14(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act))
other than Scotts, subsidiaries of Scotts, an employee benefit plan sponsored by
Scotts, or Hagedorn Partnership, L.P. or its successor or any party related to
Hagedorn Partnership, L.P. (as determined by the Board of Directors) becomes the
beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or
indirectly, of more than thirty percent (30%) of the combined voting stock of
Scotts; |
|
|
(b) |
|
The shareholders of Scotts adopt or approve a definitive agreement or
series of related agreements for the merger or other business consolidation with
another person, the agreement(s) become effective and, immediately after giving
effect to the merger or consolidation, (i) less than fifty percent (50%) of the
total voting power of the outstanding voting stock of the surviving or resulting
person is then beneficially owned (within the meaning of Rule l3d-3 under the
Exchange Act) in the aggregate by (x) the shareholders of Scotts immediately prior
to such merger or consolidation, or (y) if a record date has been set to determine
the shareholders of Scotts entitled to vote with respect to such merger or
consolidation, the shareholders of Scotts as of such record date and (ii) any
person or group (as defined in Section 13(d)(3) and 14(d)(2) of the Exchange
Act) has become the direct or indirect beneficial owner (as defined in Rule l3d-3
under the Exchange Act) of more than fifty percent (50%) of the voting power of the
voting stock of the surviving or resulting person; |
|
|
(c) |
|
Scotts, either individually or in conjunction with one or more of its
subsidiaries, sells, assigns, conveys, transfers, leases or otherwise disposes of,
or the subsidiaries sell, assign, convey, transfer, lease or otherwise dispose of,
all or substantially all of the properties and assets of Scotts and the
subsidiaries, taken as a whole (either in one transaction or a series of related
transactions), to any person (other than Scotts or a wholly owned subsidiary); |
3
|
(d) |
|
For any reason, Hagedorn Partnership, L.P. or its successor or any
party related to Hagedorn Partnership, L.P. (as determined by the Board of
Directors) becomes the beneficial owner, as defined above, directly or indirectly,
of securities of Scotts representing more than forty-nine percent (49%) of the
combined voting power of Scotts then-outstanding voting securities; or |
|
|
(e) |
|
The adoption or authorization by the shareholders of Scotts of a plan
providing for the liquidation or dissolution of Scotts. |
|
2.9 |
|
Code means the U.S. Internal Revenue Code of 1986, as amended from time to time.
For purposes of this Agreement, references to sections of the Code shall be deemed to
include references to any applicable regulations thereunder and any successor or similar
provision. |
|
|
2.10 |
|
Committee means the Compensation and Organization Committee of the Board or a
subcommittee thereof, or any other committee designated by the Board to take any actions
referenced in this Agreement. The members of the Committee shall be appointed from time to
time by and shall serve at the discretion of the Board. If the Committee does not exist or
cannot function for any reason, the Board may take any action under this Agreement that
would otherwise be the responsibility of the Committee. |
|
|
2.11 |
|
Company means The Scotts Company LLC, an Ohio corporation, or any successor company
thereto as provided in Section 8.1 herein. |
|
|
2.12 |
|
Director means any individual who is a member of the Board of Directors of Scotts. |
|
|
2.13 |
|
Disability or Disabled means for all purposes of this Agreement, a consecutive
period of ninety (90) calendar days during which the Executive is unable to perform his
duties. |
|
|
2.14 |
|
Effective Date means October1, 2007. |
|
|
2.15 |
|
Effective Date of Termination means the date on which a termination of the
Executives employment occurs. For purposes of this Agreement, references to a
termination of employment or any form thereof shall mean a separation from service as
defined under Section 409A of the Code. |
|
|
2.16 |
|
Executive means Barry Sanders. |
|
|
2.17 |
|
Good Reason means, without the Executives consent, the existence of one or more of
the following conditions: |
|
(a) |
|
A material diminution in the Executives base compensation; |
|
|
(b) |
|
A material diminution in the Executives authority, duties, or
responsibilities; |
|
|
(c) |
|
A material diminution in the authority, duties, or responsibilities of
the supervisor to whom the Executive is required to report; |
4
|
(d) |
|
A material diminution in the budget over which the Executive retains
authority; |
|
|
(e) |
|
A material change in the geographic location at which the Executive
must perform services; or |
|
|
(f) |
|
Any other action or inaction that constitutes a material breach by the
Company of this Agreement (including under Section 8.1). |
Notwithstanding the foregoing, (i) an event described in this Section 2.17 shall
constitute Good Reason only if the Company fails to cure such event within thirty (30)
days after receipt from the Executive of written notice of the event which constitutes
Good Reason and (ii) Good Reason shall cease to exist for an event on the ninetieth
(90th) day following the later of its occurrence or the Executives knowledge
thereof, unless the Executive has given the Company written notice of such event prior
to such date.
|
2.18 |
|
Long-Term Incentive Award means the Long-Term Incentive Award to be paid to the
Executive in accordance with the Companys long-term incentive plan as described in
Section 5.3 herein. |
|
|
2.19 |
|
Notice of Termination means a written notice which shall indicate the specific
termination provision in this Agreement relied upon, and shall set forth in reasonable
detail the facts and circumstances claimed to provide a basis for termination of the
Executives employment under the provisions so indicated. |
|
|
2.20 |
|
Scotts means The Scotts Miracle-Gro Company, an Ohio corporation. |
|
|
2.21 |
|
Specified Executive means a specified employee within the meaning of Treasury
Regulation §1.409A-1(i) and as determined under the Companys policy for determining
specified employees. |
|
|
2.22 |
|
Target Annual Bonus Award means the amount of money determined by multiplying the
Executives bonus target percentage by the Executives then Base Salary. For example, if
the Executives Base Salary is $100,000 and the Executives bonus target percentage is
25%, then the Executives Target Annual Bonus Award is $25,000.00. |
ARTICLE 3. POSITION AND RESPONSIBILITIES
During the term of this Agreement, the Executive agrees to serve as Executive Vice President
North America. In his capacity as Executive Vice President North America, the Executive shall
report directly to the Chief Executive Officer of the Company or, at the Chief Executive Officers
election, the Chief Operating Officer of the Company, and shall perform duties and responsibilities
of an Executive Vice President North America and other duties and responsibilities as the Chief
Executive Officer or, if applicable, the Chief Operating Officer may assign him during the term of
this Agreement.
ARTICLE 4. STANDARD OF CARE
During the term of this Agreement, the Executive agrees to devote his full time, attention,
and energies to the Companys business and shall not be engaged in any other business activity,
whether or not such business activity is pursued for gain, profit, or other pecuniary advantage
unless such
5
business activity is approved in writing by the Board or Committee, provided, however, that
board positions with nonprofit or philanthropic organizations which do not interfere with the
Executives performance of his duties and responsibilities shall not require Board or Committee
approval. The Executive covenants, warrants, and represents that he shall:
|
(a) |
|
Devote his full and best efforts to the fulfillment of his employment obligations;
and |
|
|
(b) |
|
Adhere to Scotts code of business conduct or ethics as determined by the Board, the
Committee or the Company and exercise the highest standards of conduct in the performance
of his duties. |
ARTICLE 5. COMPENSATION
As remuneration for all services to be rendered by the Executive during the term of this
Agreement, and as consideration for complying with the covenants herein, the Company shall pay and
provide to the Executive the following.
5.1 Base Salary. The Company shall pay the Executive a Base Salary in the amount of four
hundred thousand dollars ($400,000.00) per year. This Base Salary shall be paid to the Executive in
equal installments throughout the year, consistent with the normal payroll practices of the
Company. The Base Salary shall be reviewed at least annually following the Effective Date of this
Agreement, while this Agreement is in force, to ascertain whether, in the judgment of the
Committee, such Base Salary should be modified. If modified, the Base Salary as stated above shall,
likewise, be modified for all purposes of this Agreement.
5.2 Annual Bonus. The Executive shall be eligible to receive in addition to his Base Salary
an annual incentive compensation award (Annual Bonus Award) for services rendered during such
fiscal year. The amount of the Annual Bonus Award, if any, with respect to any fiscal year shall
be based upon performance targets and award levels determined by the Committee in its sole
discretion, in accordance with the Companys annual incentive compensation plan as in effect for
executives from time to time.
5.3 Long-Term Incentives. The Executive shall be eligible to receive, in addition to his Base
Salary and Annual Bonus Award, a Long-Term Incentive Award for services rendered during an Award
Period established by the Committee. The amount of the Long-Term Incentive Award, if any, with
respect to any Award Period shall be based upon performance targets and award levels determined by
the Committee in its sole discretion, in accordance with the Companys long-term incentive
compensation plan as in effect for executives from time to time.
6
5.4 Retirement Benefits. During the term of this Agreement, and as otherwise provided within
the provisions of each of the respective plans, the Company shall provide to the Executive all
retirement benefits to which other executives and employees of the Company are entitled to receive,
subject to the eligibility requirements and other provisions of such arrangements as applicable to
executives of the Company generally.
5.5 Employee Benefits. During the term of this Agreement, and as otherwise provided within the
provisions of each of the respective plans, the Company shall provide to the Executive all benefits
to which other executives and employees of the Company are entitled to receive, subject to the
eligibility requirements and other provisions of such arrangements as applicable to executives of
the Company generally. Such benefits shall include, but shall not be limited to, life insurance,
comprehensive health and major medical insurance, dental insurance, prescription drug insurance,
vision insurance, and short-term and long-term disability. The Executive shall likewise participate
in any additional benefit as may be established during the term of this Agreement, by standard
written policy of the Company.
5.6 Perquisites. The Company shall provide to the Executive on an annual basis an automobile
allowance of twelve thousand dollars ($12,000.00). This allowance shall be paid to the Executive in
equal installments throughout the year, consistent with the normal payroll practices of the
Company. Additionally, the Company shall provide to the Executive on an annual basis either (a) a
four thousand dollar ($4,000) amount to be used in lieu of the provision of personal financial
planning, or (b) personal financial planning up to a cost or value of such amount. The value of
such services or such amount will be added to the Executives taxable income. Some or all of such
value or amount of the benefits described in this Section 5.6 may be tax deductible by the
Executive, but the Company makes no tax representation relating thereto.
ARTICLE 6. EXPENSES
Upon presentation of appropriate documentation, the Company shall pay, or reimburse the
Executive, for all ordinary and necessary expenses, in a reasonable amount, which the Executive
incurs in performing his duties under this Agreement including, but not limited to, travel,
entertainment, professional dues and subscriptions, and all dues, fees, and expenses associated
with membership in various professional, business, and civic associations and societies in which
the Executives participation is in the best interest of the Company, in accordance with Company
policy.
ARTICLE 7. EMPLOYMENT TERMINATIONS
7.1 Termination Due to Death. In the event of the Executives death during the term of this
Agreement, this Agreement shall terminate effective immediately and the Companys obligations under
this Agreement shall immediately expire.
Notwithstanding the foregoing, the Company shall be obligated to pay to the Executive the
following:
|
(a) |
|
Base Salary through the Effective Date of Termination within thirty
(30) days following such Effective Date of Termination; |
|
|
(b) |
|
Subject to the Executives estate signing and not revoking a release of
claims satisfactory to the Company (a Release) within sixty (60) days following
the Effective Date of Termination, a prorated Target Annual Bonus Award based on |
7
|
|
|
the Executives target bonus opportunity established for the year in which
termination of employment occurs. The prorated amount shall be determined as a
function of time within the year that has elapsed prior to the Executives
Effective Date of Termination and shall be paid no later than seventy (70) days
following the Effective Date of Termination; and |
|
(c) |
|
All other rights and benefits the Executive is vested in, pursuant to
other plans and programs of the Company. Such rights and benefits shall be paid or
provided, as applicable, in accordance with the terms of the applicable plan or
program. |
The Company and the Executive thereafter shall have no further obligations under this
Agreement.
7.2 Termination Due to Disability. Subject to any applicable legal requirement, in the event
that the Executive becomes Disabled during the term of this Agreement, the Company shall have the
right to terminate the Executives active employment by giving the Executive written notice of such
termination. Upon the Effective Date of Termination, the Companys obligations under this
Agreement shall immediately expire.
Notwithstanding the foregoing, the Company shall be obligated to pay to the Executive the
following:
|
(a) |
|
Base Salary through the Effective Date of Termination (subject to an
offset for any disability payments that the Executive receives during this period)
within thirty (30) days following such Effective Date of Termination; |
|
|
(b) |
|
Subject to the Executive signing and not revoking a Release within
sixty (60) days following the Effective Date of Termination, a prorated Target
Annual Bonus Award based on the Executives target bonus opportunity established
for the year in which termination of employment occurs. The prorated amount shall
be determined as a function of time within the year that has elapsed prior to the
Executives Effective Date of Termination and shall be paid no later than seventy
(70) days following the Effective Date of Termination; and |
|
|
(c) |
|
All other rights and benefits the Executive is vested in, pursuant to
other plans and programs of the Company. Such rights and benefits shall be paid or
provided, as applicable, in accordance with the terms of the applicable plan or
program. |
With the exception of the covenants referenced in Article 10 (which survive the termination of
the Executives employment), after the payments and execution of the Release, the Company and the
Executive shall have no further obligations under this Agreement.
8
7.3 Voluntary Termination by the Executive. The Executive may terminate this Agreement at any
time by giving the Company written notice of his intent to terminate, delivered at least sixty (60)
calendar days prior to the Effective Date of Termination; provided, however, that the Company may
waive all or a portion of such sixty (60) day notice period.
Upon the Effective Date of Termination, the Company shall pay the Executive (a) his accrued
and unpaid Base Salary at the rate then in effect, through the Effective Date of Termination within
thirty (30) days following such Effective Date of Termination, plus (b) all other benefits to which
the Executive has a vested right as of the Effective Date of Termination pursuant to the terms and
conditions of the applicable plans and programs of the Company. With the exception of the
covenants referenced in Article 10 (which survive the termination of the Executives employment),
the Company and the Executive shall have no further obligations under this Agreement.
7.4 Termination by the Company without Cause or by the Executive with Good Reason unrelated to
a Change in Control. At all times during the term of this Agreement, the Company may terminate the
Executives employment for reasons other than death, Disability, or for Cause, by providing to the
Executive a Notice of Termination, at least sixty (60) calendar days prior to the Effective Date of
Termination. Such Notice of Termination shall be irrevocable absent express written, mutual consent
of the parties. Additionally, the Executive may terminate employment with the Company for Good
Reason by providing the Company with a Notice of Termination for Good Reason. The Notice of
Termination must set forth in reasonable detail the facts and circumstances claimed to provide a
basis for such Good Reason termination.
Upon the Effective Date of Termination, the Executive shall be entitled to:
|
(a) |
|
An amount equal to the Executives accrued and unpaid Base Salary through the
Effective Date of Termination within thirty (30) days following such Effective Date of
Termination. |
|
|
(b) |
|
Subject to the Executive signing and not revoking a Release within sixty (60) days
following the Effective Date of Termination: |
|
(i) |
|
A lump sum payment equal to two (2) times the Executives Base Salary,
at the rate in effect on the Effective Date of Termination. |
|
|
(ii) |
|
A lump sum payment equal to one (1) times the Executives Target Annual
Bonus Award, at the targeted Annual Bonus Award in effect on the Effective Date of
Termination. |
|
|
(iii) |
|
A lump sum payment equal to the product of (1) the employer portion of
the monthly cost of the Executives medical and dental insurance benefits as of the
Effective Date of Termination (assuming the same coverage level as in effect as of
the Effective Date of Termination), multiplied by (2) twelve (12). |
Except as otherwise required by Section 7.7, the lump sum payments described in this
Section 7.4(b) shall be made by the Company no later than seventy (70) days following
the Effective Date of Termination. The Company shall provide the Release to the
9
Executive on or shortly after the Effective Date of Termination, and the Executive shall
execute the Release during the time period permitted by applicable law.
|
(c) |
|
All other benefits to which the Executive has a vested right as of the Effective
Date of Termination, according to the provisions of the governing plan or program. Such
rights and benefits shall be paid or provided, as applicable, in accordance with the
terms of the applicable plan or program. |
With the exception of the covenants referenced in Article 10 (which survive the termination of
the Executives employment), after the payments and execution of the Release, the Company and the
Executive shall have no further obligations under this Agreement.
7.5 Termination for Cause. Nothing in this Agreement shall be construed to prevent the Company
from terminating the Executives employment under this Agreement for Cause.
In the event this Agreement is terminated by the Company for Cause, the Company shall pay the
Executive his Base Salary through the Effective Date of Termination within thirty (30) days
following such Effective Date of Termination, and the Executive shall immediately thereafter
forfeit all rights and benefits (other than vested benefits) he would otherwise have been entitled
to receive under this Agreement. With the exception of the covenants referenced in Article 10
(which survive the termination of the Executives employment), the Company and the Executive shall
have no further obligations under this Agreement.
7.6 Subsequent to a Change in Control, Termination by the Company without Cause or by the
Executive with Good Reason. If within two (2) years following a Change in Control, the Company
terminates the Executives employment for any reason other than death, Disability, or Cause or the
Executive terminates employment for Good Reason, the Company shall pay and provide to the
Executive:
|
(a) |
|
An amount equal to the Executives accrued and unpaid Base Salary through the
Effective Date of Termination within thirty (30) days following such Effective Date of
Termination. |
|
|
(b) |
|
Subject to the Executive signing and not revoking a Release within sixty (60) days
following the Effective Date of Termination: |
|
(i) |
|
A lump sum payment equal to two (2) times the Executives annual Base
Salary, at the Base Salary amount in effect on the Effective Date of Termination; |
|
|
(ii) |
|
A lump sum payment equal to two (2) times the Executives Targeted
Annual Bonus Award, at the targeted Annual Bonus Award in effect on the Effective
Date of Termination; |
10
|
(iii) |
|
A lump sum payment that is equal to a prorated Targeted Annual Bonus
Award based on the Executives target bonus opportunity established for the fiscal
year in which termination of employment occurs. The prorated amount shall be
determined as a function of time within the fiscal year that has elapsed prior to
the Executives Effective Date of Termination; and |
|
|
(iv) |
|
A lump sum payment equal to the product of (1) the employer portion of
the monthly cost of the Executives medical and dental insurance benefits as of the
Effective Date of Termination (assuming the same coverage level as in effect as of
the Effective Date of Termination), multiplied by (2) twenty-four (24). |
Except as otherwise required by Section 7.7, the lump sum payments described in this
Section 7.6(b) shall be made by the Company within seventy (70) days following the
Effective Date of Termination. The Company shall provide the Release to the Executive
on or shortly after the Effective Date of Termination, and the Executive shall execute
the Release during the time period permitted by applicable law.
|
(c) |
|
All other benefits to which the Executive has a vested right as of the Effective Date
of Termination, according to the provisions of the governing plan or program. Such rights
and benefits shall be paid or provided, as applicable, in accordance with the terms of the
applicable plan or program. |
With the exception of the covenants referenced in Article 10 (which survive the termination of
the Executives employment), after the payments and execution of the Release, the Company and the
Executive shall have no further obligations under this Agreement.
7.7 Required Postponement for Specified Executives.
|
(a) |
|
If the Executive is considered a Specified Executive and payment of any amounts under
this Agreement is required to be delayed for a period of six months after a separation
from service pursuant to Section 409A of the Code, payment of such amounts shall be
delayed as required by Section 409A of the Code, and the accumulated postponed amounts,
with accrued interest as described in subsection (b) below, shall be paid in a lump sum
payment within five (5) days after the end of the six (6) month period. If the Executive
dies during the postponement period prior to the payment of such amounts, the amounts
postponed on account of Section 409A of the Code, with accrued interest as described in
subsection (b) below, shall be paid to the Executives Beneficiary within sixty (60) days
after the date of the Executives death. |
|
|
(b) |
|
If payment of any amounts under this Agreement is required to be delayed pursuant to
Section 409A of the Code, the Company shall pay interest on the postponed payments from
the date on which the amounts otherwise would have been paid to the date on which such
amounts are paid at an annual rate equal to the prime rate as announced on the Executives
Effective Date of Termination by JPMorgan Chase Bank on such date. |
ARTICLE 8. ASSIGNMENT
8.1 Assignment by the Company. This Agreement may and shall be assigned or transferred
to, and shall be binding upon and shall inure to the benefit of any successor company. For the
11
purposes of this Section 8.1, a successor shall include a purchaser of all of the equity of
the Company or all or substantially all of the assets or business of the Company. Any such
successor company shall be deemed substituted for all purposes of the Company under the terms of
this Agreement.
Failure of the Company to obtain the agreement of any successor company to be bound by the
terms of this Agreement prior to the effectiveness of any such succession shall be a breach of this
Agreement, and an event constituting Good Reason (as described in Section 2.17). Except as herein
provided, this Agreement may not otherwise be assigned by the Company.
8.2 Assignment by the Executive. This Agreement shall inure to the benefit of and be
enforceable by the Executives personal or legal representatives, executors, administrators,
successors, heirs, distributees, devisees, and legatees. If the Executive dies during the term of
this Agreement, the Companys obligations to make payments or provide benefits are described
entirely in Sections 7.1 and 7.7 and all such amounts, unless otherwise provided herein, shall
be paid in accordance with the terms of this Agreement to the Executives Beneficiary.
ARTICLE 9. NOTICE
Any notices, requests, demands, or other communications provided by this Agreement shall be
sufficient if in writing and if sent by registered or certified mail to the Executive at the last
address he has filed in writing with the Company or, in the case of the Company, at its principal
offices.
ARTICLE 10. CONFIDENTIALITY, NONCOMPETITION, AND NONSOLICITATION
This Agreement shall not supersede or nullify in any way the Employee Confidentiality,
Noncompetition, Nonsolicitation Agreement executed by the Executive on April 22, 2005 and again on
subsequent dates. The Employee Confidentiality, Noncompetition, Nonsolicitation Agreement shall
remain in full force and effect and any requirements of such agreement shall be incorporated by
reference into this Agreement. The provisions of this Article 10 shall survive the termination of
this Agreement and the termination of the Executives employment.
ARTICLE 11. MISCELLANEOUS
11.1 Entire Agreement. Unless otherwise specified herein, this Agreement supersedes any prior
agreements or understandings, oral or written, between the parties hereto or between the Executive
and the Company, with respect to the subject matter hereof, including the Employment Agreement
between the parties effective October 1, 2005 through October 1, 2007 and the Employment Agreement
between the parties dated September 4, 2007, and constitutes the entire agreement of the parties
with respect thereto. Nothing in this Section 11.1 shall be construed, however, to supersede any
prior award agreements between the parties under Scotts equity-based incentive compensation plans.
12
11.2 Amendment or Modification. This Agreement shall not be varied, altered, modified,
canceled, changed, or in any way amended except by mutual agreement of the parties in a written
instrument executed by the parties hereto or their legal representatives. Notwithstanding the
foregoing, the Company may amend the Agreement, to take effect retroactively or otherwise, as
deemed necessary or advisable for the purpose of conforming the Agreement to any present or future
law relating to agreements of this or similar nature (including, but not limited to, Section 409A
of the Code), and to the administrative regulations and rulings promulgated thereunder.
11.3 Severability. In the event that any provision or portion of this Agreement shall be
determined to be invalid or unenforceable for any reason, the remaining provisions of this
Agreement shall be unaffected thereby and shall remain in full force and effect.
11.4 Counterparts. This Agreement may be executed in one (1) or more counterparts, each of
which shall be deemed to be an original, but all of which together will constitute one and the same
Agreement.
11.5 Tax Withholding. The Company may withhold from any benefits payable under this Agreement
all federal, state, city, or other taxes as may be required pursuant to any law or governmental
regulation or ruling.
11.6 Beneficiaries. For the purposes of any payments or benefits due under Sections 7.1 and
7.7 of this Agreement, the Executive may designate one or more individuals or entities as the
primary and/or contingent Beneficiaries of any amounts to be received. Such designation must be in
the form of a signed writing acceptable to the Company. The Executive may make or change such
designation at any time. An acceptable form is attached hereto as Exhibit A. If no Beneficiary is
validly designated, then the benefits payable under this Agreement shall be paid to the Executives
surviving spouse or, if there is no surviving spouse, the Executives estate.
11.7 Payment Obligation Absolute. All amounts payable by the Company hereunder shall be paid
without notice or demand. Subject to the covenants set forth in Article 10 and the terms of any
bonus, long-term incentive or other such plan or program, each and every payment made hereunder by
the Company shall be final, and the Company shall not seek to recover all or any part of such
payment from the Executive or from whomsoever may be entitled thereto, for any reasons whatsoever.
The restrictive covenants referenced in Article 10 are independent of any other contractual
obligations in this Agreement or otherwise owed by the Company to the Executive. Except as provided
in this Section 11.7, the existence of any claim or cause of action by the Executive against the
Company, whether based on this Agreement or otherwise, shall not create a defense to the
enforcement by the Company of any restrictive covenant contained herein.
11.8 Contractual Rights to Benefits. Subject to approval by the Company, this Agreement
establishes and vests in the Executive a contractual right to the benefits to which he is entitled
hereunder. However, nothing herein contained shall require or be deemed to require, or prohibit or
be deemed to prohibit, the Company to segregate, earmark, or otherwise set aside any funds or other
assets, in trust or otherwise, to provide for any payments to be made or required hereunder.
13
11.9 Specific Performance. The Executive acknowledges that the obligations undertaken by him
pursuant to this Agreement are unique and that the Company will likely have no adequate remedy at
law if the Executive shall fail to perform any of his obligations hereunder. The Executive
therefore confirms that the Companys right to specific performance of the terms of this Agreement
is essential to protect the rights and interests of the Company. Accordingly, in addition to any
other remedies that the Company may have at law or in equity, the Company shall have the right to
have all obligations, covenants, agreements, and other provisions of this Agreement specifically
performed by the Executive and the Company shall have the right to obtain preliminary injunctive
relief to secure specific performance and to prevent a breach or contemplated breach of this
Agreement by the Executive.
11.10 Voiding of Agreement Provision. If any provision under this Agreement causes an amount
to be considered deferred under Section 409A of the Code and as such become subject to income tax,
excise tax, or penalties under the Code prior to the time such amount is paid to the Executive,
such amount shall be deemed null and void with respect to such amount deferred and the Company may
amend or modify this Agreement in order to accomplish the objectives of the Agreement without
causing early taxation of such amounts and without the Company incurring additional cost or
liability.
ARTICLE 12. GOVERNING LAW
To the extent not preempted by federal law, the provisions of this Agreement shall be
construed and enforced in accordance with the laws of the state of Ohio, excluding any conflicts or
choice of law rule or principle that might otherwise refer construction or interpretation of the
Agreement to the substantive law of another jurisdiction.
ARTICLE 13. INDEMNIFICATION
The Company hereby covenants and agrees to indemnify and hold harmless the Executive against
and in respect to any and all actions, suits, proceedings, claims, demands, judgments, costs,
expenses, losses, and damages resulting from the Executives performance of his duties and
obligations under the terms of this Agreement; provided however, the Executive acted in good faith
and in a manner he reasonably believed to be in or not opposed to the best interests of the Company
or its shareholders, and with respect to a criminal action or proceeding, the Executive had no
reasonable cause to believe his conduct was unlawful.
|
|
|
|
|
|
|
Executive |
|
|
|
|
|
|
|
|
|
/s/ Barry W. Sanders |
|
|
|
|
Barry Sanders
|
|
|
|
|
|
|
|
|
|
Date:11/16/07 |
|
|
|
|
|
|
|
|
|
The Scotts Company LLC |
|
|
|
|
|
|
|
|
|
/s/ James Hagedorn |
|
|
|
|
James Hagedorn, Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
Date: 19 Nov 07 |
|
|
14
EXHIBIT A
THE SCOTTS COMPANY LLC
BENEFICIARY DESIGNATION FORM
RELATING TO CONTINGENT PAYMENTS UNDER THE EMPLOYMENT AGREEMENT
ENTERED INTO BETWEEN BY AND BETWEEN BARRY SANDERS
AND THE SCOTTS COMPANY LLC
1.00 INSTRUCTIONS FOR COMPLETING THIS BENEFICIARY DESIGNATION FORM
You may use this Beneficiary Designation Form to (1) name the person you want to receive any amount
due under the Employment Agreement, effective October 1, 2007, by and between you and The Scotts
Company LLC (Agreement) after your death or (2) change the person who will receive these
benefits.
There are several things you should know before you complete this Beneficiary Designation Form.
FIRST, if you do not elect a beneficiary, any amount due to you under the Agreement when you die
will be paid to your surviving spouse or, if you have no surviving spouse, to your estate.
SECOND, your election will not be effective (and will not be implemented) unless you complete all
applicable portions of this Beneficiary Designation Form and return it with a signed copy of the
Agreement to the legal department.
THIRD, all elections will remain in effect until they are changed (or until all death benefits are
paid).
FOURTH, this beneficiary designation supersedes and revokes all other beneficiary designations with
respect to payments under the Agreement.
2.00 DESIGNATION OF BENEFICIARY
2.01 PRIMARY BENEFICIARY:
I designate the following person as my Primary Beneficiary to receive any amount due after my death
under the Agreement:
2.02 CONTINGENT BENEFICIARY
If my Primary Beneficiary dies before I die, I direct that any amount due after my death under the
terms of the Agreement be distributed to:
Elections made on this Beneficiary Designation Form will be effective only after this Form is
received by the legal department and only if it is fully and properly completed and signed.
Barry Sanders
Sign and attach this Beneficiary Designation Form to the Agreement.
To be Completed by the Company:
EX-10.N
Exhibit
10(n)
[English Translation
Original in French]
[The Scotts Company letterhead]
EMPLOYMENT CONTRACT FOR AN UNLIMITED TIME
FOR Mr. Claude LOPEZ French Nationality
Note in margin:
Exact beginning date to be confirmed [initials]
Dear Sir:
We hereby confirm your hiring at the SCOTTS FRANCE SAS General Corporate Office, beginning on
July 1, 2001 (to be confirmed), in the position of:
EXECUTIVE DIRECTOR OF SCOTTS FRANCE
Subject to the standard three-month trial period and the physical examination for
employment purposes.
Accordingly, you will report to the Scotts International Director, General Public Division.
This Contract is subject to the provisions of the Chemical Industries National Collective
Agreement, Amendment III, and to the following specific conditions:
1. This Contract is executed for an unlimited time. However, if it is continued to that point, your
employment will be terminated when you have reached the standard retirement age currently in force
in our company at such a time.
2. Your status in our company is subject to the following conditions, which shall remain in effect
irrespective of any changes such as may eventually take place in your job assignments:
|
|
You will be held to professional secrecy, during the time that you are with our Company,
and after your departure therefrom, if such occurs, irrespective of the reason therefor. |
|
|
|
You also hereby agree not to work for a competing firm, even temporarily, or as a
consultant, while occupying your position. |
|
|
|
Your job assignments may be subsequently changed, if such is required in the interests of
the Group. |
3. You are hereby attached to Group V, ENGINEERS & EXECUTIVE STAFF.
SCOTTS FRANCE SAS, a simplified joint-stock company, with equity capital of FR 36,000,000, entered
in the Lyon Corporate and Trade Registry under number 446 720 427 RCS
CL
Contract Mr. Claude Lopez
3. You are hereby attached to Group V, ENGINEERS & EXECUTIVE STAFF.
4. Your Category: 880
5. Your professional sector is the Commercial sector.
6. Your annual gross pay is 1,182,000 francs for thirteen months. Moreover, inasmuch as you will
belong to the Scotts International Management staff and to Scotts geographical locations, you will
receive an expatriation bonus, as defined in Article 81-A-III of the General Tax Code.
It will be paid monthly in advance, and is calculated at 10% of your base salary, i.e., 118,200
francs. The details of this bonus are set forth in an amendment to this Contract.
7. You are eligible to an annual incentive, which may reach 40% of your annual pay (annual base
salary + expatriation bonus), in case goals are 100% met, and even beyond this amount, up to 96% in
case annual goals are exceeded, in accordance with the SCOTTS France Regulations on Variable
Shares.
8. In October 2001, you will receive a one-time allotment of 5000 Scotts stock options, in addition
to an annual allotment of 3000 stock options.
9. You will have a company vehicle at your disposal, in accordance with Scotts policy on company
vehicles. This benefit will figure as payment in kind on your pay slip.
10. Upon commencement of your employment with Scotts France, you will receive a one-time bonus of
400,000 francs.
11. Scotts will pay the moving costs of your goods and your family to the Lyon area, based on 2
estimates from different providers. To facilitate your living arrangements, you will also receive
the assistance of a specialized relocation firm. Should you choose to lease your lodgings, Scotts
will also cover the agency fees as well as the first six months of rent, up to the limit of the
amount deemed usual in the area.
-2-
Contract Mr. Claude Lopez
12. In the case that, during the first two years of your tenure with Scotts, events lead to a
breach of your employment contract for any reason other than fault or resignation, Scotts hereby
agrees to pay you at the time of your departure a severance payment of six months base salary. No
later than six months following your departure, Scotts will pay you a second severance payment
corresponding to your theoretical bonus target based on the six months severance pay.
13. Actual work time is calculated yearly based on 1589 hours. The number of days worked during the
year totals 206 (with extra bridge days deducted).
Owing to your status as an executive, you are not personally involved in confirming work time.
In case of breach of contract during the year, or an unfinished work year, rights to a reduction in
working time shall be based on a prorated calculation.
Pursuant to Articles 3b and 4 of the Framework Agreement on Reduction of Work Time, each year, an
amount equal to 66% of profit share shall be deducted from the amount calculated for your bonus.
However, the deduction may not exceed 15% of the initially calculated bonus.
14. You will be automatically enrolled in our plans:
|
|
|
|
|
Pension
|
|
Caisse ARRCO [Association of
Supplementary Pension Plans]: UIRIC
[Pension Union for Industry and Commerce]
|
|
21 rue Roger Salengro
94128 FONTENAY S/BOIS
CEDEX |
|
|
|
Caisse AGIRC [Executive Pension
Association]: URC [Executive Pension
Union]
|
|
21 rue Roger Salengro
94128 FONTENAY S/BOIS
CEDEX |
|
Provident fund
|
|
MEDERIC
|
|
21 rue Laffitte
75317 PARIS CEDEX 09 |
15. You hereby agree to accept deductions for social security contributions (Lyon URSSAF [Social
Security and Family Welfare Agency] 69691 VENISSIEUX CEDEX, under employee number
691530000002405212), and for pension and provident funds, from the payments made to you pursuant to
this contract.
16. You also hereby agree to accept a deduction for the Mutuelle APICIL/MICILS contribution, the
documents for which you will find enclosed.
CL
-3-
Contract Mr. Claude Lopez
17. Your recruiting will be addressed in a preliminary employment declaration to the
Lyon-Vénissieux URSSAF on June 30, 2001 (to be confirmed).
Pursuant to Law no. 78-17 of January 6, 1978, you are hereby informed that your personal data have
been entered on computer medium and provided to the Lyon-Vénissieux URSSAF, through which you can
exercise your right of access and to make changes thereto.
Accordingly, having set forth the bases whereby you assure us of your acceptance of this offer, we
ask that for proper processing you be so kind as to return a copy of this contract to us, initialed
on each page and having added the handwritten phrase read and approved, the date, and your
signature.
Please accept our best wishes.
Made in Ecully, in two copies, on April 27, 2001.
|
|
|
[signature]
Isabelle Proust-Cabrera
|
|
[signature]
Michel Farkouh |
|
|
|
Human Resources Director
Scotts France & International
|
|
Chief Executive
Scotts International, General Public |
Annotations by Claude Lopez
[remainder of page handwritten]
Read and approved
Subject to my exact commencement date, currently being discussed with my present employer.
/s/ Claude Lopez
04/27/01
-4-
EX-10.R.2
Exhibit 10
(r)(2)
The Scotts Miracle-Gro Company
Amended and Restated
2006 Long-Term Incentive Plan
Effective as of October 30, 2007
Contents
|
|
|
|
|
|
|
Article 1.
|
|
Establishment, Purpose, and Duration
|
|
|
1 |
|
Article 2.
|
|
Definitions
|
|
|
1 |
|
Article 3.
|
|
Administration
|
|
|
8 |
|
Article 4.
|
|
Shares Subject to this Plan and Maximum Awards
|
|
|
9 |
|
Article 5.
|
|
Eligibility and Participation
|
|
|
11 |
|
Article 6.
|
|
Stock Options
|
|
|
12 |
|
Article 7.
|
|
Stock Appreciation Rights
|
|
|
14 |
|
Article 8.
|
|
Restricted Stock and Restricted Stock Units
|
|
|
15 |
|
Article 9.
|
|
Performance Units/Performance Shares
|
|
|
17 |
|
Article 10.
|
|
Cash-Based Awards and Other Stock-Based Awards
|
|
|
18 |
|
Article 11.
|
|
Transferability of Awards
|
|
|
18 |
|
Article 12.
|
|
Performance Measures
|
|
|
19 |
|
Article 13.
|
|
Nonemployee Director Awards
|
|
|
21 |
|
Article 14.
|
|
Dividend Equivalents
|
|
|
21 |
|
Article 15.
|
|
Beneficiary Designation
|
|
|
21 |
|
Article 16.
|
|
Rights of Participants
|
|
|
22 |
|
Article 17.
|
|
Change of Control
|
|
|
22 |
|
Article 18.
|
|
Amendment, Modification, Suspension, and Termination
|
|
|
25 |
|
Article 19.
|
|
Withholding
|
|
|
26 |
|
Article 20.
|
|
Successors
|
|
|
26 |
|
Article 21.
|
|
General Provisions
|
|
|
26 |
|
THE SCOTTS MIRACLE-GRO COMPANY
AMENDED AND RESTATED
2006 LONG-TERM INCENTIVE PLAN
(EFFECTIVE AS OF OCTOBER 30, 2007)
Article 1.
Establishment, Purpose, and Duration
1.1 Establishment. This Plan, an incentive compensation plan, was established by The Scotts
Miracle-Gro Company. This Plan was originally effective on January 26, 2006 (the Effective
Date), and is hereby amended and restated effective as of October 30, 2007, as set forth in this
document. This Plan shall remain in effect as provided in Section 1.3 hereof.
This Plan permits the grant of Nonqualified Stock Options, Incentive Stock Options, Stock
Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance
Units, Cash-Based Awards, and Other Stock-Based Awards.
1.2 Purpose of this Plan. The purpose of this Plan is to provide a means whereby Employees,
Directors, and Third Party Service Providers develop a sense of proprietorship and personal
involvement in the development and financial success of the Company, and to encourage them to
devote their best efforts to the business of the Company, thereby advancing the interests of the
Company and its shareholders. A further purpose of this Plan is to provide a means through which
the Company may attract able individuals to become Employees or serve as Directors or Third Party
Service Providers and to provide a means whereby those individuals upon whom the responsibilities
of the successful administration and management of the Company are of importance, can acquire and
maintain stock ownership, thereby strengthening their concern for the welfare of the Company.
1.3 Duration of this Plan. Unless sooner terminated as provided herein, this Plan shall
terminate on January 25, 2016. After this Plan is terminated, no Awards may be granted but Awards
previously granted shall remain outstanding in accordance with their applicable terms and
conditions and this Plans terms and conditions. Notwithstanding the foregoing, no Incentive Stock
Options may be granted after November 1, 2015.
Article 2.
Definitions
Whenever used in this Plan, the following terms shall have the meanings set forth below, and
when the meaning is intended, the initial letter of the word shall be capitalized.
2.1 Affiliate shall mean any corporation or other entity (including, but not limited to, a
partnership or a limited liability company), that is affiliated with the Company through stock or
equity ownership or otherwise, and is designated as an Affiliate for purposes of this Plan by the
Committee.
2.2 Annual Award Limit or Annual Award Limits have the meaning set forth in Section 4.3.
2.3 Award means, individually or collectively, a grant under this Plan of Nonqualified Stock
Options, Incentive Stock Options, SARs, Restricted Stock, Restricted Stock Units, Performance
Shares, Performance Units, Cash-Based Awards, or Other Stock-Based Awards, in each case subject to
the terms of this Plan.
2.4 Award Agreement means either (i) a written agreement entered into by the Company and a
Participant setting forth the terms and provisions applicable to an Award granted under this Plan,
or (ii) a written or electronic statement issued by the Company to a Participant describing the
terms and provisions of such Award, including in each case any amendment or modification thereof.
The Committee may provide for the use of electronic, internet or other non-paper Award Agreements,
and the use of electronic, internet or other non-paper means for the acceptance thereof and actions
thereunder by a Participant.
2.5 Beneficial Owner or Beneficial Ownership shall have the meaning ascribed to such term
in Rule 13d-3 of the General Rules and Regulations under the Exchange Act.
2.6 Board or Board of Directors means the Board of Directors of the Company.
2.7 Cash-Based Award means an Award, denominated in cash, granted to a Participant as
described in Article 10.
2.8 Cause means, unless otherwise specified in an Award Agreement or in an applicable
employment agreement between the Company and a Participant, with respect to any Participant:
(a) Willful failure to substantially perform his or her duties as an Employee (for
reasons other than physical or mental illness) or director after reasonable notice to the
Participant of that failure;
(b) Misconduct that materially injures the Company or any Subsidiary or Affiliate;
(c) Conviction of, or entering into a plea of nolo contendere to, a felony; or
(d) Breach of any written covenant or agreement with the Company or any Subsidiary or
Affiliate.
2
2.9 Change in Control means any of the following events:
(a) The members of the Board on the Effective Date (Incumbent Directors) cease for
any reason other than death to constitute at least a majority of the members of the Board,
provided that any director whose election, or nomination for election by the Companys
shareholders, was approved by a vote of at least a majority of the then Incumbent Directors
also will be treated as an Incumbent Director; or
(b) Any person, including a group [as such terms are used in Sections 13(d) and
14(d)(2) of the Exchange Act, but excluding the Company, any of its Subsidiaries, any
employee benefit plan of the Company or any of its Subsidiaries or Hagedorn Partnership,
L.P. or any party related to Hagedorn Partnership, L.P. as determined by the Committee]
becomes the Beneficial Owner, directly or indirectly, of securities of the Company
representing more than thirty percent (30%) of the combined voting power of the Companys
then outstanding securities; or
(c) The adoption or authorization by the shareholders of the Company of a definitive
agreement or a series of related agreements (i) for the merger or other business
combination of the Company with or into another entity in which the shareholders of the
Company immediately before the effective date of such merger or other business combination
own less than fifty percent (50%) of the voting power in such entity; or (ii) for the sale
or other disposition of all or substantially all of the assets of the Company; or
(d) The adoption by the shareholders of the Company of a plan relating to the
liquidation or dissolution of the Company; or
(e) For any reason, Hagedorn Partnership, L. P. or any party related to Hagedorn
Partnership, L.P. as determined by the Committee becomes the Beneficial Owner, directly or
indirectly, of securities of the Company representing more than forty-nine percent (49%) of
the combined voting power of the Companys then outstanding securities.
Notwithstanding the foregoing, an Award that is subject to Code Section 409A will not be
paid or settled upon a Change in Control unless the Change in Control also constitutes a
change in control event under Code Section 409A and Treasury Regulation Section
1.409A-3(i)(5).
2.10 Change in Control Price means the price per Share paid in conjunction with any
transaction resulting in a Change in Control (as determined in good faith by the Committee if any
part of the offered price is payable other than in cash) or, in the case of a Change in Control
occurring solely by reason of events not related to a transfer of Shares, the highest Fair Market
Value of a Share on any of the thirty (30) consecutive trading days ending on the last trading day
before the Change in Control occurs.
3
2.11 Code means the U.S. Internal Revenue Code of 1986, as amended from time to time. For
purposes of this Plan, references to sections of the Code shall be deemed to include references to
any applicable regulations thereunder and any successor or similar provision, as well as any
applicable interpretative guidance issued related thereto.
2.12 Committee means the Compensation and Organization Committee of the Board or a
subcommittee thereof, or any other committee designated by the Board to administer this Plan. The
members of the Committee shall be appointed from time to time by and shall serve at the discretion
of the Board. If the Committee does not exist or cannot function for any reason, the Board may take
any action under the Plan that would otherwise be the responsibility of the Committee.
2.13 Company means The Scotts Miracle-Gro Company, an Ohio corporation, and any successor
thereto as provided in Article 20 herein.
2.14 Covered Employee means any key Employee who is or may become a Covered Employee, as
defined in Code Section 162(m), and who is designated, either as an individual Employee or class of
Employees, by the Committee within the shorter of (i) ninety (90) days after the beginning of the
Performance Period, or (ii) twenty-five percent (25%) of the Performance Period having elapsed, as
a Covered Employee under this Plan for such applicable Performance Period.
2.15 Director means any individual who is a member of the Board of Directors of the Company.
2.16 Effective Date has the meaning set forth in Section 1.1.
2.17 Employee means any individual who performs services for and is designated as an
employee of the Company, its Affiliates, and/or its Subsidiaries on the payroll records thereof. An
Employee shall not include any individual during any period he or she is classified or treated by
the Company, Affiliate, and/or Subsidiary as an independent contractor, a consultant, or any
employee of an employment, consulting, or temporary agency or any other entity other than the
Company, Affiliate, and/or Subsidiary, without regard to whether such individual is subsequently
determined to have been, or is subsequently retroactively reclassified as a common-law employee of
the Company, Affiliate, and/or Subsidiary during such period.
2.18 Exchange Act means the Securities Exchange Act of 1934, as amended from time to time,
or any successor act thereto.
4
2.19 Fair Market Value or FMV means a price that is based on the opening, closing, actual,
high, low, or average selling prices of a Share reported on the New York Stock Exchange (NYSE) or
other established stock exchange (or exchanges) on the applicable date, the preceding trading day,
the next succeeding trading day, or an average of trading days, as determined by the Committee in
its discretion. Unless the Committee determines otherwise, Fair Market Value shall be deemed to be
equal to the closing price of a Share on the relevant date if it is a trading day or, if such date
is not a trading day, on the next trading day. In the event Shares are not publicly traded at the
time a determination of their value is required to be made hereunder (a) with respect to NQSOs,
SARs and Awards that are subject to Code Section 409A, Fair Market Value shall mean the value as
determined by the Committee through the reasonable application of a reasonable valuation method,
taking into account all information material to the value of the Company, within the meaning of
Code Section 409A and (b) with respect to all other Awards, the determination of Fair Market
Value shall be made by the Committee in such manner as it deems appropriate. Such definition(s)
of FMV shall be specified in each Award Agreement and may differ depending on whether FMV is in
reference to the grant, exercise, vesting, settlement, or payout of an Award.
2.20 Full Value Award means an Award other than in the form of an ISO, NQSO, or SAR, and
which is settled by the issuance of Shares.
2.21 Grant Date means the date an Award is granted to a Participant pursuant to the Plan.
2.22 Grant Price means the price established at the time of grant of an SAR pursuant to
Article 7, used to determine whether there is any payment due upon exercise of the SAR.
2.23 Incentive Stock Option or ISO means an Option to purchase Shares granted under
Article 6 that is designated as an Incentive Stock Option and that is intended to meet the
requirements of Code Section 422, or any successor provision.
2.24 Insider shall mean an individual who is, on the relevant date, an officer or Director
of the Company, or a more than ten percent (10%) Beneficial Owner of any class of the Companys
equity securities that is registered pursuant to Section 12 of the Exchange Act, as determined by
the Board or Committee in accordance with Section 16 of the Exchange Act.
2.25 Nonemployee Director means a Director who is not an Employee on the Grant Date.
2.26 Nonemployee Director Award means any NQSO, SAR, or Full Value Award granted to a
Participant who is a Nonemployee Director pursuant to such applicable
5
terms, conditions, and limitations as the Board or Committee may establish in accordance with
this Plan.
2.27 Nonqualified Stock Option or NQSO means an Option that is not intended to meet the
requirements of Code Section 422, or that otherwise does not meet such requirements.
2.28 Option means an Incentive Stock Option or a Nonqualified Stock Option, as described in
Article 6.
2.29 Option Price means the price at which a Share may be purchased by a Participant
pursuant to the exercise of an Option.
2.30 Other Stock-Based Award means an equity-based or equity-related Award not otherwise
described by the terms of this Plan, granted pursuant to Article 10.
2.31 Participant means any eligible individual as set forth in Article 5 to whom an Award is
granted.
2.32 Performance-Based Compensation means compensation under an Award that is intended to
satisfy the requirements of Code Section 162(m) for certain performance-based compensation paid to
Covered Employees. Notwithstanding the foregoing, nothing in this Plan shall be construed to mean
that an Award which does not satisfy the requirements for performance-based compensation under Code
Section 162(m) does not constitute performance-based compensation for other purposes, including
Code Section 409A.
2.33 Performance Measures means measures as described in Article 12 on which the performance
goals are based and which are approved by the Companys shareholders pursuant to this Plan in order
to qualify Awards as Performance-Based Compensation.
2.34 Performance Period means the period of time during which the performance goals must be
met in order to determine the degree of payout and/or vesting with respect to an Award.
2.35 Performance Share means an Award under Article 9 herein and subject to the terms of
this Plan, denominated in Shares, the value of which at the time it is payable is determined as a
function of the extent to which corresponding performance criteria or Performance Measure(s), as
applicable, have been achieved.
2.36 Performance Unit means an Award under Article 9 herein and subject to the terms of this
Plan, denominated in units, the value of which at the time it is payable is determined as a
function of the extent to which corresponding performance criteria or Performance Measure(s), as
applicable, have been achieved.
2.37 Period of Restriction means the period when Restricted Stock or Restricted Stock Units
are subject to a substantial risk of forfeiture (based on the passage of time, the
6
achievement of performance goals, or the occurrence of other events as determined by the
Committee, in its discretion), as provided in Article 8.
2.38 Person shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange
Act and used in Sections 13(d) and 14(d) thereof, including a group as defined in Section 13(d)
thereof.
2.39 Plan means The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive
Plan.
2.40 Plan Year means the Companys fiscal year.
2.41 Prior Plans means The Scotts Miracle-Gro Company Amended and Restated 2003 Stock Option
and Incentive Equity Plan, as amended, and The Scotts Miracle-Gro Company Amended and Restated 1996
Stock Option Plan, as amended.
2.42 Restricted Stock means an Award granted to a Participant pursuant to Article 8.
2.43 Restricted Stock Unit means an Award granted to a Participant pursuant to Article 8,
except no Shares are actually awarded to the Participant on the Grant Date.
2.44 Share means a common share of the Company, without par value per share.
2.45 Stock Appreciation Right or SAR means an Award, designated as an SAR, pursuant to the
terms of Article 7 herein.
2.46 Subsidiary means any corporation or other entity, whether domestic or foreign, in which
the Company has or obtains, directly or indirectly, a proprietary interest of more than fifty
percent (50%) by reason of stock ownership or otherwise.
2.47 Termination or Terminate means: (a) if a Participant is an Employee, cessation of the
employee-employer relationship between a Participant and the Company and all Affiliates and
Subsidiaries for any reason; (b) if a Participant is a Nonemployee Director, termination of the
Nonemployee Directors service on the Board for any reason; and (c) if a Participant is a Third
Party Service Provider, termination of the Third Party Service Providers service relationship with
the Company and all Affiliates and Subsidiaries for any reason. Notwithstanding the foregoing,
with respect to any Award subject to Code Section 409A, any such cessation or termination also must
constitute a separation from service as defined under Treasury Regulation Section 1.409A-1(h).
2.48 Third Party Service Provider means any consultant, agent, advisor, or independent
contractor who renders services to the Company, a Subsidiary, or an Affiliate that (a) are not in
connection with the offer or sale of the Companys securities in a capital raising transaction, and
(b) do not directly or indirectly promote or maintain a market for the Companys securities.
7
Article 3.
Administration
3.1 General. The Committee shall be responsible for administering this Plan, subject to this
Article 3 and the other provisions of this Plan. The Committee may employ attorneys, consultants,
accountants, agents, and other individuals, any of whom may be an Employee, and the Committee, the
Company, and its officers and Directors shall be entitled to rely upon the advice, opinions, or
valuations of any such individuals. All actions taken and all interpretations and determinations
made by the Committee shall be final and binding upon the Participants, the Company, and all other
interested individuals.
3.2 Authority of the Committee. The Committee shall have full and exclusive discretionary
power to interpret the terms and the intent of this Plan and any Award Agreement or other agreement
or document ancillary to or in connection with this Plan, to determine eligibility for Awards and
to adopt such rules, regulations, forms, instruments, and guidelines for administering this Plan as
the Committee may deem necessary or proper. Such authority shall include, but not be limited to,
selecting Award recipients, establishing all Award terms and conditions, including the terms and
conditions set forth in Award Agreements, granting Awards as an alternative to or as the form of
payment for grants or rights earned or due under compensation plans or arrangements of the Company,
construing any provision of the Plan or any Award Agreement, and, subject to Article 18, adopting
modifications and amendments to this Plan or any Award Agreement, including without limitation, any
that are necessary to comply with the laws of the countries and other jurisdictions in which the
Company, its Affiliates, and/or its Subsidiaries operate.
3.3 Delegation. The Committee may delegate to one or more of its members or to one or more
officers of the Company, and/or its Subsidiaries and Affiliates or to one or more agents or
advisors such administrative duties or powers as it may deem advisable, and the Committee or any
individuals to whom it has delegated duties or powers as aforesaid may employ one or more
individuals to render advice with respect to any responsibility the Committee or such individuals
may have under this Plan. The Committee may, by resolution, authorize one or more officers of the
Company to do one or both of the following on the same basis as can the Committee: (a) designate
Employees to be recipients of Awards; (b) determine the size of any such Awards; provided, however,
(i) the Committee shall not delegate such responsibilities to any such officer for Awards granted
to an Employee who is considered an Insider; (ii) the resolution providing such authorization sets
forth the total number of Awards such officer(s) may grant; and (iii) the officer(s) shall report
periodically to the Committee regarding the nature and scope of the Awards granted pursuant to the
authority delegated.
8
Article 4.
Shares Subject to this Plan and Maximum Awards
4.1 Number of Shares Available for Awards.
(a) Subject to adjustment as provided in Section 4.4 herein, the maximum number of
Shares available for grant to Participants under this Plan (the Share Authorization)
shall be:
(i) Four million nine hundred twenty-seven thousand three hundred
seventy-eight (4,927,378) newly authorized Shares, plus
(ii) (A) One million seventy-two thousand six hundred twenty-two (1,072,622)
Shares not granted or subject to outstanding awards under the Companys Prior Plans
as of September 30, 2005 (on a split-adjusted basis to reflect the 2-for-1 stock
split on November 9, 2005) and (B) any Shares subject to the six million six
hundred thirteen thousand nine hundred thirty-four (6,613,934) outstanding awards
as of September 30, 2005 (on a split-adjusted basis to reflect the 2-for-1 stock
split on November 9, 2005) under the Prior Plans that on or after September 30,
2005 cease for any reason to be subject to such awards (other than by reason of
exercise or settlement of the awards to the extent they are exercised for or
settled in vested and nonforfeitable Shares), up to an aggregate maximum of six
million six hundred thirteen thousand nine hundred thirty-four (6,613,934) Shares.
(b) No more than three million (3,000,000) Shares of the Share Authorization may be
granted as Full Value Awards.
(c) The maximum number of Shares of the Share Authorization that may be issued
pursuant to ISOs under this Plan shall be six million (6,000,000) Shares.
(d) The maximum number of Shares of the Share Authorization that may be granted to
Nonemployee Directors shall be one million (1,000,000) Shares.
4.2 Share Usage. Shares covered by an Award shall only be counted as used to the extent they
are actually issued; however, the full number of Stock Appreciation Rights granted that are to be
settled by the issuance of Shares shall be counted against the number of Shares available for award
under the Plan, regardless of the number of Shares actually issued upon settlement of such Stock
Appreciation Rights. Any Shares related to Awards which terminate by expiration, forfeiture,
cancellation, or otherwise without the issuance of such Shares, are settled in cash in lieu of
Shares, or are exchanged with the Committees permission, prior to the issuance of Shares, for
Awards not involving Shares, shall be available again for grant under this Plan. The Shares
available for issuance under this Plan may be authorized and unissued Shares or treasury Shares.
9
4.3 Annual Award Limits. Unless and until the Committee determines that an Award to a Covered
Employee shall not be designed to qualify as Performance-Based Compensation, the following limits
(each an Annual Award Limit and, collectively, Annual Award Limits) shall apply to grants of
such Awards under this Plan:
(a) Options: The maximum aggregate number of Shares subject to Options granted in any
one Plan Year to any one Participant shall be two hundred thousand (200,000), as adjusted
pursuant to Sections 4.4 and/or 18.2.
(b) SARs: The maximum aggregate number of Shares subject to Stock Appreciation Rights
granted in any one Plan Year to any one Participant shall be two hundred thousand
(200,000), as adjusted pursuant to Sections 4.4 and/or 18.2.
(c) Restricted Stock or Restricted Stock Units: The maximum aggregate Awards of
Restricted Stock or Restricted Stock Units in any one Plan Year to any one Participant
shall be one hundred thousand (100,000) Shares, as adjusted pursuant to Sections 4.4 and/or
18.2.
(d) Performance Units or Performance Shares: The maximum aggregate Awards of
Performance Units or Performance Shares that a Participant may receive in any one Plan Year
shall be one hundred thousand (100,000) Shares, as adjusted pursuant to Sections 4.4 and/or
18.2, or equal to the value of one hundred thousand (100,000) Shares, as adjusted pursuant
to Sections 4.4 and/or 18.2, determined as of the date of vesting or payout, as applicable.
(e) Cash-Based Awards: The maximum aggregate amount awarded or credited with respect
to Cash-Based Awards to any one Participant in any one Plan Year may not exceed the greater
of the value of three million dollars ($3,000,000) or one hundred thousand (100,000)
Shares, as adjusted pursuant to Sections 4.4 and/or 18.2, determined as of the date of
vesting or payout, as applicable.
(f) Other Stock-Based Awards. The maximum aggregate grants with respect to Other
Stock-Based Awards pursuant to Section 10.2 in any one Plan Year to any one Participant
shall be one hundred fifty thousand (150,000) Shares, as adjusted pursuant to Sections 4.4
and/or 18.2.
4.4 Adjustments in Authorized Shares. In the event of any corporate event or transaction
(including, but not limited to, a change in the Shares of the Company or the capitalization of the
Company) such as a merger, consolidation, reorganization, recapitalization, separation, partial or
complete liquidation, stock dividend, stock split, reverse stock split, split up, spin-off, or
other distribution of stock or property of the Company, combination of Shares, exchange of Shares,
dividend in kind, or other like change in capital structure, number of outstanding Shares or
distribution (other than normal cash dividends) to shareholders of the Company, or any similar
corporate event or transaction, the Committee, in its sole discretion, in order to prevent dilution
or enlargement of Participants rights under this Plan, shall substitute or adjust, as applicable,
the number and kind of Shares that may be issued under this Plan or under particular forms of
Awards, the number and kind
10
of Shares subject to outstanding Awards, the Option Price or Grant Price applicable to
outstanding Awards, the Annual Award Limits, and other value determinations applicable to
outstanding Awards.
The Committee, in its sole discretion, may also make appropriate adjustments in the terms of
any Awards under this Plan to reflect or related to such changes or distributions and to modify any
other terms of outstanding Awards, including modifications of performance goals and changes in the
length of Performance Periods. The determination of the Committee as to the foregoing adjustments,
if any, shall be conclusive and binding on Participants under this Plan.
Notwithstanding anything to the contrary in this Section 4.4, an adjustment to an Option or
SAR shall be made only to the extent such adjustment complies with the requirements of Code Section
409A.
Subject to the provisions of Article 18 and notwithstanding anything else herein to the
contrary, without affecting the number of Shares reserved or available hereunder, the Committee may
authorize the issuance or assumption of benefits under this Plan in connection with any merger,
consolidation, acquisition of property or stock, or reorganization upon such terms and conditions
as it may deem appropriate (including, but not limited to, a conversion of equity awards into
Awards under this Plan in a manner consistent with paragraph 53 of FASB Interpretation No. 44),
subject to compliance with the rules under Code Sections 409A, 422 and 424, as and where
applicable.
Article 5.
Eligibility and Participation
5.1 Eligibility. Individuals eligible to participate in this Plan include all Employees,
Directors, and Third Party Service Providers.
5.2 Actual Participation. Subject to the provisions of this Plan, the Committee may, from time
to time, select from all eligible individuals, those individuals to whom Awards shall be
11
granted and shall determine, in its sole discretion, the nature of, any and all terms
permissible by law, and the amount of, each Award.
Article 6.
Stock Options
6.1 Grant of Options. Subject to the terms and provisions of this Plan, Options may be granted
to Participants in such number, and upon such terms, and at any time and from time to time as shall
be determined by the Committee, in its sole discretion; provided that ISOs may be granted only to
eligible Employees of the Company or of any parent or subsidiary corporation (as permitted under
Code Sections 422 and 424).
6.2 Award Agreement. Each Option grant shall be evidenced by an Award Agreement that shall
specify the Option Price, the maximum duration of the Option, the number of Shares to which the
Option pertains, the conditions upon which the Option shall become vested and exercisable, and such
other provisions as the Committee shall determine which are not inconsistent with the terms of this
Plan. The Award Agreement also shall specify whether the Option is intended to be an ISO or a
NQSO.
6.3 Option Price. The Option Price for each grant of an Option under this Plan shall be
determined by the Committee in its sole discretion and shall be specified in the Award Agreement;
provided, however, the Option Price must be at least equal to one hundred percent (100%) of the FMV
of the Shares as determined on the Grant Date; provided, further, however, that the Option Price
must be at least equal to one hundred and ten percent (110%) of the FMV of a Share on the Grant
Date with respect to any ISO issued to a Participant who, on the Grant Date, owns (as defined in
Code §424(d)) stock possessing more than ten percent (10%) of the total combined voting power of
all classes of stock of the Company or of its subsidiary corporation (as defined in Code §424(f))
(a 10% Shareholder).
6.4 Term of Options. Each Option granted to a Participant shall expire at such time as the
Committee shall determine at the time of grant; provided, however, no Option shall be exercisable
later than the day before the tenth (10th) anniversary date of its grant; provided, further,
however, that no ISO granted to a 10% Shareholder shall be exercisable later than the day before
the fifth (5th) anniversary of its Grant Date. Notwithstanding the foregoing, for Nonqualified
Stock Options granted to Participants outside the United States, the Committee has the authority to
grant Nonqualified Stock Options that have a term greater than ten (10) years.
6.5 Exercise of Options. Options granted under this Article 6 shall be exercisable at such
times and be subject to such restrictions and conditions as the Committee shall in each instance
approve, which terms and restrictions need not be the same for each grant or for each Participant.
Notwithstanding anything in this Plan to the contrary, to the extent that
12
the aggregate FMV of the Shares (determined as of the Grant Date of the applicable ISO) with
respect to which ISOs are exercisable for the first time by a Participant during any calendar year
(under all plans of the Company and its subsidiary corporations (as defined in Code §424(f))
exceeds $100,000, such Options shall be treated as Nonqualified Stock Options.
6.6 Payment. Options granted under this Article 6 shall be exercised by the delivery of a
notice of exercise to the Company or an agent designated by the Company in a form specified or
accepted by the Committee, or by complying with any alternative procedures which may be authorized
by the Committee, setting forth the number of Shares with respect to which the Option is to be
exercised, accompanied by full payment for the Shares.
A condition of the issuance of the Shares as to which an Option shall be exercised shall be
the payment of the Option Price. The Option Price of any Option shall be payable to the Company in
full either: (a) in cash or its equivalent; (b) by tendering (either by actual delivery or
attestation) previously acquired Shares having an aggregate Fair Market Value at the time of
exercise equal to the Option Price (provided that except as otherwise determined by the Committee,
the Shares that are tendered must have been held by the Participant for at least six (6) months (or
such other period, if any, as the Committee may permit) prior to their tender to satisfy the Option
Price if acquired under this Plan or any other compensation plan maintained by the Company or have
been purchased on the open market); (c) by a cashless (broker-assisted) exercise; (d) by a
combination of (a), (b) and/or (c); or (e) any other method approved or accepted by the Committee
in its sole discretion.
Subject to any governing rules or regulations, as soon as practicable after receipt of written
notification of exercise and full payment (including satisfaction of any applicable tax
withholding), the Company shall deliver to the Participant evidence of book entry Shares, or upon
the Participants request, Share certificates in an appropriate amount based upon the number of
Shares purchased under the Option(s).
Unless otherwise determined by the Committee, all payments under all of the methods indicated
above shall be paid in United States dollars.
6.7 Restrictions on Share Transferability. The Committee may impose such restrictions on any
Shares acquired pursuant to the exercise of an Option granted under this Article 6 as it may deem
advisable, including, without limitation, minimum holding period requirements, restrictions under
applicable federal securities laws, under the requirements of any stock exchange or market upon
which such Shares are then listed and/or traded, or under any blue sky or state securities laws
applicable to such Shares.
6.8 Termination of Employment or Service. Each Participants Award Agreement shall set forth
the extent to which the Participant shall have the right to exercise the Option following the
Participants Termination. Such provisions shall be determined in the sole discretion of the
Committee, shall be included in the Award Agreement entered into with each Participant, need not be
uniform among all Options issued pursuant to this Article 6, and may reflect distinctions based on
the reasons for Termination.
13
6.9 Notification of Disqualifying Disposition. If any Participant shall make any disposition
of Shares issued pursuant to the exercise of an ISO under the circumstances described in Code
Section 421(b) (relating to certain disqualifying dispositions), such Participant shall notify the
Company of such disposition within ten (10) calendar days thereof.
Article 7.
Stock Appreciation Rights
7.1 Grant of SARs. Subject to the terms and conditions of this Plan, SARs may be granted to
Participants at any time and from time to time as shall be determined by the Committee.
Subject to the terms and conditions of this Plan, the Committee shall have complete discretion
in determining the number of SARs granted to each Participant and, consistent with the provisions
of this Plan, in determining the terms and conditions pertaining to such SARs.
The Grant Price for each grant of an SAR shall be determined by the Committee and shall be
specified in the Award Agreement; provided, however, the Grant Price on the Grant Date must be at
least equal to one hundred percent (100%) of the FMV of the Shares as determined on the Grant Date.
7.2 SAR Agreement. Each SAR Award shall be evidenced by an Award Agreement that shall specify
the Grant Price, the term of the SAR, and such other provisions as the Committee shall determine.
7.3 Term of SAR. The term of an SAR granted under this Plan shall be determined by the
Committee, in its sole discretion, and except as determined otherwise by the Committee and
specified in the SAR Award Agreement, no SAR shall be exercisable later than the tenth (10th)
anniversary date of its grant. Notwithstanding the foregoing, for SARs granted to Participants
outside the United States, the Committee has the authority to grant SARs that have a term greater
than ten (10) years.
7.4 Exercise of SARs. SARs may be exercised upon whatever terms and conditions the Committee,
in its sole discretion, imposes.
7.5 Settlement of SARs. Upon the exercise of an SAR, a Participant shall be entitled to
receive payment from the Company in an amount determined by multiplying:
(a) The excess of the Fair Market Value of a Share on the date of exercise over the
Grant Price; by
(b) The number of Shares with respect to which the SAR is exercised.
14
At the discretion of the Committee, the payment upon SAR exercise may be in cash, Shares, or
any combination thereof, or in any other manner approved by the Committee in its sole discretion.
The Committees determination regarding the form of SAR payout shall be set forth in the Award
Agreement pertaining to the grant of the SAR.
7.6 Termination of Employment or Service. Each Award Agreement shall set forth the extent to
which the Participant shall have the right to exercise the SAR following the Participants
Termination. Such provisions shall be determined in the sole discretion of the Committee, shall be
included in the Award Agreement entered into with Participants, need not be uniform among all SARs
issued pursuant to this Plan, and may reflect distinctions based on the reasons for Termination.
7.7 Other Restrictions. The Committee shall impose such other conditions and/or restrictions
on any Shares received upon exercise of an SAR granted pursuant to this Plan as it may deem
advisable or desirable. These restrictions may include, but shall not be limited to, a requirement
that the Participant hold the Shares received upon exercise of an SAR for a specified period of
time.
Article 8.
Restricted Stock and Restricted Stock Units
8.1 Grant of Restricted Stock or Restricted Stock Units. Subject to the terms and provisions
of this Plan or an Award Agreement, the Committee, at any time and from time to time, may grant
Shares of Restricted Stock and/or Restricted Stock Units to Participants in such amounts as the
Committee shall determine. Restricted Stock Units shall be similar to Restricted Stock except that
no Shares are actually awarded to the Participant on the Grant Date.
8.2 Restricted Stock or Restricted Stock Unit Agreement. Each Restricted Stock and/or
Restricted Stock Unit grant shall be evidenced by an Award Agreement that shall specify the
Period(s) of Restriction, the number of Shares of Restricted Stock or the number of Restricted
Stock Units granted, and such other provisions as the Committee shall determine.
8.3 Other Restrictions. The Committee shall impose such other conditions and/or restrictions
on any Shares of Restricted Stock or Restricted Stock Units granted pursuant to this Plan as it may
deem advisable including, without limitation, a requirement that Participants pay a stipulated
purchase price for each Share of Restricted Stock or each Restricted Stock Unit, restrictions based
upon the achievement of specific performance goals, time-based restrictions on vesting following
the attainment of the performance goals, time-based restrictions, and/or restrictions under
applicable laws or under the requirements of any stock exchange or market upon which such Shares
are listed or traded, or holding requirements or sale restrictions placed on the Shares by the
Company upon vesting of such Restricted Stock or Restricted Stock Units.
15
To the extent deemed appropriate by the Committee, the Company may retain the certificates
representing Shares of Restricted Stock in the Companys possession until such time as all
conditions and/or restrictions applicable to such Shares have been satisfied or lapse.
Except as otherwise provided in this Article 8, Shares of Restricted Stock covered by each
Restricted Stock Award shall become freely transferable by the Participant after all conditions and
restrictions applicable to such Shares have been satisfied or lapse (including satisfaction of any
applicable tax withholding obligations), and Restricted Stock Units shall be paid in cash, Shares,
or a combination of cash and Shares as the Committee, in its sole discretion shall determine.
8.4 Certificate Legend. In addition to any legends placed on certificates pursuant to Section
8.3, each certificate representing Shares of Restricted Stock granted pursuant to this Plan may
bear a legend such as the following or as otherwise determined by the Committee in its sole
discretion:
The sale or transfer of the common shares of The Scotts Miracle-Gro Company represented by
this certificate, whether voluntary, involuntary, or by operation of law, is subject to certain
restrictions on transfer as set forth in The Scotts Miracle-Gro Company Amended and Restated 2006
Long-Term Incentive Plan, and in the associated Award Agreement. A copy of this Plan and such Award
Agreement will be provided by The Scotts Miracle-Gro Company, without charge, within five (5) days
after receipt of a written request therefor.
8.5 Voting Rights. Unless otherwise determined by the Committee and set forth in a
Participants Award Agreement, to the extent permitted or required by law, as determined by the
Committee, Participants holding Shares of Restricted Stock granted hereunder may be granted the
right to exercise full voting rights with respect to those Shares during the Period of Restriction.
A Participant shall have no voting rights with respect to any Restricted Stock Units granted
hereunder.
8.6 Termination of Employment or Service. Each Award Agreement shall set forth the extent to
which the Participant shall have the right to retain Restricted Stock and/or Restricted Stock Units
following the Participants Termination. Such provisions shall be determined in the sole discretion
of the Committee, shall be included in the Award Agreement entered into with each Participant, need
not be uniform among all Shares of Restricted Stock or Restricted Stock Units issued pursuant to
this Plan, and may reflect distinctions based on the reasons for Termination.
8.7 Section 83(b) Election. The Committee may provide in an Award Agreement that the Award of
Restricted Stock is conditioned upon the Participant making or refraining from making an election
with respect to the Award under Code Section 83(b). If a Participant makes an election pursuant to
Code Section 83(b) concerning a Restricted Stock Award, the Participant shall be required to file
promptly a copy of such election with the Company.
16
Article 9.
Performance Units/Performance Shares
9.1 Grant of Performance Units/Performance Shares. Subject to the terms and provisions of this
Plan, the Committee, at any time and from time to time, may grant Performance Units and/or
Performance Shares to Participants in such amounts and upon such terms as the Committee shall
determine.
9.2 Value of Performance Units/Performance Shares. Each Performance Unit shall have an initial
value that is established by the Committee at the time of grant. Each Performance Share shall have
an initial value equal to the Fair Market Value of a Share on the Grant Date. The Committee shall
set performance goals in its discretion which, depending on the extent to which they are met, will
determine the value and/or number of Performance Units/Performance Shares that will be paid out to
the Participant.
9.3 Earning of Performance Units/Performance Shares. Subject to the terms of this Plan, after
the applicable Performance Period has ended, the holder of Performance Units/Performance Shares
shall be entitled to receive payout on the value and number of Performance Units/Performance Shares
earned by the Participant over the Performance Period, to be determined as a function of the extent
to which the corresponding performance goals have been achieved.
9.4 Form and Timing of Payment of Performance Units/Performance Shares. Payment of earned
Performance Units/Performance Shares shall be as determined by the Committee and as evidenced in
the Award Agreement. Subject to the terms of this Plan, the Committee, in its sole discretion, may
pay earned Performance Units/Performance Shares in the form of cash or in Shares (or in a
combination thereof) equal to the value of the earned Performance Units/Performance Shares at the
close of the applicable Performance Period, or as soon as practicable after the end of the
Performance Period. Any Shares may be granted subject to any restrictions deemed appropriate by the
Committee. The determination of the Committee with respect to the form of payout of such Awards
shall be set forth in the Award Agreement pertaining to the grant of the Award.
9.5 Termination of Employment or Service. Each Award Agreement shall set forth the extent to
which the Participant shall have the right to retain Performance Units and/or Performance Shares
following the Participants Termination. Such provisions shall be determined in the sole discretion
of the Committee, shall be included in the Award Agreement entered into with each Participant, need
not be uniform among all Awards of Performance Units or Performance Shares issued pursuant to this
Plan, and may reflect distinctions based on the reasons for Termination.
17
Article 10.
Cash-Based Awards and Other Stock-Based Awards
10.1 Grant of Cash-Based Awards. Subject to the terms and provisions of the Plan, the
Committee, at any time and from time to time, may grant Cash-Based Awards to Participants in such
amounts and upon such terms as the Committee may determine.
10.2 Other Stock-Based Awards. The Committee may grant other types of equity-based or
equity-related Awards not otherwise described by the terms of this Plan (including the grant or
offer for sale of unrestricted Shares) in such amounts and subject to such terms and conditions, as
the Committee shall determine. Such Awards may involve the transfer of actual Shares to
Participants, or payment in cash or otherwise of amounts based on the value of Shares and may
include, without limitation, Awards designed to comply with or take advantage of the applicable
local laws of jurisdictions other than the United States.
10.3 Value of Cash-Based and Other Stock-Based Awards. Each Cash-Based Award shall specify a
payment amount or payment range as determined by the Committee. Each Other Stock-Based Award shall
be expressed in terms of Shares or units based on Shares, as determined by the Committee. The
Committee may establish performance goals in its discretion. If the Committee exercises its
discretion to establish performance goals, the number and/or value of Cash-Based Awards or Other
Stock-Based Awards that will be paid out to the Participant will depend on the extent to which the
performance goals are met.
10.4 Payment of Cash-Based Awards and Other Stock-Based Awards. Payment, if any, with respect
to a Cash-Based Award or an Other Stock-Based Award shall be made in accordance with the terms of
the Award, in cash or Shares as the Committee determines and as specified in the Award Agreement.
10.5 Termination of Employment or Service. The Committee shall determine the extent to which
the Participant shall have the right to receive Cash-Based Awards or Other Stock-Based Awards
following the Participants Termination. Such provisions shall be determined in the sole discretion
of the Committee, shall be included in an agreement entered into with each Participant, need not be
uniform among all Awards of Cash-Based Awards or Other Stock-Based Awards issued pursuant to the
Plan, and may reflect distinctions based on the reasons for Termination.
Article 11.
Transferability of Awards
11.1 Transferability. Except as provided in Section 11.2 below, during a Participants
lifetime, his or her Awards shall be exercisable only by the Participant or the Participants legal
representative. Awards shall not be transferable other than by will or the laws of descent and
distribution; no Awards shall be subject, in whole or in part, to attachment, execution, or levy of
any kind; and any purported transfer in violation hereof shall be null and void. The Committee may
establish such procedures as it deems appropriate
18
for a Participant to designate a beneficiary to whom any amounts payable or Shares deliverable
in the event of, or following, the Participants death, may be provided.
11.2 Committee Action. The Committee may, in its discretion, determine that notwithstanding
Section 11.1, any or all Awards (other than ISOs) shall be transferable to and exercisable by such
transferees, and subject to such terms and conditions, as the Committee may deem appropriate;
provided, however, no Award may be transferred for value (as defined in the General Instructions to
Form S-8).
Article 12.
Performance Measures
12.1 Performance Measures. The performance goals upon which the payment or vesting of an Award
to a Covered Employee that is intended to qualify as Performance-Based Compensation shall be
limited to the following Performance Measures:
|
(a) |
|
Net earnings or net income (before or after taxes); |
|
|
(b) |
|
Earnings per share (basic or diluted); |
|
|
(c) |
|
Net sales or revenue growth; |
|
|
(d) |
|
Net operating profit; |
|
|
(e) |
|
Return measures (including, but not limited to, return on assets, capital,
invested capital, equity, sales, or revenue); |
|
|
(f) |
|
Cash flow (including, but not limited to, operating cash flow, free cash flow,
cash flow return on equity, and cash flow return on investment); |
|
|
(g) |
|
Earnings before or after taxes, interest, depreciation, and/or amortization; |
|
|
(h) |
|
Gross or operating margins; |
|
|
(i) |
|
Productivity ratios; |
|
|
(j) |
|
Share price (including, but not limited to, growth measures and total shareholder
return); |
|
|
(k) |
|
Expense targets; |
|
|
(l) |
|
Margins; |
|
|
(m) |
|
Operating efficiency; |
|
|
(n) |
|
Market share; |
19
|
(o) |
|
Customer satisfaction; |
|
|
(p) |
|
Working capital targets; |
|
|
(q) |
|
Economic value added or EVA(R) (net operating profit after tax minus the sum of
capital multiplied by the cost of capital); |
|
|
(r) |
|
Developing new products and lines of revenue; |
|
|
(s) |
|
Reducing operating expenses; |
|
|
(t) |
|
Developing new markets; |
|
|
(u) |
|
Meeting completion schedules; |
|
|
(v) |
|
Developing and managing relationships with regulatory and other governmental
agencies; |
|
|
(w) |
|
Managing cash; |
|
|
(x) |
|
Managing claims against the Company, including litigation;
and |
|
|
(y) |
|
Identifying and completing strategic acquisitions. |
Any Performance Measure(s) may be used to measure the performance of the Company, Subsidiary,
and/or Affiliate as a whole or any business unit of the Company, Subsidiary, and/or Affiliate or
any combination thereof, as the Committee may deem appropriate, or any of the above Performance
Measures as compared to the performance of a group of comparator companies, or published or special
index that the Committee, in its sole discretion, deems appropriate, or the Company may select
Performance Measure (j) above as compared to various stock market indices. The Committee also has
the authority to provide for accelerated vesting of any Award based on the achievement of
performance goals pursuant to the Performance Measures specified in this Article 12.
12.2 Evaluation of Performance. The Committee may provide in any such Award that any
evaluation of performance may include or exclude any of the following events that occurs during a
Performance Period: (a) asset write-downs, (b) litigation or claim judgments or settlements, (c)
the effect of changes in tax laws, accounting principles, or other laws or provisions affecting
reported results, (d) any reorganization and restructuring programs, (e) extraordinary nonrecurring
items as described in Accounting Principles Board Opinion No. 30 and/or in managements discussion
and analysis of financial condition and results of operations appearing in the Companys annual
report to shareholders for the applicable year, (f) acquisitions or divestitures, and (g) foreign
exchange gains and losses. To the extent such inclusions or exclusions affect Awards to Covered
Employees, they shall be prescribed in a form that meets the requirements of Code Section 162(m)
for deductibility.
12.3 Adjustment of Performance-Based Compensation. Awards that are intended to qualify as
Performance-Based Compensation may not be adjusted upward. The Committee
20
shall retain the discretion to adjust such Awards downward, either on a formula or
discretionary basis or any combination, as the Committee determines.
12.4 Committee Discretion. In the event that applicable tax and/or securities laws change to
permit Committee discretion to alter the governing Performance Measures without obtaining
shareholder approval of such changes, the Committee shall have sole discretion to make such changes
without obtaining shareholder approval. In addition, in the event that the Committee determines
that it is advisable to grant Awards that shall not qualify as Performance-Based Compensation, the
Committee may make such grants without satisfying the requirements of Code Section 162(m) and base
vesting on Performance Measures other than those set forth in Section 12.1.
Article 13.
Nonemployee Director Awards
The Board shall determine all Awards to Nonemployee Directors. The terms and conditions of any
grant to any such Nonemployee Director shall be set forth in an Award Agreement.
Article 14.
Dividend Equivalents
Any Participant selected by the Committee may be granted dividend equivalents based on the
dividends declared on Shares that are subject to any Award (other than Options or SARs), to be
credited as of dividend payment dates, during the period between the Grant Date and the date the
Award vests or expires, as determined by the Committee. Such dividend equivalents shall be
converted to cash or additional Shares by such formula and at such time and subject to such
limitations as may be determined by the Committee.
Article 15.
Beneficiary Designation
Each Participant under this Plan may, from time to time, name any beneficiary or beneficiaries
(who may be named contingently or successively) to whom any benefit under this Plan is to be paid
in case of his death before he receives any or all of such benefit. Each such designation shall
revoke all prior designations by the same Participant, shall be in a form prescribed by the
Committee, and will be effective only when filed by the Participant in writing with the Company
during the Participants lifetime. In the absence of any such beneficiary designation, benefits
remaining unpaid or rights remaining unexercised at the
21
Participants death shall be paid to or exercised by the Participants spouse, executor,
administrator, or legal representative.
Article 16.
Rights of Participants
16.1 Employment or Service. Nothing in this Plan or an Award Agreement shall interfere with or
limit in any way the right of the Company, its Affiliates, and/or its Subsidiaries, to Terminate
any Participant at any time or for any reason not prohibited by law, nor confer upon any
Participant any right to continue his employment or service as a Director or Third Party Service
Provider for any specified period of time.
Neither an Award nor any benefits arising under this Plan shall constitute an employment
contract with the Company, its Affiliates, and/or its Subsidiaries and, accordingly, subject to
Articles 3 and 18, this Plan and the benefits hereunder may be terminated at any time in the sole
and exclusive discretion of the Committee without giving rise to any liability on the part of the
Company, its Affiliates, and/or its Subsidiaries.
16.2 Participation. No individual shall have the right to be selected to receive an Award
under this Plan, or, having been so selected, to be selected to receive a future Award.
16.3 Rights as a Shareholder. Except as otherwise provided herein, a Participant shall have
none of the rights of a shareholder with respect to Shares covered by any Award until the
Participant becomes the record holder of such Shares.
Article 17.
Change of Control
17.1 Accelerated Vesting and Settlement. Subject to Section 17.2, on the date of any Change in
Control:
(a) Each Option and SAR (other than Options and SARs of Nonemployee Directors)
outstanding on the date of a Change in Control (whether or not exercisable) will be
cancelled in exchange (i) for cash equal to the excess of the Change in Control Price over
the Option Price or Grant Price, as applicable, associated with the cancelled Option or SAR
or, (ii) at the Committees discretion, for whole Shares with a Fair Market Value equal to
the excess of the Change in Control Price over the Option Price or Grant Price, as
applicable, associated with the cancelled Option or SAR and the Fair Market Value of any
fractional Share will be distributed in cash. However, the Committee, in its sole
discretion, may offer the holders of the Options or SARs to be cancelled a reasonable
opportunity (not longer than 15 days beginning on the date of the Change in Control) to
exercise all their outstanding Options and SARs (whether or not otherwise then
exercisable);
22
(b) All performance goals associated with Awards for which performance goals have been
established will be deemed to have been met on the date of the Change in Control, all
Performance Periods accelerated to the date of the Change in Control and all outstanding
Awards for which performance goals have been established (including those subject to the
acceleration described in this subsection) will be distributed in a single lump sum cash
payment within thirty (30) days following such Change in Control; and
(c) All other then-outstanding Awards whose exercisability or vesting depends merely
on the satisfaction of a service obligation by a Participant to the Company, Subsidiary, or
Affiliate (Service Award) shall vest in full and be free of restrictions related to the
vesting of such Awards. All Service Awards whose vesting is so accelerated will be
distributed, if not already held by a Participant and to the extent applicable, (i) in a
single lump-sum cash payment within thirty (30) days following such Change in Control based
on the Change in Control Price or, (ii) at the Committees discretion, in the form of whole
Shares based on the Change in Control Price.
17.2 Alternative Awards. Section 17.1 will not apply to the extent that the Committee
reasonably concludes in good faith before the Change in Control occurs that Awards will be honored
or assumed or new rights substituted for the Award (collectively, Alternative Awards) by the
Employees employer or Third Party Service Providers employer (or the parent or a subsidiary of
such employers) immediately after the Change in Control, provided that any Alternative Award must:
(a) Be based on stock that is (or, within 60 days of the Change in Control, will be)
traded on an established securities market;
(b) Provide the Employee with the rights and entitlements substantially equivalent to
or better than the rights, terms and conditions of each Award for which it is substituted,
including an identical or better exercise or vesting schedule and identical or, in the case
of an Award that is not subject to Section 409A of the Code, better timing and methods of
payment;
(c) Have substantially equivalent economic value to the Award (determined at the time
of the Change in Control) for which it is substituted; and
(d) Provide that, if the Employee is involuntarily Terminated without Cause or the
Employee constructively Terminates, any conditions on the Employees rights under, or any
restrictions on transfer or exercisability applicable to, each Alternative Award will be
waived or lapse.
For purposes of this section, a constructive Termination means a Termination by an Employee
following a material reduction in the Employees compensation or job responsibilities (when
compared to the Employees compensation and job responsibilities on the date of the Change in
Control) or the relocation of the Employees principal place of employment to a location at least
fifty (50) miles from his or her principal place of
23
employment on the date of the Change in Control (or other location to which the Employee has
been reassigned with his or her written consent), in each case without the Employees written
consent.
Notwithstanding anything herein to the contrary, no Alternative Award shall be made with
respect to an Option or SAR if it would cause the Option or SAR to fail to comply with the
requirements of Code Section 409A.
17.3 Nonemployee Directors Awards. Upon a Change in Control, each outstanding:
(a) Option or SAR held by a Nonemployee Director will be cancelled unless (i) the
Shares continues to be traded on an established securities market after the Change in
Control or (ii) the Nonemployee Director continues to be a Board member after the Change in
Control. In the situations just described, the Options or SARs held by a Nonemployee
Director will be unaffected by a Change in Control. Any Options and SARs held by a
Nonemployee Director to be cancelled under the next preceding sentence will be exchanged
(iii) for cash equal to the excess of the Change in Control Price over the Option Price or
Grant Price, as applicable, associated with the cancelled Option or SAR held by a
Nonemployee Director or, (iv) at the Boards discretion, for whole Shares with a Fair
Market Value equal to the excess of the Change in Control Price over the Option Price or
Grant Price, as applicable, associated with the cancelled Option or SAR held by a
Nonemployee Director and the Fair Market Value of any fractional Share will be distributed
in cash. However, the Board, in its sole discretion, may offer Nonemployee Directors
holding Options or SARs to be cancelled a reasonable opportunity (not longer than 15 days
beginning on the date of the Change in Control) to exercise all their outstanding Options
and SARs (whether or not otherwise then exercisable).
(b) Restricted Stock or Restricted Stock Unit held by a Nonemployee Director will be
settled within thirty (30) days following such Change in Control for a lump sum cash
payment equal to the Change in Control Price.
(c) All other types of Awards held by a Nonemployee Director will be settled within
thirty (30) days following such Change in Control for a lump sum cash payment equal to the
Change in Control Price less any amount the Nonemployee
24
Director would be required to pay in order for the Award to be exercised or settled,
other than any such amount related to taxes.
Article 18.
Amendment, Modification, Suspension, and Termination
18.1 Amendment, Modification, Suspension, and Termination. Subject to Section 18.3, the
Committee may, at any time and from time to time, alter, amend, modify, suspend, or terminate this
Plan and any Award Agreement in whole or in part; provided, however, that, without the prior
approval of the Companys shareholders and except as provided in Section 4.4, Options or SARs
issued under this Plan will not be repriced, replaced, or regranted through cancellation, or by
lowering the Option Price of a previously granted Option or the Grant Price of a previously granted
SAR, and no material amendment of this Plan shall be made without shareholder approval if
shareholder approval is required by law, regulation, or stock exchange rule.
18.2 Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events. The
Committee may make adjustments in the terms and conditions of, and the criteria included in, Awards
in recognition of unusual or nonrecurring events (including, without limitation, the events
described in Section 4.4 hereof) affecting the Company or the financial statements of the Company
or of changes in applicable laws, regulations, or accounting principles, whenever the Committee
determines that such adjustments are appropriate in order to prevent unintended dilution or
enlargement of the benefits or potential benefits intended to be made available under this Plan.
The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and
binding on Participants under this Plan. Notwithstanding anything to the contrary in this Section
18.2, an adjustment to an Option or SAR shall be made only to the extent such adjustment complies
with the requirements of Code Section 409A.
18.3 Awards Previously Granted. Notwithstanding any other provision of this Plan to the
contrary (other than Section 18.4), no termination, amendment, suspension, or modification of this
Plan or an Award Agreement shall adversely affect in any material way any Award previously granted
under this Plan, without the written consent of the Participant holding such Award.
18.4 Amendment to Conform to Law. Notwithstanding any other provision of this Plan to the
contrary, the Board may amend the Plan or an Award Agreement, to take effect retroactively or
otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or an Award
Agreement to any present or future law relating to plans of this or similar nature (including, but
not limited to, Code Section 409A), and to the administrative regulations and rulings promulgated
thereunder. By accepting an Award under this Plan, each Participant agrees to any amendment made
pursuant to this Section 18.4 to any Award granted under the Plan without further consideration or
action.
25
Article 19.
Withholding
19.1 Tax Withholding. The Company shall have the power and the right to deduct or withhold at
the time amounts under the Plan are distributed, or require a Participant to remit to the Company,
the minimum statutory amount to satisfy federal, state, and local taxes, domestic or foreign,
required by law or regulation to be withheld with respect to any taxable event arising as a result
of this Plan.
19.2 Share Withholding. With respect to withholding required upon the exercise of Options or
SARs, upon the lapse of restrictions on Restricted Stock and Restricted Stock Units, or upon the
achievement of performance goals related to Performance Shares, or any other taxable event arising
as a result of an Award granted hereunder, a Participant may elect, subject to the approval of the
Committee, to satisfy the withholding requirement, in whole or in part, by having the Company
withhold Shares having a Fair Market Value on the date the tax is to be determined equal to the
minimum statutory total tax that could be imposed on the transaction; provided that such Shares
would otherwise be distributable to the Participant at the time of the withholding. All such
elections shall be irrevocable, made in writing, and signed by the Participant, and shall be
subject to any restrictions or limitations that the Committee, in its sole discretion, deems
appropriate.
Article 20.
Successors
All obligations of the Company under this Plan with respect to Awards granted hereunder shall
be binding on any successor to the Company, whether the existence of such successor is the result
of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all
of the business and/or assets of the Company.
Article 21.
General Provisions
21.1 Forfeiture Events.
(a) The Committee may specify in an Award Agreement that the Participants rights,
payments, and benefits with respect to an Award shall be subject to reduction,
cancellation, forfeiture, or recoupment upon the occurrence of certain specified events, in
addition to any otherwise applicable vesting or performance conditions of an Award. Such
events may include, but shall not be limited to, termination of employment for Cause,
termination of the Participants provision of services to the Company, Affiliate, and/or
Subsidiary, violation of material Company, Affiliate, and/or Subsidiary policies, breach of
noncompetition, confidentiality, or other restrictive covenants that may apply to the
Participant, or other conduct by the
26
Participant that is detrimental to the business or reputation of the Company, its
Affiliates, and/or its Subsidiaries.
(b) If the Company is required to prepare an accounting restatement due to the
material noncompliance of the Company, as a result of misconduct, with any financial
reporting requirement under the securities laws, if the Participant knowingly or grossly
negligently engaged in the misconduct, or knowingly or grossly negligently failed to
prevent the misconduct, or if the Participant is one of the individuals subject to
automatic forfeiture under Section 304 of the Sarbanes-Oxley Act of 2002, the Participant
shall reimburse the Company the amount of any payment in settlement of an Award earned or
accrued during the twelve- (12-) month period following the first public issuance or filing
with the United States Securities and Exchange Commission (whichever first occurs) of the
financial document embodying such financial reporting requirement.
21.2 Legend. The certificates for Shares may include any legend which the Committee deems
appropriate to reflect any restrictions on transfer of such Shares.
21.3 Gender and Number. Except where otherwise indicated by the context, any masculine term
used herein also shall include the feminine, the plural shall include the singular, and the
singular shall include the plural.
21.4 Severability. In the event any provision of this Plan shall be held illegal or invalid
for any reason, the illegality or invalidity shall not affect the remaining parts of this Plan, and
this Plan shall be construed and enforced as if the illegal or invalid provision had not been
included.
21.5 Requirements of Law. The granting of Awards and the issuance of Shares under this Plan
shall be subject to all applicable laws, rules, and regulations, and to such approvals by any
governmental agencies or stock exchange as may be required.
21.6 Delivery of Title. The Company shall have no obligation to issue or deliver evidence of
title for Shares issued under this Plan prior to:
(a) Obtaining any approvals from governmental agencies that the Company determines are
necessary; and
(b) Completion of any registration or other qualification of the Shares under any
applicable national or foreign law or ruling of any governmental body that the Company
determines to be necessary.
21.7 Inability to Obtain Authority. The inability of the Company to obtain authority from any
regulatory body having jurisdiction, which authority is deemed by the Companys counsel to be
necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any
liability in respect of the failure to issue or sell such Shares as to which such requisite
authority shall not have been obtained.
27
21.8 Investment Representations. The Committee may require any individual receiving Shares
pursuant to an Award under this Plan to represent and warrant in writing that the individual is
acquiring the Shares for investment and without any present intention to sell or distribute such
Shares.
21.9 Employees Based Outside of the United States. Notwithstanding any provision of this Plan
to the contrary, in order to comply with the laws in other countries in which the Company, its
Affiliates, and/or its Subsidiaries operate or have Employees, Directors, or Third Party Service
Providers, the Committee, in its sole discretion, shall have the power and authority to:
(a) Determine which Affiliates and Subsidiaries shall be covered by this Plan;
(b) Determine which Employees, Directors, and/or Third Party Service Providers outside
the United States are eligible to participate in this Plan;
(c) Modify the terms and conditions of any Award granted to Employees and/or Third
Party Service Providers outside the United States to comply with applicable foreign laws;
(d) Establish subplans and modify exercise procedures and other terms and procedures,
to the extent such actions may be necessary or advisable. Any subplans and modifications to
Plan terms and procedures established under this Section 21.9 by the Committee shall be
attached to this Plan document as appendices; and
(e) Take any action, before or after an Award is made, that it deems advisable to
obtain approval or comply with any necessary local government regulatory exemptions or
approvals.
Notwithstanding the above, the Committee may not take any actions hereunder, and no Awards
shall be granted, that would violate applicable law.
21.10 Uncertificated Shares. To the extent that this Plan provides for issuance of
certificates to reflect the transfer of Shares, the transfer of such Shares may be effected on a
noncertificated basis, to the extent not prohibited by applicable law or the rules of any stock
exchange.
21.11 Unfunded Plan. Participants shall have no right, title, or interest whatsoever in or to
any investments that the Company, and/or its Subsidiaries, and/or its Affiliates may make to aid it
in meeting its obligations under this Plan. Nothing contained in this Plan, and no action taken
pursuant to its provisions, shall create or be construed to create a trust of any kind, or a
fiduciary relationship between the Company and any Participant, beneficiary, legal representative,
or any other individual. To the extent that any individual acquires a right to receive payments
from the Company, its Subsidiaries, and/or its Affiliates under this Plan, such right shall be no
greater than the right of an unsecured general creditor of the Company,
28
a Subsidiary, or an Affiliate, as the case may be. All payments to be made hereunder shall be
paid from the general funds of the Company, a Subsidiary, or an Affiliate, as the case may be and
no special or separate fund shall be established and no segregation of assets shall be made to
assure payment of such amounts except as expressly set forth in this Plan.
21.12 No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to this
Plan or any Award. The Committee shall determine whether cash, Awards, or other property shall be
issued or paid in lieu of fractional Shares or whether such fractional Shares or any rights thereto
shall be forfeited or otherwise eliminated.
21.13 Retirement and Welfare Plans. Neither Awards made under this Plan nor Shares or cash
paid pursuant to such Awards may be included as compensation for purposes of computing the
benefits payable to any Participant under the Companys or any Subsidiarys or Affiliates
retirement plans (both qualified and non-qualified) or welfare benefit plans unless such other plan
expressly provides that such compensation shall be taken into account in computing a Participants
benefit.
21.14 Deferred Compensation. If any Award would be considered deferred compensation as
defined under Code Section 409A and if this Plan fails to meet the requirements of Code Section
409A with respect to such Award, then such Award shall be null and void. However, other than with
respect to Options and SARs, the Committee (or, with respect to Nonemployee Directors, the Board)
may permit deferrals of compensation pursuant to the terms of a Participants Award Agreement, a
separate plan or a subplan which meets the requirements of Code Section 409A and any related
guidance. Additionally, to the extent any Award is subject to Code Section 409A, notwithstanding
any provision herein to the contrary, the Plan does not permit the acceleration or delay of the
time or schedule of any distribution related to such Award, except as permitted by Code Section
409A, the Treasury Regulations thereunder, and/or the Secretary of the United States Treasury.
21.15 Nonexclusivity of this Plan. The adoption of this Plan shall not be construed as
creating any limitations on the power of the Board or Committee to adopt such other compensation
arrangements as it may deem desirable for any Participant.
21.16 No Constraint on Corporate Action. Nothing in this Plan shall be construed to: (i)
limit, impair, or otherwise affect the Companys or a Subsidiarys or an Affiliates right or power
to make adjustments, reclassifications, reorganizations, or changes of its capital or business
structure, or to merge or consolidate, or dissolve, liquidate, sell, or transfer all or any part of
its business or assets; or, (ii) limit the right or power of the Company or a Subsidiary or an
Affiliate to take any action which such entity deems to be necessary or appropriate.
21.17 Governing Law. The Plan and each Award Agreement shall be governed by the laws of the
State of Ohio, excluding any conflicts or choice of law rule or principle that might otherwise
refer construction or interpretation of this Plan to the substantive law of another jurisdiction.
Unless otherwise provided in the Award Agreement, recipients of an Award under this Plan are deemed
to submit to the exclusive jurisdiction and venue of the
29
federal or state courts of Ohio, to resolve any and all issues that may arise out of or relate
to this Plan or any related Award Agreement.
21.18 Indemnification. Subject to requirements of Ohio law, each individual who is or shall
have been a member of the Board, or a Committee appointed by the Board, or an officer of the
Company to whom authority was delegated in accordance with Article 3, shall be indemnified and held
harmless by the Company against and from any loss, cost, liability, or expense that may be imposed
upon or reasonably incurred by him or her in connection with or resulting from any claim, action,
suit, or proceeding to which he or she may be a party or in which he or she may be involved by
reason of any action taken or failure to act under this Plan and against and from any and all
amounts paid by him or her in settlement thereof, with the Companys approval, or paid by him or
her in satisfaction of any judgment in any such action, suit, or proceeding against him or her,
provided he or she shall give the Company an opportunity, at its own expense, to handle and defend
the same before he or she undertakes to handle and defend it on his/her own behalf, unless such
loss, cost, liability, or expense is a result of his/her own willful misconduct or except as
expressly provided by statute.
The foregoing right of indemnification shall not be exclusive of any other rights of
indemnification to which such individuals may be entitled under the Companys Articles of
Incorporation or Code of Regulations, as a matter of law, or otherwise, or any power that the
Company may have to indemnify them or hold them harmless.
21.19 Controlling Language. Unless otherwise specified herein, in the event of a conflict
between the terms of the Plan and the terms of an Award Agreement, the terms of the Plan shall
control.
30
EX-10(T)(2)
Exhibit
10(t)(2)
[Grantee]
[Address]
[Address]
Dear [Grantee]:
This letter agreement amends the Restricted Stock award granted to you on [Grant Date]
pursuant to the terms of The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan, as amended
from time to time (the Plan), and the Award Agreement for Employees (the Award Agreement). This
amendment shall be effective as of October 30, 2007 (the Amendment Effective Date). Unless
otherwise defined in this letter agreement, capitalized terms used herein shall have the meanings
provided to them in the Award Agreement.
The Compensation and Organization Committee (the Committee) has determined that your Award
Agreement shall be amended to provide for a reasonable rate of interest to be calculated with
respect to certain cash dividends held in escrow during the Period of Restriction (as defined in
the Plan) relating to your shares of Restricted Stock. Accordingly, the following paragraph is
hereby added to the Award Agreement:
A reasonable rate of interest, as determined by the Committee in its sole discretion, will
be credited to you and held in escrow during the Period of Restriction (as defined in the
Plan) with respect to any cash dividends that were or are declared and paid in respect of
your shares of Restricted Stock during the period that began on December 20, 2006 and that
ends on [Vesting Date]. At the end of the Period of Restriction, such interest will be
distributed to you if all restrictions and conditions relating to your shares of Restricted
Stock are met or will be forfeited if those restrictions and conditions have not been met.
|
|
|
|
|
|
|
|
|
THE SCOTTS MIRACLE-GRO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
|
|
|
Acknowledged and agreed,
effective as of the Amendment
Effective Date:
EX-10.T.3
Exhibit
10(t)(3)
THE SCOTTS MIRACLE-GRO COMPANY
2006 LONG-TERM INCENTIVE PLAN
NONQUALIFIED STOCK OPTION AWARD AGREEMENT FOR EMPLOYEES
NONQUALIFIED STOCK OPTION GRANTED
TO [Grantees Name] ON [Grant Date]
The Scotts Miracle-Gro Company (Company) believes that its business interests are best served by
ensuring that you have an opportunity to share in the Companys business success. To this end, the
Company adopted The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (Plan) through which
key employees, like you, may acquire (or share in the appreciation of) common shares, without par
value, of the Company (Shares). Capitalized terms that are not defined in this Award Agreement
have the same meanings as in the Plan.
This Award Agreement describes the type of Award that you have been granted and the terms and
conditions of your Award. To ensure you fully understand these terms and conditions, you should:
|
|
|
- |
|
Read the Plan and this Award Agreement carefully; and
|
|
- |
|
Contact [Title] at [Telephone Number] if you have any questions about your Award. Or, you may
send a written inquiry to the address shown below: |
The Scotts Miracle-Gro Company
Attention: [Title]
14111 Scottslawn Road
Marysville, Ohio 43041
Also, no later than [Date 30 Days After Grant Date], you must return a signed copy of this Award
Agreement to:
[Third Party Administrator]
Attention: [TPA Contacts Name]
[TPA Contacts Address]
[TPA Telephone Number]
The Company intends that this Award not be considered to provide for deferred compensation under
Section 409A of the Code and that this Award Agreement be so administered and construed. You agree
that the Company may modify this Award Agreement, without any further consideration, to fulfill
this intent, even if those modifications change the terms of your Award and reduce its value or
potential value.
1. DESCRIPTION OF YOUR NONQUALIFIED STOCK OPTION
You have been granted a Nonqualified Stock Option (NSO) to purchase [Number of Common Shares]
Shares at an exercise price of $[Exercise Price] for each Share (Exercise Price) on or before
[Expiration Date No Later Than 10 Years After Grant Date] (Expiration Date), subject to the terms
and conditions of the Plan and this Award Agreement. The Grant Date of the NSO is [Grant Date].
2. LIMITS ON EXERCISING YOUR NSO
(a) Normally, your NSO will vest (and become exercisable) on [Vesting Date] (the Vesting
Date) but only if you are actively employed by the Company or any Subsidiary or Affiliate on the
Vesting Date and all other conditions described in this Award Agreement and the Plan are met. This
does not mean that you must exercise your NSO on this date; this is merely the first date that you
may do so. However, except as described below, your NSO will expire to the extent it is not
exercised on or before the Expiration Date.
There are some special situations in which your NSO may vest earlier. These are described in
Sections 4(a) and 4(c) of this Award Agreement.
(b) At any one time, you may not exercise your NSO to buy fewer than 100 Shares (or, if less,
the number of Shares underlying the vested portion of your NSO). Also, you may never exercise your
NSO to purchase a fractional Share. Any fractional Share shall be redeemed for cash equal to the
Fair Market Value of such fractional Share.
3. EXERCISING YOUR NSO
(a) After your NSO vests, you may exercise the NSO by completing an Exercise Notice. A copy of
this Exercise Notice is attached to this Award Agreement. Also, a copy of this Exercise Notice and
a description of the procedures that you must follow to exercise your NSO are available from [Third
Party Administrator] at [TPA Telephone Number] or at the address given above.
(b) You may use one of three methods to exercise your NSO and to pay any taxes related to that
exercise. You will decide on the method at the time of exercise.
CASHLESS EXERCISE AND SELL: If you elect this alternative, you will be deemed to
have simultaneously exercised the NSO and to have sold the Shares underlying the
portion of the NSO you exercised. When the transaction is complete, you will receive
cash (but no Shares) equal to the difference between the aggregate Fair Market Value
of the Shares deemed to have been acquired through the exercise minus the aggregate
Exercise Price and related taxes.
2
COMBINATION EXERCISE: If you elect this alternative, you will be deemed to have
simultaneously exercised the NSO and to have sold a number of those Shares with a
Fair Market Value equal to the aggregate Exercise Price and related taxes. When the
transaction is complete, the balance of the Shares subject to the portion of the NSO
you exercised will be transferred to you.
EXERCISE AND HOLD: If you elect this alternative, you must pay the full Exercise
Price plus related taxes (in cash, a cash equivalent or in Shares having a Fair
Market Value equal to the Exercise Price and which you have owned for at least six
months before the exercise date). When the transaction is complete, you will receive
the number of Shares purchased.
If you do not elect one of these methods, we will apply the Cashless Exercise and Sell method
described above.
4. GENERAL TERMS AND CONDITIONS
(a) YOU MAY FORFEIT YOUR NSO IF YOU TERMINATE. Normally, you may exercise your NSO after it
vests and before the Expiration Date. However, your NSO may be cancelled earlier than the
Expiration Date if you Terminate. For purposes of this Award Agreement, Terminate (or any form
thereof) means cessation of the employee-employer relationship between you and the Company and all
Affiliates and Subsidiaries for any reason.
(i) If you are Terminated for Cause, the portion of your NSO that has not been
exercised will be forfeited (whether or not then vested) on the date you Terminate; or
(ii) If you die or you Terminate due to your Disability (as defined below), your NSO
will become fully vested and expire on the earlier of the Expiration Date or 12 months after
you Terminate. For purposes of this Award Agreement, Disability means your inability to
perform your normal duties for a period of at least six months due to a physical or mental
infirmity; or
(iii) If you Terminate after reaching either (A) age 55 and completing at least 10
years of employment with the Company, its Affiliates and/or its Subsidiaries or (B) age 62
regardless of your years of service, your NSO will become fully vested and expire on the
earlier of the Expiration Date or 12 months after you Terminate; or
(iv) If you Terminate for any other reason, the unvested portion of your NSO will be
forfeited immediately and the vested portion of your NSO will expire on the earlier of the
Expiration Date or 90 days after you Terminate.
Note, it is your responsibility to keep track of when your NSO expires.
3
(b) YOU MAY FORFEIT YOUR NSO IF YOU ENGAGE IN CONDUCT THAT IS HARMFUL TO THE COMPANY (OR ANY
AFFILIATE OR SUBSIDIARY). You will forfeit your NSO and must return to the Company all Shares and
other amounts you have received through the Plan if, without the Companys written consent, you do
any of the following within 180 days before and 730 days after you Terminate:
(i) You serve (or agree to serve) as an officer, director, manager, consultant or
employee of any proprietorship, partnership, corporation or other entity or become the owner
of a business or a member of a partnership, limited liability company or other entity that
competes with any portion of the Companys (or any Affiliates or Subsidiarys) business
with which you have been involved any time within five years before your Termination or
render any service (including, without limitation, advertising or business consulting) to
entities that compete with any portion of the Companys (or any Affiliates or Subsidiarys)
business with which you have been involved any time within five years before your
Termination;
(ii) You refuse or fail to consult with, supply information to or otherwise cooperate
with the Company or any Affiliate or Subsidiary after having been requested to do so;
(iii) You deliberately engage in any action that the Company concludes has caused
substantial harm to the interests of the Company or any Affiliate or Subsidiary;
(iv) On your own behalf or on behalf of any other person, partnership, association,
corporation, limited liability company or other entity, you solicit or in any manner attempt
to influence or induce any employee of the Company or any Affiliate or Subsidiary to leave
the Companys or any Affiliates or Subsidiarys employment or use or disclose to any
person, partnership, association, corporation, limited liability company or other entity any
information obtained while an employee of the Company or any Affiliate or Subsidiary
concerning the names and addresses of the Companys or any Affiliates or Subsidiarys
employees;
(v) You disclose confidential and proprietary information relating to the Companys or
any Affiliates or Subsidiarys business affairs (Trade Secrets), including technical
information, product information and formulae, processes, business and marketing plans,
strategies, customer information and other information concerning the Companys or any
Affiliates or Subsidiarys products, promotions, development, financing, expansion plans,
business policies and practices, salaries and benefits and other forms of information
considered by the Company or any Affiliate or Subsidiary to be proprietary and confidential
and in the nature of Trade Secrets;
(vi) You fail to return all property (other than personal property), including keys,
notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes,
disks, cards, surveys, maps, logs, machines, technical data, formulae or any other tangible
property or document and any and all copies, duplicates or reproductions that you have
produced or received or have otherwise been submitted to you in the course of your
employment with the Company or any Affiliate or Subsidiary; or
4
(vii) You engaged in conduct that the Committee reasonably concludes would have given
rise to a Termination for Cause had it been discovered before you Terminated.
(c) CHANGE IN CONTROL. Normally, your NSO will vest only in the circumstances described in
Section 2(a). However, if there is a Change in Control, your NSO may vest earlier. You should read
the Plan carefully to ensure that you understand how this may happen.
(d) AMENDMENT AND TERMINATION. Subject to the terms of the Plan, we may amend or terminate
this Award Agreement or the Plan at any time.
(e) RIGHTS BEFORE YOUR NSO IS EXERCISED. You may not vote, or receive any dividends associated
with, the Shares underlying your NSO before your NSO is exercised with respect to such Shares.
(f) BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive or to
exercise the vested portion of your NSO that is unexercised when you die. This may be done only on
the attached Beneficiary Designation Form and by following the rules described in that Form. The
Beneficiary Designation Form need not be completed now and is not required as a condition of
receiving your Award. If you die without completing a Beneficiary Designation Form or if you do not
complete that Form correctly, your beneficiary will be your surviving spouse or, if you do not have
a surviving spouse, your estate.
(g) TRANSFERRING YOUR NSO. Normally your NSO may not be transferred to another person.
However, you may complete a Beneficiary Designation Form to name the person who may exercise your
NSO if you die before the Expiration Date. Also, the Committee may allow you to place your NSO into
a trust established for your benefit or for the benefit of your family. Contact [Third Party
Administrator] at [TPA Telephone Number] or at the address given above if you are interested in
doing this.
(h) GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio,
excluding any conflicts or choice of law rule or principle that might otherwise refer construction
or interpretation of the Plan to the substantive law of another jurisdiction.
(i) OTHER AGREEMENTS. Your NSO will be subject to the terms of any other written agreements
between you and the Company or any Affiliate or Subsidiary to the extent that those other
agreements do not directly conflict with the terms of the Plan or this Award Agreement.
(j) ADJUSTMENTS TO YOUR NSO. Subject to the terms of the Plan, your NSO will be adjusted, if
appropriate, to reflect any change to the Companys capital structure (e.g., the number of Shares
underlying your NSO and the Exercise Price will be adjusted to reflect a stock split).
5
(k) OTHER TERMS AND CONDITIONS. Your NSO is subject to more rules described in the Plan. You
should read the Plan carefully to ensure you fully understand all the terms and conditions of the
grant of the NSO made to you under this Award Agreement.
5. YOUR ACKNOWLEDGMENT OF AWARD CONDITIONS
By signing below, you acknowledge and agree that:
|
(a) |
|
A copy of the Plan has been made available to you; |
|
|
(b) |
|
You understand and accept the terms and conditions of your NSO; |
(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees
and without any further consideration) to any necessary change to your NSO or this Award Agreement
to comply with any law and to avoid paying penalties under Section 409A of the Code, even if those
changes affect the terms of your NSO and reduce its value or potential value; and
(d) You must return a signed copy of this Award Agreement to the address given above before
[Date 30 Days After Grant Date].
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[Grantees Name] |
|
|
|
|
|
THE SCOTTS MIRACLE-GRO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BY:
|
|
|
|
|
|
|
|
BY: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date signed: |
|
|
|
|
|
|
|
[Name of Company representative] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[Title of Company representative] |
|
|
|
|
|
|
|
|
|
|
|
|
Date signed: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6
THE SCOTTS MIRACLE-GRO COMPANY
2006 LONG-TERM INCENTIVE PLAN
NONQUALIFIED STOCK OPTION EXERCISE NOTICE
FOR NONQUALIFIED STOCK OPTION GRANTED
TO [Grantees Name] ON [Grant Date]
Additional copies of this Nonqualified Stock Option Exercise Notice (Exercise Notice) (and any
further information you may need about this Exercise Notice or exercising your NSO) are available
from [Third Party Administrator] at the address given below.
By completing this Exercise Notice and returning it to [Third Party Administrator] at the address
given below, I elect to exercise all or a portion of the NSO and to purchase the Shares described
below. Capitalized terms not defined in this Exercise Notice have the same meanings as in the Plan
and applicable Award Agreement.
NOTE: You must complete a separate Exercise Notice for each NSO being exercised (e.g., if
you are simultaneously exercising an NSO to purchase 200 Shares granted on January 1, 2008
and an NSO to purchase 100 Shares granted on January 1, 2009 under a separate award
agreement, you must complete two Exercise Notices, one for each NSO being exercised).
NSO TO BE EXERCISED AND SHARES TO BE PURCHASED: This Exercise Notice relates to the following NSO
and number of Shares (fill in the blanks):
Grant Date of NSO: [Grant Date]
Number of Shares Being Purchased:
EXERCISE PRICE: The aggregate Exercise Price due is $ .
NOTE: This amount must equal the product of [Exercise Price] multiplied by the number of
Shares being purchased.
PAYMENT OF EXERCISE PRICE: I have decided to pay the Exercise Price and any related taxes by (check
one):
NOTE: These methods are described in the applicable Award Agreement.
Cashless Exercise and Sell.
Combination Exercise.
Exercise and Hold.
NOTE:
|
|
|
If you select the Exercise and Hold method, you must follow the procedures
described in the Award Agreement to pay the Exercise Price and the taxes related to
this exercise. You should contact [Third Party Administrator] at the address given
below to find out the amount of taxes due. |
|
|
|
|
If you select either the Cashless Exercise and Sell method or the Combination
Exercise method, you should contact [Third Party Administrator] at the address
given below to be sure you understand how your choice of payment will affect the
number of Shares you will receive. |
YOUR ACKNOWLEDGMENT
By signing below, you acknowledge and agree that:
|
|
|
You fully understand the effect (including the investment effect) of exercising your NSO
and buying Shares and understand that there is no guarantee that the value of these Shares
will appreciate or will not depreciate; |
|
|
|
|
This Exercise Notice will have no effect if it is not returned to [Third Party
Administrator] at the address given below before the NSO expires, as specified in the Award
Agreement under which the NSO was granted; and |
|
|
|
|
The Shares you are buying by completing and returning this Exercise Notice will be
issued to you as soon as administratively practicable. You will not have any rights as a
shareholder of the Company until the Shares are issued. |
[Grantees Name]
A signed copy of this Exercise Notice must be received at the following address no later than the
date the NSO expires, as specified in the Award Agreement under which the NSO was granted:
[Third Party Administrator]
Attention: [TPA Contacts Name]
[TPA Contacts Address]
[TPA Telephone Number]
*****
2
ACKNOWLEDGEMENT OF RECEIPT
A signed copy of the Nonqualified Stock Option Exercise Notice was received on:
Has effectively exercised the portion of the NSO described in this Exercise Notice; or
Has not effectively exercised the portion of the NSO described in this Exercise Notice
because:
The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan Committee
Note: Keep a copy of this Exercise Notice as part of the Plans permanent records.
3
EX-10.T.4
Exhibit 10(t)(4)
THE SCOTTS MIRACLE-GRO COMPANY
2006 LONG-TERM INCENTIVE PLAN
RESTRICTED STOCK AWARD AGREEMENT FOR EMPLOYEES
RESTRICTED STOCK GRANTED
TO [Grantees Name] ON [Grant Date]
The Scotts Miracle-Gro Company (Company) believes that its business interests are best served by
ensuring that you have an opportunity to share in the Companys business success. To this end, the
Company adopted The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (Plan) through which
key employees, like you, may acquire (or share in the appreciation of) common shares, without par
value, of the Company (Shares). Capitalized terms that are not defined in this Award Agreement
have the same meanings as in the Plan.
This Award Agreement describes the type of Award that you have been granted and the terms and
conditions of your Award. To ensure you fully understand these terms and conditions, you should:
- Read the Plan and this Award Agreement carefully; and
- Contact [Title] at [Telephone Number] if you have any questions about your Award. Or, you may
send a written inquiry to the address shown below:
The Scotts Miracle-Gro Company
Attention: [Title]
14111 Scottslawn Road
Marysville, Ohio 43041
Also, no later than [Date 30 Days After Grant Date], you must return a signed copy of this Award
Agreement to:
[Third Party Administrator]
Attention: [TPA Contacts Name]
[TPA Contacts Address]
[TPA Telephone Number]
The Company intends that this Award not be considered to provide for deferred compensation under
Section 409A of the Code and that this Award Agreement be so administered and construed. You agree
that the Company may modify this Award Agreement, without any further consideration, to fulfill
this intent, even if those modifications change the terms of your Award and reduce its value or
potential value.
1. DESCRIPTION OF YOUR RESTRICTED STOCK
You have been granted [Number of Common Shares] Shares of Restricted Stock, subject to the terms
and conditions of the Plan and this Award Agreement. Until the Period of Restriction (as described
below) lapses, your Restricted Stock will be subject to a risk of forfeiture and you may not sell
or transfer your Shares of Restricted Stock. Your Restricted Stock will be held in escrow until it
is distributed or forfeited, as described below.
2. PERIOD OF RESTRICTION
Subject to the terms of the Plan and this Award Agreement (including Section 3), the restrictions
imposed on your Restricted Stock normally will lapse if you are actively employed by the Company or
any Subsidiary or Affiliate on [Vesting Date] (the Vesting Date). If all applicable terms and
conditions have been satisfied, your Restricted Stock will be released from escrow and distributed
to you as soon as administratively practicable, but no later than 60 days, after the Vesting Date.
3. GENERAL TERMS AND CONDITIONS
(a) YOU WILL FORFEIT YOUR RESTRICTED STOCK IF YOU TERMINATE. Normally, your Restricted Stock
will be settled on the Vesting Date. However, the Shares of Restricted Stock will be forfeited if
you Terminate for any reason before the Vesting Date. For purposes of this Award Agreement,
Terminate (or any form thereof) means cessation of the employee-employer relationship between you
and the Company and all Affiliates and Subsidiaries for any reason.
(b) YOU MAY FORFEIT YOUR RESTRICTED STOCK IF YOU ENGAGE IN CONDUCT THAT IS HARMFUL TO THE
COMPANY (OR ANY AFFILIATE OR SUBSIDIARY). You will forfeit any outstanding Restricted Stock and
must return to the Company all Shares and other amounts you have received through the Plan if,
without the Companys written consent, you do any of the following within 180 days before and 730
days after you Terminate:
(i) You serve (or agree to serve) as an officer, director, consultant, manager or
employee of any proprietorship, partnership, corporation or other entity or become the owner
of a business or a member of a partnership, limited liability company or other entity that
competes with any portion of the Companys (or any Affiliates or Subsidiarys) business
with which you have been involved any time within five years before your Termination or
render any service (including, without limitation, advertising or business consulting) to
entities that compete with any portion of the Companys (or any Affiliates or Subsidiarys)
business with which you have been involved any time within five years before your
Termination;
(ii) You refuse or fail to consult with, supply information to or otherwise cooperate
with the Company or any Affiliate or Subsidiary after having been requested to do so;
2
(iii) You deliberately engage in any action that the Company concludes has caused
substantial harm to the interests of the Company or any Affiliate or Subsidiary;
(iv) On your own behalf or on behalf of any other person, partnership, association,
corporation, limited liability company or other entity, you solicit or in any manner attempt
to influence or induce any employee of the Company or any Affiliate or Subsidiary to leave
the Companys or any Affiliates or Subsidiarys employment or use or disclose to any
person, partnership, association, corporation, limited liability company or other entity any
information obtained while an employee of the Company or any Affiliate or Subsidiary
concerning the names and addresses of the Companys or any Affiliates or Subsidiarys
employees;
(v) You disclose confidential and proprietary information relating to the Companys or
any Affiliates or Subsidiarys business affairs (Trade Secrets), including technical
information, product information and formulae, processes, business and marketing plans,
strategies, customer information and other information concerning the Companys or any
Affiliates or Subsidiarys products, promotions, development, financing, expansion plans,
business policies and practices, salaries and benefits and other forms of information
considered by the Company or any Affiliate or Subsidiary to be proprietary and confidential
and in the nature of Trade Secrets;
(vi) You fail to return all property (other than personal property), including keys,
notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes,
disks, cards, surveys, maps, logs, machines, technical data, formulae or any other tangible
property or document and any and all copies, duplicates or reproductions that you have
produced or received or have otherwise been submitted to you in the course of your
employment with the Company or any Affiliate or Subsidiary; or
(vii) You engaged in conduct that the Committee reasonably concludes would have given
rise to a Termination for Cause had it been discovered before you Terminated.
(c) CHANGE IN CONTROL. Normally, your Restricted Stock will vest only under the circumstances
described in Section 2. However, if there is a Change in Control, your Restricted Stock may vest
earlier. You should read the Plan carefully to ensure that you understand how this may happen.
(d) AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or
terminate this Award Agreement or the Plan at any time.
(e) RIGHTS BEFORE YOUR RESTRICTED STOCK VESTS. During the Period of Restriction (even though
your Restricted Stock is held in escrow until it is settled or forfeited):
(i) You may exercise any voting rights associated with the Shares of Restricted Stock
while it is held in escrow.
3
(ii) You will be entitled to receive any dividends paid with respect to the Shares of
Restricted Stock, although these dividends will be held in escrow and subject to the same
restrictions on transferability and forfeitability as the Shares of Restricted Stock with
respect to which they were paid under this Award Agreement. A reasonable rate of interest,
as determined by the Committee in its sole discretion, will be credited to you and held in
escrow during the Period of Restriction with respect to any such cash dividends that are
declared and paid during the period beginning on [Grant Date] and ending on the Vesting
Date. At the end of the Period of Restriction, any such dividends and interest thereon will
be distributed to you in accordance with Section 2 of this Award Agreement or forfeited,
depending on whether or not you have met the conditions described in this Award Agreement
and the Plan.
(f) BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive any
Restricted Stock that is vested before you die but settled after you die. This may be done only on
the attached Beneficiary Designation Form and by following the rules described in that Form. The
Beneficiary Designation Form does not need to be completed now and is not required as a condition
of receiving your Award. However, if you die without completing a Beneficiary Designation Form or
if you do not complete that Form correctly, your beneficiary will be your surviving spouse or, if
you do not have a surviving spouse, your estate.
(g) TRANSFERRING YOUR RESTRICTED STOCK. Normally your Restricted Stock may not be transferred
to another person. However, as described in Section 3(f), you may complete a Beneficiary
Designation Form to name the person to receive any Restricted Stock that is vested before you die
but settled after you die. Also, the Committee may allow you to place your Restricted Stock into a
trust established for your benefit or the benefit of your family. Contact [Third Party
Administrator] at [TPA Telephone Number] or at the address given above if you are interested in
doing this.
(h) GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio,
excluding any conflicts or choice of law rule or principle that might otherwise refer construction
or interpretation of the Plan to the substantive law of another jurisdiction.
(i) OTHER AGREEMENTS. Your Restricted Stock will be subject to the terms of any other written
agreements between you and the Company or any Affiliate or Subsidiary to the extent that those
other agreements do not directly conflict with the terms of the Plan or this Award Agreement.
(j) ADJUSTMENTS TO YOUR RESTRICTED STOCK. Subject to the terms of the Plan, your Restricted
Stock will be adjusted, if appropriate, to reflect any change to the Companys capital structure
(e.g., the number of Shares underlying your Restricted Stock will be adjusted to reflect a stock
split).
(k) OTHER RULES. Your Restricted Stock is subject to more rules described in the Plan. You
should read the Plan carefully to ensure you fully understand all the terms and conditions of the
grant of Restricted Stock under this Award Agreement.
4
4. YOUR ACKNOWLEDGMENT OF AWARD CONDITIONS
By signing below, you acknowledge and agree that:
(a) A copy of the Plan has been made available to you;
(b) You understand and accept the terms and conditions of your Award;
(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees
and without any further consideration) to any necessary change to your Award or this Award
Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even
if those changes affect the terms of your Award and reduce its value or potential value; and
(d) You must return a signed copy of this Award Agreement to the address given above before
[Date 30 Days After Grant Date].
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[Grantees Name] |
|
|
|
THE SCOTTS MIRACLE-GRO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date signed: |
|
|
|
[Name of Company Representative] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[Title of Company Representative] |
|
|
|
|
|
|
|
|
|
|
Date signed: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5
EX-10.T.5
Exhibit 10(t)(5)
THE SCOTTS MIRACLE-GRO COMPANY
2006 LONG-TERM INCENTIVE PLAN
PERFORMANCE SHARE AWARD AGREEMENT FOR EMPLOYEES
(WITH RELATED DIVIDEND EQUIVALENTS)
PERFORMANCE SHARES GRANTED
TO [Grantees Name] ON [Grant Date]
The Scotts Miracle-Gro Company (Company) believes that its business interests are best served by
ensuring that you have an opportunity to share in the Companys business success. To this end, the
Company adopted The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (Plan) through which
key employees, like you, may acquire (or share in the appreciation of) common shares, without par
value, of the Company (Shares). Capitalized terms that are not defined in this Award Agreement
have the same meanings as in the Plan.
This Award Agreement describes the type of Award that you have been granted and the terms and
conditions of your Award. To ensure you fully understand these terms and conditions, you should:
- Read the Plan and this Award Agreement carefully; and
- Contact [Title] at [Telephone Number] if you have any questions about your Award. Or, you may
send a written inquiry to the address shown below:
The Scotts Miracle-Gro Company
Attention: [Title]
14111 Scottslawn Road
Marysville, Ohio 43041
Also, no later than [Date 30 Days After Grant Date], you must return a signed copy of this Award
Agreement to:
[Third Party Administrator]
Attention: [TPA Contacts Name]
[TPA Contacts Address]
[TPA Telephone Number]
The Company intends that this Award not be considered to provide for deferred compensation under
Section 409A of the Code and that this Award Agreement be so administered and construed. You agree
that the Company may modify this Award Agreement, without any further consideration, to fulfill
this intent, even if those modifications change the terms of your Award and reduce its value or
potential value.
1. DESCRIPTION OF YOUR AWARD
You have been granted the right to receive up to [Number of Common Shares] Performance Shares and
an equal number of related dividend equivalents, subject to the terms and conditions of the Plan
and this Award Agreement. Each whole Performance Share represents the right to receive one full
Share at the time and in the manner described in this Award Agreement. Each dividend equivalent
represents the right to receive a cash amount and/or additional Performance Shares (determined in
accordance with Section 4(e)(ii)) in respect of the dividends that are declared and paid during the
Performance Period (as described in Section 2) with respect to the Share represented by the related
Performance Share.
2. PERFORMANCE PERIOD AND SETTLEMENT
(a) The Performance Period is the period beginning on [Grant Date] and ending on [Vesting
Date] (the Vesting Date).
(b) As soon as practicable following the Vesting Date, the Committee will ascertain whether
any of the performance goals (as described in Section 3) were satisfied during the Performance
Period and the extent to which such performance goals have been satisfied. If none of the
performance goals were satisfied during the Performance Period, all of your Performance Shares will
be forfeited. If one or more of the performance goals were satisfied during the Performance
Period:
(i) The Committee will ascertain the number of Performance Shares which you earned (and
which have become vested) over the Performance Period, to be determined as a function of the
extent to which the corresponding performance goals have been achieved; and
(ii) Within 60 days after the Vesting Date, the Company will distribute to you (A) a
number of full Shares equal to the number of whole Performance Shares that became vested on
the Vesting Date and (B) a cash amount for any fractional Performance Share that became
vested on the Vesting Date, determined based upon the Fair Market Value of a Share on the
Vesting Date; provided, however, that, if you have made a valid deferral election under a
nonqualified deferred compensation plan maintained by the Company or any Affiliate or
Subsidiary (NQDC Plan) with respect to some or all of your Performance Shares, such
Performance Shares shall not be settled under this Section 2(b)(ii), but instead shall be
settled in accordance with the terms and conditions of the NQDC Plan.
(c) There are some special situations in which your Performance Shares may vest earlier.
These are described in Section 4(c) of this Award Agreement.
3. PERFORMANCE GOALS
The performance goals established by the Committee with respect to the Performance Shares are
detailed in Attachment A.
2
4. GENERAL TERMS AND CONDITIONS
(a) YOU WILL FORFEIT YOUR PERFORMANCE SHARES IF YOU TERMINATE BEFORE THE END OF THE
PERFORMANCE PERIOD. Except as provided in Section 4(c), your Performance Shares will be forfeited
if you Terminate for any reason (including retirement) before the Vesting Date. For purposes of
this Award Agreement, Terminate (or any form thereof) means cessation of the employee-employer
relationship between you and the Company and all Affiliates and Subsidiaries for any reason.
(b) YOU MAY FORFEIT YOUR PERFORMANCE SHARES IF YOU ENGAGE IN CONDUCT THAT IS HARMFUL TO THE
COMPANY (OR ANY AFFILIATE OR SUBSIDIARY). You will forfeit any outstanding Performance Shares and
must return to the Company all Shares and other amounts you have received through the Plan if,
without the Companys written consent, you do any of the following within 180 days before and 730
days after you Terminate:
(i) You serve (or agree to serve) as an officer, director, consultant, manager or
employee of any proprietorship, partnership, corporation or other entity or become the owner
of a business or a member of a partnership, limited liability company or other entity that
competes with any portion of the Companys (or any Affiliates or Subsidiarys) business
with which you have been involved any time within five years before your Termination or
render any service (including, without limitation, advertising or business consulting) to
entities that compete with any portion of the Companys (or any Affiliates or Subsidiarys)
business with which you have been involved any time within five years before your
Termination;
(ii) You refuse or fail to consult with, supply information to or otherwise cooperate
with the Company or any Affiliate or Subsidiary after having been requested to do so;
(iii) You deliberately engage in any action that the Company concludes has caused
substantial harm to the interests of the Company or any Affiliate or Subsidiary;
(iv) On your own behalf or on behalf of any other person, partnership, association,
corporation, limited liability company or other entity, you solicit or in any manner attempt
to influence or induce any employee of the Company or any Affiliate or Subsidiary to leave
the Companys or any Affiliates or Subsidiarys employment or use or disclose to any
person, partnership, association, corporation, limited liability company or other entity any
information obtained while an employee of the Company or any Affiliate or Subsidiary
concerning the names and addresses of the Companys or any Affiliates or Subsidiarys
employees;
(v) You disclose confidential and proprietary information relating to the Companys or
any Affiliates or Subsidiarys business affairs (Trade Secrets), including technical
information, product information and formulae, processes, business and marketing plans,
strategies, customer information and other information concerning the Companys or any
Affiliates or Subsidiarys products, promotions, development,
3
financing, expansion plans, business policies and practices, salaries and benefits and
other forms of information considered by the Company or any Affiliate or Subsidiary to be
proprietary and confidential and in the nature of Trade Secrets;
(vi) You fail to return all property (other than personal property), including keys,
notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes,
disks, cards, surveys, maps, logs, machines, technical data, formulae or any other tangible
property or document and any and all copies, duplicates or reproductions that you have
produced or received or have otherwise been submitted to you in the course of your
employment with the Company or any Affiliate or Subsidiary; or
(vii) You engaged in conduct that the Committee reasonably concludes would have given
rise to a Termination for Cause had it been discovered before you Terminated.
(c) CHANGE IN CONTROL. Normally, your Performance Shares will vest only in the circumstances
described in Section 2 above. However, if there is a Change in Control, your Performance Shares
may vest earlier. You should read the Plan carefully to ensure that you understand how this may
happen.
(d) AMENDMENT AND TERMINATION. Subject to the terms of the Plan, the Company may amend or
terminate this Award Agreement or the Plan at any time.
(e) RIGHTS BEFORE YOUR PERFORMANCE SHARES VEST.
(i) Except as provided in Section 4(e)(ii) below, you will have none of the rights of a
shareholder with respect to Shares underlying the Performance Shares unless and until you
become the record holder of such Shares.
(ii) With respect to each dividend equivalent:
(A) If a cash dividend is declared and paid on the Shares underlying the
Performance Shares, you will be credited with a cash amount equal to the product of
(I) the number of Performance Shares granted under this Award Agreement that have
not been settled or forfeited as of the dividend payment date, multiplied by (II)
the amount of the cash dividend paid per Share. Also, a reasonable rate of
interest, as determined by the Committee in its sole discretion, will be credited
during the Performance Period with respect to any cash amount so credited during the
period beginning on [Grant Date] and ending on the Vesting Date. Such cash amount
and interest thereon shall be subject to the same terms and conditions as the
related Performance Shares and shall be settled in cash if, when and to the extent
the related Performance Shares are settled.
(B) If a Share dividend is declared and paid on the Shares underlying the
Performance Shares, you will receive an additional number of Performance Shares
equal to the product of (I) the number of Performance Shares granted under this
Award Agreement (including additional Performance Shares previously received in
accordance with this Section 4(e)(ii)(B)) that have not been settled or
4
forfeited as of the dividend payment date, multiplied by (II) the dividend paid
per Share. Such amount shall be subject to the same terms and conditions as the
related Performance Shares and shall be settled in Shares if, when and to the extent
the related Performance Shares are settled, rounded down to the nearest whole Share.
(C) In the event a Performance Share is forfeited under this Award Agreement,
the related dividend equivalent, plus any applicable interest, will also be
forfeited.
(f) BENEFICIARY DESIGNATION. You may name a beneficiary or beneficiaries to receive any
Performance Shares and related dividend equivalents that vest before you die but are settled after
you die. This may be done only on the attached Beneficiary Designation Form and by following the
rules described in that Form. The Beneficiary Designation Form does not need to be completed now
and is not required as a condition of receiving your Award. However, if you die without
completing a Beneficiary Designation Form or if you do not complete that Form correctly, your
beneficiary will be your surviving spouse or, if you do not have a surviving spouse, your estate.
(g) TRANSFERRING YOUR PERFORMANCE SHARES AND RELATED DIVIDEND EQUIVALENTS. Normally, your
Performance Shares and the related dividend equivalents may not be transferred to another person.
However, as described in Section 4(f), you may complete a Beneficiary Designation Form to name the
person to receive any Performance Shares and related dividend equivalents that vest before you die
but are settled after you die. Also, the Committee may allow you to place your Performance Shares
and related dividend equivalents into a trust established for your benefit or the benefit of your
family. Contact [Third Party Administrator] at [TPA Telephone Number] or at the address given
above if you are interested in doing this.
(h) GOVERNING LAW. This Award Agreement shall be governed by the laws of the State of Ohio,
excluding any conflicts or choice of law rule or principle that might otherwise refer construction
or interpretation of the Plan to the substantive law of another jurisdiction.
(i) OTHER AGREEMENTS. Your Performance Shares and the related dividend equivalents will be
subject to the terms of any other written agreements between you and the Company or any Affiliate
or Subsidiary to the extent that those other agreements do not directly conflict with the terms of
the Plan or this Award Agreement.
(j) ADJUSTMENTS TO YOUR PERFORMANCE SHARES. Subject to the terms of the Plan, your
Performance Shares will be adjusted, if appropriate, to reflect any change to the Companys capital
structure (e.g., the number of your Performance Shares will be adjusted to reflect a stock split).
(k) OTHER RULES. Your Performance Shares and the related dividend equivalents are subject to
more rules described in the Plan. You should read the Plan carefully to ensure you fully
understand all the terms and conditions of the grant of Performance Shares and the related dividend
equivalents made to you under this Award Agreement.
5
5. YOUR ACKNOWLEDGMENT OF AWARD CONDITIONS
By signing below, you acknowledge and agree that:
(a) A copy of the Plan has been made available to you;
(b) You understand and accept the terms and conditions of your Award;
(c) You will consent (on your own behalf and on behalf of your beneficiaries and transferees
and without any further consideration) to any necessary change to your Award or this Award
Agreement to comply with any law and to avoid paying penalties under Section 409A of the Code, even
if those changes affect the terms of your Award and reduce its value or potential value; and
(d) You must return a signed copy of this Award Agreement to the address given above before
[Date 30 Days After Grant Date].
* * * * *
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[Grantees Name] |
|
|
|
THE SCOTTS MIRACLE-GRO COMPANY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date signed: |
|
|
|
[Name of Company Representative] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[Title of Company Representative] |
|
|
|
|
|
|
|
|
|
|
Date signed: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6
ATTACHMENT A
[Insert Performance Goals]
EX-10(DD)
Exhibit 10(dd)
Summary of Compensation for Directors of The Scotts Miracle-Gro Company
Annual Retainer; Reimbursement of Expenses
Each director of The Scotts Miracle-Gro Company (Scotts Miracle-Gro) who is not an employee of
Scotts Miracle-Gro or its subsidiaries (a non-employee director) receives a $40,000 annual
retainer for Scotts Miracle-Gro Board of Directors and Board committee meetings. Each member of the
Audit Committee of Scotts Miracle-Gros Board of Directors receives an additional $5,000 annually.
Annual retainers are pro-rated if a non-employee director is appointed by the Board of Directors
during the year. Non-employee directors receive reimbursement of all reasonable travel and other
expenses of attending Scotts Miracle-Gro Board of Directors and Board committee meetings.
Stock Units
Prior to January 26, 2006, non-employee directors were able to elect under The Scotts Miracle-Gro
Company 1996 Stock Option Plan (now known as The Scotts Miracle-Gro Company Amended and Restated
1996 Stock Option Plan) (the 1996 Plan) and The Scotts Miracle-Gro Company 2003 Stock Option and
Incentive Equity Plan (now known as The Scotts Miracle-Gro Company Amended and Restated 2003 Stock
Option and Incentive Equity Plan) (the 2003 Plan), to receive all or a portion, in 25%
increments, of their annual cash retainer in cash or in stock units. If stock units were elected,
the non-employee director received a number of stock units determined by dividing the chosen dollar
amount by the closing price of Scotts Miracle-Gros common shares on the New York Stock Exchange
(NYSE) on the first trading day following the date of the annual meeting of shareholders of
Scotts Miracle-Gro for which the deferred value of the annual cash retainer otherwise would have
been paid. The terms of the stock units and their settlement are set forth in the 1996 Plan and the
2003 Plan, as applicable.
Following
the approval of The Scotts Miracle-Gro Company 2006 Long-Term Incentive Plan (now known
as The Scotts Miracle-Gro Company Amended and Restated 2006 Long-Term Incentive Plan) (the 2006
Plan) by the shareholders of Scotts Miracle-Gro on
January 26, 2006, the non-employee directors have had the opportunity to elect, under the 2006 Plan, to receive all
or a portion (in 25% increments) of their 2007 and 2006 annual cash retainer in cash or in stock
units. If stock units were elected, the non-employee director received a number of stock units
determined by dividing the chosen dollar amount by the closing price of Scotts Miracle-Gros common
shares on NYSE on the first trading day following the date of the annual meeting of shareholders of
Scotts Miracle-Gro for which the deferred value of the annual cash retainer otherwise would have
been paid. Final distributions in respect of stock units are to be made in cash or common shares,
as elected by the non-employee director, upon the date that the non-employee director ceases to be
a member of the Scotts Miracle-Gro Board of Directors, upon the date the non-employee director has
specified in his or her deferral form or upon a change in control (as defined in the 2006 Plan),
whichever is earliest. If stock units are to be settled in cash, the amount distributed will be
calculated by multiplying the number of stock units to be settled in cash by the fair market value
of Scotts Miracle-Gros common shares. If stock units are to be settled in common shares, the
number of common shares distributed will equal the whole number of stock units to be settled in
common shares, with the fair market value of any fractional stock units distributed in cash.
Distributions may be made either in a lump sum or in installments over a period of up to ten years,
as elected by the non-employee director. However, upon a change in control, each outstanding stock
unit held by a non-employee director will be settled for a lump sum cash payment equal to the
change in control price per common share.
Non-Qualified Stock Options
Prior to January 26, 2006, individuals then serving as non-employee directors automatically
received an annual grant, on the first business day following the date of each annual meeting of
shareholders of Scotts Miracle-Gro, of non-qualified stock options (NSOs) to purchase 10,000
common shares at an exercise price equal to the fair market value of the Scotts Miracle-Gro common
shares on the grant date. Non-employee directors who were members of one or more committees of the
Scotts Miracle-Gro Board of Directors received NSOs to purchase an additional 1,000 common shares
for each committee on which they served. Additionally, non-employee directors who chaired a
committee received NSOs to purchase an additional 2,000 common shares for each committee they
chaired. These NSOs were granted under the 1996 Plan or the 2003 Plan. Since the approval of the
2006 Plan, no further automatic grants have been or will be made under the 1996 Plan or the 2003
Plan.
Grants of NSOs to directors under the 2006 Plan are discretionary. On January 26, 2007, consistent
with the automatic grants which had previously been
made under the 1996 Plan and the 2003 Plan, each of the individuals then serving as a non-employee
director of Scotts Miracle-Gro received a grant of NSOs to purchase 10,000 common shares of Scotts
Miracle-Gro. Non-employee directors who were members of one or more committees of the Board of
Directors received NSOs to purchase an additional 1,000 common shares for each committee on which
they served. Additionally, non-employee directors who chaired a committee received NSOs to purchase
an additional 2,000 common shares for each committee they chaired. Each of the NSOs granted on
January 26, 2007 has an exercise price $53.15, the closing price of Scotts
Miracle-Gros common shares on NYSE on the grant date. The NSOs granted to the non-employee
directors then serving on January 26, 2007 will vest and become exercisable on January 26, 2008.
Once vested, NSOs remain exercisable until the earlier to occur of the tenth anniversary of the
grant date or the first anniversary of the date the non-employee director ceases to be a member of
Scotts Miracle-Gros Board of Directors. However, if the non-employee director ceases to be a
member of the Scotts Miracle-Gro Board of Directors after having been convicted of, or pled guilty
or nolo contendere to, a felony, his or her NSOs will be cancelled on the date he or she ceases to
be a director. If the non-employee director ceases to be a member of the Scotts Miracle-Gro Board
of Directors after having retired after serving at least one full term, his or her NSOs will remain
exercisable for a period of five years following retirement subject to the stated terms of the
NSOs.
Upon a change in control of Scotts Miracle-Gro, each non-employee directors outstanding NSOs
granted under the 2003 Plan or the 2006 Plan will be cancelled, unless (a) Scotts Miracle-Gros
common shares remain publicly traded, (b) the non-employee director remains a director of Scotts
Miracle-Gro after the change in control or (c) the non-employee director exercises, with the
permission of the Compensation and Organization Committee (in the case of NSOs granted under the
2003 Plan) or the Board of Directors (in the case of NSOs granted under the 2006 Plan), the
non-employee directors outstanding NSOs within 15 days of the date of the change in control. In addition, each
non-employee directors outstanding NSOs granted under the 1996 Plan will be cancelled unless the
non-employee director exercises, with the permission of the Compensation and Organization
Committee, the non-employee directors outstanding NSOs within 15 days of the date of the change in
control. For each cancelled NSO, a non-employee director will receive cash in the amount of, or
common shares having a value equal to, the difference between the change in control price per
common share and the exercise price per common share associated with the cancelled NSO.
EX-21
EXHIBIT
21
SUBSIDIARIES OF THE SCOTTS MIRACLE-GRO COMPANY
|
Gutwein & Co., Inc., an Indiana corporation |
SMG Brands, Inc., a Delaware corporation |
SMG Growing Media, Inc., an Ohio corporation |
Rod McLellan Company, a California corporation |
SMGM LLC, an Ohio limited liability company
|
The Scotts Company LLC, an Ohio limited liability company |
EG Systems, Inc., dba Scotts LawnService, an Indiana corporation |
Hyponex Corporation, a Delaware corporation |
OMS Investments, Inc., a Delaware corporation |
Scotts Temecula Operations, LLC, a Delaware limited liability company |
Sanford Scientific, Inc., a New York corporation |
Scotts Global Services, Inc., an Ohio corporation |
Scotts Manufacturing Company, a Delaware corporation |
Miracle-Gro Lawn Products, Inc., a New York corporation |
Scotts Products Co., an Ohio corporation |
Scotts Servicios, S.A. de C.V. (Mexico)1 |
Scotts Professional Products Co., an Ohio corporation |
Scotts Servicios, S.A. de C.V. (Mexico)2 |
Scotts-Sierra Horticultural Products Company, a California corporation |
Scotts-Sierra Crop Protection Company, a California corporation
|
Scotts-Sierra Investments, Inc., a Delaware corporation |
ASEF BV (Netherlands) |
Scotts Australia Pty Ltd. (Australia) |
Scotts Benelux BVBA (Belgium)3 |
Scotts Canada Ltd. (Canada) |
Scotts Czech s.r.o. (Czech Republic) |
Scotts de Mexico SA de CV (Mexico) |
Scotts France Holdings SARL (France) |
Scotts France SARL (France)4
|
Scotts France SAS (France)5 |
Scotts Holding GmbH (Germany) |
Scotts Celaflor GmbH & Co. KG (Germany)
|
Scotts Celaflor HGmbH (Austria) |
Scotts Holdings Limited (United Kingdom) |
Levington Group Ltd. (United Kingdom) |
The Scotts Company (UK) Ltd. (United Kingdom) |
The Scotts Company (Manufacturing) Ltd. (United Kingdom) |
|
|
|
1 |
|
Not wholly-owned, Scotts Professional
Products Co. owns 50% |
|
2 |
|
Not wholly-owned, Scotts Products Co. owns
50% |
|
3 |
|
Not wholly-owned, OMS Investments, Inc. owns .01% |
|
4 |
|
Not wholly-owned, Scotts Holdings Ltd. owns .01% |
|
5 |
|
Not wholly-owned, Scotts France SARL owns .01% |
|
OM Scott International Investments Ltd. (United Kingdom) |
Corwen Home and Garden Limited (United Kingdom)
|
Scotts International B.V. (Netherlands) |
Scotts Deutschland GmbH (Germany)
|
Scott O.M. España, S.A. (Spain) |
Scotts Italia S.r.l. (Italy)6 |
Scotts Horticulture Ltd. (Ireland) |
Scotts Hungary KFT (Hungary)7 |
Scotts PBG Malaysia Sdn. Bhd. (Malaysia) |
Scotts Poland Sp.z.o.o. (Poland) |
Scotts Sweden AB (Sweden) |
The Scotts Company (Nordic) A/S (Denmark) |
The Scotts Company Italia S.r.l. (Italy) |
The Scotts Company Kenya Ltd. (Kenya) |
Turf-Seed Europe (Ireland)8 |
Smith & Hawken, Ltd., a Delaware corporation
|
Swiss Farms Products, Inc., a Delaware corporation |
|
|
|
6 |
|
Not wholly-owned, James Hagedorn owns .05% |
|
7 |
|
Not wholly-owned, OMS Investments, Inc. owns
3% |
|
8 |
|
Not wholly-owned, Owned 51% by Tempoverde,
Srl. |
EX-23
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (No.
333-98239) and the Registration Statements on Form S-8 (File Nos. 033-47073, 333-06061, 333-27561,
333-72715, 333-76697, 333-104490, 333-124503, 333-131466 and 333-147397) of our reports dated November 29, 2007
relating to the financial statements (which report expressed an unqualified opinion and includes an explanatory paragraph relating to
the Companys adoption of Statement of Financial Accounting Standards No. 158, Employers
Accounting for Defined Benefit Pension and Other Postretirement Plans on September 30,
2007), and financial statement schedules of The
Scotts Miracle-Gro Company, and the effectiveness of The Scotts Miracle-Gro Companys internal
control over financial reporting, appearing in this Annual Report on Form 10-K of The Scotts
Miracle-Gro Company for the year ended September 30, 2007.
/s/ Deloitte & Touche LLP
Columbus, Ohio
November 29, 2007
EX-24
Exhibit 24
POWER OF ATTORNEY
The undersigned officer and director of The Scotts Miracle-Gro Company, an Ohio corporation
(the Corporation), which anticipates filing with the Securities and Exchange Commission,
Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the
Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby
constitutes and appoints David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ James Hagedorn
|
|
|
James Hagedorn |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Mark R. Baker
|
|
|
Mark R. Baker |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Gordon F. Brunner
|
|
|
Gordon F. Brunner |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Arnold W. Donald
|
|
|
Arnold W. Donald |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Joseph P. Flannery
|
|
|
Joseph P. Flannery |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Thomas N. Kelly Jr.
|
|
|
Thomas N. Kelly Jr. |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Katherine Hagedorn Littlefield
|
|
|
Katherine Hagedorn Littlefield |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Karen G. Mills
|
|
|
Karen G. Mills |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Nancy G. Mistretta
|
|
|
Nancy G. Mistretta |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Patrick J. Norton
|
|
|
Patrick J. Norton |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ Stephanie M. Shern
|
|
|
Stephanie M. Shern |
|
|
|
|
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn, David C. Evans and Vincent C. Brockman, and each of them, with full power
of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in
any and all capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any
and all applications or documents to be filed with the Securities and Exchange Commission
pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may
approve, and to file the same, with all exhibits thereto and other documents in connection
therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact
and agent full power and authority to do and perform any and all acts and things whatsoever
required and necessary to be done in the premises, as fully to all intents and purposes as the
undersigned could do if personally present. The undersigned hereby ratifies and confirms all that
each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to
be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 8th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ John S. Shiely
|
|
|
John S. Shiely |
|
|
|
|
POWER OF ATTORNEY
The undersigned officer of The Scotts Miracle-Gro Company, an Ohio corporation (the
Corporation), which anticipates filing with the Securities and Exchange Commission, Washington,
D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of
the Corporation on Form 10-K for the fiscal year ended September 30, 2007, hereby constitutes and
appoints James Hagedorn and Vincent C. Brockman, and each of them, with full power of substitution
and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all
capacities, such Annual Report on Form 10-K and any and all amendments thereto, and any and all
applications or documents to be filed with the Securities and Exchange Commission pertaining to
such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to
file the same, with all exhibits thereto and other documents in connection therewith with the
Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power
and authority to do and perform any and all acts and things whatsoever required and necessary to be
done in the premises, as fully to all intents and purposes as he could do if personally present.
The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his
substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 9th day
of November, 2007.
|
|
|
|
|
|
|
|
|
/s/ David C. Evans
|
|
|
David C. Evans |
|
|
|
|
|
EX-31(A)
Exhibit 31(a)
Rule 13a-14(a)/15d-14(a) Certification
(Principal Executive Officer)
I, James Hagedorn, certify that:
|
1. |
|
I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the
fiscal year ended September 30, 2007; |
|
|
2. |
|
Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the
period covered by this report; |
|
|
3. |
|
Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report; |
|
|
4. |
|
The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a. |
|
Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in which this report is
being prepared; |
|
|
b. |
|
Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted
accounting principles; |
|
|
c. |
|
Evaluated the effectiveness of the registrants disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and |
|
|
d. |
|
Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and |
|
5. |
|
The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and
the audit committee of the registrants board of directors (or persons performing the
equivalent functions): |
|
a. |
|
All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
and |
|
|
b. |
|
Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting. |
|
|
|
|
|
|
|
Dated: November 29, 2007
|
|
By:
|
/s/ James Hagedorn |
|
|
|
|
|
|
|
Printed Name:
|
James Hagedorn
|
|
|
|
Title:
|
President, Chief Executive Officer and Chairman of the Board |
|
|
EX-31(B)
Exhibit 31(b)
Rule 13a-14(a)/15d-14(a) Certification
(Principal Financial Officer)
I, David C. Evans, certify that:
|
1. |
|
I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the
fiscal year ended September 30, 2007; |
|
|
2. |
|
Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the
period covered by this report; |
|
|
3. |
|
Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report; |
|
|
4. |
|
The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a. |
|
Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in which this report is
being prepared; |
|
|
b. |
|
Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted
accounting principles; |
|
|
c. |
|
Evaluated the effectiveness of the registrants disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and |
|
|
d. |
|
Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and |
|
5. |
|
The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and
the audit committee of the registrants board of directors (or persons performing the
equivalent functions): |
|
a. |
|
All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
and |
|
|
b. |
|
Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting. |
|
|
|
|
|
Dated: November 29, 2007
|
|
By:
|
|
/s/ David C. Evans |
|
|
|
|
|
|
|
Printed Name: David C. Evans
|
|
|
Title:
|
|
Executive Vice President and Chief Financial Officer |
EX-32
Exhibit 32
SECTION 1350 CERTIFICATION*
In connection with the Annual Report of The Scotts Miracle-Gro Company (the Company) on Form 10-K
for the fiscal year ended September 30, 2007 as filed with the Securities and Exchange Commission
on the date hereof (the Report), the undersigned James Hagedorn, President, Chief Executive
Officer and Chairman of the Board of the Company, and David C. Evans, Executive Vice President and
Chief Financial Officer of the Company, certify, pursuant to Section 1350 of Chapter 63 of Title 18
of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to the best of their knowledge:
|
1) |
|
The Report fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934, as amended; and |
|
|
2) |
|
The information contained in the Report fairly presents, in all material respects, the
consolidated financial condition and results of operations of the Company and its
subsidiaries. |
|
|
|
/s/ James Hagedorn
|
|
/s/ David C. Evans |
|
|
|
James Hagedorn
|
|
David C. Evans |
President, Chief Executive Officer
|
|
Executive Vice President |
and Chairman of the Board
|
|
and Chief Financial Officer |
|
|
|
November 29, 2007
|
|
November 29, 2007 |
|
|
|
* |
|
THIS CERTIFICATION IS BEING FURNISHED AS REQUIRED BY RULE 13a-14(b) UNDER THE SECURITIES
EXCHANGE ACT OF 1934, AS AMENDED (THE EXCHANGE ACT), AND SECTION 1350 OF CHAPTER 63 OF TITLE
18 OF THE UNITED STATES CODE, AND SHALL NOT BE DEEMED FILED FOR PURPOSES OF SECTION 18 OF
THE EXCHANGE ACT OR OTHERWISE SUBJECT TO THE LIABILITY OF THAT SECTION. THIS CERTIFICATION
SHALL NOT BE DEEMED TO BE INCORPORATED BY REFERENCE INTO ANY FILING UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, OR THE EXCHANGE ACT, EXCEPT TO THE EXTENT THAT THE COMPANY SPECIFICALLY
INCORPORATES THIS CERTIFICATION BY REFERENCE. |